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1. Introduction 
1.1. Basic requirement for culture medium 
1.1.1. Nutritional components 
Cells need the basic nutritional conditions to grow in vitro, including: 
1. Amino acid 
Amino acid is the raw material for the cell to synthesize protein. All the cells need twelve 
essential amino-acids: arginine, cystine, isoleucine, leucine, lysine, methionine, 
phenylalanine, threonine, tryptophan, histidine, tyrosine and valine, which are L-amino 
acids. Furthermore, glutamine is another component playing important role in the cell 
metabolism process. The nitrogen contained in glutamine is not only the source of purine 
and pyrimidine of nucleic acid, but also the essential material for the synthesis of the Tri-, bi-, 
mono-phosphate acid glycosides. 
2. Monosaccharide 
Cultured cells use aerobic glycolysis and anaerobic glycolysis of hexose as main energy 
source. In addition, hexose is used for the synthesis of some amino acid, fat and nucleic acid. 
Cell absorptive capacity varies among different monosaccharides, with the highest for 
glucose and the lowest for galactose. 
3. Vitamin 
Vitamins mainly act as coenzymes or prothetic groups in cell metabolism processes. Biotin, 
folate, nicotinamide, pantothenic acid, pyridoxine, riboflavin, thiamine and vitamin B12 are 
common component in culture medium. 
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4. Inorganic ion and trace element 
Besides some basic elements (including sodium, potassium, calcium, magnesium, nitrogen 
and phosphorus), cell growth needs some trace elements, such as molybdenum, vanadium, 
iron, zinc and selenium, copper, manganese. 
1.2. Somatomedin and hormones 
Cells grown in vivo are always regulated by somatomedin and hormones. Many researches 
demonstrate that various somatomedin and hormones are very important to maintain cell 
function and status (differentiated or undifferentiated). Some hormones have promoting 
growth effects on different cell typs. For instance, insulin can promote the use of glucose 
and amino acids in the cell. Some hormones are cell-type specific, as hydrocortisone that can 
promote the growth of epidermal cells and prolaction that induces the proliferation of 
mammary epithelial cell. 
1.3. Osmotic pressure 
Cells need an isotonic environment and human plasma osmotic pressure is about 290 
mOsm/kg, which is thought to be ideal osmotic pressure to culture human cells. Mouse 
plasma osmotic pressure is about 320 mOsm/kg. Osmotic pressure of 260-320 mOsm/kg fits 
for most mammalian cells.  
1.4. pH 
The suitable pH for most cells is 7.2-7.4; otherwise it will produce harmful effects. The 
culture medium should have some buffer capacity. The main substance causing pH changes 
is CO2 produced in cell metabolism process. In an airtight environment, CO2 can combine 
H2O2 to produce carbonic acid and thus reduce the pH value of the medium. Synthesized 
medium employs NaHCO3-CO2 buffer system to solve this problem. In the buffer system, 
the boost in [H+] increases the reaction rate H+ + salt => weak acid and takes some H+ out of 
circulation. It is based on the constant equilibrium. 
2 2 2NaHCO3  H O Na HO  H O  CO
+ −+ ←→ + + + ↑  
2. Natural medium 
Natural medium is described as animal body fluids or medium of tissue extraction, 
including plasma, serum, lymph, chicken embryos leaching solution. Natural medium 
contains rich nutrients, various somatomedin and hormones, similar osmotic pressure and 
pH to body environment. As this medium has a very complicated production process and 
big batch-to-batch variation, the medium is gradually replaced by the synthetic medium. 
Today, serum is still the widely used natural medium. 
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2.1. Serum 
2.1.1. Types of serum 
Serum can derive from different animals. Current serum used in tissue culture is cattle 
serum. Human serum, horse serum is used for some specific cells. Cattle serum has several 
advantages as used in cell culture: adequate resource, mature preparation technique, long 
application time. 
Cattle serum includes bovine calf serum, newborn calf serum and fetal bovine serum. Take 
sample for cattle serum from Gibco Life Technologies Company, fetal bovine serum derives 
from caesarean section fetal bovine; newborn calf serum comes from newborn calf born 
within 24h; bovine calf serum comes from calf with 10 to 30 days. Fetal bovine serum has 
highest quality because the fetal bovine doesn’t expose to outside environment and has 
lowest antibodies and complement. 
2.1.2. Main components of serum and its function 
Serum is made from plasma by removing hemaleucin and contains various plasma protein, 
polypeptide, fat, carbohydrate, growth factor, hormones and inorganic mineral, etc. All 
these substances keep the physiological balance of promoting or inhibiting cell growth. The 
following table shows the main components of serum and their mean concentration. 
 
Component Mean concentration Component 
Mean 
concentration 
Na+ 137mol/L Alkaline phosphomonoesterase 225U/L 
K+ 11 mol/L Lactic dehydrogenase 860U/L 
Cl- 103 mol/L Insulin 0.4μg/L 
SeO32- 26μg/L Thyroid stimulator 1.2μg/L 
Ca2+ 136mg/L Folliclestimulating hormone 9.5μg/L 
Fibonectin 35 mg/L Bovine somatotropin 39μg/L 
Urea acid 29 mg/L Prolactin 17μg/L 
Creatine 31mg/L T3 1.2μg/L 
Hemoglobin 113 mg/L Cholesterol 310μg/L 
Bilirubin(total) 4 mg/L Cortisone 0.5μg/L 
Inorganic 
phosphorus 
100mg/L Testosterone 0.4μg/L 
Glucose 1250mg/L Progesterone 80μg/L 
Urea 160mg/L Prostaglandin E 6μg/L 
Total protein 38g/L Prostaglandin F 12μg/L 
Albumin 23g/L Vitamin A 90μg/L 
α2- macroglobulin 3g/L Vitamin E 1 mg/L 
Endotoxin 0.35μg/L Fe2+,Zn2+, Cu2+,Mn2+,Co2+, Co3-,etc μg/L to ng/L 
Table 1. The main components of serum and their mean concentration. 
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The main function of serum is listed as follow: 
a. Provide essential nutrients 
Serum contains various amino acids, vitamins, inorganic minerals, fat, and nucleic acid 
derivatives, which are essential nutrients for cell growth. 
b. Provide adherence and extension factor 
Many cells cultured in vitro have to attach the culture vessel to grow, which is dependent on 
extracellular matrix. Cells can secrete extracellular matrix in vivo, but this ability will 
decrease or even disappear according to the increment of passages. Serum contains some 
components, (fibronection, laminin, etc), which can promote cell adherence. 
c. Provide hormone and various growth factors 
Serum contains various hormones, such as insulin, adrenocortical hormone (hydrocortisone, 
dexamethasone), steroid hormone (estradiol, testosterone, and progesterone), etc. The 
growth factors include fibroblast growth factor (FGF), epidermal growth factor (EGF), 
pleteletdericed growth factor (PDGF), and others. 
d. Provide binding protein(s) 
The binding proteins carry low molecular weight material. For example, the albumin carries 
vitamins, fat (fatty acid, cholesterol) and hormones. Transferrin carries iron. 
e. Provide protection for some specific cells 
Some cells (such as epithelial cells, myeloid cells) can release protease, which can be 
neutralized by the anti-protease ingredient in the serum. Serum is widely used to terminate 
the effect of the trypsin. Serum albumin facilitates the serum viscosity and protects the cell 
from mechanical damage, especially in the suspension cell culture. The   trace elements and 
ions, such as SeO3 and Selenium, play very important role in metabolic detoxification 
2.1.3. Disadvantages of using serum in tissue culture 
The composition of serum is complicated, including favorable components and 
unavoidable harmful ingredient. The disadvantages of using serum in tissue culture are 
listed as follow.  
a. For most cells, serum is not physiological fluid in vivo. Cells only contact serum during 
the injury healing or blood coagulation. Thus the utilization of serum may change the 
normal condition of some cell. Serum may promote the growth of some cell (such as 
fibroblast) and inhibit the proliferation of other cells (such as epidermal kerotinocyte) 
b. Some components may be toxic to cells. Take polyamine oxidase for example, it can 
react with the polyamine (such as spermine and spermidine) to form the toxic poly-
spermine in highly proliferated cells. Furthermore, complements, antibodies and 
bacteriotoxin can affect the cell growth, or even lead to cell death. 
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c. Each batch of serum varies from others and the component can not maintain 
uniformity.  
d. The productive process may infect with mycoplasma or virus, which potentially affect 
cells and lead to the fail experiment and unreliable experimental results. 
2.2. Rat tail collagen 
Rat tail collagen, used as either a thin layer on tissue-culture surfaces to enhance cell 
attachment and proliferation, or as a gel to promote expression of cell-specific morphology 
and function. This product is ideal for coating of surfaces, providing preparation of thin 
layers for culturing cells, or use as a solid gel.  Rat Tail Collagen is suitable for applications 
using a variety of cell lines including hepatocytes, fibroblasts and epithelial cells 
3. Synthetic medium 
The synthetic medium is artificial designed and prepared medium. Nowadays the synthetic 
medium already becomes standardized commodity with wide varieties and convenience to 
use. 
3.1. Basic medium 
3.1.1. Basic components 
After experimental selection, the simplest medium is minimum essential media (MEM), 
which contains more than 20 kinds of substance and can be divided to 4 subgroups.  
Inorganic salt: CaCl2, KCl, MgSO4, NaCl, NaHCO3, NaH2PO4 
Amino acid: arginine, cystine, isoleucine, leucine, lysine, methionine, phenylalanine, 
threonine, tryptophan, histidine, tyrosine and valine. 
Vitamins: partial polyoxometalates calcium, choline chloride, folic acid, inositol, 
nicotinamide, pyridoxine, riboflavin, thiamine 
Carbohydrate: glucose 
Besides the above substance related to cell growth, the medium usually also uses phenol red 
as pH indicator. 
MEM is not common basic medium and common medium has more than 30 kinds of 
component, such as RPMI1640, DMEM. These mediums generally add some non-essential 
amino acids and vitamins, including serine, proline, biotin, Vitamin B12, etc. 
3.2. Category 
Nowadays, there are more than tens of basic medium available. The most common ones are 
listed as follow: 
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threonine, tryptophan, histidine, tyrosine and valine. 
Vitamins: partial polyoxometalates calcium, choline chloride, folic acid, inositol, 
nicotinamide, pyridoxine, riboflavin, thiamine 
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a. MEM 
MEM, also called Eagle's minimal essential medium, is a cell culture medium developed by 
Harry Eagle that can be used to maintain cells in tissue culture. It only contains 12 kinds of 
non-essential animo acids, glutamine, 8 vitamins and some basic Inorganic salts 
b. DMEM 
A variation of MEM, called Dulbecco’s modied Eagle's medium (DMEM), (Dulbecco/Vogt 
modified Eagle's minimal essential medium), contains approximately four times as much of 
the vitamins and amino acids present in the original formula and two to four times as much 
glucose. Additionally, it contains iron and phenol red. DMEM is further divide into high-
glucose type (4500g/L glucose) and low-glucose type (1000g/L glucose). High-glucose 
DMEM is suitable for some tumor cells with faster growth speed and difficult attachment, as 
it is beneficial to retain and grow in one place. 
c. IMDM 
It is modified by Iscove basic DMEM and contains 42 ingredients. It includes selenium as 
well as additional amino acids and vitamins. In addition, this unique medium lacks iron, 
with potassium nitrate replacing ferric nitrate. It is well suited for difficult proliferating, 
low-density cell cultures, including hybrid cell selection after cell fusion, selection of 
transformed cell after DNA transfection. 
d. RPMI1640 
Roswell Park Memorial Institute medium, commonly referred to as RPMI, is a form of 
medium used in cell culture and tissue culture. The initial formula is suitable for growth of the 
suspension cells, mainly for lymphoid cells. This medium contains a great deal of phosphate 
and is formulated for use in a 5% carbon dioxide atmosphere. RPMI1640, the most mature 
improved medium, is suitable for most types of cells, including tumor cells, normal cells, 
primary culture cells, passage cell. RPMI1640 is one of the most common used medium. 
e. 199/109 medium 
199 medium is developed by Morgan and his coworkers in 1950 and is one of the earliest 
culture medium. It was originally developed as a completely defined media formulation for 
chick embryo cell culture. 199 medium has more than 60 components and contain almost all 
the amino acids, vitamins, growth hormone, nucleic acid derivative, etc. 109 medium is 
improved based on 199 medium and better formulated for the cell culture in a serum-free 
environment.  
f. HamF10/HamF12 
Ham's F-10 medium is a classical media designed by Ham to support the growth of mouse 
and human diploid cells in 1962. Ham's F-12, as improved products, has been used for the 
growth of primary rat hepatocytes and rat prostate epithelial cells.  A clonal toxicity assay 
using CHO cells has also been reported with Ham's F-12 as the medium of choice.  Ham's F-
12 is also available with 25 mM HEPES buffer that provides more effective buffering in the 
optimum pH range of 7.2-7.4 
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g. McCoy’s 5A 
In 1959, McCoy and his coworkers reported the amino acid requirements for in vitro 
cultivation of Novikoff Hepatoma Cells. These studies were performed using Basal Medium 
5A, and subsequently modified to create a new medium known as McCoy’s 5A Medium. 
This media has been employed to support the growth of primary cultures derived from 
adrenal glands, bone marrow (normal), gingiva, lung, mouse kidney, omentum, skin, spleen 
and other tissues. It is a general purpose medium for primary and established cell lines. 
All these medium are already commercialized and one medium have different forms, such 
as powder or liquid, large pack or pouch pack. The liquid form is subdivided 10x 
concentrated solution, 2x concentrated solution and working solution. Some medium don’t 
have phenol red and some don’t have calcium ion and magnesium. The user can choose 
product according to the experiment requirement. The basic components of partial medium 




Components MEM DMEM IMDM RPMI
1640 
F10 F12 McCoys5A 199 
CaCl2 200.00 200.00 165.00 - 33.30 33.20 100.00 200.00 
KCl 400.00 400.00 330.00 400.00 285.00 223.60 400.00 400.00 
MgSO4 98.00 97.67 98.00 48.84 74.60 - 98.00 98.00 
NaCl 6800.00 6400.00 4500.00 6000.00 7400.00 7599.00 5100.00 6800.00 
NaHCO3 2200.00 3700.00 3024.00 2000.00 1200.00 1176.00 2200.00 2200.00 
NaH2PO4 140.00 125.00 125.00 - - - 580.00 140.00 
KNO3 - - 0.076 - - - - - 
NaSeO3 - - 0.017 - - - - - 
Ca(NO3)2 - - - 100.00 - - - - 
CuSO4 - - - 800.00 153.70 142.00 - - 
Na2HPO4 - - - - 0.03 0.86 - - 
MgCl2 - - - - - 57.22 - - 
Fe(NO3)3 - 0.10 - - - - - - 
CuSO4 - - - - 0.0025 0.0025 - - 
FeSO4 - - - - 0.083 0.083 - - 
KH2PO4 - - - - 83.00 - - - 
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Amino acids 
 
Components MEM DMEM IMDM RPMI1640 F10 F12 McCoys5A 199 
L-ArginineHCl 126.00 84.00 84.00 200.00 211.00 211.00 42.10 70.00 
L-Cystine2HCl 31.00 63.00 91.20 65.00 - - - 26.00 
L-CystineHCl H2O - - - - 25.00 35.00 31.50 0.10 
L-HistidineHCl 
H2O 
42.00 42.00 42.00 15.00 23.00 21.00 21.00 22.00 
L-Isoleucine 52.00 105.00 105.00 50.00 2.60 4.00 39.40 40.00 
L-Leucine 52.00 105.00 105.00 50.00 13.00 13.00 39.40 60.00 
L-LysineHCl 73.00 146.00 146.00 40.00 29.00 36.50 36.50 70.00 
L-Methionine 15.00 30.00 30.00 15.00 4.50 4.50 15.00 15.00 
L-Phenylalanine 32.00 66.00 66.00 15.00 5.00 5.00 16.50 25.00 
L-Threomine 48.00 95.00 95.00 20.00 3.60 12.00 17.90 30.00 
L-Tryptophan 10.00 16.00 16.00 5.00 0.60 2.00 3.10 10.00 
L-
Tyrosine2Na2H2O 
52.00 104.00 104.00 29.00 2.62 7.80 26.20 58.00 
L-Valine 46.00 94.00 94.00 20.00 3.50 11.70 17.60 25.00 
L-Alanine - - 25.00 - 9.00 8.90 13.90 25.00 
L-Asparagine - - 25.00 50.00 15.00 15.00 45.00 - 
L-Aspartic acid - - 30.00 20.00 13.00 13.00 20.00 30.00 
L-Glutamic acid - - 75.00 20.00 14.70 14.70 22.10 75.00 
L-Glutamine - 584.00 284.00 300.00 146.00 146.00 219.20 100.00 
Glycine - 30.00 30.00 10.00 7.50 7.50 7.50 50.00 
L-Proline - - 40.00 20.00 11.50 34.50 17.30 40.00 
L-Serine - 42.00 42.00 30.00 10.50 10.50 26.30 25.00 
L-Hydroxyproline - - - 20 - - 19.70 10.00 
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Vitamins 
 
Components MEM DMEM IMDM RPMI1640 F10 F12 McCoys5A 199 
K-Ca-Pantothenate 1.00 4.00 4.00 0.25 0.70 0.50 0.20 0.01 
Choline Chloride 1.00 4.00 4.00 3.00 0.70 14.00 5.00 0.50 
Folic acid 1.00 4.00 4.00 1.00 1.30 1.30 10.00 0.01 
i-Inositol 2.00 7.20 7.20 35.00 0.50 18.00 36.00 0.05 
Niacinamide 1.00 4.00 4.00 1.00 0.60 0.04 0.50 0.025 
Pyridoxal HCl 1.00 - 4.00 - - - 0.50 0.025 
Pyridoxine HCl - 4.00 - 1.00 0.20 0.06 0.50 0.025 
Riboflavin 0.10 0.40 0.40 0.20 0.40 0.04 0.20 0.01 
Thiamine HCl 1.00 4.00 4.00 1.00 1.00 0.30 0.20 0.01 
Biotin - - 0.013 0.20 0.024 0.007 0.20 0.01 
Bitamin B12 - - 0.013 0.005 1.40 1.40 2.00 - 
Para-aminobenzoic acid - - - 1.00 - - 1.00 0.05 
Niacin - - - - - - 0.50 0.025 
Ascorbic acid - - - - - - 0.50 0.05 
a-Tocopherol phosphate - - - - - - - 0.01 
Calciferol - - - - - - - 0.10 
Menadione - - - - - - - 0.01 





Components MEM DMEM IMDM
RPMI
1640 F10 F12 McCoys5A 199 
D-Glucose 1000.00 4500.00 44500.002000.001100.001802.00 3000.00 1000.00 
Phenol red 10.00 15.00 15.00 5.00 1.20 1.20 10.00 20.00 
HEPES - - 5958.00 - - - 5958.00 - 
Sodium pyruvate - - 110.00 - 110.00 110.00 - - 
Glutathione(reduced) - - - 1.00 - - 0.50 0.05 
Hypoxanthine.Na - - - - 4.70 4.77 - 0.04 
Thymidine - - - - 0.70 0.70 - - 
Lipoic acid - - - - 0.20 0.21 - - 
Linoleic acid - - - - - 0.08 - - 
Putrescine 2HCl - - - - - 0.16 - - 
Bacto-peptone - - - - - - 600.00 - 
Thymine - - - - - - - 0.30 
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Amino acids 
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Adenine sulphate - - - - - - - 10.00 
Adenosine-5-triphosphate - - - - - - - 0.20 
Cholesterol - - - - - - - 0.20 
2-deoxy-D-ribose - - - - - - - 0.50 
Adenosine-5-phosphate - - - - - - - 0.20 
Guanine HCl - - - - - - - 0.30 
Ribose - - - - - - - 0.50 
Sodium acetate - - - - - - - 50.00 
Tween 80 - - - - - - - 20.00 
Uracil - - - - - - - 0.30 
Xanthine Na - - - - - - - 0.34 
 
 
Table 2. The basic components of some medium (mg/L) 
3.3. Serum-free medium 
Serum free media (SFM) are important tools that allow researchers to grow a specific cell 
type or perform a specific application in the absence of serum. 
3.3.1. Advantages of using serum free media include: 
a. Easier purification and downstream processing 
b. Precise evaluations of cellular function 
c. Increased definition 
d. More consistent performance 
e. Increased growth and/or productivity 
f. Better control over physiological responsiveness 
g. Enhanced detection of cellular mediators 
3.3.2. Things to consider in serum-free culture 
Overall, cells in serum-free culture are more sensitive to extremes of pH, temperature, 
osmolality, mechanical forces, and enzyme treatment.  
a. Antibiotics 
It is best not to use antibiotics in serum-free media. If you do, we recommend that you use 5- 
to 10-fold less than you would in a serum- supplemented medium. This is because serum 
proteins tend to bind a certain amount of the antibiotic added; without these serum proteins 
the level of antibiotic may be toxic to certain cells. 
b. Higher density 
Cells must be in the mid-logarithmic phase of growth with viability >90% prior to 
adaptation. Sequential adaptation may be necessary.  
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Seeding cultures at a higher density than normal at each passage during SFM adaptation 
may help the process. Because some percentage of cells may not survive in the new culture 
environment, having more cells present will increase the number of viable cells to further 
passage. 
c. Clumping 
Cell clumping often occurs during adaptation to SFM. We recommend that you gently 
triturate the clumps to break them up when passaging cells. 
d. Morphology 
It is not uncommon to see slight changes in cellular morphology during and after adaptation 
to SFM. As long as doubling times and viability remain good, slight changes in morphology 
should not be a reason for concern. 
3.4. Basic formula of serum-free medium 
SFM includes basic culture medium and supplements. Basic culture mediums commonly 
use HamF12 and DMEM as 1:1 mixture. The supplements include: 
a. Promote adherence substances 
Many cells cultured in vitro have to attach the culture vessel for growth and SFM need to 
add some supplements for promoting attachment and extension, mainly extracellular matrix 
(fibronection, laminin, etc).  
b. Somatomedin and hormones 
Different growth factors need to add different cells. For example, EGF for the Keratinocytes, 
NGF for the Neurocyte, ECGF for the endothelial cell. The following table summarizes the 
utilization of some growth factor. 
c. Enzyme inhibitor 
Adherent cell need to trypsinize and passage. The SFM must have enzyme inhibitor to stop 
the activity of trypsin and protect the cell. The commonest enzyme inhibitor is soybean 
trypsin inhibitor 
d. Binding protein(s) and translocator 
The common binding protein and translocators are transferring and bovine serum albumin. 
e. trace element 
Selenium is most common trace element. 
4. How to use 
Sequential adaptation is preferred method for adapting cells to serum-free media 
(SFM).Because the change from 75% to 100% SFM may be too stressful for your cells, you 
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may need to carry the cells for 2–3 passages in a 10% serum-supplemented medium: 90% 
SFM mixture. Most cell lines can be considered fully adapted after 3 passages in 100% SFM. 
Occasionally you may have trouble getting your cells past a certain step even before going 
100% SFM. If this happens, go back and passage the cells 2–3 times in the previous ratio of 
serum-supplemented media to serum-free media. 
 
Growth factor Target cell(common) Target cell(specific) Recommended 
concentration 


















ECGF endothelial cell endothelial cell 1-3mg/ml 
IGF-1 Most cells  1-10ng/ml 














TGF-β Inhibit epiblast   
Table 3. The utilization of some growth factor 
4.1. Protein free medium(PFM) and chemical defined medium(CDM) 
Protein free medium (PFM) is a proprietary serum-free and protein-free growth medium 
that does not contain any hormones or growth factors. This medium is optimized for the 
cultivation of Chinese Hamster Ovary (CHO) cells in addition to many derivatives of this 
parent line. The absence of protein in the medium eliminates any transmission risk of blood 
borne diseases, resulting in a product that is far safer than the current culture media on the 
market. 
Chemical defined medium (CDM) is a media in which the chemical nature of all the 
ingredients and their amounts are known.  
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5. Other medium 
5.1. Balanced salt solution (BSS)  
Balanced salt solutions can provide an environment that maintains the structural and 
physiological integrity of cells in vitro. Solutions most commonly include sodium, 
potassium, calcium, magnesium, and chloride. Balanced salt solutions are used for washing 
tissues and cells and are usually combined with other agents to treat the tissues and cells. 
They provide the cells with water and inorganic ions, while maintaining a physiological pH 
and osmotic pressure. The following table lists the formula of several common BSS. 
 
 Ringer PBS Tyrode Earle Hank’s D-Hank’s Dulbecco 
NaCl 9.00 8.00 8.00 6.80 8.00 8.00 8.00 
KCl 0.42 0.20 0.20 0.40 0.40 0.40 0.20 
CaCl2 0.25 - 0.20 0.20 0.14 - 0.10 
MgCl26H2O - - 0.10 - - - 0.10 
MgSO47H2O - - - 0.20 0.20 - - 
Na2HPO4H2O - 1.56 - - 0.06 0.06 - 
NaH2PO42H2O - - 0.05 0.14 - - 1.42 
KH2PO4 - 0.20 - - 0.06 0.06 0.20 
NaHCO3 - - 1.00 2.20 0.35 0.35 - 
Glucose - - 1.00 1.00 1.00 - - 
Phenol red - - - 0.02 0.02 0.02 0.02 
Table 4. The formula of several common BSS 
5.2. Medium used for digestion 
Primary cell cultures usually need to digest and dissociate the tissue to cell suspension. 
Continuous passage cultures need to digest the adherent cell from culture dishes. The 
common digestion solutions are trypsin, EDTA solution and collagenase solution. 
5.2.1. Trypsin 
In a tissue culture lab, trypsins are used to re-suspend cells adherent to the cell culture dish 
wall during the process of harvesting cells. Trypsin is used to cleave proteins bonding the 
cultured cells to the dish, so that the cells can be suspended in fresh solution and transferred 
to fresh dishes. 
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serum-supplemented media to serum-free media. 
 
Growth factor Target cell(common) Target cell(specific) Recommended 
concentration 


















ECGF endothelial cell endothelial cell 1-3mg/ml 
IGF-1 Most cells  1-10ng/ml 














TGF-β Inhibit epiblast   
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Trypsin is an endopeptidase produced by the gastro-intestines of mammals, and has an 
optimal operating pH of about 8 and an optimal operating temperature of about 37 °C. The 
biochemical assays performed on Trypsin 1:250 determine both trypsin specific-activity at 
the level of certain co-purified enzymes that influence cell removal and viability 
5.2.2. EDTA solution 
In Cell Culture applications, EDTA is used for its chelating properties which binds to 
calcium and other ions and thus prevents adjoining of cadherins(i.e. the integral membrane 
proteins involved in calcium-dependent cell-adhesion) between cells, preventing the 
clumping of cells growing in liquid suspension or even detaching adherent cells for 
passaging. The working concentration is 0.02%. Trypsin//EDTA is a combined method for 
detaching cells. 
5.2.3. Collagenase solution 
Collagenase is especially valuable when tissues are too fibrous or too sensitive to allow the 
use of trypsin, which is ineffective on fibrous material and damaging to sensitive material. 
Dissociation is usually achieved either by perfusing whole organs or by incubating smaller 
pieces of tissue with enzyme solution. The working solution is 0.1-0.3mg/ml or 200000U/L. 
The optimal operating pH is about 6.5. 
5.3. pH adjusting medium 
5.3.1. NaHCO3 solution 
Sodium bicarbonate is used as part of a buffering system commonly used to maintain 
physiological pH 7.2 - 7.4 in a culture environment. The concentration of the sodium 
bicarbonate in the medium must be matched with the level of CO2 in the atmosphere above 
the medium. For media containing 1.5 to 2.2 g/L sodium bicarbonate, use 5% CO2. For media 
containing 3.7 g/L sodium bicarbonate, use 10% CO2. 
5.3.2. HEPES 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) is a zwitterionic organic 
chemical buffering agent. The level of HEPES in cell culture media may vary from 10mM to 
25mM. It is added to the media solely for extra buffering capacity when cell culture requires 
extended periods of manipulation outside of a CO2 incubator. 
5.4. Antibiotics 
Researchers use antibiotics and antimycotics to prevent contamination. The common ones 
are Penicillin & Streptomycin (P/S). Penicillin Streptomycin mixtures contain 5,000 units of 
penicillin (base) and 5,000 μg of streptomycin (base)/ml utilizing penicillin G (sodium salt) 
 
Culture Conditions and Types of Growth Media for Mammalian Cells 17 









Amphotericin B -20oC 2.5 μg/ml ~3 days 
Ampicillin 4oC 100 μg/ml ~3 days 
Chloramphenicol -20oC 5 μg/ml ~5 days 
Ciprofoxacin -20oC 10 μg/ml not known 
Gentamicin 4oC 50 μg/ml ~5 days 
Hygromycin B 4oC 500 μg/ml not known 
Kanamycin -20oC 100 μg/ml ~5 days 
Neomycin -20oC 50 μg/ml ~5 days 
Penicillin -20oC 100 U/ml ~3 days 
Puromycin -20oC 20 μg/ml not known 
Streptomycin -20oC 100 μg/ml ~3 days 
Tetracycline -20oC 10 μg/ml ~4 days 
Table 5. Antibiotics Storage Conditions Working Concentration Stability in Culture (37°C)  
5.5. Glutamine 
Glutamine is an unstable essential amino acid required in cell culture media formulations. 
Most commercially available media are formulated with free L-glutamine which is either 
included in the basal formula or added to liquid formulations at time of use. The 
concentration of L-glutamine used in classical media is usually 0.002mol/L. 
Author details 
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1. Introduction 
The term “cell culture” refers to the in vitro proliferation of cells and tissues and involves 
the use of either primary cells typically having a finite life span in culture or continuous cell 
lines that are abnormal and immortalized. In the last several decades, efforts have been 
mainly focused on the sub-culturing of established cell lines and on optimizing culture 
conditions, including selection of appropriate culture medium, in order to achieve rapid cell 
growth. The conventional CO2 incubator only provides minimum requirements for keeping 
cells alive in a culture environment; pH and temperature are held at 7.4 and 37°C, 
respectively, and sub-saturated humidity is maintained to avoid evaporative condensation 
of the culture medium. To avoid contamination of the culture medium from aerosol 
bacteria, the conventional clean bench removes particles from the working atmosphere by 
continuous displacement of ambient air that passes through a high-efficiency particle 
(HEPA) filter, whereas the medium exposed to ambient air quickly discharges dissolved 
CO2. In vivo, the pH of blood is strictly maintained at ~ pH 7.4 by means of physiological 
buffer systems, whereas the pH of culture medium mainly depends on a sodium 
bicarbonate/CO2 buffer, which is adjusted to a pH of 7.4 in an atmosphere of 5% CO2; the 
pKa is 6.1, and the buffering capacity at pH 7.4 is very weak. The pH and temperature are 
generally uniform in almost all organs, tissues, and cells in living mammals; however, the 
dissolved oxygen or oxygen partial pressure (PO2) in various organs and tissues is generally 
much lower than that in the ambient air (159 mmHg); it decreases to 100 mmHg and 25 
mmHg or less in arterial blood and in the periphery, respectively. Although oxygen is 
essential to produce ATP through the tricarboxylic acid cycle, it is quite toxic at high 
concentrations [1-3]. Tissues and cells in body fluids are protected from reactive oxygen 
species (ROS) by multiple physiological anti-oxidant systems, whereas those in artificial 
culture medium lack an extracellular protective system and are exposed to high levels of O2. 
Numerous studies have cited a variety of harmful effects of ROS, such as lipid and protein 
 The Author(s). Licensee InTech. This chapter is distribut d und r the terms of the Creative Commons 
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peroxidation as well as membrane and DNA damage [4-8]. Although lower PO2 implies 
lower production of ROS, it also implies hypoxia that can damage various cellular functions 
[9, 10]. The recent advances in tissue engineering focus on clinical applications of cultured 
cells in regenerative medicine. When primary cells and stem cells are retrieved from human 
tissue, their original physicochemical environments and metabolic features are quite 
different from each other. Moreover, induction of differentiation stimulates changes in gene 
expression over a time course, which may affect cellular metabolism. The above-mentioned 
point of view suggests that ranges in cell viability, in terms of PO2 and tolerance for ROS 
(which need to be controlled for normal proliferation and prevention of malignant 
transformation), may be quite narrow for primary cells in comparison to cell lines. The 
stringent control of oxygen during bioprocessing is undoubtedly important; however, the 
exact influence of PO2 and ROS is not completely understood because past experimental 
data have been obtained by using conventional culture apparatuses or their improved 
models. Although the performance of apparatuses has already been proven by sub-
culturing of established cell lines, they have not been designed for stringent control of 
oxygen throughout the culture period. Every time the incubator door is opened, the O2 
environment is quickly lost and requires a long time to recover. To clarify the net influence 
of PO2 and ROS, it is essential to develop advanced equipment that can provide a stringent 
control of oxygen around the pericellular environment throughout the culture period. 
2. Delivery of human babies by assisted reproductive technology: 
Elementary regenerative medicine involving the transplantation of 
cultured embryos 
In the past 30 years, researchers have made significant progress in the field of clinical 
reproductive medicine through assisted reproductive technology (ART). In 1978, the first 
human baby was born through in vitro fertilization-embryo transfer. To date, more than a 
million children have already been born with the help of ART. Fertilization through intra-
cytoplasmic sperm injection (ICSI) [11] is becoming increasingly popular, and it now 
accounts for more than half of clinical ART cases worldwide. ART is the first example of 
large-scale clinical application of regenerative medicine to cultured human stem cells, which 
involves in vitro fertilization of gametes (primary stem cells) and subsequent culture of 
early embryos up to the blastocyst stage, followed by transfer into the uterus. Some recent 
cohort studies could not deny the possibility of birth defects in babies who were delivered 
as a consequence of ART [12-14], although ART is recognized as an elementary clinical 
regenerative medicine that makes use of native stem cells. We point out two major issues in 
this regard: one is quality control of the gametes, and the other is quality assurance of the 
culture environments. It is well known that human ejaculate contains a heterogeneous 
sperm population that possesses a variety of abnormalities. ICSI is a technique mainly used 
in male infertility, which occurs as a result of dysfunction of spermatogenesis and is 
accompanied by various functional deteriorations in the sperm. Nuclear damage to human 
sperm, in particular, DNA fragmentation as a consequence of double-strand breaks, has 
attracted attention. If a sperm with damaged DNA is incorporated into the embryonic 
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genome, it may lead to sperm-derived chromosomal aberrations [15], which may in turn 
result in higher miscarriage rates [16] and an increased risk of pregnancy loss [17]. The 
resultant aberrations can also be potentially inherited through the germ line by future 
generations [18-20]. Several studies have reported that the rate of DNA-damaged sperm 
increases in infertile men with poor semen quality, who are the primary candidates for ICSI 
[21]. Although the techniques in clinical ICSI are well established, the sperm is selected 
merely based on motility and gross morphology, as observed under a microscope, and there 
are no validated methods to address and assure sperm nuclear DNA integrity. 
There is a concern about higher malformations resulting from ICSI cycles, due to the 
possibility of iatrogenic transmission of genetic abnormalities to the offspring [14, 22, 23]. 
Studies comparing ART cycles and natural births suggest that infants conceived by IVF  
ICSI techniques have three times a risk of a congenital heart defect [24] as well as a higher 
risk of autosomal and gonosomal aneuploidies [25]. It still remains unclear whether culture 
environments provided by conventional culture apparatus or their improved models have 
been responsible for the results of various cohort analyses. In general, we have to consider 
the heterogeneity of the cell population at the start of culture as well as some transformation 
during the culture. The lumen of the fallopian tube, where the oocyte fertilizes with the 
sperm, shows very low PO2 [26], contrary to the endometrium at the implantation phase, 
which shows thickening with increased blood flow; thus, the implanting blastocyst is 
exposed to higher PO2. During this one-week trip in the oviduct, the embryo undergoes 
early development in a PO2 gradient. To determine optimal physicochemical environment 
for primary and stem cells, including the embryo, one has to pay attention to complicated 
cross-interactions between the atmosphere, especially PO2, and the composition of culture 
medium: ATP production is influenced by peri- and intra-cellular PO2 as well as energy 
sources in the medium. Even if PO2 is kept low during cell culture, the handling of cells in a 
clean bench is critical, while temperature, PO2, and pH of the medium are dramatically 
changed. Tolerances to such parameters varies quite differently among cell types. For 
example, some neuronal cells have a low threshold for oxygen toxicity, and exposure of 
these cells to ambient air in a clean bench induces apoptosis [3]. Such cells have to be treated 
in an enclosed space filled with low-oxygen gas mixtures. In contrast, some cells can readily 
induce apoptosis under low PO2 conditions [9]. It is well-known that long-term subculture 
of cell lines induces some genetic transformations. Some researchers [27-31] have proposed 
that this phenotypic variability might originate from epigenetic alterations, and the 
methylation profiles of stem cell lines are fundamentally changed during subculture, thus 
complicating their use in basic and clinical research. Several reports have also discussed the 
epigenetics of early development [32] and the genetic and epigenetic features of children 
delivered through ICSI [33]. Kohoda et al. suggested that ICSI induces transcriptome 
perturbation [34]. To ensure the reliability of clinical embryo cultures, or in general terms, 
clinical cell cultures, as a premise for human implantation, we have to recognize the 
complicated cross-interactions of gas phase with composition of the culture medium, cell 
features, and their heterogeneity with regard to genetic and epigenetic regulation. 
Numerous reports have emphasized that reducing PO2 during in vitro cultures increases the 
proportion of blastocyst formation in mice [35-37], hamsters [38], sheep [39], and cattle [40]. 
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genome, it may lead to sperm-derived chromosomal aberrations [15], which may in turn 
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Other studies found no clear effect in mice [41]. As mentioned above, PO2 and ROS might be 
essential parameters at least in early embryogenesis [42]. The discrepancies in the results of 
the above-mentioned studies may be partially explained by differences in culture hardware 
as well as culture methods: for example, oxygen tension in droplets of medium under oil 
will be 1ess than those without an oil overlay [43]. Adding EDTA to culture medium 
increased the proportions of mouse [41, 44] and cattle [40] embryos that developed to 
blastocysts. Chelating transition metals such as zinc, iron, and copper may prevent chemical 
reactions that generate harmful oxygen radicals [45]. Because oviductal oxygen tension is less 
than atmospheric levels [26], mammalian embryos may be protected from oxidative stress in 
vivo in part by a relatively low oxygen tension in the oviduct [46]. The influence of low PO2 
and hypoxic culture conditions on some cellular functions has also been studied in somatic 
cells. When BeWo cells, an in vitro model of human trophoblasts, were cultured in 2% O2, 
reverse-transcriptase polymerase chain reaction (RT-PCR) indicated increased transcription of 
the organic cation transporter (OCTN2) gene compared to that observed under 20% O2 [47]. 
Hirao et al. ([48] observed that MC3T3-E1 cells and calvariae from 4-day-old mice cultured in 
5% or 20% O2 conditions showed osteoblastic differentiation and subsequent transformation to 
osteocytes, which was promoted by low PO2. The importance of a lower PO2 environment was 
a cited factor; however, excessively low PO2 are also important to consider for cellular growth, 
differentiation, gene expression, phenotype manipulation, epigenetics, and moreover, for 
survival. We consider it essential to determine the narrow range between hyperoxia and 
hypoxia, but not to overestimate the benefit of lower PO2. 
3. Individual cell culture systems in a disposable capsule with controlled 
atmosphere 
As will be described later (Figs. 7 and 8), established cell lines that adapt to 5.0% CO2-air 
often tolerate prolonged changes in pH and PO2. In contrast, clinical cultures of primary and 
stem cells used for human transplantation demands rigorous duplication of in vivo 
environments because it is of prime importance for maintaining normality or to minimize 
phenotypic changes within the cells. We have previously established an individual cell 
culture system that emphasizes the precise control of oxygen concentration and quick 
recovery from disturbances (Figs. 1 and 2) [49]. As shown in Fig. 1, the culture bath has an 
aluminum block with 16 wells for heat storage, and the block and inner space are kept at 
37.0 °C by a temperature sensor. The apparatus is first used as a multivariate screening 
system for the simultaneous determination of the narrow range between hyperoxia and 
hypoxia and for designing the optimal formula corresponding to the gas phase. This system 
can provide up to 16 types of different premixed gases into each capsule individually. The 
commonly used infrared CO2 sensor and the Galvanic current O2 sensor devices have 
sufficient sensitivity and undergo scheduled calibrations to maintain accuracy assurance. 
When a small amount of gas is infused for fine control of the gas phase, static diffusion 
causes an inhomogeneous gas concentration in the chamber, and the display values are often 
similar to those around the sensors. We therefore used pre-mixed gases and a small capsule for 
precise control of O2 concentration. Pure O2, CO2, and N2 gases were mixed according to their 
weight base molar ratios and compressed in the gas canister.. The following gases were used 
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for cell culture experiments: 2.0% O2, 5.0% CO2, and 93% N2 as an example of hypoxic culture. 
For purging the capsule, 5.0% CO2 and 95% N2 were used. The gas compositions were 
measured using gas chromatography, according to the pre-shipment review. 
 
Sixteen small capsules for individual cultures were placed in a well of an aluminum dry block. 
Figure 1. Individual cell culture apparatus 
 
A bench top was covered with an acrylic chamber to prevent leakage of 5.0% CO2-air. Photograph A shows the system 
equipped with a built-in microscope, personal computer, monitor, and printer. Photograph B shows the apparatus for 
general handling of cultures without microscopic observation. A minimal volume of internal space is preferable for 
precision control of the gas phase. 
Figure 2. 5.0% CO2-air circulation clean bench 
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The degree of cleanliness of air was defined by a “cleanliness class”, which is specified by 
the number of particles of a size 0.5 μm or over in one cubic feet of air. For instance, a 
cleanliness class of 100 is interpreted as less than 100 particles in one cubic feet of air. The 
simultaneous measurements of particle size and number were performed using a light-
scattering particle counter. The intake air stream was first passed through a high-intensity 
laser beam. As a result, the particles in the sample caused light scattering, and their numbers 
and intensities were detected. Room air often shows a cleanliness class of 106–105, and the 
aim of a conventional clean bench is to provide a low-dust environment below a cleanliness 
class of 102. The cell handling is, however, performed in ambient air, allowing temperature 
decrease, dissolution of O2, and pH change by removal of CO2. We newly developed the 
5.0% CO2-air circulation clean benches with or without a built-in microscope (Fig. 2). The 
bench top was covered with an acrylic chamber to prevent leakage of the ambient 
atmosphere, with the set-up resembling an infant incubator. Pure CO2 was infused with the 
aid of a gas sensor control to maintain 5.0% CO2-air. The bench top and the ambient 
temperature were kept at 37°C and 30°C–34°C by temperature control (Fig. 2). In addition, a 
small chamber was set on the bench top, so that if cells could not tolerate 5.0% CO2-air for 
more than a few minutes, they were isolated in the chamber, and the humidified culture gas 
was supplied. If the bench top was contaminated with some infectious material such as 
body fluid, it was merely wiped off. In the newly developed system, a cover shield was 
placed on the bench top, and a disposable clear film was set and discarded at each operation 
(Fig. 3). Although the conventional clean bench filtered fresh air only once, the newly 
developed system circulated the enclosed 5.0% CO2-air through a HEPA filter every 24 sec. 
Before starting the filtration process, the cleanliness class was found to be 105; however, a 
cleanliness class of 1 was readily achieved by repeated filtration within 5 min (Fig. 4). 
Furthermore, particles within the size range of 0.3 μm–0.5 μm were reduced to less than 100 
within 5 min. 
 
In the newly developed system, a bench top was shielded with a clear film for infection control. 
Figure 3. Disposable cover film on bench top 
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Measurements were performed at five time points on a bench. Values are represented as mean ± standard error. 
Figure 4. Change in cleanliness class after starting filters 
The conventional CO2 incubator has a structural problem when it comes to achieving a 
stable hypoxic environment. As summarized in Table 1, whenever the door is opened, a 
large amount of ambient air intrudes, and the reduced CO2 can be readily recovered by 
infusion of pure gas; however, it took more than 30 min to exclude O2 by flushing with N2. 
Thus, we developed a disposable small capsule to control the gas phase, especially for 
hypoxic tissue culture (Fig. 5). A 500-ml plastic capsule containing 220 ml of the gas buffer 
solution (20 mM H, 25 mM NaHCO3, and 0.05% Phenol Red) was used as the CO2 incubator. 
First, it was equilibrated by ventilation of the pre-mixed culture gas (10 ml/min) for at least 
overnight. Following gas equilibration, the pH was adjusted to 7.4 ± 0.05, and the O2 
concentration was measured using a Galvanic current O2 sensor. Coexistence of a large 
amount of gas buffer solution, which serves the same function as the culture medium in 
terms of gas equilibration, stabilizes the physicochemical environment by functioning as a 
heat storage and gas pool. Inflow of air when the cap is opened should be excluded as soon 
as possible. To achieve this, the anoxic purging gas (5.0% CO2 and 95% N2) was flushed (500 
ml/min) just after closing the cap. As a consequence, the oxygen level returned to 2.0% 
within 4 min, after which the gas supply was changed automatically to culture gas, which was 
infused (10 ml/min) continuously to maintain positive pressure (Fig. 6). If the gas purging 
process was omitted, it took 120 min until recovery, despite the inner space volume being only 
280 ml (Fig. 6). This fact suggested that the void volume of the culture capsule should be 
minimized as much as possible, and coexistence of the gas buffer enhance the stability of the 
gas phase in the culture environment. In this system, gas control through a CO2 sensor was not 
necessary, and we also did not need to consider the improper gas control caused by sensor 
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deterioration. Gas equilibration of each capsule was roughly estimated by checking the color 
of phenol red in the gas buffer (Fig. 5), and the precision control of the culture environment 
was monitored by measuring the temperature and pH of the gas buffer. Although 
simultaneous culturing of multiple tissues is usually possible in a single CO2 incubator, the 
present method allows the culturing of individual tissues in disposable capsules. The system 
also has additional advantages in that it allows easy and error-free identification of dishes and 
avoids disturbances in culture conditions when the door of the unit is opened. 
 
A maximum of five culture dishes (6.0 cm in diameter) can be placed on the tray of the stainless stand. The gas buffer 
is placed at the bottom. Two tubes protruding from the cap are inlets and outlets for gas. In-line gas filters (pore size, 
0.22 μm) are placed at the inlets and outlets. 
Figure 5. Use of disposable capsules for individual cultures with precise control of oxygen 
concentration and quick recovery from disturbances in culture conditions 
 
: purge with 5.0% CO2 and 95% N2; ------ : without purging, supply of culture gas only 
Figure 6. Effect of gas purging on O2 concentration recovery in capsule 
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The door of a conventional incubator (chamber volume: 30 L) was opened for 10, 20, and 30 sec, and the values on the 
display unit of the built-in device were observed. The durations required for the recovery were recorded. 
Table 1. Time requirement for recovery of gas phase after door opening 
The most common cultureware or vessels are sterile, disposable, and specially treated with 
polystyrene plastic. The cultureware includes petri dishes, multiwell plates, microtiter 
plates, roller bottles, and screw-cap flasks. All cultureware is equipped with lids or caps to 
prevent contamination from aerosol bacteria, and these culture vessels are designed to stack. 
Handling of culture media in conventional or in 5.0% CO2-air circulation clean benches 
caused dissolution of oxygen in the media. After the lid was mounted on the culture dish or 
the cap of the flask was loosely closed, ambient air or 5.0% CO2-air remained in the inner 
space of the cultureware. We placed an O2 sensor on the lid of a culture dish (90 mm 
diameter, 10 mm height) or on the body of a culture flask (250 ml) to measure the ventilation 
velocity between the outer and inner spaces of the cultureware. As shown in Fig. 7, when 
the lid is held in the normal position and placed in the culture gas containing 2.0% O2, it 
took more than 40 min for equilibration, despite the inner space volume being only about 60 
ml. When the lid was held over the spacers (2 mm and 7 mm in height), the time for 
equilibration was again shortened to 20 min. If the cells demand a faster velocity of 
ventilation, a lid made out of gas-permeable materials should be used, or cultureware 
without lids should be used. A flask with a screw cap has a larger void volume than that of 
a dish, and, hence, more reliable results were obtained using a flask. The cap of the flask was 
opened in ambient air and closed loosely. When the flask was placed in the culture-gas 
environment, the ventilation velocity was found to be extremely low, and it took more than 
20 h to attain equilibration (Fig. 8-A). Moreover, the same duration was required for gas 
leakage, which served as a reversal process (Fig. 8-B). We examined purging of ambient air 
with anoxic gas in the same manner as described in Fig. 6. A needle was inserted in the cap 
as a gas injection port, and the flask was capped loosely (Fig. 8). The flushing (500 ml/min) 
of anoxic gas obviously accelerated the ventilation, and the oxygen level returned to 2.0% 
within 4 min (Fig. 8-C). This result suggested that the conventional use of a flask with a 
loose cap, which is subsequently placed in the CO2 incubator, is unfavorable for primary 
and stem cells, which were intolerant to prolonged changes in pH and PO2. An air-tight 
plastic vessel often suffers from gas leakage through the sealant of wide open-mouthed 
containers as well as due to the gas permeability of materials. After the cap was closed, the 
gas phase was recovered by flushing (Fig. 6), and a minimum amount of culture gas (10 
ml/min) was supplied constantly (Fig. 9-A) or intermittently (Fig. 9-B) in order to maintain 
positive pressure. The constant supply of culture gas held PO2 steady, whereas the 
intermittent supply caused narrow, wave-like changes due to gas leakage, although their 
margins of fluctuation were not so much different from each other. The intermittent supply 
saved gas consumption. The computer-assisted programmable system allowed greater 
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flexibility to evaluate optimum environmental settings. Fig. 10 shows a time-course model 
of switching of the gas phase with intermittent gas supply. 
 
Figure 7. Effect of gap between lid and culture dish on ventilation velocity 
 
The photograph in the figure shows the experimental set-up of the injection port. 
Figure 8. Ventilation velocity of loose cap flask and effects of purging with anoxic gas 
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The intermittent method constituted a repetitive cycle of a 10-min gas supply followed by a 50-min pause. 
Figure 9. Time-course changes in O2 concentration during constant and intermittent gas supply 
 
Culture gas was changed from 2.0% O2 to 5.0% O2 in mid-course, and then changed back to 2.0% O2. 
Figure 10. A model of computer-assisted programmable intermittent gas supply 
The 16 capsules placed in the culture bath (Figs. 1 and 5) were used as a multivariate 
assessment system to determine the optimal formula corresponding to the narrow range 
between hyperoxia and hypoxia. Fig. 11 presents the model usage to optimize the 
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The photograph in the figure shows the experimental set-up of the injection port. 
Figure 8. Ventilation velocity of loose cap flask and effects of purging with anoxic gas 
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The intermittent method constituted a repetitive cycle of a 10-min gas supply followed by a 50-min pause. 
Figure 9. Time-course changes in O2 concentration during constant and intermittent gas supply 
 
Culture gas was changed from 2.0% O2 to 5.0% O2 in mid-course, and then changed back to 2.0% O2. 
Figure 10. A model of computer-assisted programmable intermittent gas supply 
The 16 capsules placed in the culture bath (Figs. 1 and 5) were used as a multivariate 
assessment system to determine the optimal formula corresponding to the narrow range 
between hyperoxia and hypoxia. Fig. 11 presents the model usage to optimize the 
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combination of three parameters, namely the four premixed gases with 0% to 6.0% O2 and 
the dosage of two constituents. For example, the capsule at the right edge/bottom line the 
combination of the constituent α, dose 4 and the constituent β, dose 5/6.0% O2. The formula 
of widely used media (for example, RPMI and MEM) has been established more than half of 
a century ago; at that time, the multifaceted pharmacological actions and the concept of 
genotoxicity of some constituents had not yet been established. Amino acids are often added 
as supplements in the media, some of which serve as the most abundant neurotransmitters 
in the brain. Amino acids are responsible for almost all rapid signaling between neurons. 
For example, glutamate is used as a nitrogen source to promote the syntheses of proteins 
and nucleic acids, and it is the major excitatory neurotransmitter that is distributed in all 
regions of the brain ([50]. Inadequate dosing causes glutamate-induced excitotoxicity ([51]. 
Extracellular ATP ([52], while the decomposed species, adenosine [53], is responsible for 
calcium channel regulation. It is very important to evaluate whether target cells are 
pharmacologically sensitive to some of the constituents as well as to impurities and their 
degraded agents. Moreover, it is important to note that the term “sensitive” includes 
genotoxicity. 
 
The apparatus can provide a maximum of 16 premixed gases in each capsule, and the combination of a few parameters 
can be determined simultaneously. 
Figure 11. Multivariate assessment of environmental settings 
4. Conclusion 
To date faster proliferation has often been associated with the optimum culture 
environment, we have to investigate minutely whether this enhanced proliferation is not 
caused by genetic transformation or malignant changes or not. The present review dealt 
with “cell handling and culture under controlled oxygen concentration”. The precision 
control of oxygen to determine the narrow range between hyperoxia and hypoxia is likely to 
play an important role in ensuring the safety of cell cultures, especially for primary and 
stem cells. 
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1. Introduction 
Mycoplasmas are the smallest and simplest self-replicating bacteria [1]. These 
microorganisms lack a peptidoglycan based rigid cell wall and thus are not susceptible to 
antibiotics, such as penicillin and its analogues, which are effective against most bacterial 
contaminants of cell cultures. The trivial name mycoplasma encompasses all species 
included in the class Mollicutes: i.e. the genera Mycoplasma, Acholeplasma, Spiroplasma, 
Anaeroplasma and Ureaplasma. Because mycoplasmas have an extremely small genome (0.58–
2.20 Mb compared with the 4.64 Mb of Escherichia coli), these organisms have limited 
metabolic options for replication and survival. The smallest genome of a self-replicating 
organism known at present is the genome of Mycoplasma genitalium (0.58 Mb; Ref. 2). 
Comparative genomic studies suggested that the genome of this organism still carries 
almost double the number of genes included in the minimal gene set essential for cellular 
function [3]. Owing to their limited biosynthetic capabilities, most mycoplasmas are 
parasites, exhibiting strict host and tissue specificities [4]. The aim of this review is to collate 
present knowledge on the strategies employed by mycoplasmas while interacting with 
tissue culture cells. Prominent among these strategies is the adherence of mycoplasmas to 
host cells, the invasion of mycoplasmas into host cells and the fusion of mycoplasmas with 
host cells. We shall discuss the intriguing questions of how a mycoplasma infecting tissue 
culture cells subvert and damage the host cells by mediating transformation of the cells, 
affecting the signal-transduction pathways and the metabolism of immune and non-
immune cells. We shall also present and discuss the common procedures for isolation, 
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host cells. We shall discuss the intriguing questions of how a mycoplasma infecting tissue 
culture cells subvert and damage the host cells by mediating transformation of the cells, 
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immune cells. We shall also present and discuss the common procedures for isolation, 
identification and eradication of a mycoplasma contamination of tissue cultures. 
2. Mycoplasmas contaminating cultured cells  
It is well established that stable cell cultures are frequently contaminated by mycoplasmas. 
In a study carried out in the USA at the Food and Drug Administration (FDA), over 20,000 
 The Author(s). Licensee InT . ch pter is distributed under the terms of the Cr ative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
 
Biomedical Tissue Culture 36 
cell cultures were examined during a period of 30 years, 15% of which were found to be 
contaminated [5]. Higher incidences of contamination have also been reported. Three 
different surveys in Japan showed an incidence of mycoplasma contamination of 60-80%, 
and an incidence of 65% was reported in Argentina [5]. At least 20 distinct Mycoplasma or 
Acholeplasma species have been isolated from contaminated cell lines. Ninety-five percent of 
the contaminants were identified as either M. orale, M. arginini, M. hyorinis, M. fermentans or 
A. laidlawii [5]. although the frequency of isolation of a particular species varies with the 
particular study. 
In general, primary cell cultures are less frequently contaminated than continuous cell lines. 
However, since many viral vaccines (such as those for measles, mumps, rubella, polio and 
rabies) are produced in primary cell cultures, many countries require such cultures to be 
screened carefully for mycoplasma contamination before approval can be given for release 
of the vaccine (or other biological products intended for human use) to the market-place.  
All cell types, including virus-infected, transformed, or neoplastic cell cultures grown in 
monolayers and/or in suspension, derived from all host-types examined, are subject to 
contamination. Mammalian and avian cell lines were the most commonly contaminated 
although, on occasions, cell cultures derived from reptiles, fish, insects or plants were also 
contaminated. Most studies have examined fibroblast cell cultures, but epithelial, 
endothelial, lymphocytic and hybridoma cell-culture lines have also been found to be 
contaminated. Frequently, the number of mycoplasmas far exceeds (often by 1000-fold) the 
number of tissue-culture cells in an infected cell culture. The information available on the 
contamination of cultures of differentiated cell lines is limited, and more data are needed 
before a proper assessment can be made. Mycoplasma contamination of vaccines presents a 
potential health hazard; consequently, identifying the source(s) of contamination is a key 
concern. The probable source of most mycoplasma contaminants in primary cell culture is 
the original tissue used to develop the primary cell culture lot. Whereas lung, kidney, or 
liver tend to be mycoplasma-free, the foreskin, the lower female-urogenital tract, or tumor 
tissues, are subject to mycoplasma colonization, and generally show a higher rate of 
contamination [5]. Nonetheless, contamination from exogenous sources also occurs during 
cell propagation and continuous cell cultures are the most frequently contaminated. The 
main source of contamination is, in many cases, infection by previously-contaminated cell 
cultures that have been maintained and processed in the same laboratory [5]. Mycoplasmas 
are spread by using laboratory equipment, media, or reagents that have been contaminated 
by previous use in processing mycoplasma-infected cell cultures. New cell-culture 
acquisitions should be quarantined, tested and guaranteed mycoplasma-free before 
introduction into the tissue-culture laboratory. Common experimental stock materials, such 
as virus pools, or monoclonal antibody preparations, can also be a key source of 
mycoplasma contamination. As there is no legal requirement for suppliers to provide 
mycoplasma-free products, bovine serum should be considered as a possible source of 
contamination. Mycoplasma contaminants of bovine serum are primarily bovine species, 
with A. laidlawii and M. arginini being isolated most frequently [5]. 
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3. Mode of interaction with host cells  
3.1. Adherence to host cells 
Most mycoplasmas are typical extracellular microorganisms able to adhere to the surface of 
tissue culture cells. Many mycoplasmas exhibit the typical polymorphism of mycoplasmas, 
with the most common filamentous, flask shapes or ovoid structures (Figure 1, Ref. 6). The 
adherence of mycoplasmas to host cells is an initial and essential step in tissue colonization 
[4]. The lack of a cell wall has forced mycoplasmas to develop sophisticated molecular 
mechanisms to enable their prolonged adhesion. Adherence is associated with adhesins as 
well as host cell receptors that mediate interaction of the bacteria with the host cells [7]. 
 
Figure 1. Transmission electron microscopy of M. hyorhinis (A) and of a melanoma cell culture infected 
by M. hyorhinis (B). Flask shaped bacteria in close proximity to melanoma cells are indicated by arrows. 
A polar, tapered cell extension at one of the poles containing an electron-dense core in the 
cytoplasma was described in some mycoplasmas (Figure 2). This structure, termed the tip 
organelle, functions mainly as an attachment and motility organelle. A variety of surface 
proteins that participate in the adhesion process are densely clustered at the tip organelle 
[4]. The role of host cell surface sialoglycoconjugates as receptors for mycoplasmas has been 
suggested [8]. The carbohydrate moiety of the glycoprotein, which serves as a receptor for 
M. pneumoniae on human erythrocytes, has been identified as having a terminal NeuAc(α2–
3)Gal(β1–4)GlcNAc sequence [9]. Nevertheless, neuraminidase treatment has frequently 
failed to abolish the ability of various eukaryotic cells to bind M. pneumoniae [10]. A sialic 
acid-free glycoprotein, isolated from cultured human lung fibroblasts, which serves as a 
receptor for M. pneumoniae, has been isolated by Geary et al. [11]. Sulfated glycolipids 
containing terminal Gal(3SO4)β1 residues were also found to function as receptors [12]. 
Clearly, there is more than one type of receptor for the various adhering mycoplasmas.  
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Figure 2. A, scanning electron microscopy of filamentous M. pneumoniae. B, transmission electron 
microscopy of flask-shaped M. pneumoniae (M) attached by the terminal tip organelle (arrow) to ciliated 
mucosal cells. Magnification: A, x10,000; B, x36,000. 
The attachment of mycoplasmas to the surface of host cells may interfere with membrane 
receptors or alter transport mechanisms of the host cell. The disruption of the K+ channels of 
ciliated bronchial epithelial cells by M. hyopneumoniae that resulted in ciliostasis has been 
described [13]. The host cell membrane is also vulnerable to toxic materials released by the 
adhering mycoplasmas. Although toxins have not been associated with mycoplasmas, the 
production of cytotoxic metabolites and the activity of cytolytic enzymes are well 
established. Oxidative damage to the host cell membrane by peroxide and superoxide 
radicals excreted by the adhering mycoplasmas appears to be experimentally well-
substantiated [14]. The intimate contact of the mycoplasma with the host cell membrane 
may also result in the hydrolysis of host cell phospholipids catalyzed by the potent 
membrane-bound phospholipases present in many mycoplasma species [15]. This could 
trigger specific signal cascades [16] or release cytolytic lysophospholipids capable of 
disrupting the integrity of the host cell membrane [17, 18].  
3.2. Invasion of host cells 
It is generally accepted that mycoplasmas remain attached to the surface of host cells [1]. 
However, some mycoplasmas have evolved mechanisms for entering host cells that are 
not naturally phagocytic. The intracellular location is obviously a privileged niche, well 
protected from the action of many antibiotics. Mycoplasma invasion of host cells was 
intensively studied with M. penetrans, isolated from the urogenital tract of acquired 
immunodeficiency syndrome (AIDS) patients [19, 20]. It was shown that this 
microorganism has invasive properties and localizes in the cytoplasm and perinuclear 
regions [21, 22, 23]. Mycoplasmal invasion of host cells is a complex process that involves 
a variety of mycoplasmal and host cell factors. It is likely that surface molecules (proteins 
and lipids) that facilitate the adhesion process of mycoplasmas will have an effect on the 
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invasion. Nevertheless, adherence to the surface of host cells is not sufficient to trigger 
events that lead to invasion. The signals generated by the interaction of host cells with 
invasive mycoplasmas have yet to be investigated. It has been shown that bacterial 
invasion is based on the ability of several bacteria to bind sulfated polysaccharides or 
fibronectin [24]. It was suggested that these compounds form a molecular bridge between 
the bacteria and eukaryotic surface proteins [25] that enables invasion. Fibronectin 
binding activity was detected in M. penetrans. This organism, which contains a 65-kDa 
fibronectin binding protein, binds selectively immobilized fibronectin [23]. The finding 
that M. fermentans binds plasminogen (Plg) and in the presence of urokinase-type Plg 
activated (uPA) internalization was apparent (26, 27), indicates that the ability of M. 
fermentans to invade host cell stems from its potential to bind and activate Plg to plasmin, 
a protease with broad substrate specificity. Plg and uPA are two proteins that play an 
important role in the invasion of several human malignant tumors [28], therefore it is not 
surprising that the same system stimulates M. fermentans invasion. Other mycoplasmas 
known to be surface parasites such as M. pneumoniae [29], M. genitalium [30], M. 
gallisepticum [31], and M. hyorhinis [6] were also found under certain circumstances to 
reside within host cells. 
In studying bacterial invasion, it is essential to differentiate between microorganisms 
adhering to a host cell and those which have penetrated the cell. The light microscopic and 
electron microscopic observations of mycoplasmas engulfed in membrane vesicles lead to 
conflicting interpretations. It is not clear whether mycoplasmas are intra, or are they at the 
bottom of crypts formed by the invagination of the cell membrane [32]. A more 
sophisticated ultrastructural study was based on a combined immunochemistry and 
electron microscopy approach. Staining surface polysaccharides of the host cell with 
ruthenium red allows a better differentiation between intracellular and extracellular 
mycoplasmas [33]. Currently, the gentamicin resistance assay is the most common assay to 
differentiate intracellular from extracellular bacteria [7, 34]. In this assay, the extracellular 
bacteria are killed by gentamicin, but the intracellular bacteria are shielded from the 
antibiotic because of the limited penetration of the gentamicin into eukaryotic cells. The 
gentamicin procedure was successfully adapted to mycoplasma systems [21, 31]. Usually the 
number of intracellular bacteria is determined by washing the host cells free of the 
antibiotic, lysing them with mild detergents to release the bacteria and counting the colonies 
[35]. Because mycoplasmas are as susceptible to detergent lysis as the host cells, dilutions of 
the mycoplasma-infected host cells should be plated directly onto solid mycoplasma media 
without lysing them beforehand. Each mycoplasma colony represents one infected host cell 
rather than a single intracellular mycoplasma [34].  
Immunofluorescent staining of internalized bacteria and of those remaining on the cell 
surface, combined with confocal laser scanning microscopy, has demonstrated that several 
mycoplasmas penetrate eukaryotic cells (Figure 3; Refs. 22, 36) This nondestructive, high-
resolution method allowed infected host cells to be optically sectioned after fixation and 
immunofluorescent labeling. Imaging single infected HeLa cells revealed that invasion is 
both time and temperature dependent. Penetration of melanoma cells by M. hyorhinis has 
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been observed as early as 30 min after infection [6], whereas invasion of cultured HEp-2 
cells by M. penetrans has been shown to begin after 2 h of infection [36]. 
The intracellular fate of invading bacteria can vary greatly. Most invasive bacteria appear to 
be able to survive intracellularly for extended periods of time, at least if they have reached a 
suitable host cell [37]. Other engulfed bacteria are degraded intracellularly via phagosome-
lysosome fusion. The invasive bacteria either remain and multiply within the endosomes 
after invasion or are released via exocytosis and/or the lysis of the endosomes which may 
allow multiplication within the cytoplasm. Most ultrastructural studies performed with 
engulfed mycoplasmas revealed mycoplasmas within membrane-bound vesicles [30, 33, 38]. 
Persistence of M. penetrans within NIH/3T3 cells, Vero cells, human endothelial cells, HeLa 
cells, WI-38 cells, and HEp-2 cells has been observed over a 48–96 h postinfection [19, 23]. M. 
gallisepticum remains viable within HeLa cells during 24–48 h of intracellular residence [31]. 
The observation of vesicles stuffed with M. penetrans in various host cells was taken as an 
indication that M. penetrans is able to divide within intracellular vesicles of the host cells 
[19]. Nonetheless, the intracellular multiplication of mycoplasmas remains to be 
convincingly demonstrated. 
  
Figure 3. Confocal micrographs demonstrating binding and internalization of M. hyorhinis (green 
fluorescence) by melanoma cells. A, Control of uninfected melanoma cells; B, Formaldehyde fixed 
melanoma cells infected with mycoplasma (bacteria on the melanoma cell surface); C, Native melanoma 
cells infected by mycoplasma (bacteria internalized by cells). 
Almost all invasive bacteria that come into contact with the host cell surface trigger 
cytoskeletal rearrangements that facilitate bacterial internalization [35, 39]. Involvement of 
the host cell cytoskeleton in internalization is considered to be the result of a host cell signal 
transduction cascade induced by the invasive bacterium. As in many signal transduction 
processes initiated by bacteria, kinases and/or phosphatases are usually involved [39]. The 
invading mycoplasmas generate uptake signals that trigger the assembly of highly 
organized cytoskeletal structures in the host cells [23]. Yet, the nature of these signals and 
the mechanisms used to transduce them are not fully understood. Specific activation of 
protein kinases occurs during the internalization of most of the bacteria taken up by 
microtubule-dependent mechanisms [16]. It has been shown that invasion of HeLa cells by 
M. penetrans is associated with tyrosine phosphorylation of a 145-kDa host cell protein [21]. 
Tyrosine phosphorylation activates phospholipase C to generate two second messengers: 
phosphatidylinositol metabolites and diacylglycerol (DAG). Changes in host cell lipid 
turnover occur as a result of M. penetrans binding and/or invasion of Molt-3 lymphocytes 
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[40]. These changes include the accumulation of DAG and the release of unsaturated fatty 
acids, predominantly long-chain polyunsaturated ones such as docosahexanoic acid (C22:6, 
40]. Nonetheless, metabolites of phosphatidylinositol were not detected. These observations 
support the hypothesis that M. penetrans stimulates host phospholipases to cleave 
membrane phospholipids, thereby initiating the signal transduction cascade. Because in 
HeLa cells, which are invaded by M. penetrans, DAG is generated, it is likely that the protein 
kinase C is activated in the host cells. Indeed, transient protein kinase C activation was 
demonstrated in invaded HeLa cells by several methods, including translocation to the 
plasma membrane and enzymatic activity [22]. However, activation was weak and transient, 
peaking at 20 min postinfection. How any of these different signal transduction events lead 
to specific microtubule activity resulting in mycoplasmal internalization is unknown. The 
role of these signals in the penetration, survival, and proliferation of mycoplasmas within 
host cells, as well as the involvement of the lipid intermediates in the pathobiological 
alterations taking place in the host cells, merit further investigation.  
3.3 Fusion with host cells 
The lack of a rigid cell wall allows direct and intimate contact of the mycoplasma membrane 
with the cytoplasmic membrane of the eukaryotic cell. Under appropriate conditions, such 
contact may lead to cell fusion. Fusion of mycoplasmas with eukaryotic host cells has been 
first observed in electron microscopic studies [41]. The development of energy transfer and 
fluorescence methods has enabled investigation of the fusion process on a quantitative basis 
in an experimental cell culture-mycoplasma system and has also allowed the identification 
of fusogenic mycoplasmas. In all the fusogenic Mycoplasma species tested, fusogenicity is 
dependent on the unesterified cholesterol content of the cell membrane [42]. Fusogenic 
activity can be found only among mycoplasmas requiring unesterified cholesterol for 
growth, whereas species, which do not require cholesterol, are nonfusogenic. Among the 
Mycoplasma species, the human mycoplasma, M. fermentans, is highly fusogenic, capable of 
fusing with a variety of cells [2]. It is widely accepted that the reorganization of the 
membrane structure that occurs during fusion requires that the lipid bilayer is broken up 
and that other inverted configurations, such as reversed nonbilayer aggregates, are being 
formed [43, 44, 45]. It has been shown that the polar lipid fraction of M. fermentans is capable 
of enhancing the fusion of small, unilamellar phosphatidylcholine-cholesterol (1:1 molar 
ratio) vesicles with Molt-3 lymphocytes in a dose-dependent manner, suggesting that a lipid 
component acts as a fusogen [17, 46]. In an attempt to identify the fusogen, detailed lipid 
analyses of M. fermentans membranes were performed [17, 47, 48], revealing that the polar 
lipid fraction of this organism contains unusual choline-containing ether 
phosphoglycolipids, 1-O-alkyl/alkenyl-2-O-acyl-glycero-3-phosphocholine and its lyso-form 
1-O-alkyl/alkenyl-glycero-3-phosphocholine [49]. The ether lipids, mainly the lyso-
derivative has a marked effect on the fusion of M. fermentans with host eukaryotic cells [50]. 
Very little is known about the role of membrane proteins in the fusion process. The 
observation that fusion of M. fermentans with Molt-3 cells was inhibited by pretreatment of 
intact M. fermentans with proteolytic enzymes [51] implies that this organism possesses a 
 
Biomedical Tissue Culture 40 
been observed as early as 30 min after infection [6], whereas invasion of cultured HEp-2 
cells by M. penetrans has been shown to begin after 2 h of infection [36]. 
The intracellular fate of invading bacteria can vary greatly. Most invasive bacteria appear to 
be able to survive intracellularly for extended periods of time, at least if they have reached a 
suitable host cell [37]. Other engulfed bacteria are degraded intracellularly via phagosome-
lysosome fusion. The invasive bacteria either remain and multiply within the endosomes 
after invasion or are released via exocytosis and/or the lysis of the endosomes which may 
allow multiplication within the cytoplasm. Most ultrastructural studies performed with 
engulfed mycoplasmas revealed mycoplasmas within membrane-bound vesicles [30, 33, 38]. 
Persistence of M. penetrans within NIH/3T3 cells, Vero cells, human endothelial cells, HeLa 
cells, WI-38 cells, and HEp-2 cells has been observed over a 48–96 h postinfection [19, 23]. M. 
gallisepticum remains viable within HeLa cells during 24–48 h of intracellular residence [31]. 
The observation of vesicles stuffed with M. penetrans in various host cells was taken as an 
indication that M. penetrans is able to divide within intracellular vesicles of the host cells 
[19]. Nonetheless, the intracellular multiplication of mycoplasmas remains to be 
convincingly demonstrated. 
  
Figure 3. Confocal micrographs demonstrating binding and internalization of M. hyorhinis (green 
fluorescence) by melanoma cells. A, Control of uninfected melanoma cells; B, Formaldehyde fixed 
melanoma cells infected with mycoplasma (bacteria on the melanoma cell surface); C, Native melanoma 
cells infected by mycoplasma (bacteria internalized by cells). 
Almost all invasive bacteria that come into contact with the host cell surface trigger 
cytoskeletal rearrangements that facilitate bacterial internalization [35, 39]. Involvement of 
the host cell cytoskeleton in internalization is considered to be the result of a host cell signal 
transduction cascade induced by the invasive bacterium. As in many signal transduction 
processes initiated by bacteria, kinases and/or phosphatases are usually involved [39]. The 
invading mycoplasmas generate uptake signals that trigger the assembly of highly 
organized cytoskeletal structures in the host cells [23]. Yet, the nature of these signals and 
the mechanisms used to transduce them are not fully understood. Specific activation of 
protein kinases occurs during the internalization of most of the bacteria taken up by 
microtubule-dependent mechanisms [16]. It has been shown that invasion of HeLa cells by 
M. penetrans is associated with tyrosine phosphorylation of a 145-kDa host cell protein [21]. 
Tyrosine phosphorylation activates phospholipase C to generate two second messengers: 
phosphatidylinositol metabolites and diacylglycerol (DAG). Changes in host cell lipid 
turnover occur as a result of M. penetrans binding and/or invasion of Molt-3 lymphocytes 
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[40]. These changes include the accumulation of DAG and the release of unsaturated fatty 
acids, predominantly long-chain polyunsaturated ones such as docosahexanoic acid (C22:6, 
40]. Nonetheless, metabolites of phosphatidylinositol were not detected. These observations 
support the hypothesis that M. penetrans stimulates host phospholipases to cleave 
membrane phospholipids, thereby initiating the signal transduction cascade. Because in 
HeLa cells, which are invaded by M. penetrans, DAG is generated, it is likely that the protein 
kinase C is activated in the host cells. Indeed, transient protein kinase C activation was 
demonstrated in invaded HeLa cells by several methods, including translocation to the 
plasma membrane and enzymatic activity [22]. However, activation was weak and transient, 
peaking at 20 min postinfection. How any of these different signal transduction events lead 
to specific microtubule activity resulting in mycoplasmal internalization is unknown. The 
role of these signals in the penetration, survival, and proliferation of mycoplasmas within 
host cells, as well as the involvement of the lipid intermediates in the pathobiological 
alterations taking place in the host cells, merit further investigation.  
3.3 Fusion with host cells 
The lack of a rigid cell wall allows direct and intimate contact of the mycoplasma membrane 
with the cytoplasmic membrane of the eukaryotic cell. Under appropriate conditions, such 
contact may lead to cell fusion. Fusion of mycoplasmas with eukaryotic host cells has been 
first observed in electron microscopic studies [41]. The development of energy transfer and 
fluorescence methods has enabled investigation of the fusion process on a quantitative basis 
in an experimental cell culture-mycoplasma system and has also allowed the identification 
of fusogenic mycoplasmas. In all the fusogenic Mycoplasma species tested, fusogenicity is 
dependent on the unesterified cholesterol content of the cell membrane [42]. Fusogenic 
activity can be found only among mycoplasmas requiring unesterified cholesterol for 
growth, whereas species, which do not require cholesterol, are nonfusogenic. Among the 
Mycoplasma species, the human mycoplasma, M. fermentans, is highly fusogenic, capable of 
fusing with a variety of cells [2]. It is widely accepted that the reorganization of the 
membrane structure that occurs during fusion requires that the lipid bilayer is broken up 
and that other inverted configurations, such as reversed nonbilayer aggregates, are being 
formed [43, 44, 45]. It has been shown that the polar lipid fraction of M. fermentans is capable 
of enhancing the fusion of small, unilamellar phosphatidylcholine-cholesterol (1:1 molar 
ratio) vesicles with Molt-3 lymphocytes in a dose-dependent manner, suggesting that a lipid 
component acts as a fusogen [17, 46]. In an attempt to identify the fusogen, detailed lipid 
analyses of M. fermentans membranes were performed [17, 47, 48], revealing that the polar 
lipid fraction of this organism contains unusual choline-containing ether 
phosphoglycolipids, 1-O-alkyl/alkenyl-2-O-acyl-glycero-3-phosphocholine and its lyso-form 
1-O-alkyl/alkenyl-glycero-3-phosphocholine [49]. The ether lipids, mainly the lyso-
derivative has a marked effect on the fusion of M. fermentans with host eukaryotic cells [50]. 
Very little is known about the role of membrane proteins in the fusion process. The 
observation that fusion of M. fermentans with Molt-3 cells was inhibited by pretreatment of 
intact M. fermentans with proteolytic enzymes [51] implies that this organism possesses a 
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proteinase-sensitive receptor(s) responsible for binding and/or the establishment of tight 
contact with the cell surface of the host cell involved in fusion. During the fusion process, 
mycoplasma components may be delivered into the host cell and affect the normal functions 
of the cell. A whole array of hydrolytic enzymes has been identified in mycoplasmas [1, 15, 
52]. Most remarkable are the mycoplasmal nucleases [1] that may degrade host cell DNA. It 
has recently been shown that M. fermentans contains a potent phosphoprotein phosphatase 
[52]. The delivery of an active phosphoprotein phosphatase into the eukaryotic cell upon 
fusion may interfere with the normal signal transduction cascade of the host cell.  
4. Effects of mycoplasmas on cell cultures 
Effects on cell function and metabolism have long been recognized as common in 
mycoplasma contaminated cell cultures. The nature of the effects depends on the 
contaminating species and strain of mycoplasma, and on the type of cell infected. 
Frequently, the effects are due to nutrient deprivation, such as the depletion of amino acids, 
sugars, fatty acids, cholesterol or nucleic-acid precursors [5], the depletion of choline [4] or 
the activity of mycoplasmal endonucleases [53], mycoplasmal arginine deiminase [54] or 
mycoplasmal thymidine phosphorylase [55]. Some mycoplasmas have been shown to 
produce severe cytopathic effects (CPE) characterized by stunted, abnormal growth and 
rounded, degenerated cells, apparently due to the promotion or inhibition of apoptosis [56]. 
The promotion of apoptosis may be due to direct effects of mycoplasma components. Thus, 
M. bovis infection sensitizes some host cells to apoptosis through participation of 
mycoplasmal endonucleases [53]. Choline deficiency induced by M. fermentans enhances rat 
astrocyte apoptosis [4]. Some mycoplasmas promote host cell death via induction of pro-
apoptotic genes [57, 58]. Pro-apoptotic and anti-apoptotic mycoplasmas appear to alter 
apoptosis regulatory genes differently [59].  
4.1. Competition for precursors 
Genomic analyses of mycoplasmas have revealed the limited biosynthetic capabilities of 
these microorganisms [60, 61]. Mycoplasmas apparently lost almost all the genes involved in 
the biosynthesis of amino acids, fatty acids, cofactors, and vitamins and therefore depend on 
the host microenvironment to supply the full spectrum of biochemical precursors required 
for the biosynthesis of macromolecules [1]. Competition for these biosynthetic precursors by 
mycoplasmas may disrupt host cell integrity and alter host cell function. Nonfermenting 
Mycoplasma spp. utilize the arginine dihydrolase pathway for generating ATP [62] and 
rapidly deplete the host's arginine reserves affecting protein synthesis, growth and host cell 
divisions. The effect on the cellular genome may be expressed in chromosomal breakage, 
multiple translocation events, reduction in chromosome number and the appearance of new 
and/or additional chromosome variants [63]. Since histones are arginine rich, it was 
suggested that mycoplasmas may exert their effects on cellular genomes by depleting 
arginine and thus inhibiting histone synthesis [62]. However, as fermenting mycoplasmas 
also induce chromosomal aberrations, other mechanisms, including competition for nucleic 
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acid precursors, or degradation of host-cell DNA by mycoplasma nucleases, may be 
involved. M. fermentans infection of cell cultures has been shown to result in a choline-
deficient environment and in the induction of apoptosis [64]. Choline is an essential dietary 
component that ensures the structural integrity and signaling functions of the cell 
membranes; it is the major source of methyl groups in the diet, and it directly affects lipid 
transport and metabolism and the cholinergic neurotransmission and transmembrane 
signaling of cells of the nervous system [65].  
4.2. Cytopathic effects 
Mycoplasmal attachment to eukaryotic cells may sometimes lead to a pronounced 
cytopathic effect. Attachment permits the mycoplasma contaminant to release noxious 
enzymatic and cytolytic metabolites directly onto the tissue cell membrane. Some 
mycoplasmas selectively colonize defined areas of the cell culture. This results in 
microcolony formation producing microlesions and small foci of necrosis, e.g., M. pulmonis, 
or form plaques, e.g., M. gallisepticum, in an agar overlay system [5]. Microcolonization 
suggests that mycoplasma-specific receptors are localized in defined areas of the cell 
monolayer. However, other fermenting mycoplasmas, e.g., M. hyorhinis, attach to every cell 
and destroy the entire monolayer, producing a generalized cytopathic effect. With HeLa 
cells infected by the invasive M. penetrans, the most pronounced effect was the vacuolation 
of the host cells [22]. The vacuoles appeared to be empty, differing from the described 
membrane-bound vesicles containing clusters of bacteria [19]. The number and size of the 
vacuoles depended on duration of infection. Because vacuolation is not obtained with M. 
penetrans cell fractions [22], it is unlikely that a necrotizing cytotoxin is involved in the 
generation of the cellular lesions. A possible mechanism that leads to vacuolation may be 
associated with the accumulation of organic peroxides upon invasion of HeLa cells by M. 
penetrans. Indeed, when HeLa cells were grown with the antioxidant α-tocopherol, the level 
of accumulated organic peroxides was extremely low, and vacuolation was almost 
completely abolished [22].  
Being unable to synthesize nucleotides, mycoplasmas developed potent nucleases, either 
soluble ones secreted into the extracellular medium or membrane-bound nucleases [1, 66, 
67] apparently as a means of producing nucleic acid precursors required for metabolism. It 
has been shown that, occasionally, secreted mycoplasmal nucleases are taken up by the host 
cells [68]. Thus, it was suggested that the cytotoxicity of M. penetrans is mediated at least in 
part by a secreted mycoplasmal endonuclease that is cleaving DNA and/or RNA of the host 
cells [66], and the endonuclease activity of M. bovis was implicated in the increased 
sensitivity of lymphocytic cell lines to various inducers of apoptosis [69].  
4.3. Transformation of cells mediated by mycoplasmas 
Cell culture contamination may go undetected because mycoplasma infections do not 
produce the overt turbid growth that is commonly associated with bacterial and fungal 
contamination. Mycoplasma growth can grow in close interaction with mammalian cells, 
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proteinase-sensitive receptor(s) responsible for binding and/or the establishment of tight 
contact with the cell surface of the host cell involved in fusion. During the fusion process, 
mycoplasma components may be delivered into the host cell and affect the normal functions 
of the cell. A whole array of hydrolytic enzymes has been identified in mycoplasmas [1, 15, 
52]. Most remarkable are the mycoplasmal nucleases [1] that may degrade host cell DNA. It 
has recently been shown that M. fermentans contains a potent phosphoprotein phosphatase 
[52]. The delivery of an active phosphoprotein phosphatase into the eukaryotic cell upon 
fusion may interfere with the normal signal transduction cascade of the host cell.  
4. Effects of mycoplasmas on cell cultures 
Effects on cell function and metabolism have long been recognized as common in 
mycoplasma contaminated cell cultures. The nature of the effects depends on the 
contaminating species and strain of mycoplasma, and on the type of cell infected. 
Frequently, the effects are due to nutrient deprivation, such as the depletion of amino acids, 
sugars, fatty acids, cholesterol or nucleic-acid precursors [5], the depletion of choline [4] or 
the activity of mycoplasmal endonucleases [53], mycoplasmal arginine deiminase [54] or 
mycoplasmal thymidine phosphorylase [55]. Some mycoplasmas have been shown to 
produce severe cytopathic effects (CPE) characterized by stunted, abnormal growth and 
rounded, degenerated cells, apparently due to the promotion or inhibition of apoptosis [56]. 
The promotion of apoptosis may be due to direct effects of mycoplasma components. Thus, 
M. bovis infection sensitizes some host cells to apoptosis through participation of 
mycoplasmal endonucleases [53]. Choline deficiency induced by M. fermentans enhances rat 
astrocyte apoptosis [4]. Some mycoplasmas promote host cell death via induction of pro-
apoptotic genes [57, 58]. Pro-apoptotic and anti-apoptotic mycoplasmas appear to alter 
apoptosis regulatory genes differently [59].  
4.1. Competition for precursors 
Genomic analyses of mycoplasmas have revealed the limited biosynthetic capabilities of 
these microorganisms [60, 61]. Mycoplasmas apparently lost almost all the genes involved in 
the biosynthesis of amino acids, fatty acids, cofactors, and vitamins and therefore depend on 
the host microenvironment to supply the full spectrum of biochemical precursors required 
for the biosynthesis of macromolecules [1]. Competition for these biosynthetic precursors by 
mycoplasmas may disrupt host cell integrity and alter host cell function. Nonfermenting 
Mycoplasma spp. utilize the arginine dihydrolase pathway for generating ATP [62] and 
rapidly deplete the host's arginine reserves affecting protein synthesis, growth and host cell 
divisions. The effect on the cellular genome may be expressed in chromosomal breakage, 
multiple translocation events, reduction in chromosome number and the appearance of new 
and/or additional chromosome variants [63]. Since histones are arginine rich, it was 
suggested that mycoplasmas may exert their effects on cellular genomes by depleting 
arginine and thus inhibiting histone synthesis [62]. However, as fermenting mycoplasmas 
also induce chromosomal aberrations, other mechanisms, including competition for nucleic 
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acid precursors, or degradation of host-cell DNA by mycoplasma nucleases, may be 
involved. M. fermentans infection of cell cultures has been shown to result in a choline-
deficient environment and in the induction of apoptosis [64]. Choline is an essential dietary 
component that ensures the structural integrity and signaling functions of the cell 
membranes; it is the major source of methyl groups in the diet, and it directly affects lipid 
transport and metabolism and the cholinergic neurotransmission and transmembrane 
signaling of cells of the nervous system [65].  
4.2. Cytopathic effects 
Mycoplasmal attachment to eukaryotic cells may sometimes lead to a pronounced 
cytopathic effect. Attachment permits the mycoplasma contaminant to release noxious 
enzymatic and cytolytic metabolites directly onto the tissue cell membrane. Some 
mycoplasmas selectively colonize defined areas of the cell culture. This results in 
microcolony formation producing microlesions and small foci of necrosis, e.g., M. pulmonis, 
or form plaques, e.g., M. gallisepticum, in an agar overlay system [5]. Microcolonization 
suggests that mycoplasma-specific receptors are localized in defined areas of the cell 
monolayer. However, other fermenting mycoplasmas, e.g., M. hyorhinis, attach to every cell 
and destroy the entire monolayer, producing a generalized cytopathic effect. With HeLa 
cells infected by the invasive M. penetrans, the most pronounced effect was the vacuolation 
of the host cells [22]. The vacuoles appeared to be empty, differing from the described 
membrane-bound vesicles containing clusters of bacteria [19]. The number and size of the 
vacuoles depended on duration of infection. Because vacuolation is not obtained with M. 
penetrans cell fractions [22], it is unlikely that a necrotizing cytotoxin is involved in the 
generation of the cellular lesions. A possible mechanism that leads to vacuolation may be 
associated with the accumulation of organic peroxides upon invasion of HeLa cells by M. 
penetrans. Indeed, when HeLa cells were grown with the antioxidant α-tocopherol, the level 
of accumulated organic peroxides was extremely low, and vacuolation was almost 
completely abolished [22].  
Being unable to synthesize nucleotides, mycoplasmas developed potent nucleases, either 
soluble ones secreted into the extracellular medium or membrane-bound nucleases [1, 66, 
67] apparently as a means of producing nucleic acid precursors required for metabolism. It 
has been shown that, occasionally, secreted mycoplasmal nucleases are taken up by the host 
cells [68]. Thus, it was suggested that the cytotoxicity of M. penetrans is mediated at least in 
part by a secreted mycoplasmal endonuclease that is cleaving DNA and/or RNA of the host 
cells [66], and the endonuclease activity of M. bovis was implicated in the increased 
sensitivity of lymphocytic cell lines to various inducers of apoptosis [69].  
4.3. Transformation of cells mediated by mycoplasmas 
Cell culture contamination may go undetected because mycoplasma infections do not 
produce the overt turbid growth that is commonly associated with bacterial and fungal 
contamination. Mycoplasma growth can grow in close interaction with mammalian cells, 
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often silently for a long period of time. However, prolonged interactions with mycoplasmas 
with seemingly low virulence could, through a gradual and progressive course, induce 
chromosomal instability as well as malignant transformation, promoting tumorous growth 
of mammalian cells [70, 71]. Mycoplasmal-induced malignant transformation is a multistage 
process [70] associated with increased or decreased expression of many genes, especially 
cancer-related genes [72]. Over expression of H-ras and c-myc oncogenes were found to be 
closely associated with both the initial reversible and the subsequent irreversible states of 
the mycoplasma-mediated transformation of cells [71]. In some cases, mycoplasmas have 
been shown to induce the production of proteins that play essential roles in the 
development of malignancy. Examples are the mycoplasmal-promoted production in 
diverse types of cultured cells of bone morphogenetic protein 2 (BMP2) that enhances tumor 
growth by increasing cell proliferation [73]; mycoplasma-induced diminished activation of 
the tumor suppression protein p53, and enhanced fibroblast transformation by the 
oncogenic H-ras [74] ; promotion of cancer cell motility and migration by P37, the major 
immunogen of M. hyorhinis, through activation of the matrix metalloproteinase-2 [75]. 
4.4. Modulation of immune and non-immune cell metabolism 
The effects of mycoplasmas on the immune system are well established and include effects 
on differentiation and activation of innate immunity cells (macrophages, dentritic cells, 
neutrophils, NK) and on adaptive immunity cells (T and B cells). Mycoplasma and 
mycoplasmal components are potent macrophage activators, and stimulate the release of 
various proinflammatory cytokines, such as tumor necrosis factor α (TNFα), interleukin-
1(IL-1), IL-6, NO [4, 76]. In turn, some cytokines participate in lymphocyte differentiation 
and maturation [4]. M. fermentans induces a partial differentiation of the human monocytic 
cell line THP-1 [77]. Mycoplasma-contaminated exosome fractions of dentritic cells are 
mitogens for naive B lymphocytes and promote immunoglobulin secretion [78].  
Mycoplasmas and mycoplasmal components interact with diverse non-immune cells [56, 57, 
58, 79], with some information available on the cellular proteins affected by them. M. 
salivarium and M. fermentans induce the cell surface expression of intercellular adhesion 
molecule 1 (ICAM-1) in human gingival fibroblasts [80]. Hyperammonia toxicity in 
irradiated hepatoma cells has been shown to be due to contamination by mycoplasma 
containing arginine deiminase, that converts arginine to citrulline and ammonia [54]. M. 
pneumoniae induces the expression of the major airway protein mucin (MUC5AC) in 
cultured airway epithelial cells isolated from asthmatic subjects, but not in cells isolated 
from normal subjects; the preferential expression of MUC5AC in cells isolated from 
asthmatic subjects suggests that asthmatic epithelial cells may be primed to respond to the 
mycoplasma [81], thus pointing to the importance of identifying consequences of 
mycoplasma contamination that may be observed only in certain specific types of cultured 
cells. Catabolic mycoplasmal enzymes may interfere with chemotherapy. This is illustrated 
by the finding that the antiviral and cytostatic activity of pyrimidine nucleoside analogues 
(used as chemotherapeutic agents) is markedly decreased in M. hyorhinis contaminated cells, 
due to the mycoplasmal thymidine phosphorylase that degrades pyrimidine nucleoside 
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analogues [55]. Contamination of human cultured neuroblastoma SH-SY5Y and melanoma 
cell lines by M. hyorhinis results in increased levels of calpastatin (the endogenous inhibitor 
of the ubiquitous Ca2+-dependent protease calpain). The calpastatin upregulation resides in 
the M. hyorhinis lipoprotein fraction (LPP), via the IκB/NF-κB transcription pathway [79]. 
LPPs of several other mycoplasma species have also been found to upregulate calpastatin 
[J.D. Kornspan, T. vaisid, S. Rottem and N.S. Kosower, unpublished data]. Amyloid-β-
peptide and Ca2+ (these are central to the pathogenesis of Alzheimer’s Disease) activate 
calpain and are toxic to neuroblastoma cultured cells. The increased calpastatin levels in the 
mycoplasma-infected cells attenuate the calpain-related amyloid-β-peptide and Ca2+-
toxicity. Calpain and calpastatin are widely distributed in biological systems, with the ratio 
of calpastatin to calpain varying among cells. The calpain-calpastatin system has been 
implicated in a variety of cellular physiological and pathological processes [82]. Since 
calpastatin level is important in the control of calpain activity, mycoplasmas may play a role 
in a variety of metabolic and signal transduction pathways in some types of cultured cells. 
The mycoplasma-induced elevation of calpastatin provides an example of mycoplasmal 
effects on intracellular proteins in non-immune cells, resulting in important alterations in 
the host cell functions. 
4.5. Effect on virus infection  
Mycoplasmas may alter the progress of viral infections in cell cultures [83, 84]. As 
mycoplasmas may also cause virus-like CPE, many investigators have mistaken cytolytic 
mycoplasmas for viruses. Like viruses, mycoplasmas are filterable, hemadsorbant, 
hemagglutinant, resistant to certain antibiotics, able to induce chromosomal aberrations, and 
sensitive to detergents, ether and chloroform; thus the first established mycoplasma 
pathogens of humans (M. pneumoniae), animals (M. mycoides) or plants (Spiroplasma spp.) 
were believed to be viruses. Some mycoplasmas have no detectable effect on viral growth. 
Others can decrease, or even increase, virus yields in infected cell culture [85]. The effect 
depends on the strain or species of mycoplasma, the virus, and the cell culture used. At least 
two mechanisms responsible for decreasing viral yields in vitro have been identified. The 
cytolytic, fermenting mycoplasmas suppress metabolism and growth, resulting in a decrease 
in viral yields. Arginine-utilizing mycoplasmas decrease the titers of arginine-requiring 
DNA viruses by depleting arginine from the medium [62]. Mycoplasmas may render cell 
cultures less sensitive to exogenously supplied interferon and thus to increase virus yields 
[86]. Mycoplasmas may also inhibit viral transformation of cell cultures by known oncogenic 
viruses [5, 87]. 
4.6. Signal transduction pathways 
Mycoplasmas and mycoplasmal membrane LPPs attach to certain Toll-like receptors (TLRs) 
of the host cell membrane. The main TLR involved appears to be TLR2, with participation of 
TLR6 as coreceptor. In some cases, TLR1 is also involved [88]. The interaction with the 
receptors triggers cascades of cellular signals within the cell, and the complex pathways 
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often silently for a long period of time. However, prolonged interactions with mycoplasmas 
with seemingly low virulence could, through a gradual and progressive course, induce 
chromosomal instability as well as malignant transformation, promoting tumorous growth 
of mammalian cells [70, 71]. Mycoplasmal-induced malignant transformation is a multistage 
process [70] associated with increased or decreased expression of many genes, especially 
cancer-related genes [72]. Over expression of H-ras and c-myc oncogenes were found to be 
closely associated with both the initial reversible and the subsequent irreversible states of 
the mycoplasma-mediated transformation of cells [71]. In some cases, mycoplasmas have 
been shown to induce the production of proteins that play essential roles in the 
development of malignancy. Examples are the mycoplasmal-promoted production in 
diverse types of cultured cells of bone morphogenetic protein 2 (BMP2) that enhances tumor 
growth by increasing cell proliferation [73]; mycoplasma-induced diminished activation of 
the tumor suppression protein p53, and enhanced fibroblast transformation by the 
oncogenic H-ras [74] ; promotion of cancer cell motility and migration by P37, the major 
immunogen of M. hyorhinis, through activation of the matrix metalloproteinase-2 [75]. 
4.4. Modulation of immune and non-immune cell metabolism 
The effects of mycoplasmas on the immune system are well established and include effects 
on differentiation and activation of innate immunity cells (macrophages, dentritic cells, 
neutrophils, NK) and on adaptive immunity cells (T and B cells). Mycoplasma and 
mycoplasmal components are potent macrophage activators, and stimulate the release of 
various proinflammatory cytokines, such as tumor necrosis factor α (TNFα), interleukin-
1(IL-1), IL-6, NO [4, 76]. In turn, some cytokines participate in lymphocyte differentiation 
and maturation [4]. M. fermentans induces a partial differentiation of the human monocytic 
cell line THP-1 [77]. Mycoplasma-contaminated exosome fractions of dentritic cells are 
mitogens for naive B lymphocytes and promote immunoglobulin secretion [78].  
Mycoplasmas and mycoplasmal components interact with diverse non-immune cells [56, 57, 
58, 79], with some information available on the cellular proteins affected by them. M. 
salivarium and M. fermentans induce the cell surface expression of intercellular adhesion 
molecule 1 (ICAM-1) in human gingival fibroblasts [80]. Hyperammonia toxicity in 
irradiated hepatoma cells has been shown to be due to contamination by mycoplasma 
containing arginine deiminase, that converts arginine to citrulline and ammonia [54]. M. 
pneumoniae induces the expression of the major airway protein mucin (MUC5AC) in 
cultured airway epithelial cells isolated from asthmatic subjects, but not in cells isolated 
from normal subjects; the preferential expression of MUC5AC in cells isolated from 
asthmatic subjects suggests that asthmatic epithelial cells may be primed to respond to the 
mycoplasma [81], thus pointing to the importance of identifying consequences of 
mycoplasma contamination that may be observed only in certain specific types of cultured 
cells. Catabolic mycoplasmal enzymes may interfere with chemotherapy. This is illustrated 
by the finding that the antiviral and cytostatic activity of pyrimidine nucleoside analogues 
(used as chemotherapeutic agents) is markedly decreased in M. hyorhinis contaminated cells, 
due to the mycoplasmal thymidine phosphorylase that degrades pyrimidine nucleoside 
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analogues [55]. Contamination of human cultured neuroblastoma SH-SY5Y and melanoma 
cell lines by M. hyorhinis results in increased levels of calpastatin (the endogenous inhibitor 
of the ubiquitous Ca2+-dependent protease calpain). The calpastatin upregulation resides in 
the M. hyorhinis lipoprotein fraction (LPP), via the IκB/NF-κB transcription pathway [79]. 
LPPs of several other mycoplasma species have also been found to upregulate calpastatin 
[J.D. Kornspan, T. vaisid, S. Rottem and N.S. Kosower, unpublished data]. Amyloid-β-
peptide and Ca2+ (these are central to the pathogenesis of Alzheimer’s Disease) activate 
calpain and are toxic to neuroblastoma cultured cells. The increased calpastatin levels in the 
mycoplasma-infected cells attenuate the calpain-related amyloid-β-peptide and Ca2+-
toxicity. Calpain and calpastatin are widely distributed in biological systems, with the ratio 
of calpastatin to calpain varying among cells. The calpain-calpastatin system has been 
implicated in a variety of cellular physiological and pathological processes [82]. Since 
calpastatin level is important in the control of calpain activity, mycoplasmas may play a role 
in a variety of metabolic and signal transduction pathways in some types of cultured cells. 
The mycoplasma-induced elevation of calpastatin provides an example of mycoplasmal 
effects on intracellular proteins in non-immune cells, resulting in important alterations in 
the host cell functions. 
4.5. Effect on virus infection  
Mycoplasmas may alter the progress of viral infections in cell cultures [83, 84]. As 
mycoplasmas may also cause virus-like CPE, many investigators have mistaken cytolytic 
mycoplasmas for viruses. Like viruses, mycoplasmas are filterable, hemadsorbant, 
hemagglutinant, resistant to certain antibiotics, able to induce chromosomal aberrations, and 
sensitive to detergents, ether and chloroform; thus the first established mycoplasma 
pathogens of humans (M. pneumoniae), animals (M. mycoides) or plants (Spiroplasma spp.) 
were believed to be viruses. Some mycoplasmas have no detectable effect on viral growth. 
Others can decrease, or even increase, virus yields in infected cell culture [85]. The effect 
depends on the strain or species of mycoplasma, the virus, and the cell culture used. At least 
two mechanisms responsible for decreasing viral yields in vitro have been identified. The 
cytolytic, fermenting mycoplasmas suppress metabolism and growth, resulting in a decrease 
in viral yields. Arginine-utilizing mycoplasmas decrease the titers of arginine-requiring 
DNA viruses by depleting arginine from the medium [62]. Mycoplasmas may render cell 
cultures less sensitive to exogenously supplied interferon and thus to increase virus yields 
[86]. Mycoplasmas may also inhibit viral transformation of cell cultures by known oncogenic 
viruses [5, 87]. 
4.6. Signal transduction pathways 
Mycoplasmas and mycoplasmal membrane LPPs attach to certain Toll-like receptors (TLRs) 
of the host cell membrane. The main TLR involved appears to be TLR2, with participation of 
TLR6 as coreceptor. In some cases, TLR1 is also involved [88]. The interaction with the 
receptors triggers cascades of cellular signals within the cell, and the complex pathways 
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culminate in a variety of host cell responses. Mycoplasmas and mycoplasmal LPP are 
known to activate the transcription factors NF- B [74, 79] and AP-1 [1 4], via TLR- 
downstream cascades involving kinases (MAPKKKs-IKKs and MAPKKKs-MAPKKs- 
MAPKs). Known mycoplasma-affected target genes are mainly those responsible for 
proinflammatory proteins [4], and those involved in malignant cell transformation [72], with 
little information available on genes responsible for other proteins [53, 79, 80, 81]. 
5. Detecting mycoplasmas in cell cultures  
The ubiquitous nature of mycoplasma in man, animals and the environment increases the 
likelihood of the introduction of these organisms into cell cultures or a manufacturing 
process. Currently, the recommended test requirements for biologics are as follows: (1) The 
master- and working cell seed banks must be free of mycoplasmas. (2) The product-harvest 
concentrates must be free of mycoplasmas. (3) All products produced in cell cultures, a 
generic term used for all tissue cells grown in vitro, must be tested. This includes viral 
vaccines (such as poliovirus, adenovirus, measles, rubella, mumps and rabies), monoclonal 
antibodies, immunological modifiers and cell-culture-derived blood products, such as 
tissue-type plasminogen and erythropoietin. Guidelines for mycoplasma testing of cell 
cultures and biologics is addressed in several international pharmacopoeias e.g., United 
States Pharmacopoeia, (USP 33/NF 28 <63>and <1226>, Mycoplasma tests, 2010); European 
Pharmacopoeia (EP 2.6.7., Mycoplasmas, 7th ed.; 2012); Japanese Pharmacopoeia (JP); 
Section 21 of the Code of Federal Regulations (CFR), International Conference on 
Harmonisation (ICH), and FDA- Points to Consider (PTC) documents. Several different 
approaches are being used to detect mycoplasmas in contaminated tissue cultures including 
the culture procedures, a variety of nonspecific procedures and the polymerase chain 
reactions (PCR). 
5.1. Standard culture procedures 
The culture procedures require that the tested material will be inoculated onto solid and 
liquid growth media capable of growing a variety of mycoplasma including aerobic, 
microaerophilic and anaerobic strains. Broth cultures are incubated and sub passaged to 
plate agar. After the required incubation period, the agar plates are observed 
microscopically for the presence of mycoplasma colonies [5]. The variation inherent in the 
complex media usually used for in vitro culture of mycoplasmas is due to batch variation in 
compounds such as sera, or yeast extract. Such variation makes the development of defined 
media attractive. However, a key problem has been the supply of lipids in an available, but 
non-toxic form, hence, defined artificial media have been developed for only a few species 
[1]. Most mycoplasmas produce microscopic (100 - 400 µm in diameter) colonies with a 
characteristic 'fried-egg' appearance, growing embedded in the agar, although some (e.g. M. 
pulmonis) may not grow completely embedded, and some freshly-isolated pathogens (e.g. 
M. pneumoniae) produce a more granular, diffuse colony-type. Since they usually grow 
embedded, mycoplasma colonies can be distinguished from other bacteria by: (1) specific 
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colony shape; (2) being difficult to scrape from the agar surface. Mycoplasmas growing on 
agar can be identified more specifically by immunofluorescent procedures, using 
fluorophores conjugated to species-specific antibodies [4]. The traditional culture-based 
techniques are relatively sensitive, capable of detecting as few as 1-10 colony forming units 
of mycoplasmas and therefore are required by pharmacopoeias and regulatory authorities 
worldwide. Nonetheless, this procedure is time consuming requiring a minimum of 28 days 
to complete, costly and not sensitive to non-cultivable strains, therefore, the development of 
more accurate and faster techniques are needed to facilitate faster detection of a 
contaminating mycoplasma and more rapid corrective action. 
5.2. Polymerase chain reaction (PCR) 
PCR methodology has existed for decades, however conventional PCR and real-time PCR 
assays have only recently been considered for mycoplasma detection in cell cultures and 
biological products. These assays are often based on the amplification of conserved regions of 
the 16S rDNA [89, 90] or the spacer region between the 16S and 23S rDNA [91, 92]. The PCR 
approach is rapid (1-2 days), inexpensive, and independent of culture conditions. Specific 
oligonucleotide primers capable of amplifying the conserved regions and thus detecting DNA 
of multiple Mollicutes species while excluding other contaminating DNA are used in the PCR 
assays. In comparison to conventional PCR methods, real-time PCR assays are quicker, 
simpler, and more suitable for handling a large number of samples [93]. Nonetheless, some of 
the primers used are not entirely specific for Mollicutes [94, 95]. Thus, sequence homologies 
between Mollicutes spp. and Chlamydia spp. led to false-positive results in Chlamydial cell 
cultures tested for mycoplasma contamination with a commercial PCR kit [96].  
Throughout the last decade, new PCR assays for mycoplasma detection, which appeared to 
resolve these issues, were described, while being sufficiently simple and inexpensive for 
routine use. For example, a PCR assay which applied readily available techniques in DNA 
extraction together with a modified single-step PCR using a primer pair that was 
homologous to a broad spectrum of mycoplasma species was proposed [97]. A high 
sensitivity and specificity for mycoplasma detection in cell production cultures was made 
possible through the combination of three key techniques: 8-methoxypsoralen and UV light 
treatment to decontaminate PCR reagents of DNA; hot-start Taq DNA polymerase to reduce 
nonspecific priming events; and touchdown PCR to increase sensitivity while also reducing 
nonspecific priming events. Another proposed PCR assay for mycoplasma detection was a 
sensitive two-stage PCR procedure which detected 13 common mycoplasmal contaminants 
[92]. For primary amplification, the DNA regions encompassing the 16S and 23S rRNA 
genes of 13 species were targeted using general mycoplasma primers. The primary PCR 
products were then subjected to secondary nested PCR, using two different primer pair sets, 
designed via the multiple sequence alignment of nucleotide sequences obtained from the 13 
mycoplasmal species. The nested PCR, which generated DNA fragments of 165-353 bp, was 
found to be able to detect 1-2 copies of the target DNA, and evidenced no cross-reactivity 
with the genomic DNA of related microorganisms or of human cell lines, thereby 
confirming the sensitivity and specificity of the primers used.  
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Throughout the last decade, new PCR assays for mycoplasma detection, which appeared to 
resolve these issues, were described, while being sufficiently simple and inexpensive for 
routine use. For example, a PCR assay which applied readily available techniques in DNA 
extraction together with a modified single-step PCR using a primer pair that was 
homologous to a broad spectrum of mycoplasma species was proposed [97]. A high 
sensitivity and specificity for mycoplasma detection in cell production cultures was made 
possible through the combination of three key techniques: 8-methoxypsoralen and UV light 
treatment to decontaminate PCR reagents of DNA; hot-start Taq DNA polymerase to reduce 
nonspecific priming events; and touchdown PCR to increase sensitivity while also reducing 
nonspecific priming events. Another proposed PCR assay for mycoplasma detection was a 
sensitive two-stage PCR procedure which detected 13 common mycoplasmal contaminants 
[92]. For primary amplification, the DNA regions encompassing the 16S and 23S rRNA 
genes of 13 species were targeted using general mycoplasma primers. The primary PCR 
products were then subjected to secondary nested PCR, using two different primer pair sets, 
designed via the multiple sequence alignment of nucleotide sequences obtained from the 13 
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found to be able to detect 1-2 copies of the target DNA, and evidenced no cross-reactivity 
with the genomic DNA of related microorganisms or of human cell lines, thereby 
confirming the sensitivity and specificity of the primers used.  
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Other studies showed that reverse transcription-PCR (RT-PCR) methods based on detection 
of the 16S rRNA, which is present in multiple (103–104) copies per bacterial cell [98, 99], are 
more sensitive than PCR detecting the 16S rDNA. Thus, a direct side-by-side comparison of 
RT-PCR and PCR targeting the 16S rRNA and the 16S rRNA gene, respectively, 
demonstrated that RT-PCR was able to provide up to a two-logarithm higher sensitivity of 
bacteria detection in comparison with the PCR-based assay [90, 100] and the sensitivity 
provided by RT-PCR is approaching the sensitivity of conventional microbiological culture 
methods [100]. Therefore, it was suggested that RT-PCR methods targeting the bacterial 16S 
or 23S rRNAs are having the real potential to provide the sensitivity of mycoplasma 
detection close to or even higher than that of conventional culture methods [101] .  
Recently, the MycoTOOL PCR test kit from Roche (Roche, Diagnostic GmbH, Penzberg, 
Germany) was approved by the European Medicines Agency (EMEA) for release testing of 
pharmaceutical products. It is the first commercially available Mycoplasma PCR test that 
can replace traditional Mycoplasma tests (culture method as well as indicator cell culture 
method) during pharmaceutical production. In June 2009 the FDA approved the PCR 
concept of this test for seven commercial products from Genentech. Earlier, Bayer Health 
Care received approval for a pharmaceutical product from the EMEA and Japan’s Ministry 
of Health, Labour and Welfare (MHLW) using the same PCR-based test concept. Guidelines 
describing acceptable protocols for specific PCR methods are provided by the EP and JP. 
The pharmacopoeias, PTC, and CFR protocols vary with their recommendations on how to 
conduct the PCR assays. 
5.3. Indirect non-specific procedures 
Some 'non-cultivable' mycoplasma strains cannot readily be grown on standard agar or 
broth-culture media [5], and cell-assisted culture is required for their isolation. Cell-culture 
systems are therefore a valuable ancillary tool for the isolation and detection of 
mycoplasmas and 'indicator cell culture' procedures using either VERO (African green 
monkey kidney), or NIH 3T3 cell cultures have been developed [102]. These cell lines are 
susceptible to infection by the majority of mycoplasmas and are therefore a reliable 
'indicator' system for detecting mycoplasma infection. These approaches are particularly 
useful for the identification and detection of mycoplasmas that adhere to host-cell surfaces. 
The indirect non-specific procedures require that the tested material will be inoculated 
directly onto tissue culture cover slips or flasks containing a monolayer of the indicator  
cells. The indicator cell culture inoculated with the tested material are than fixed and stained 
with DNA-binding fluorochromes using bisbenzimidazole (such as Hoechst or DAPI  
stains) [103].  
Identification of contaminating mycoplasma is by visual observation via fluorescent 
microscopy. Mycoplasmas are detected by their characteristic particulate or filamentous 
pattern of bright fluorescence on the cell surface (Figure 4) and, if contamination is heavy, in 
surrounding areas. These procedures are suitable for use with either non-specific DNA 
stains for detecting mycoplasmas, or in conjunction with mycoplasma-speciation methods, 
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such as by immunofluorescence procedures using species-specific polyclonal antisera, or 
monoclonal antibodies, conjugated with fluorescein or peroxidase [104]. A wide variety of 
luminol-dependent chemiluminescence and bioluminescent methods were described [5, 63].  
 
Figure 4. Mycoplasma contaminated eukaryotic cells stained with a fluorescent DNA stain. 
Biochemical identification methods have also been in use [5, 78]. Procedures based on the 
comparative utilization of uridine versus uracil in contaminated versus mycoplasma-free 
cell cultures have been suggested [105]. Other methods are based on the detection of 
enzyme activity present in mycoplasmas, but absent, or minimal in uninfected cell cultures. 
The enzymic activities measured include: arginine deiminase [62]; thymidine, uridine, 
adenosine or pyrimidine nucleoside phosphorylase [102]; hypoxanthine or uracil 
phosphoribosyl transferase activities [106]. Positive results are based on arbitrary values, 
making low levels of mycoplasma contamination difficult to detect. Detection kit that 
provide a new, sensitive and rapid biochemical method was recently presented (Cambrex, 
Bio Science, Caravaggio, Bergamo, Italy). The test is based on a bioluminescent assay which 
can be assessed within 20 min for daily determination of the mycoplasma status of cell 
cultures. The performance sensitivity and specificity of the kit was evaluated and compared 
to the PCR/ELISA detection kit (Roche, Diagnostic GmbH, Penzberg, Germany) and the 
standard culture method [5]. Recently, a simple and inexpensive assay monitoring 
mycoplasma contamination, based on degradation of the Gaussia luciferase reporter in cell 
cultures was described [107]. This assay has been shown to be more sensitive for detecting 
mycoplasma contamination in seven different cell lines as compared to a commercially 
available bioluminescent assay [107]  
6. Eliminating mycoplasmas from infected cultures 
Ever since mycoplasma contamination of cell cultures was first reported, attempts have been 
made to develop methods for the elimination of mycoplasmas, including the use of antibiotics 
such as tetracycline, kanamycin, novobiocin, tylosin, gentamycin, doxycycline, thiayline and 
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quinolones; surface-active agents; anti-mycoplasma antisera and prolonged heating treatments 
(40-42 °C) [63, 108]. Eliminating mycoplasmas by passage of a cell culture through nude mice 
[109] has been successful for some, but not all, mycoplasmas. An efficient procedure for 
eliminating mycoplasmas is based on the selective incorporation of 5-bromouracil (5-BrUra) 
into mycoplasmas, and the induction of breaks by light in the 5-BrUra-containing DNA [110]. 
The unusually high content of A+T makes the mycoplasma DNA an excellent candidate for the 
induction of breakage by the combined action of 5-BrUra, 33258-Hoechst and visible light 
[110]. Some of the elimination procedures may apply to some, but not all, mycoplasma species; 
some of them are laborious and/or time consuming. It was suggested, therefore, that whenever 
possible, the infected cell culture should be discarded and replaced with a mycoplasma-free 
culture [108]. When the cell culture is irreplaceable, the use of antibiotic mixtures, are the 
commonest approaches. One has to keep in mind that cell-culture contaminants that have been 
continuously exposed to antibiotics develop resistance to the drug, and antibiotic-resistant 
strains have been isolated for most Mycoplasma species tested. Treatment may also induce the 
selection of a subpopulation of cells and the treated cell culture may differ in its characteristics 
from the original culture.  
Among the antibiotics that were shown to have strong anti-mycoplasma properties are 
different inhibitors of protein synthesis mainly tetracyclines or macrolides as well as 
quinolones [111]. The target enzymes of quinolones are considered to be DNA gyrase and 
topoisomerase IV which are essential enzymes for controlling the topological state of DNA 
in DNA replication and transcription . Most recently the quinolone garenoxacin was found 
to be a most valuable quinolone in the elimination M. pneumoniae [112].  
The addition of antibiotics to the culture medium during a limited period of time (1-3 wk) is 
a simple, inexpensive, and very practical approach for decontaminating continuous cell 
lines. BM-cyclin (trade name of Roche, Mannheim, Germany), a combination of tiamulin 
and minocycline (both inhibiting protein synthesis), was introduced by Jung et al. [113] who 
show that three cycles of treatment of a contaminated cell culture with BM-cyclin I 
(containing the macrolide tiamulin) at a final concentration of 10 µg/ml for 3 days followed 
by BM-cyclin II (containing the tetracycline minocycline) at a concentration of 5 µg/ml for 4 
days completely eradicated mycoplasmal infection from cultured cells [113]. 
Uphoff and Drexler [111, 114] examined the effectiveness of several quinolones and BM-
cycline protocols. The contaminated cell cultures were exposed to one of the following five 
antibiotic regimens: mycoplasma removal agent (MRA, quinolone; a 1-wk treatment), 
enrofloxacin (quinolone; 1 wk), sparfloxacin (quinolone; 1 wk), ciprofloxacin (quinolone; 2 
wk), and BM-Cyclin (alternating tiamulin and minocycline; 3 wk). The mycoplasma 
infection was permanently eliminated by the various antibiotics in 66-85% of the cultures 
treated. Mycoplasma resistance was seen in 7-21%, and loss of the culture as a result of 
cytotoxically caused cell death occurred in 3-11% of the cultures treated [111, 114].  
Recently, MycoZap (trade name of Lonza, Verviers, Belgium) treatment has been introduced 
as a new therapeutic tool able to overcome the eukaryotic cytotoxicity of fluoroquinolones 
and BM-Cyclins [115]. MycoZap kit (Lonza, Verviers, Belgium) includes a combination of 
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patented antibiotic and antimetabolic agents. An evaluation of the MycoZap kit 
performance was recently presented by Mariotti et al., [116] who exposed mycoplasma 
contaminated cells to the MycoZap protocol and compared the results obtained to the 
eradication efficiency of enrofloxacin (Fluka, Bio-Chemika, Missouri, USA), MRA 
(Euroclone, Lugano, Switzerland), ciprofloxacin and the BM-Cyclin protocol. Treatment of 
contaminated cell cultures by MycoZap, MRA, ciprofloxacin, enrofloxacin and BM-cycline, 
eliminated mycoplasma infection by 46%, 29%, 43%, 40% and 57% respectively. The use of 
an eradication mixture based on a combination of the antibiotics BM-Cyclins, ciprofloxacin, 
enrofloxacin and MRA was able to clean 88.6% of the infected cultures, whereas the addition 
of MycoZap to the eradication mixture resulted in the eradication of mycoplasmas from 
100% of the contaminated cell cultures [116]. 
7. Conclusions 
Mycoplasmas are shown to cause various alterations in cultured cells. As described above, 
some alterations are due to direct effects on the cells by mycoplasma components, and other 
alterations are due to indirect effects, via inducing the host cell to alter its gene and protein 
expression and activity. It is important to emphasize the fact that mycoplasmal-altered cell 
phenotype and function is often observed in specific types of cells under special conditions, 
e.g., when the cultured cells are exposed to certain agents. The detection of mycoplasma 
contamination, and the identification of the factors and pathways involved in the 
mycoplasmal effects are thus of utmost importance in handling cultured cells, including 
using stem cells for differentiation to specific tissues. 
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by BM-cyclin II (containing the tetracycline minocycline) at a concentration of 5 µg/ml for 4 
days completely eradicated mycoplasmal infection from cultured cells [113]. 
Uphoff and Drexler [111, 114] examined the effectiveness of several quinolones and BM-
cycline protocols. The contaminated cell cultures were exposed to one of the following five 
antibiotic regimens: mycoplasma removal agent (MRA, quinolone; a 1-wk treatment), 
enrofloxacin (quinolone; 1 wk), sparfloxacin (quinolone; 1 wk), ciprofloxacin (quinolone; 2 
wk), and BM-Cyclin (alternating tiamulin and minocycline; 3 wk). The mycoplasma 
infection was permanently eliminated by the various antibiotics in 66-85% of the cultures 
treated. Mycoplasma resistance was seen in 7-21%, and loss of the culture as a result of 
cytotoxically caused cell death occurred in 3-11% of the cultures treated [111, 114].  
Recently, MycoZap (trade name of Lonza, Verviers, Belgium) treatment has been introduced 
as a new therapeutic tool able to overcome the eukaryotic cytotoxicity of fluoroquinolones 
and BM-Cyclins [115]. MycoZap kit (Lonza, Verviers, Belgium) includes a combination of 
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patented antibiotic and antimetabolic agents. An evaluation of the MycoZap kit 
performance was recently presented by Mariotti et al., [116] who exposed mycoplasma 
contaminated cells to the MycoZap protocol and compared the results obtained to the 
eradication efficiency of enrofloxacin (Fluka, Bio-Chemika, Missouri, USA), MRA 
(Euroclone, Lugano, Switzerland), ciprofloxacin and the BM-Cyclin protocol. Treatment of 
contaminated cell cultures by MycoZap, MRA, ciprofloxacin, enrofloxacin and BM-cycline, 
eliminated mycoplasma infection by 46%, 29%, 43%, 40% and 57% respectively. The use of 
an eradication mixture based on a combination of the antibiotics BM-Cyclins, ciprofloxacin, 
enrofloxacin and MRA was able to clean 88.6% of the infected cultures, whereas the addition 
of MycoZap to the eradication mixture resulted in the eradication of mycoplasmas from 
100% of the contaminated cell cultures [116]. 
7. Conclusions 
Mycoplasmas are shown to cause various alterations in cultured cells. As described above, 
some alterations are due to direct effects on the cells by mycoplasma components, and other 
alterations are due to indirect effects, via inducing the host cell to alter its gene and protein 
expression and activity. It is important to emphasize the fact that mycoplasmal-altered cell 
phenotype and function is often observed in specific types of cells under special conditions, 
e.g., when the cultured cells are exposed to certain agents. The detection of mycoplasma 
contamination, and the identification of the factors and pathways involved in the 
mycoplasmal effects are thus of utmost importance in handling cultured cells, including 
using stem cells for differentiation to specific tissues. 
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1. Introduction 
Breast cancer is the most common cancer in women, with more than 1,000,000 new cases and 
more than 410,000 deaths each year [38]; [39]. At present, breast cancer is mainly treated by 
surgical therapy as well as cytotoxic, hormonal and immunotherapeutic agents. These 
methods achieve response rates ranging from 60 to 80% for primary breast cancers and about 
50% of metastases [22]; [24]. However, up to 20 to 70% of patients relapse within 5 years [10]. 
The reason for recurrence is the existence of cancer stem cells in malignant tumors such 
brain, prostate, pancreatic, liver, colon, head and neck, lung and skin tumors [3]; [7]; [14]; 
[15]; [21]; [32]; [49]; [51]. Breast cancer stem cells (BCSCs) were first detected by Al-Hajj et al. 
(2003) that showed cells expressing CD44 protein and weakly or not expressing CD24 
protein could establish new tumors in xeno-grafted mice. Using these markers, researchers 
isolated BCSCs from primary [41]; [47] and established breast cancer cell lines [16]. Another 
technique used is cell culture in serum-free medium to form mammospheres. 
Mammospheres exhibit many stem cell-like properties such as differentiation into all three 
mammary epithelial lineages [11]; [12]. These BCSCs have been demonstrated to cause 
treatment resistance and relapse. Thus, BCSC-targeting therapy is considered a promising 
therapy for treating breast cancer. 
Recently, BCSC-targeting therapies have been researched by various groups worldwide. 
Strategies include targeting the self-renewal of BCSCs [30]; [31], indirectly targeting the 
microenvironment [29]; [50]; [31] and directly killing BCSCs by chemical agents that induce 
differentiation [25]; [19]; [42]; [43], immunotherapy [4]; [5]; [40] and oncolytic viruses [26]; [34]. 
In all strategies, isolation of BCSCs is an important step to recover starting materials for all 
subsequent steps. Thus, isolation of BCSCs is a pivotal step for successful outcomes. Almost all 
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more than 410,000 deaths each year [38]; [39]. At present, breast cancer is mainly treated by 
surgical therapy as well as cytotoxic, hormonal and immunotherapeutic agents. These 
methods achieve response rates ranging from 60 to 80% for primary breast cancers and about 
50% of metastases [22]; [24]. However, up to 20 to 70% of patients relapse within 5 years [10]. 
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[15]; [21]; [32]; [49]; [51]. Breast cancer stem cells (BCSCs) were first detected by Al-Hajj et al. 
(2003) that showed cells expressing CD44 protein and weakly or not expressing CD24 
protein could establish new tumors in xeno-grafted mice. Using these markers, researchers 
isolated BCSCs from primary [41]; [47] and established breast cancer cell lines [16]. Another 
technique used is cell culture in serum-free medium to form mammospheres. 
Mammospheres exhibit many stem cell-like properties such as differentiation into all three 
mammary epithelial lineages [11]; [12]. These BCSCs have been demonstrated to cause 
treatment resistance and relapse. Thus, BCSC-targeting therapy is considered a promising 
therapy for treating breast cancer. 
Recently, BCSC-targeting therapies have been researched by various groups worldwide. 
Strategies include targeting the self-renewal of BCSCs [30]; [31], indirectly targeting the 
microenvironment [29]; [50]; [31] and directly killing BCSCs by chemical agents that induce 
differentiation [25]; [19]; [42]; [43], immunotherapy [4]; [5]; [40] and oncolytic viruses [26]; [34]. 
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studies have focused more on treatment strategies than isolation of BCSCs. Indeed, to date, 
there are only three methods used to identify and isolate BCSCs, namely fluorescence-activated 
cell sorting (FACS) based on BCSC markers such as CD44, CD24 and CD133 [2]; [52]; [46]; [41], 
identification of the side population (SP) that effluxes Hoechst 33342 [13]; [8]; [28] and 
mammosphere formation [44]; [54]. All these methods possess some limitations. 
The first limitation is the resulting heterogenous population of BCSCs. Using these 
techniques, the BCSC population contains phenotypes with differences in CD44 and CD24 
expression levels. These differences reflect variations in some cellular behaviors. BCSCs 
isolated by SP sorting or mammosphere culture may contain a small population that do not 
exhibit the CD44+CD24- phenotype. Thus, in this study, we attempted to establish a new 
method to isolate a homogenous population from malignant breast tumors.  
Our study is based on the cell cloning technique that is applied to select hybridomas for 
monoclonal antibody production. Using a cell sorter with the index sorting function, we aim 
establish a new protocol that can isolate and establish BCSC clones at a high efficiency.  
2. Materials and methods 
2.1. Primary culture 
Primary culture of breast cancer cells from malignant breast tumors was carried out as 
described elsewhere [41]; [42]. Tumor biopsies were obtained from consenting patients at 
the Oncology Hospital in Ho Chi Minh city, Vietnam, and then transferred to the laboratory 
on ice. All samples were kept in phosphate-buffered saline (PBS) containing 1× antibiotics 
and an antimycotic (Sigma-Aldrich, St Louis, MO). Tumors were homogenized into small 
fragments (approximately 1–2 mm3) using scissors. These samples were seeded in 35-mm 
culture dishes (Nunc, Roskilde, Denmark) in M171 medium (Invitrogen, Carlsbad, CA) 
containing mammary epithelial growth supplement (MEGS) (Invitrogen, Carlsbad, CA), and 
incubated at 37°C with 5% CO2. Five patients participated in this study.  
2.2. Single-cell sorting 
Primary cells were detached by 0.25% trypsin/EDTA. The cell suspension was washed twice 
with PBS to eliminate trypsin. The cell pellet was resuspended in sorting buffer (PBS 
containing 0.2 mM EDTA and 1 mg/mL bovine serum albumin (BSA) at 1x106 cells/ml. 
Single-cell sorting was performed on a BD FACSJazz (BD Bioscience, Franklin Lakes, NJ) 
using the index sorting function. One cell was sorted into one well of a 96-well plate that 
contained M171 medium with MEGS. One sample was sorted into 2880 wells in 30 plates. 
After sorting, all wells were checked for a single cell/well under an inverted microscope.  
2.3. Single cell-based culture and selection of mesenchymal-like cells 
After single-cell sorting, cells were cultured in M171 medium containing MEGS and incubated 
at 37°C with 5% CO2. Half medium volumes were exchanged every 3 days for 30 days. Then, 
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only wells that contained cell colonies were used to select mesenchymal-like cell clones by 
replacing M171 medium with DMEM/F12 supplemented 10% fetal bovine serum (FBS) for 2 
days. In this medium, all epithelial-like cells did not survive. Surviving mesenchymal-like cell 
clones were continuously subcultured for three to five passages. Cell clones that rapidly 
underwent an epithelial-mesenchymal transition (EMT) were considered as BCSC candidates. 
These cells were used to analyze some characteristics of BCSCs in subsequent experiments.  
2.4. CD44+CD24-/dim-based cell sorting  
BCSCs were isolated from primary cultures based on CD44+CD24- expression by FACS as 
described elsewhere [42]. Briefly, 1 ml cell suspensions in PBS (1x107 cells) were double 
stained with 20 μl anti-CD44-FITC and 20 μl anti-CD24-PE. Samples were incubated in the 
dark at room temperature for 45 min. The CD44+CD24-/dim cell population was identified 
by the software controlling the BD FACSJazz. Cells were sorted into 2-ml tubes containing 1 
ml culture medium (DMEM/F12 supplemented with 10% FBS and a 1× antibiotic-mycotic 
(Sigma-Aldrich, St Louis, MO).  
2.5. Rhodamine 123 efflux and SP analysis 
Cells were stained with 0.1 μg/mL rhodamine (Sigma-Aldrich) at 37°C for 30 min, and then 
washed twice with 2% FBS in PBS. Two filters (FL1 and FL3) were used to detect rhodamine 
123. Cells incubated with 50 μM verapamil and 0.1 μg/ml rhodamine 123 for 30 min were 
used as a positive control.  
2.6. Immunophenotyping 
Cell markers were analyzed following a previously published protocol [43]. Briefly, cells 
were washed twice in PBS containing 1% BSA (Sigma-Aldrich). Cells were stained for 30 
min at 4°C with anti-CD13-FITC, anti-CD90-PE and anti-CD133-PerCP monoclonal 
antibodies (BD Biosciences). Stained cells were analyzed by a BD FACSCalibur (BD 
Biosciences) flow cytometer. Isotype controls were used in all analyses.  
2.7. Mammosphere culture 
Cells were detached with 0.25% trypsin/EDTA and resuspended in serum-free DMEM/F12 
(1:1; GeneWorld, Ho Chi Minh, VN) containing 15 ng/ml basic fibroblast growth factor, 20 
ng/ml epidermal growth factor (EGF), 2 mM/l L-glutamine, 4 U/l insulin growth factor (Sigma-
Aldrich) and B27 supplement (1:50; Invitrogen). Cells were cultured at 37°C with 5% CO2. 
2.8. Cell cycle analysis 
Cells were washed twice in PBS and fixed in cold 70% ethanol for at least 3 h at 4°C. Then, 
cells were washed twice in PBS and stained with 1 ml PI (20 μg/ml). Fifty microliters of 
RNase A (10 μg/ml) was added to samples, followed by incubation for 3 h at 4°C. Stained 
cells were analyzed by flow cytometry using CellQuest Pro software (BD Biosciences). 
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studies have focused more on treatment strategies than isolation of BCSCs. Indeed, to date, 
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cell sorting (FACS) based on BCSC markers such as CD44, CD24 and CD133 [2]; [52]; [46]; [41], 
identification of the side population (SP) that effluxes Hoechst 33342 [13]; [8]; [28] and 
mammosphere formation [44]; [54]. All these methods possess some limitations. 
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only wells that contained cell colonies were used to select mesenchymal-like cell clones by 
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underwent an epithelial-mesenchymal transition (EMT) were considered as BCSC candidates. 
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cells were analyzed by flow cytometry using CellQuest Pro software (BD Biosciences). 
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2.9. Doxorubicin resistance analysis 
BCSCs were cultured to 104 cells/well in a 24-well plate (Nunc, Roskilde, Denmark), in 
DMEMF12/10% FBS. After 24 h culture to confluence, cells were treated with 0, 1 and 3 
μg/ml doxorubicin (Sigma-Aldrich). Doxorubicin resistance was analyzed by apoptosis 
using annexin-V-FITC and PI on a FACSCalibur. 
2.10. In vivo tumorigenesis 
Non-obese diabetic (NOD)/SCID mice (5–6-weeks-old) (NOD.CB17-Prkdcscid/J; Charles River 
Laboratories) were used in this study. All mice were housed in clean cages and maintained 
according to institutional guidelines on animal welfare. Mice were subcutaneously injected 
with 1x106, 105, 104 and 103 cells (n=3, each dose). Mice were followed up for 1 month to detect 
tumors. 
2.11. Statistical analysis 
All experiments were performed in triplicate. A value of P ≤ 0.05 was considered significant. 
Data were analyzed using Statgraphics v 7.0 software (Statgraphics Graphics System, 
Warrenton, VA). 
3. Results 
3.1. Primary culture 
The study was carried out to primary culture five tumors from five patients. There were 3/5 
samples that outgrew cells (Fig. 1A). These cells from the three samples were propagated 
until 80% confluence. In almost all samples, epithelial-like cells appeared before 
mesenchymal-like cells, which spread out from tumor fragments from day 5. Mesenchymal-
like cells usually appeared at day 20. Then, cells proliferated rapidly and formed colonies. 
At this time, two cell shapes were mostly observed in the primary culture (Fig. 1B). These 
were epithelial-like cells with a bean shape and large nucleus, and mesenchymal-like cells 
with a small nucleus and elongated shape. Cells were subcultured once to expand enough 
cells for further experiments. The primary cells from these samples were used in both single-
cell sorting and CD44+CD24-/dim-based cell sorting.  
 
Figure 1. Primary breast cells derived from malignant tumors. (A) Primary cells began to migrate from 
tumors. (B) Primary cells rapidly proliferated with two main shapes indicating stromal and epithelial-
like cells. (C) Cell populations were subcultured for a second passage and cultured in DMEM/F12 
supplemented with 10% FBS.  
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3.2. Single cell-based culture, cell selection and EMT  
Primary cells were individually sorted into the wells of 96-well plates. A total of 2880 wells 
were used for one primary cell population. Single cells were cultured in M171 medium 
containing MEGS for 2 weeks. There were 14.67±5.13 colonies formed per 96-well plate. 
Single cells in other wells did not proliferate or died (n=3). Similarly to primary culture, 
there were two kinds of cell clones. One kind of cell clone was epithelial-like, and the other 
was mesenchymal-like. To enrich mesenchymal-like cells and eliminate epithelial-like cells, 
we changed the medium from M171 medium containing MEGS to DMEM/F12 
supplemented with FBS that was suitable for mesenchymal-like cells. After all epithelial-like 
cell clones died in 24 h, mesenchymal-like cell clones continued to expand to 70–80% 
confluence and were then subcultured. From one sample, 6.33±3.06 mesenchymal-like cell 
clones were derived per 96-well plate (Fig. 1C). These cell clones were subcultured 
continuously for three to five passages to identify the cell clone with the earliest EMT. At the 
third passage, EMT began to occur in some cell clones. These early EMT cell clones were 
considered as BCSCs. EMT occurred randomly in wells, in which some cells changed shape 
from mesenchymal (Fig. 2A) to epithelial (Fig 2. B). This process continued until all cells 
showed epithelial-like shapes (Fig. 2C). We randomly selected one cell clone to analyze the 
characteristics of BCSCs. These procedures were performed similarly for all three samples.  
 
Figure 2. EMT of primary cells. Nearly 100% of cells exhibited a mesenchymal-like shape (A) when 
cultured in DMEM/F12 supplemented with 10% FBS. EMT of some cells (B) formed an islet of epithelial-
like cells. Transitioned cells rapidly proliferated as condensed colonies (C).  
3.3. Immunophenotype, rhodamine 123 efflux and mammosphere formation 
We randomly selected three cell clones from the three samples to analyze the 
immunophenotype, rhodamine 123 efflux and mammosphere formation. The results are 
shown in Fig. 3. BCSC candidates showed a highly homogenous CD44+CD24- phenotype 
(Fig. 3A) with more than 98% positive (98.82±0.72%) (n=3). These cell clones also contained a 
subpopulation (SP- Rhodamine 123 efflux phenotype) that showed more than 66.64±8.51% 
(n=3) (Fig. 3B). In addition, cell clones could form mammospheres when cultured in serum-
free medium (Fig. 3C). Compared with BCSCs from CD44+CD24-/dim cell sorting, the cell 
population was only 90.10±4.12% CD24- and 8.19±3.38% CD24dim (Fig. 3D). Notably, 
CD44+CD24-/dim-sorted BCSCs contained a smaller SP than single-cell sorted BCSCs 
(34.56±3.48% vs. 66.64±8.51%) (Fig. 3E). However, the two kinds of BCSCs strongly exhibited 
mammosphere formation (Fig. 3F).  
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Figure 3. Flow cytometric analyses of immunophenotype and rhodamine 123 efflux. Cell clones 
exhibited the characteristics of BCSCs with near 100% CD44+CD24- (A), and were more than 50% SP-
positive (D). Marker expression and the SP decreased in CD44+CD24-/dim-sorted cells. (D; E). However, 
both types of sorted cells could form mammospheres in serum-free medium (C, F).  
 
Figure 4. Doxorubicin resistance and the cell cycle of BCSCs isolated by CD44+CD24--sorting and 
single-cell sorting. At 3 μg/ml doxorubicin, BCSCs obtained from single-cell sorting did not undergo 
apoptosis (A), whereas apoptosis was observed among CD44+CD24- BCSCs (B). However, the cell cycles 
of these two populations were not significantly different (C–D).  
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3.4. Doxorubicin resistance and the cell cycle 
BCSCs sorted by two strategies were evaluated in this study. BCSCs from single-cell sorting 
could resist doxorubicin more than CD44+CD24-/dim-sorted BCSCs. At 0 and 1 μg/ml 
doxorubicin, cells did not undergo apoptosis. However, at 3 μg/ml doxorubicin, no BCSCs 
underwent apoptosis from single-cell sorting, but there were 2.54±1.29% apoptotic CD44+CD24-
/dim BCSCs (Fig. 4A, B). Although these results showed that there was no significant different 
between BCSCs obtained from single-cell sorting and CD44+CD24-/dim-sorting (Fig. 4C, D).  
3.5. In vivo tumor formation 
Tumorigenicity is an essential characteristic of cancer stem cells. In almost all studies, tumor 
formation at a low number of injected cells is considered as the gold standard for cancer stem 
cell confirmation. In this study, we injected 1×103, 104 and 105 cells into the mammary pad of 
NOD/SCID mice. At 1×103 cells per mouse, BCSCs were able to form tumors (Fig. 5A, B). To  
 
Figure 5. Tumor formation in NOD/SCID mice after injection of 1×103 BCSCs. Tumors formed 
subcutaneously (A) at sizes from 5×6 mm (B), which were analyzed histochemically by HE staining (C).  
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confirm the histopathology of tumors, 10 μm tumor sections were stained with hematoxylin-
eosin (HE). As shown in Figure 5C, tumors exhibited cancer cells with large nuclei. This 
result was similar to that of BCSCs from CD44+CD24-/dim-sorting in our previous studies [41]; 
[42]; [43].  
4. Discussion 
BCSCs are the origin of breast tumors. Thus far, the aim of many studies has been BCSC 
targeting. Recently, preclinical trials have demonstrated that agents targeting BCSCs are 
more effective than those targeting tumor cells. In all BCSC-based therapies, BCSCs are 
important for tumor targeting. However, the procedures used to isolate BCSCs are 
complicated and time consuming. Moreover, all present protocols obtain heterogenous 
populations of BCSCs. Indeed, sorting CD44+CD24- cells, a population considered as 
BCSCs, can express various levels of CD44 and CD24. SPs are also considered as BCSCs, but 
only a subpopulation show a CD44+CD24- phenotype. Thus, the aim of this study was to 
establish a new protocol to isolate homogenous BCSCs.  
Similar to other techniques, our technique also cultured primary cells from malignant 
tumors as a first step. We successfully cultured 3/5 samples under this condition. Cells 
rapidly expanded around tumor fragments after 2 weeks. Various cell types appeared in 
primary culture, including mainly epithelial-like and mesenchymal-like cells. These results 
were consistent with our previous studies [41]; [42]. The primary cell population may 
contain at least six cell types including fibroblasts, mammary epithelial cells, mammary 
epithelial stem cells, breast cancer stem cells, breast cancer cells and stromal cells. To isolate 
homogenous BCSCs at a high purity, we applied single-cell sorting to individually isolate 
single cells in the wells of 96-well plates. For each sample, we sorted single cells into 2880 
wells in 30 plates. From such a plate, we derived 14.67±5.13 cell clones, while other cells 
could not proliferate or died. Using this method, we can select cells that rapidly proliferate 
and survive when cultured alone. Indeed, normal cells and differentiated cells hardly 
proliferate when seeded as single cells. We considered that BCSCs existed among these 
clones. By changing the medium from M171 medium containing MEGS to DMEM/F12 
supplemented with 10% FBS to select mesenchymal-like cell clones, all cell clones with an 
epithelial phenotype died and cell clones with a mesenchymal phenotype survived and 
proliferated. 
There were 6.33±3.06 surviving cell clones per plate, with a mesenchymal-like shape. They 
were continuously subcultured for three to five passages, and cell clones that underwent the 
earliest EMT were chosen for further study. The results showed that cell clones will the 
earliest EMT occurred at the third passage. EMT resulted in cells spreading out to form an 
area with epithelial-like cells among mesenchymal-like cells. After 72 h, all cells transitioned 
into epithelial cells. We randomly selected three cell clones from a sample to analyze the 
characteristics of BCSCs. All three cell clones after EMT showed the properties of BCSCs. 
The cell population exhibited the common CD44+CD24- phenotype of BCSCs at 
98.82±0.72%. This population was used to evaluate the SP by rhodamine 123 efflux. The 
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results showed that the SP was CD44+CD24-/dim. To assess the multidrug-resistance 
property, we checked and compared with two other techniques, we recognized that BCSCs 
from single-cell sorting with higher antitumor drug resistance but the same tumor formation 
in NOD/SCID mice compared with CD44+CD24-/dim-sorting.  
Single-cell sorting combined with subculture to isolate EMT cell clones exhibited several 
benefits for selection of BCSCs. Indeed, single-cell cloning is considered as the best 
technique for selection of a homogenous cell population. This technique is popular for cell 
cloning of hybridomas for monoclonal antibody production. However, in monoclonal 
antibody production, almost all studies use limited dilution or ring/syringe isolation. These 
two techniques have some limitations; particularly the low efficiency in dilution to obtain 
single cells in each well and it is laborious, time-consuming and uneconomical to screen 
samples with a low concentration of desired cells. Using the index sorting of the FACSJazz, 
it is easy to seed one cell in each well of 96-well plates. Single-cell sorting offers a new tool to 
efficiently and rapidly perform cell cloning.  
In the next step, we cultured single cells to obtain cell clones for subculture. In mammalian 
cell culture, single-cell culture is usually suitable for transformed cells and immortal cell 
lines. Normal cells usually undergo apoptosis after 50±10 divisions because of the Hayflick 
limitation [27]. Thus, single-cell culture is only suitable for immortal cells. Indeed, in our 
study, when primary cells from tumors were individually cultured, some types of non-
immortal cells can be eliminated after culture and subculture. Using single cell-based 
culture and sub-culture, almost all cell clones of stromal, epithelial and breast cancer cells 
can be lost over time. Thus, after three passages, some cell clones survive and can form 
continuous cultures. There were two cell types, namely epithelial-like cells and 
mesenchymal-like cells. We considered that mammary epithelial stem/progenitor cells 
exhibited the epithelial shape and breast cancer stem cells exhibited the mesenchymal shape. 
Mammary epithelial stem cells cannot survive in medium without hydrocortisone and EGF, 
whereas BCSCs do not depend on hydrocortisone or EGF [18]. Moreover, serum can inhibit 
the growth of normal epithelial cells from mammary tumors [17]. To eliminate mammary 
epithelial stem/progenitor cells, we changed the culture medium to DMEM/F12 
supplemented with 10% FBS. After 48 h culture in this new medium, all epithelial-like cell 
clones did not survive, while all mesenchymal-like cell clones survived.  
We propose that at this step, we successfully selected BCSC clones or BCSC-like clones. In 
the next experiment, we selected the strongest BCSC clone. The strongest BCSC clone was 
selected based on the time of EMT. EMT is related to the initiation of metastasis and cancer 
by BCSCs [2]; [52]; [20]; [53]; [48]; [45]; [35]. EMT can result in cells with stem cell properties 
[33]. Notably, Morel et al. (2008) could obtain BCSCs from EMT [37]. In a recent study, Blick 
et al. (2010) determined that EMT occurs together with the CD44+CD24-/dim phenotype of 
BCSCs [6]. Thus, in this study, cell clones that rapidly transitioned from mesenchymal to 
epithelial phenotypes were chosen as the most appropriate BCSC clone. 
However, based on immunophenotypic and rhodamine 123 analyses, we found that BCSCs 
from single-cell sorting might not be homogenous. Indeed, a few cells did not exhibit the 
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confirm the histopathology of tumors, 10 μm tumor sections were stained with hematoxylin-
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characteristics of BCSCs. All three cell clones after EMT showed the properties of BCSCs. 
The cell population exhibited the common CD44+CD24- phenotype of BCSCs at 
98.82±0.72%. This population was used to evaluate the SP by rhodamine 123 efflux. The 
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results showed that the SP was CD44+CD24-/dim. To assess the multidrug-resistance 
property, we checked and compared with two other techniques, we recognized that BCSCs 
from single-cell sorting with higher antitumor drug resistance but the same tumor formation 
in NOD/SCID mice compared with CD44+CD24-/dim-sorting.  
Single-cell sorting combined with subculture to isolate EMT cell clones exhibited several 
benefits for selection of BCSCs. Indeed, single-cell cloning is considered as the best 
technique for selection of a homogenous cell population. This technique is popular for cell 
cloning of hybridomas for monoclonal antibody production. However, in monoclonal 
antibody production, almost all studies use limited dilution or ring/syringe isolation. These 
two techniques have some limitations; particularly the low efficiency in dilution to obtain 
single cells in each well and it is laborious, time-consuming and uneconomical to screen 
samples with a low concentration of desired cells. Using the index sorting of the FACSJazz, 
it is easy to seed one cell in each well of 96-well plates. Single-cell sorting offers a new tool to 
efficiently and rapidly perform cell cloning.  
In the next step, we cultured single cells to obtain cell clones for subculture. In mammalian 
cell culture, single-cell culture is usually suitable for transformed cells and immortal cell 
lines. Normal cells usually undergo apoptosis after 50±10 divisions because of the Hayflick 
limitation [27]. Thus, single-cell culture is only suitable for immortal cells. Indeed, in our 
study, when primary cells from tumors were individually cultured, some types of non-
immortal cells can be eliminated after culture and subculture. Using single cell-based 
culture and sub-culture, almost all cell clones of stromal, epithelial and breast cancer cells 
can be lost over time. Thus, after three passages, some cell clones survive and can form 
continuous cultures. There were two cell types, namely epithelial-like cells and 
mesenchymal-like cells. We considered that mammary epithelial stem/progenitor cells 
exhibited the epithelial shape and breast cancer stem cells exhibited the mesenchymal shape. 
Mammary epithelial stem cells cannot survive in medium without hydrocortisone and EGF, 
whereas BCSCs do not depend on hydrocortisone or EGF [18]. Moreover, serum can inhibit 
the growth of normal epithelial cells from mammary tumors [17]. To eliminate mammary 
epithelial stem/progenitor cells, we changed the culture medium to DMEM/F12 
supplemented with 10% FBS. After 48 h culture in this new medium, all epithelial-like cell 
clones did not survive, while all mesenchymal-like cell clones survived.  
We propose that at this step, we successfully selected BCSC clones or BCSC-like clones. In 
the next experiment, we selected the strongest BCSC clone. The strongest BCSC clone was 
selected based on the time of EMT. EMT is related to the initiation of metastasis and cancer 
by BCSCs [2]; [52]; [20]; [53]; [48]; [45]; [35]. EMT can result in cells with stem cell properties 
[33]. Notably, Morel et al. (2008) could obtain BCSCs from EMT [37]. In a recent study, Blick 
et al. (2010) determined that EMT occurs together with the CD44+CD24-/dim phenotype of 
BCSCs [6]. Thus, in this study, cell clones that rapidly transitioned from mesenchymal to 
epithelial phenotypes were chosen as the most appropriate BCSC clone. 
However, based on immunophenotypic and rhodamine 123 analyses, we found that BCSCs 
from single-cell sorting might not be homogenous. Indeed, a few cells did not exhibit the 
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CD44+CD24- immunophenotype or SP phenotype, indicating that BCSCs had differentiated 
into other cell types during proliferation. Such differentiation may be induced by medium 
containing serum. Some studies show that serum can induction differentiation of BCSCs 
[47]; [23]. Moreover, single cell-based culture easily induces differentiation [36]. Thus, 
single-cell sorting can obtain a pure population of BCSCs that must be maintained in a 
suitable medium to inhibit spontaneous differentiation.  
5. Conclusion 
Single-cell sorting is suitable for isolation of BCSCs to obtain a homogenous population for 
further experimentation and BCSC-targeting therapies. BCSCs obtained by this technique 
exhibit high purity, high resistance to doxorubicin, and form tumors in NOD/SCID mice at a 
low cell number. Compared with CD44+CD24- sorting, mammosphere culture and SP-based 
sorting, single-cell sorting in combination with subculture enables selection of EMT cell 
clones that give rise to a BCSC population with advantages such a homogenous population, 
higher doxorubicin resistance and mammosphere formation at high levels. However, 
spontaneous differentiation in culture is a problem that needs to be addressed. Single-cell 
sorting offers a new technique to detect and isolate BCSCs as well as other cancer stem cell 
types.  
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1. Introduction 
As early as 1950s, researchers began to apply in vitro culture technology in testing 
cytotoxicity of multiple drugs on different cells, which could basically determine the cytoxic 
dose range of these drugs. Regarding to the continuous development of novel 
chemotherapy drugs and large growth of chemical compounds closely related to human 
practice and life (including pharmaceutical, cosmetics, food additives, pesticide, industrial 
chemical, etc), there is great need to explore a convenient and effective way for selection, 
pre-clinical evaluation or pre-production safety assessment.  
In vitro, tissue-based models are common and widely used for screening and ranking 
chemicals, especially in testing of drugs at the preclinical stages. The toxic effects include 
general cytotocixity, genotoxicity, mutagenesis and carcinogenesis. Cell-based assays are 
currently considered central to toxicity testing, biomaterial testing, and environmental 
material exposure testing. Nearly all of the assays could be adapted to other application for 
bioactivity test. For instance, the established cell lines have been successfully employed in a 
number of fields of medical research. Especially, many aspects of modern virology have 
been developed using animal cells in culture. 
There are several strategies for using in vitro, tissue-based models in testing of drugs at the 
preclinical stages. One such strategy is to refine the choice of cells and end points of one 
method. For instance, human corneal cells are now used to screen for local eye toxicity of 
chemicals, with a method employing sophisticated end points. Another strategy is to use 
batteries of tests with different cell types, to cover most aspects of basic cell functions. A 
third strategy is to do more basic research into fundamental mechanisms of toxicity or 
bioactivity. When such mechanisms have been clarified, rational in vitro models could be set 
 The Author(s). Licens e InTech. T is c apter is distribut d under the terms of the Crea ive Co mons 
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up. By contrast, a fourth approach ignores whether the toxic mechanisms screened for is 
known or not. As long as the end point of the test correlates well with in vivo toxicity, the 
test may be used. 
2. Cultures   
The possibility of using cell or tissue cultures as suitable material for testing agents in 
pharmacology has often been suggested. The culture methods include organ culture, sphere 
culture, suspension culture, clone culture on soft agar and monolayer cell culture, etc.  
Organ culture provides drug evaluation a model more close to in vivo situation, but this 
model are not suitable for efficacy quantitative experiment because of the size differentiation 
of organ implants and heterogeneity of the cells within the explants between repeated 
experiments. Sphere culture of the tumor cells is similar to tumor nodules in vivo and can be 
used to study the influence of three-dimensional relationship on drug sensitivity. 
Suspension culture is beneficial to furthest prevent the growth of “cell pollution source”-
connective tissue cells (i.e. fibroblast), which is widely applied to chemosensitivity study 
and convenient to perform radionuclide analysis. Clone culture on soft agar is fit for cell 
with high capacity of self-renewal (i.e. tumor cell), other than cells with limited proliferation 
ability. Monolayer cell culture is best for cytotoxicity test of cell lines and chemosensitivity 
of various tumor biopsy materials. This test can implement automatic operation due to 
small cell amount requirement and its convenience and flexibility in drug treatment, reply 
and pharmacodynamic quantitative study.  
Generally, a primary cell line possesses many characteristics of the original cells, such as 
similar chromosomal numbers and the specialized biochemical properties of the parent 
tissue, e.g. in the case of liver cells the ability to secrete albumin. On the contrary established 
cell lines invariably have different chromosome numbers and lose a number of specialized 
biochemical properties of the parent tissues. This latter fact imposes some restrictions on the 
utilization of established cultures in the design of tests of toxicity. However, established cell 
lines have been successfully employed in a number of fields of medical research. Especially, 
many aspects of modern virology have been developed using animal cells in culture.  
3. Method used 
3.1. Cytotoxicity 
Cytotoxicity is considered primarily as the potential of a compound to induce cell death. 
Most in vitro cytotoxicity tests measure necrosis. However, an equally important 
mechanism of cell death is apoptosis, which requires different methods for its evaluation. 
Moreover, detailed studies on dose and time dependence of toxic effects to cells, together 
with the observation of effects on the cell cycle and their reversibility, can provide valuable 
information about mechanisms and type of toxicity, including necrosis, apoptosis or other 
events. 
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In vitro cytotoxicity tests are useful and necessary to define basal cytotoxicity, for example 
the intrinsic ability of a compound to cause cell death as a consequence of damage to basic 
cellular functions. Cytotoxicity tests are also necessary to define the concentration range for 
further and more detailed in vitro testing to provide meaningful information on parameters 
such as genotoxicity, induction of mutations or programmed cell death. By establishing the 
dose at which 50% of the cells are affected (i.e. TC50), it is possible to compare 
quantitatitively responses of single compound in different systems or of several compound 
in individual systems. 
The endpoint/parameters used in cellular toxicity testing including: 
• Membrane permeability changes-dye exclusion(trypan blue);the release of intracellular 
enzymens like lactate dehydrogenase; preloaded 51Cr; nucleoside release; uridine 
uptake;vital dye uptake, etc. 
• Reduced mitochondrial function 
• Changes in cell morphology 
• Changes in cell replication 
• Apoptosis evaluation-changes in morphology; membrane rearrangements; DNA 
fragmentation; caspase activation; cytochrome c release from mitochondria, etc 
3.2. Cellular response and functional response regarding to general 
toxicity(protein/gene expression) 
The basic methodology of general toxicity has changed little during past decades. Toxicity in 
laboratory animals has been evaluated by mainly using clinical chemistry, hematological 
and histological parameters as indicators of organ damage. The effect of a toxic chemical on 
a biological system in most cases is fundamentally reflected, at the cellular level, by its 
influence on gene expression. Consequently, measurement of the transcription (mRNA) and 
translation (protein) products of gene expression can explore valuable information about the 
potential toxicity of chemicals before the development of a toxic/pathological response. 
The rapid progress in genomic (DNA sequence), transcriptomic (gene expression) and 
proteomic (the study of proteins expressed by a genome, tissue or cell) technologies, in 
combination with the ever-increasing power of bioinformatics, creates a unique opportunity 
to form the basis of improved hazard identification for more predictive safety evaluation.  
For example, currently available methods for the study of gene expression at the transcript 
level include: 
• Hybrdizization-based techniques: Northern blotting;S1-mapping/RNase protection; 
Differential plaque hybridization; 
• PCR-based techniques: Subtraction cloning; DNA microarrays; Differential display; 
RDA(representational difference analysis); Quantitative (real time) PCR;  
• Sequence-based techniques:ESTs(expressed sequence tags); SAGE(serial analysis of 
gene expression); MPSS(massively parallel signature sequencing); DNA-sequencing 
chip; Mass-spectrometry sequencing 
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Two-dimensional gel electrophoresis is a highly sensitive means of screening for toxicity 
and probing toxic mechanisms, which combines separation of proteins by isoelectric 
focusing(IEF) in the first dimension followed by sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis(SDS-PAGE) based on molecular weight in the second dimension. 
By comparing gene/proteins expressed following exposure of a biological test system to a 
chemical with those present under untreated conditions, it is possible to identify changes in 
biochemical pathways via observed alteration in sets of gene/proteins that may be related to 
the tocicity, which provide the means to profile expression of thousands of messenger RNAs 
or proteins. 
Over the last few decades, a large amount of research has resulted in an explosion of 
information regarding mechanisms of toxicity and new tools to study the biological 
responses to toxic stress. Some of the key cellular responses to toxicant exposure, which 
could potentially be used as early markers of toxicity, include the following: 
• Responses following exposure to toxicants that form reactive electrophiles (e.g. 
oxidative stress) such as loss of glutathione (GSH), increased production and sensitivity 
to reactive oxygen species (ROS), increase in cellular calcium, lipid peroxidation, loss of 
ATP and mitochondrial/endoplasmic reticulum (ER) specific events. 
• The cellular response to stress, including an increase in synthesis of the heat shock 
(Hsp) family of proteins, induction of the stress-activated protein kinases (SAPKs) and 
glucoseregulated proteins (Grps). 
• Changes in the levels of key enzymes, such as the phase I and phase II metabolising 
enzymes involved in the detoxification of toxic chemicals. 
• Induction of the metal-binding proteins, metallothioneins (MTs). 
• Perturbations to cellular membranes, gap junctions and intercellular communication 
inhibition (involving the connexins Cx43, Cx32 and Cx26).  
• Induction of cell proliferation (for which suitable markers could include TNF-α, TNF-β, 
plasminogen activator inhibitor-2 (PAI-2), the tumour proliferative marker Ki-67 
antigen and proliferating cell nuclear antigen (PCNA). 
3.3. Toxicokinetic study 
Toxicokinetic modelling describes the absorption, distribution, metabolism and elimination 
of xenobiotics as a function of dose and time within an organism. Toxicokinetic models can 
be divided into two main classes: data-based compartmental models and physiologically-
based compartmental models. In vitro approaches can be used to obtain useful information 
in this area. One representative model, the physiologically-based toxicokinetic (PB-TK) 
model, can be obtained by studies in vitro, including tissue–blood partition coefficients, the 
kinetics of any active transport processes, and the kinetics of metabolism by the liver and 
any other organ capable of biotransforming the compound (e.g. the lung). The output of 
toxicokinetic models is the prediction of concentration/time courses in different tissues. This 
information can be combined with the basal cytotoxicity data to make a prediction of the 
acute systemic toxicity of the chemical. 
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3.4. Specific toxicity 
3.4.1. Genotoxicity 
In vitro system can also be used to determine genotoxicity for identifying potential 
carcinogens, which includes three levels of mutation, namely gene, chromosome and genomic 
mutations. It is acknowledged that the generally accepted objectives of genotoxicity testing 
of chemicals are: (a) identification of germ cell mutagens, because of their possible 
involvement in the etiology of human heritable genetic defects; (b) identification of somatic 
cell mutagens, because of their involvement in neoplastic transformation. 
As far as test methods are concerned, it is recommended that OECD protocols be used, 
which updated six previous guidelines and introduced a new one in 1997. These guidelines 
provide guidance for the conduct of in vitro screening tests (e.g. gene mutations in bacteria 
and in mammalian cells, chromosomal aberrations in vitro) as well as for the in vivo assays 
(e.g. micronuclei and chromosomal aberrations in rodent bone marrow, rat liver 
unscheduled DNA synthesis, chromosomal aberrations in spermatogonia). 
A number of useful techniques have been developed with which it is also possible to 
determine the genetic toxicology. For example, a protocol for in vitro micronucleus test is 
currently being evaluated for inclusion, which might be considered in test batteries as an 
alternative to in vitro chromosomal aberration assay. By using centromeric specific probes 
based on fluorescence in situ hybridization (FISH), chromosome loss and non-disjunction 
specific probes allow rapid scoring of aneuploidy in a variety of cell types, including human 
cells. mammalian cell assays should be routinely performed according to the standard 
updated protocols for the detection of either gene mutation (at tk, HPRT, or other loci), or 
structuralchromosomal aberrations by metaphase analysis. 
On the other hand, non-genotoxic carcinogenicity of the compound is able to be evaluated 
through the following common mechanism: 
• Persistent cytotoxicity accompanied by proliferative regeneration. 
• Chronic inflammation 
• Hormones 
• Ligands for xenobiotic receptors 
• DNA methylation 
Furthermore, there are also some potential short-term tests designed for non-genotoxic 
carcinogens. They are: 
• Detection of mitogenesis 
• The application of gene arrays and other approaches to transcription profiling 
• In vitro cell transformation assays 
• Transgenic cell systems 
• Cytosine methylation 
• Quantitative structure-activity relationships(QSAR) and other computational 
approaches 
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Overall, no single system will be will be adequate to detect all non-genotoxic carcinogens or 
even a large number of them. However, by focusing on those mechanisms that appear to be 
of relevance to humans, it may be possible to identify key toxicological responses, which 
provide a clear indication of carcinogenic potential. 
3.4.2. Developmental toxicity 
Reproductive toxicology embraces studies on male and female fertility and on 
developmental toxicity, with special emphasis on embryotoxicity and teratogenicity. Over 
the past 20 years, more than 30 different culture systems have been proposed as tests for 
developmental toxicity. The culture systems fall into the following categories: 
• Tests on non-vertebrate species, including Hydra, slime moulds, brine shrimps and 
Drosophila. 
• Tests on lower vertebrate embryos or embryonic cell aggregates, including fish, 
amphibians and birds. 
• Tests on whole mammalian embryos. 
• Tests on micromass cultures from mammalian embryos (limb buds, midbrain). 
• Tests on embryonic stem cells or embryonic stem cell lines. 
• Tests on other mammalian cell lines (e.g. human embryonic palate mesenchymal cells, 
mouse ovarian tumour cells, neuroblastoma cells, teratocarcinoma cells). 
3.4.3. Cell lines and embryonic stem cells 
A number of established cell lines have been used for screening purposes in 1980s. These 
include: human embryonic palate mesenchymal cells, mouse ovarian tumour cells and 
neuroblastoma cells. The results show a high number of false positives. 
However, the use of omnipotent embryonic stem cell lines shows more promising results. 
For instance, blastocyst totipotent embryonic stem cells (ES) can be cultured under 
conditions in which the cells form several types of differentiated cells, such as muscle cells 
or haematopoietic cells. These culture systems can be used to determine the two essential 
features of embryotoxicity: inhibition of differentiation and/or a higher sensitivity to cytotoxic 
effects in embryonic cells than adult tissues. Results of such a test were comparable to the 
outcome of an embryotoxicity test with rat whole embryo cultures. The use of ES cells in the 
production of transgenic cells with targeted mutations and reporter constructs should enable 
the development of tests with simplified endpoints, which can be used in robotised assay 
systems. What’s more, new developments in which multipotent (or even totipotent) stem cells 
can be isolated from adult tissues are very promising. For example, nervous tissue stem cells 
can give raise to haematopoietic stem cells and vice versa. 
Besides, testing systems using aggregate and micromass cultures, embryos of lower order 
species, avian and mammaliam whole embryo culture for detecting the developmental 
toxicity have been described and widely used. They allow the detection of 
dysmorphogenesis in many organs and the comparison of specific dysmorphogenic effects 
with general adverse effects on growth and differentiation. In addition, they enable the 
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potencies of structurally related compounds to be ranked. Limitations of these systems are 
related to the fact that they are relatively complex, cover only a part of organogenesis, 
require high technical skills and they also can be costly. 
In conclusion, in vitro culture detection system is more suitable for anti-cancer drug and 
teratogenic, carcinogenic, and mutagenic chemicals. Main application area include that 1) 
Identify potential active compounds; 2) Study the mechanism of chemical toxicity; 3) Predict 
effective toxicity drug possibly used in treatment for cancer patients; 4) Screen effective 
component and its active range from a variety of compounds; 5) Determine the types of 
effector cells; 6) Confirm toxicity range; 7) Investigate relationship between the drug 
concentration and exposure time. 
Although the drug efficacy, adverse reaction and safety evaluation of need certain animal 
experiment, the in vitro culture technology has already become common tool for testing 
cytotoxicity and efficacy globally. The advantages are that 1) established cell lines provide 
cell sources with uniform or similar genetic background for in vitro test, which make the 
drug selection more stable, convenient and economic.2) This technique can precisely control 
the object, time and dose of drug action as well as the cell growth conditions. For example, 
clinical medicine study can choose human cells. Tissue-specific drugs need to select targeted 
and relevant cells. Researchers employ tumor cell lines to evaluate anti-cancer drugs by 
observing the cell reaction to drug from cytological view. Therefore, this in vitro detection 
avoid the drawbacks of in vivo experiment about lack of specific effector cell, drug 
metabolism reaction, different drug resistance between species and individuals. 3) It’s easier 
to distinguish the direct drug effect and indirect internal effect by adding drugs or other 
chemicals directly to cell culture system, or even injecting drug into the cell. 4) Animal 
protection moral appeal reduction of animal experiment internationally. Thus the 
application of in vitro technology in drug test becomes more and more widespread.  
Definitely, determining the action of different drugs on the cell in vitro under various 
dosages is not completely suitable for in vivo status. The disadvantages of in vitro test are 1) 
in vivo growing environment is quite complicated compared to the simple in vitro culture 
condition. The in vivo experiments possess not only comprehensive functional regulating 
system, but also the metabolism, modification (such as increase or decrease of 
pharmaceutical biochemistry through the liver, kidneys and other organs), immunological 
effect. 2) Cytotoxicity and activity test using in vitro system is suitable for monomer drug 
other than compound medicines and Chinese patent medicine. 3) It is easier to test water-
soluble drug compared to the water insoluble drug, which may need suitable solvent to 
dissolve and control group in experimental design to exclude the effect of the solvent itself 
to the cell. 4) In vitro system is mainly applicable to acute toxicity research, thus analysis of 
chronic effect requires improving the culture system. 
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1. Introduction 
1.1. Discussion between neuronists and reticularists 
We do not consider it possible to cast any doubts on the grounds of the Neuronal Doctrine; 
however, the interneuronal syncytial connection still does exist and the cytoplasmic fusion 
of neurons still is possible. 
The reticular theory of the general syncytial cytoplasmic connection of neuronal processes as 
the principle of organization of the nervous system was already known to the German 
histologist Joseph von Gerlach [1]. It was supported by almost all neurologists of the XIX 
century [2] and was passionately defended by the famous Camillo Golgi.  
The presence of the cytoplasmic syncytium1 in the nervous system was defended by such 
known histologists as Nissl, Ranvier, Schwann, and others. The theory of nervous network 
had its attractive and convenient explanations [2]. By suggesting the general cytoplasmic 
connection of nerve fibers, it considered nervous network as anastomoses, roundabout 
pathways of blood vessels and allowed explaining comparatively easily the relatively fast 
recovery of functions in cerebral stroke. The reticular theory suggested not the discrete 
single, but the grouped functioning of neurons, which at present seems more realistic [3, 4]. 
However, this theory was not based on the most important — absolute scientific facts. The 
wonderful histological method invented by C. Golgi (reazione nera) and celebrated by S. 
Ramon y Cajal could not compensate low resolving power of the optic microscope. Not 
infrequently the superpositions of nerve processes one upon another were interpreted as 
their fusion and formation of network. The reticular theory had to be replaced by the 
Neuronal Doctrine. 
                                                                                    
1 Here and further the term “syncytium” implies the true cytoplasmic connection of different neurons or different 
processes of one neuron rather than the quasisyncytium representing the interneuronal electric connection with aid of 
gap junction. The term “syncytium” is incorrectly borrowed by many electrophysiologists [15]. 
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Lucky findings of mossy and climbing fibers by S. Ramon y Cajal proved convincingly the 
existence of nerve terminals and a possibility of individual existence of neurons. Then S. 
Ramon y Cajal and his supporters obtained numerous preparations in different parts of the 
nervous system, which convinced scientific community in the rightness of the Neuronal 
Doctrine of W. Waldeyer and S. Ramon y Cajal [5, 6]. Disputes of Cajal and Golgi 
represented one of the largest collisions of ideas in development of the scientific thought [7]. 
Discussion of neurohistologists was quite emotional. Santiago Ramon y Cajal thought that – 
hypothesis of the network is a terrible enemy, – contagion of reticularism, whereas Camillo 
Cajal opposed to him defiantly emotionally his views in his Nobel lecture [2]. 
It seemed that discovery of synapses with aid of electron microscope [8, 9] had become the 
absolute and last proof of victory of the Neuronal Doctrine. In most neurobiologists the 
erroneous opinion was formed about the absence in principle of the syncytial connection in 
the nervous system. However, the proof of the presence of synapses, strictly speaking, is not 
the proof of the absence of the syncytial interneuronal connection. This is the typical error 
(paralogism), a usual contrivance in discussions of sophists of the IV century B.C. [10]. 
All neurons have synapses (incomplete premise). 
Synapse is the form of connection of neurons. 
Hence, the form of connection of all neurons is synapse. 
Both reticularists and neuronists assumed the exclusively one way of connection in the 
nervous system. Both the former and the latter in principle did not tolerate compatibility of 
the theories. This was characteristic both of S. Ramon y Cajal and of C. Golgi (Neuronismo o 
Reticularismo), either the neuronal or the reticular theory [11]. However, this classical 
approach in discussions "either – or" already at that time could have been replaced by the 
approach "both – and", as the third opinion already existed [12]. Some researchers adhering 
to the Neuronal Theory noted a possibility of the existence of the interneuronal syncytium in 
particular places and under some conditions [13, 14]. Even C. Golgi extended the theory of 
network only to organization of axonal branchings, whereas dendrites, in his opinion, 
terminated freely [2]. At present, in the literature there is the sufficient amount of evidences 
for accepting the concept and proofs of reticularists erroneous and nevertheless for claiming 
that the syncytial connection between neurons does exist. 
2. Findings of syncytial connection in the nervous system 
However, in the literature there already are the irrefutable facts of the presence in the 
nervous system of the true cytoplasmic syncytial interneuronal connection. After 
information of absolute facts of fusion of nerve processes in invertebrates [16], some authors 
were ready to recognize the giant neurons to be the non-nerve cells rather than to agree with 
facts of their syncytial connection [17]. It is impossible to ignore detection of the syncytial 
connection in molluscs, crustaceans, polychaetes, and other invertebrates [18-24]. All these 
works first of all offer absolute proofs of that the interneuronal syncytium in the nervous 
system in principle does exist.  
 
Use of Cell Culture to Prove Syncytial Connection and Fusion of Neurons 85 
Data about "fused neurons, that produce the giant axons...", are "example of a situation, that 
is against the strict letter of the neuron doctrine but can fit easily into the cell theory" [25]. It 
turns out that in nature the presence of chemical synapses in animals is quite compatible at 
solution of special tasks with the presence of the cytoplasmic syncytial connection. In nature 
the Neuronal Doctrine and structural elements of the reticular theory are compatible. 
Of principal importance are the data that syncytial connections can also be formed between 
stumps of sectioned fiber at its regeneration by ingrowth of the central stump into the 
peripheral one [26-28]. By the example of formation of the earthworm giant axon, in some 
cases, the "Calenary theory" was even demonstrated to be true [29]; this theory was a variant of 
the syncytial fusion of neurons and suggested formation of nerve fibers by fusion of individual 
nerve cells into chains. This theory was held by one of pillars of neuronism van Gehuhten [2]. 
We were the first to reveal with aid of electron microscope the syncytial connection in situ in 
the piglet enteral nervous system [30]. Subsquently, this way of interneuronal connection was 
shown in molluscs [31, 32], in the crawfish peripheral nervous system [33], in cat autonomic 
ganglia [34], in rabbit hippocampus [35, 36], and in the human cerebral cortex [12, 37].  
Morphology of fusion of living neurons at present has not yet been studied, and to do this, it 
is the most convenient with use of tissue culture. 
3. Obtaining and cultivation of isolated mollusc neurons  
By having obtained convincing data about the existence of interneuronal syncytial 
connection in invertebrates, we found it quite important to reveal such form of connection in 
living mollusc neurons in cell culture [38]. For this, the peripharyngeal ring of the mollusc 
Lymnaea stagnalis with all ganglia (Fig. 1) were performed in 0.4% pronase with temperature 
of 20°С (use of another protease is also possible). We used lyophilized pronase from 
Streptomyces griseus (Sigma). The mean molecular mass is 20000. The pronase solution was 
prepared on the basis of isotonic solution for molluscs. 
Use of pronase for enzymatic treatment of ganglia was due to the following causes. Pronase 
represents a complex preparation composed of 11-14 proteases. Its hydrolytic activity is 
spread onto the large spectrum of proteins, peptides, amides, and amino acid esters [39]. 
Proteases are known to have properties of a neurotrophic factor. They stimulate growth and 
branching of neurites [40, 41]. M.A. Kostenko was the first to develop the method of 
proteolytic isolation of individual neurons with aid of pronase [42]. Subsequently this 
method of enzymatic dissociation has become widely used in electrophysiological and 
biophysical studies [43-46]. Other methods of cell disintegration also are known [47]. 
At treatment of ganglia with pronase, the earlier and greater damages are characteristic of 
elements of connective tissue and glia. This is due to that they are in the composition of 
sheaths and are the first to deal with acting factors. This also depends on that glial cells have 
very large surface of their lamellas [48] and accordingly the extremely high ratio of the 
membrane area to the cell volume (i.e., have very low thermodynamic and structural 
stability). They always are the first to respond to external actions. If time of the proteolytic 
treatment is decreased, some number of gliocytes can be preserved in culture.  
 
Biomedical Tissue Culture 84 
Lucky findings of mossy and climbing fibers by S. Ramon y Cajal proved convincingly the 
existence of nerve terminals and a possibility of individual existence of neurons. Then S. 
Ramon y Cajal and his supporters obtained numerous preparations in different parts of the 
nervous system, which convinced scientific community in the rightness of the Neuronal 
Doctrine of W. Waldeyer and S. Ramon y Cajal [5, 6]. Disputes of Cajal and Golgi 
represented one of the largest collisions of ideas in development of the scientific thought [7]. 
Discussion of neurohistologists was quite emotional. Santiago Ramon y Cajal thought that – 
hypothesis of the network is a terrible enemy, – contagion of reticularism, whereas Camillo 
Cajal opposed to him defiantly emotionally his views in his Nobel lecture [2]. 
It seemed that discovery of synapses with aid of electron microscope [8, 9] had become the 
absolute and last proof of victory of the Neuronal Doctrine. In most neurobiologists the 
erroneous opinion was formed about the absence in principle of the syncytial connection in 
the nervous system. However, the proof of the presence of synapses, strictly speaking, is not 
the proof of the absence of the syncytial interneuronal connection. This is the typical error 
(paralogism), a usual contrivance in discussions of sophists of the IV century B.C. [10]. 
All neurons have synapses (incomplete premise). 
Synapse is the form of connection of neurons. 
Hence, the form of connection of all neurons is synapse. 
Both reticularists and neuronists assumed the exclusively one way of connection in the 
nervous system. Both the former and the latter in principle did not tolerate compatibility of 
the theories. This was characteristic both of S. Ramon y Cajal and of C. Golgi (Neuronismo o 
Reticularismo), either the neuronal or the reticular theory [11]. However, this classical 
approach in discussions "either – or" already at that time could have been replaced by the 
approach "both – and", as the third opinion already existed [12]. Some researchers adhering 
to the Neuronal Theory noted a possibility of the existence of the interneuronal syncytium in 
particular places and under some conditions [13, 14]. Even C. Golgi extended the theory of 
network only to organization of axonal branchings, whereas dendrites, in his opinion, 
terminated freely [2]. At present, in the literature there is the sufficient amount of evidences 
for accepting the concept and proofs of reticularists erroneous and nevertheless for claiming 
that the syncytial connection between neurons does exist. 
2. Findings of syncytial connection in the nervous system 
However, in the literature there already are the irrefutable facts of the presence in the 
nervous system of the true cytoplasmic syncytial interneuronal connection. After 
information of absolute facts of fusion of nerve processes in invertebrates [16], some authors 
were ready to recognize the giant neurons to be the non-nerve cells rather than to agree with 
facts of their syncytial connection [17]. It is impossible to ignore detection of the syncytial 
connection in molluscs, crustaceans, polychaetes, and other invertebrates [18-24]. All these 
works first of all offer absolute proofs of that the interneuronal syncytium in the nervous 
system in principle does exist.  
 
Use of Cell Culture to Prove Syncytial Connection and Fusion of Neurons 85 
Data about "fused neurons, that produce the giant axons...", are "example of a situation, that 
is against the strict letter of the neuron doctrine but can fit easily into the cell theory" [25]. It 
turns out that in nature the presence of chemical synapses in animals is quite compatible at 
solution of special tasks with the presence of the cytoplasmic syncytial connection. In nature 
the Neuronal Doctrine and structural elements of the reticular theory are compatible. 
Of principal importance are the data that syncytial connections can also be formed between 
stumps of sectioned fiber at its regeneration by ingrowth of the central stump into the 
peripheral one [26-28]. By the example of formation of the earthworm giant axon, in some 
cases, the "Calenary theory" was even demonstrated to be true [29]; this theory was a variant of 
the syncytial fusion of neurons and suggested formation of nerve fibers by fusion of individual 
nerve cells into chains. This theory was held by one of pillars of neuronism van Gehuhten [2]. 
We were the first to reveal with aid of electron microscope the syncytial connection in situ in 
the piglet enteral nervous system [30]. Subsquently, this way of interneuronal connection was 
shown in molluscs [31, 32], in the crawfish peripheral nervous system [33], in cat autonomic 
ganglia [34], in rabbit hippocampus [35, 36], and in the human cerebral cortex [12, 37].  
Morphology of fusion of living neurons at present has not yet been studied, and to do this, it 
is the most convenient with use of tissue culture. 
3. Obtaining and cultivation of isolated mollusc neurons  
By having obtained convincing data about the existence of interneuronal syncytial 
connection in invertebrates, we found it quite important to reveal such form of connection in 
living mollusc neurons in cell culture [38]. For this, the peripharyngeal ring of the mollusc 
Lymnaea stagnalis with all ganglia (Fig. 1) were performed in 0.4% pronase with temperature 
of 20°С (use of another protease is also possible). We used lyophilized pronase from 
Streptomyces griseus (Sigma). The mean molecular mass is 20000. The pronase solution was 
prepared on the basis of isotonic solution for molluscs. 
Use of pronase for enzymatic treatment of ganglia was due to the following causes. Pronase 
represents a complex preparation composed of 11-14 proteases. Its hydrolytic activity is 
spread onto the large spectrum of proteins, peptides, amides, and amino acid esters [39]. 
Proteases are known to have properties of a neurotrophic factor. They stimulate growth and 
branching of neurites [40, 41]. M.A. Kostenko was the first to develop the method of 
proteolytic isolation of individual neurons with aid of pronase [42]. Subsequently this 
method of enzymatic dissociation has become widely used in electrophysiological and 
biophysical studies [43-46]. Other methods of cell disintegration also are known [47]. 
At treatment of ganglia with pronase, the earlier and greater damages are characteristic of 
elements of connective tissue and glia. This is due to that they are in the composition of 
sheaths and are the first to deal with acting factors. This also depends on that glial cells have 
very large surface of their lamellas [48] and accordingly the extremely high ratio of the 
membrane area to the cell volume (i.e., have very low thermodynamic and structural 
stability). They always are the first to respond to external actions. If time of the proteolytic 
treatment is decreased, some number of gliocytes can be preserved in culture.  
 
Biomedical Tissue Culture 86 
 
Figure 1. The peripharyngeal nerve ring of the mollusc Lymnaea stagnalis L in vivo. 
1 – cerebral ganglion; 2 – intercerebral commissure; 3 – buccal ganglia; 4 – esophagus. MBS-2. Magnification – 20×. 
 
Figure 2. Microcameras (а, b) and Г-shaped micropipettes (c), with whose aid isolated neurons were 
cultured and prepared. 
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After 40-60 min of incubation of ganglia in pronase, they were washed out from proteolytic 
enzymes in isotonic solution and got free from their connective tissue. To make sure in the 
viability of neurons, they were placed under a MSSO-IV42 microscope (LOMO, St. 
Petersburg) and by using a gold microelectrode with the tip diameter of about 20 µm in the 
glass isolation the extracellular leading of the spontaneous electric activity of individual 
cells was performed. They generated spikes with frequency of 1.5 ± 0.3 imp/s. The amplitude 
of spikes was equal to 22 ± 4 µV, while their duration – to 4 ms [38].  
After cleaning from capsules, the procedure of multiple suction of ganglia (pipetting) into 
the specially designed Г-shaped glass micropipettes with the tip diameter of 0.8 and 0.6 mm 
was performed (Fig. 2).  
The experience shows that the molluscan neurons can be seeded onto the glass without 
special support. For cultivation of neurons we used microcameras of the following 
construction (Fig.  2, а, b). 
1. The glass rings, 0.8 cm in height and 0.8 cm in diameter, attached with a mixture of 
paraffin and vaseline (1:1) to coverslips served the base of the camera.  
2. The Carelli flask in our modification represents camera, 4 ml in volume, with two round 
holes on the upper and lower walls (Fig. 2, b), which for preservation of sterility were 
closed by coverslips and soldered with the paraffin—vaseline mixture. The cylindric 
camera branches designed for change of the nutrition medium were closed by a lid. The 
cells were seeded onto the lower coverslip, which allowed microscopy with aid of 
inverted microscope at high magnification (with objectives 40× and 60×). Besides, 
clearness and contrast of image were significantly improved. At filling of only the lower 
camera indentation (1.5-2 mm in depth) a meniscus of the medium was formed, and the 
surface tension produced aggregation of neurons near the camera center. Cells in this 
aggregate were not flattened, but could long survive by preserving the sphere-like shape 
and the granular cytoplasm. We managed to avoid aggregation of neurons at the 
complete filling of the camera with nutrition medium. The cells were attached to the 
surface of the lower coverslip, spread on it, and generated processes. Our proposed 
camera allows observing the details of growing neurons, invisible at low magnifications 
or resulted from light dispersion at its passage through the thick bottom of the glass or 
plastic Petri dish. Thus, for instance, it is clearly seen that the structures sometimes 
mistaken by researchers for cell processes are in reality dense cytoskeleton strands inside 
lamellas. For experimental studies, the serum-free nutrition medium of certain chemical 
composition was used. As the stock medium, we used the standard RРМI 1640 medium. 
The thereby isolated cells were repeatedly washed with Ringer solution. The upfloating 
connective tissue and dying gliocytes were carefully removed with the same micropipette. 
As a result of micropipetting, we managed to obtain a significant amount of isolated glia-
free neurons (Fig. 3). By varying pronase concentration, time of incubation, and activity of 
ganglion pipetting, it was possible to obtain either the isolated neuronal bodies or neurons 
with fragments of their processes. The more time of treatment with pronase and its 
concentration, the lower chances to isolate neuron with its processes. 
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Figure 1. The peripharyngeal nerve ring of the mollusc Lymnaea stagnalis L in vivo. 
1 – cerebral ganglion; 2 – intercerebral commissure; 3 – buccal ganglia; 4 – esophagus. MBS-2. Magnification – 20×. 
 
Figure 2. Microcameras (а, b) and Г-shaped micropipettes (c), with whose aid isolated neurons were 
cultured and prepared. 
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The medium directly for cultivation was prepared based on the stock single medium RРМI 
1640 medium by its dilution with a special salt solution. The composition of the salt solution 
(mol): 75 NaCl, 5 КСl, 2.5 СаСl2, 2.5 МgСl2. To obtain the nutritive medium, 250 ml of the 
single RРМI 1640 medium were diluted in 1 l of the salt solution. Concentration of amino 
acids after dilution decreased 5 times. Such medium composition is optimal for successful 
cultivation of dissociated neurons of Lymnaea stagnalis. 
рН of the prepared medium raised to 7.6 with aid of Tris-НСl, and for sterilization filtrated 
immediately the medium by passing it through Millipore membranes with diameter of 
pores of 0.22 µm by using a Peristaltic miniflon pump type 304 (Poland). In the process of 
filtration, pH of medium reached the value of 7.8 optimal for cultivation. For control of pH, 
there was used a pH-meter-millivoltmeter of the "рН 150" type ("Izmeritel", Gomel). 
The light microscopy was performed by using a MBI-13 inverted phase-contrast microscope 
(LOMO, St. Petersburg) with a thermostated camera and water-heat filter. 
Observations were performed only on living neurons. The neuron viability signs are the 
clear external cell contour (the intact membrane), the granular cytoplasm that has the clear 
light dispersion and fills completely the body contour; the nucleus contours are not seen. 
Considered damaged were the neurons, in which the granular cytoplasm was separated at 
small sites from the outer cell body contour with a layer of homogenous flooded 
cytoplasm. Not infrequently the nucleus contours are well expressed. The hopelessly 
traumatized cells usually had the aggregated cytoplasm with large flooded 
submembranous spaces and the Brownian movement in them of granules or the visible 
disturbance of the membrane integrity. The sign of insufficient treatment with pronase 
served preservation of fragments of the glial membrane connected with the cell body. The 
neuron was as if in the villous membrane with uneven contours, while its own 
"membrane" was not seen. 
Observation on behavior of regenerating processes can begin at the very first day; however, 
at long illumination under microscope, especially in the absence of water filter, neurites stop 
growing and branching. 
Thus, the exposed detailed procedure allows obtaining the viable single neurons that 
regenerate nerve processes (Fig. 3, d) and form interneuronal contacts and extensive nerve 
plexuses. It is important to emphasize that we are dealing here with culturing of the glia-
deprived brain neurons of the adult animals and that the culture medium is strongly 
identified and does not contain uncertain growth factors. This makes it possible to take into 
account sufficiently exactly the effects of various outer agents on living neurons, their 
processes, and interneuronal contact. 
To reveal the principal possibility of formation of syncytium in the nervous system, it is 
necessary, first, to reproduce on living cells the process of fusion of outer cellular neuronal 
membranes and, second, to prove combination of the neuroplasm of two different cells. The 
most convenient for this is use of living neurons in the tissue culture.  
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Figure 3. Isolated molluscan neurons after treatment with pronase. 
a – neuron isolated without processes; b, c – variants of neurons isolated with processes; d – isolated neuron  at the 4th 
day of cultivation in the RPMI 1640 medium. Supravital microscopy. Obj. 20Ph, eyep. 10. 
4. Structural kinetics of neurons during formation of syncytium 
The primary neuronal cultures were studied in phase contrast, which increased essentially 
the degree of detection of structural details with aid of a light microscope. However, the 
main virtue of the method of supravital studies was a possibility of studying the structural 
kinetics of the culture, the ability of the method to reveal structural transformation of 
neuron in time. This advantage of the method also allowed developing peculiar absolute 
criteria making it possible to prove formation of syncytial connections in living neurons at 
the light microscopy level [32, 49]. The studies were carried out by using the many-day (3-6 
days) automatic time-lapse microvideo shooting and computer analysis. To prove formation 
of the neuronal cytoplasmic connection, we used criteria that allow with aid of videostudy 
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of kinetics of living neurons differentiating fusion of processes from their contact. For this 
purpose, as the theoretical substantiation (criterion of syncytial connection) there was used 
inverted statement of the law of the Wallerian degeneration [50]. Astonishing as it is, 
detection of syncytium was helped by the concept of the Wallerian degeneration that at its 
time was one of important proofs of the absence of syncytial connection in the nervous 
system.  
Since after separation of the nerve process from the neuronal body (the trophic center) it 
should necessarily degenerate, so if such process does not degenerate after separation of the 
body of its neuron, this means that it is in the cytoplasmic connection with body of the other 
neuron. 
We were the first to propose the novel way of revealing syncytial connection between 
neurons by using the light microscopy observations of dynamics of structural processes in 
the tissue culture.  
Figure 4 shows the initial establishment of "end-to-end" contacts between filopodia (3) of the 
lamellar processes of cells A and B. Then, after 15 min, contacts start to form between 
lamellae 1, 2 neighboring cells A, B and the boundary between them becomes unclear. It can 
be suggested that these lamellae have a syncytial coupling, as with time they form a single 
intracytoplasmic cytoskeletal filament (Fig. 4, d-f, 4) which, being continuous, runs from one 
lamella to other lamellae. Cell A is connected with cell B via lamella 2 of cell B (Fig. 4, d, 4). 
However, this remains insufficient as evidence of a syncytial coupling between these 
lamellar processes, though, as often occurs in primary cultures, cell B dies (Fig. 4, e, 5) and 
its lamellar processes 2 and cytoskeletal filament 4 remain intact. Lacking its body (the 
trophic center), process 2 of cell B does not undergo Wallerian degeneration, as occurs in all 
other cases when neuron processes are detached from their bodies. In the present case, they 
persist for 4 h, i.e., until the end of the observation period. Furthermore, by contracting, cells 
A and B are brought closer together (the distance between them decreases by 9.2% and the 
anastomosis connecting them straightens, Fig. 4, d, f). This is possible only in one case, if the 
process preserving viability got time to acquire a new trophic center, i.e., established the 
direct cytoplasmic connection with the other cell. This process is schematically presented in 
three stages (Fig. 5). 
Exchange of neuroplasm can be observed after fusion of processes. Thus, the plexus of 
tubular nerve processes presented in Fig. 6, a, b shows that growing neurite 1 establishes 
contact with process 2 of the other cell. Further video frames show displacement of the 
cytoplasm of varicosity 3 of process 1 into process 2 of cell 4 (Fig. 6, b-f), which provides 
further support for the formation of syncytial connections between different cells by fusion 
of their processes. The cytoplasmic varicosity 3 of process 1 slowly, over 6 h 14 min, moves 
to the site of contact between processes 1 and 2 (Fig. 6, c) and, passing it (Fig. 6, d), moves 
from process 1 into process 2. The varicosity then approaches cell 4 (Fig. 6, e) and fuses with 
it (Fig. 6, f). It is suggested that displacement of the cytoplasmic varicosity from the process 
of one neuron to the process of the other one can only occur when there is a syncytial 
connection between the neuroplasm of their processes. 
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Figure 4. Dynamics of formation of syncytial connection between processes of neurons of the mollusc 
Lymnaea stagnalis in tissue culture. 
а-f – stages of formation of syncytium (time – from beginning of culturing); А, B – neurons forming syncytium; 1 – 
process of neuron А; 2 – lamellar process of neuron B; 3 – combined filopodia of growth cones of cells A and B prior to 
fusion of their lamellar processes; 4 – the formed single cytoskeletal structure inserted into lamellopodia of both cells; 5 
– dead neuron. Tissue culture, time-lapse computer videoshooting. Obj. 20Ph, eyep. 10. 
 
Figure 5. Schematic presentation of formation of syncytial collection between processes of two neurons.  
а-c – stages of process; 1 – filopodia of growth cones; 2 – formation of the cytoskeletal strand common to two neurons; 
3 – the dead neuron. 
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Figure 5. Schematic presentation of formation of syncytial collection between processes of two neurons.  
а-c – stages of process; 1 – filopodia of growth cones; 2 – formation of the cytoskeletal strand common to two neurons; 
3 – the dead neuron. 
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Figure 6. Formation of syncytial connection between processes of two cells and translocation of the 
cytoplasmic varicosity from one process into the other. 
а-f – stages of formation of syncytium; 1 – process of the lower cell; 2 – process of the upper cell; 3 – the varicosity that 
flows over through the place of fusion of two processes; 4 – body of the upper cell. Tissue culture, time-lapse computer 
videoshooting. Time from the beginning of culturing is shown. Obj. 20Ph, eyep. 10. 
Such behavior of cytoplasmic varicosities, in our opinion, can serve another criterion of 
formation of the cytoplasmic syncytial connection of neurons. 
In the dissociated culture, in isolated neurons that have no contacts with other neurons there 
are formed multiple contacts between their processes (autapses) (Fig. 7, а). Some of these 
processes seem to form syncytial connection, as cytoplasmic varicosities from some 
processes are freely translocated onto neighbor processes. Processes 1 and 2 (Fig. 7, b) 
approach the process 3, while their cytoplasmic varicosities overcome sites of their 
connections (Fig. 7, d-f). This phenomenon occurs for 5 h between all processes of the 
isolates neuron 
Such are the facts of fusion of neurons with formation of the syncytial interneuronal 
connection in tissue culture. However, by the example of cells of other types it is shown that 
their syncytial connection is easily transformed into the cell fusion. Dynamics of fusion of 
neuronal bodies has not yet been studied at present. 
 
Use of Cell Culture to Prove Syncytial Connection and Fusion of Neurons 93 
 
 
Figure 7. Translocation of cytoplasmic varicose thickenings along the syncytially connected processes 
of the same neuron (а). 
b-f – stages of overflowing of cytoplasmic thickenings, 1, 2 – nerve processes of the lower neuron, 3 – process of the 
upper neuron, 4 – cytoplasmic varicosities translocating from the lower to the upper processes. Tissue culture, time-
lapse computer videoshooting. Time – from the beginning of culturing. Obj. 20Ph, eyep. 10. 
5. Spontaneous syncytial fusion of bodies of molluscan living neurons 
It seemed unachievable to wish obtaining in the supravital experiment the fusion of living 
neuron bodies with formation of binucleated cells. However, numerous experiments on 
proteolytic dissociation of ganglia with obtaining isolated neurons got success several 
times. Preparations of living, just isolated mollusc cells turned out to contain binucleated 
neurons. The fact that indeed these were individual binucleated, rather than attached 
paired cells is indicated, first, by the treatment itself of cells with pronase that regularly, 
in 100% of cases, dissociates molluscan ganglia into single neurons by eliminating all 
gliocytes and fibroblasts. Second, these cells sometimes had common fused nerve 
processes (Fig. 8). Lastly, the angle between the fused cells (the angle of waist) exceeded 
125°, which has been proven electrophysiologically [51] to be the convincing evidence for 
fusion of neurons.  
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Figure 8. Spontaneous fusion of two neurons isolated from the molluscan perinuclear ring. Obj. 40Ph, 
eyep. 10. 
 
Figure 9. Binucleated neurons of Lymnaea stagnalis after two days of incubation in the cultural RPMI 
1640 medium. Phase contrast. Obj. 20Ph, eyep. 10. 
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Unfortunately, the revealed fused neurons and the very process of the cell fusion directly 
after isolation are observed quite seldom. However, after careful washing out from pronase, 
after two days of incubation of neurons in the culturing medium there is noted a significant 
number of the fused neurons whose fusion angles are much higher than 125º (Fig. 9). Such 
cells also have other absolute features of fusion.  
This has allowed us to suggest that neurons, by using their own potentials for fusion, some 
time after isolation, without help of draining agents, are able to form intersomatic syncytial 
cytoplasmic connections and to fuse. But since in the experiment there was involved a 
complex of proteolytic enzymes (0.4% pronase), a possibility existed that the cell fusion had 
been provoked by proteolytc enzymes. To check this, we performed a special series of 
experiments on electron microscopy study of effect of pronase on molluscan neurons. 
Nowhere in this experiments could we detect formation of typical specialized membranous 
contacts and syncytial perforations. It can be concluded that the treatment itself of neurons 
with pronase does not induce their fusion. It only removes glial interlayers between the 
nerve cell bodies by promoting the fusion. 
6. Development of method of artificial syncytial cytoplasmatic fusion of 
neurons in vitro 
Our application of several procedures used at fusion of non-nervous cells [52, 53] had no 
success. Attempts at using polyethyleneglycol as a draining agent turned out to be 
unsuccessful, as these neurons do not endure the temperature necessary for keeping 
polyethyleneglycol in melted state. For fusion of neurons with aid of latex balls of polysterol 
there was needed the culture medium deprived of Ca and Mg ions causing aggregation of 
balls. Such medium is also poorly endured by molluscan neurons. As a result, these 
methods turned out to be poorly effective for the studied neurons. 
At developing the new way [54], two groups of experiments were performed. In the first 
group, isolated neurons were studied in usual culture for 2-5 days, while in the second 
group, the structural processes were analyzed in the cell aggregate after two days. 
Since earlier nobody has performed the experimental fusion of non-infected neurons, we 
developed a special method for fusion of the molluscan cells that have the satellite gliocytes.  
Ganglion neurons of the mollusc Limnaea stagnalis first were freed from the ganglion 
connective tissue and satellite gliocytes with aid of proteolytic treatment. Neurons were 
carefully washed out from pronase. Then they were studied in the Eagle MEM cultural 
medium (Sigma, England). A part of cells were aggregated by centrifugation (3000 g, 15 
min) and preserved in the cultural nutritive medium for 2 days by allowing the neurons to 
restore their natural capabilities for adhesion and fusion. Then, with aid of a light phase-
contrast microscope, semithin sections were analyzed, while with aid of the standard 
transmissional electron microscope, ultrastructure of borders of contacting neurons was 
studied. 
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Figure 8. Spontaneous fusion of two neurons isolated from the molluscan perinuclear ring. Obj. 40Ph, 
eyep. 10. 
 
Figure 9. Binucleated neurons of Lymnaea stagnalis after two days of incubation in the cultural RPMI 
1640 medium. Phase contrast. Obj. 20Ph, eyep. 10. 
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Figure 10. Dynamics of fusion of large and small neurons in tissue culture. 
a – fusion of two neurons for 57 h; b – fusion of three neurons for 37 h; 1, 2, 3 – fusing neurons. Time-lapse 
videoshooting. Obj. 20Ph, eyep. 10. 
Experimental aggregates of neurons were carefully washed out from pronase with cultural 
medium and were kept under the “normal” conditions natural for cultivated neurons. 
Therefore, we consider the processes revealed in the aggregates as natural, depending only 
on potentials of the cells themselves. It is suggested that treatment with pronase promoted 
only the removal of glial membranes.  
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Under conditions of the performed experiment the single living neurons often  
form paired or multicellular aggregates and fuse between each other. Fig. 10 presents 
dynamics of fusion of neurons in tissue culture. Initially, neurons are approached to each 
other by using the dotted contact. Later, the area of contact is enlarged and acquires shape 
of the large flatness.The angle of waist, of the node between the fusing cells increases. At 
fusion of small neurons this phenomenon is expressed worse due to large curvature of 
small spheres. Lastly, the smaller neuron is invaginated almost completely into the larger 
cell. 
At the second day of culturing, the neuronal processes start growing and provide contacts of 
neurons; by contracting, the processes make the neuronal bodies adjacent to each other (Fig. 
11). The contacting neuronal bodies form the 8-like structures that are separated by vacuole-
like structures (Fig. 11, c, d). These vacuole-like structures at the borders of cells are clearly 





Figure 11. Formation of syncytial connection of two isolated neurons tissue culture. 
a-c – approaching and fusion of neurons revealed in phase contrast; d – vacuole-like structures revealed with aid of 
computer Solarise effect (the same neurons as those in Fig. 1, c); 1 – nerve processes; N1, N2 – neurons; arrows – 
vacuole-like structures. Time – from the beginning of shooting. Obj. 40Ph, eyep. 10. 
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In semithin sections, we have managed to reveal along the contacting neuron edges  
the multiple outgrowths (the cytoplasmic feet) that are firmly adjacent to the "feet" of the 
neighbor cell. The paired feet are separated from each other by large vacuole-like "empty" 
structures that represent the local sharply enlarged fragments of the intercellular  
space (Fig. 12). The alternating bridges and the vacuole-like structures are clearly 
arranged along the cell borders and can serve a reliable orienteer of these borders under 
light microscope, especially at using the computer software ACDSee. It is these bridges  
that represent the cytoplasmic connections uniting the cytoplasm of adjacent cells. Here it 
is worth noting that the described vacuole-like local fusions are completely identical to 
such structures found at fusion of filopodia of growth cones [55, 56]. We have managed  
to detect the formed trinucleated neurons forming, in fact, the multinucleated symplast 
(Fig. 13). 
 
        
 
Figure 12. Light-optical signs of syncytial fusion of neurons in semithin sections. 
а – additional staining with toluidine blue; b – vacuole-like structures revealed with aid of computer effect Emboss; 1 – 
cytoplasmic fusion bridges; 2 – vacuole-like enlargements of intercellular cleft; N1, N2 – adjacent neurons; Nuc –  
nuclei. Obj. 40Ph, eyep. 10. 
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Figure 13. Chain of syncytially connected (draining) neurons. 
а – computer effect of Emboss; b – computer effect Solarise; 1 – cytoplasmic bridges of fusion; 2 – vacuole-like 
enlargements of intercellular cleft; N1-N4 – fused neurons; Nuc – nucleus. Obj. 40Ph, eyep. 10. 
With aid of electron microscope, indeed, it can be showing that bridges serve loci of fusion 
of two cells (Fig. 14). Although in some electron pictures the bridges of two contacting 
neurons can be separated with their external membranes (Fig. 14, b), the majority of 
membranes separating the cytoplasm of neighbor cells in the foot area turn out to be 
destroyed (Fig. 14, c, d). Instead of the external cell membranes separating the neuron 
cytoplasm, there are revealed only their short residual fragments that locally preserve the 
intercellular cleft, about 20 nm in width. In other places the neuroplasms of adjacent cells 
pass directly into each other (Fig. 15). Actually the cells turn out to be fused. 
Thus, in these experiments, we were the first to manage modeling the syncytial connection 
between neurons in vitro, to prove their fusion, and thereby to confirm the principal 
similarity of neurons with other, non-nervous cells in the subject of intercellular interactions. 
Besides, results of these experiments, in our opinion, answer the chief question of the 
discussion about the principal possibility or impossibility of the syncytial connection of 
neurons. Not the initial small membrane pores and perforations have been demonstrated, 
but almost complete destruction of membranes of paired neurons and fusion of their 
cytoplasm have been shown. Fusion of neurons has been shown to occur not simultaneous 
on the entire contacting surface.  
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Initially, there are formed the fusion bridges, the local sites where membranes of contacts 
are destroyed and intercellular clefts between them are sharply enlarged in places and 
remind vacuoles (Fig. 16). This is the first absolute parameter of fusion. 
The second absolute parameter of fusion of neurons is proven by McCarthy et al. [51]. It 
consists in that the adjacent cells first have the shape of the figure eight with the acute angle 
of waist. Then such structure gradually loses the shape of zero, i.e., strives for the shape of 
ball. The authors showed experimentally, with aid of microelectrode technique, that if the 
waist angle between paired contacting neurons exceeded 125°, these neurons had already 




Figure 14. Borders of fused neurons. 
a – multiple formations of cytoplasmic bridges of fusion and vacuole-like enlargements of intercellular cleft between 
two contacting neurons; b – preserved external cell membranes on the border of cytoplasmic bridges of two neurons; c, 
d – variants of destroyed borders between two fused neurons in the area of cytoplasmic bridge; 1 – cytoplasmic 
bridges of contacting neurons; 2 – vacuole-like enlargements of intercellular cleft; 3 – intercellular cleft; 4 – cistern of 
endoplasmic network; 5 – residual fragments of destroyed membranes on the border of two neurons; N1, N2 – 
adjacent neurons; Nuc – nucleus. Bar: a – 0.05 nm; b-d – 0.1 nm. 
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Figure 15. Residual fragments of destroyed external membranes in the area of bridges of adjacent neurons. 
а, b – variants of fragments; 1 – remnants of adjacent membranes with rounded ends; 2 – vacuole-like enlargements at 
the site of intercellular cleft. N1, N2 – adjacent neurons; Nuc – nucleus. Bar – 0.1 nm. 
The data obtained in model experiments in tissue culture about the syncytial fusion of 
neuronal bodies are leading us to another, seemingly independent problem of mechanism of 
formation of binucleated and polynucleated cells [12]. 
The doubtless proves of formation of neurosyncytia have also revealed in tissue culture with 
aid of the phase-contrast microscopy of the structural neuron kinetics. 
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1. Syncytial connection between nerve processes is found in the case that nerve processes 
of some neurons, which contact with branches of another neuron do not die if the body 
of this neuron dies or is amputated. By the law of Wallerian degeneration the process 
separated from the cell body is to die necessarily. But if it does not degenerate, it means 
that it is connected cytoplasmically with the other neuron body. 
2. The cytoplasmic syncytial connection of neurons can also be considered in the case that 
cytoplasmic varicosities are translocated from branch of one neuron to the branch of the 
other, contacting neuron. 
 
Figure 16. Light optical morphological parameters of syncytial fusion of neurons. 
а, b – formation and visualization of fusion bridges and of bordering vacuole-like structures, rounding of the total 
structure of two fused cells; c, d – an increase of the waist angle of two fused cells higher than 135°; e, f – rounding of 
fused neurons; 1 – neuronal body; 2 – boundary vesicle-like structures; e, f – phase contrast. Obj. 20Ph, eyep. 10. 
3. In semithin sections and under electron microscope, parameters of fused neurons serve 
the contacting “feet” of adjacent cells forming the fusion bridges, in which the residual 
fragments of destroyed boundary membranes of adjacent neurons are detected. The 
same criteria of syncytial connection serve the vacuole-like structures, significant local 
enlargements of intercellular clefts located between the fusion bridges. The local 
vacuole-like enlargements are also seen at phase-contrast microscopy on living fused 
neurons.  
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4. As seen with aid of a microelectrode leading and of recording of membrane 
permeability to stains with different molecular masses, an increase of the waist angle of 
attached neurons higher than 125° corresponds to conversion of gap junction pores into 
syncytial perforation and to fusion of neurons [51].  
5. Since we have proven the binucleated neurons to be formed by the cytoplasmic 
syncytial fusion, their presence also is the absolute parameter of the existence of the 
syncytial connection in the nervous system. 
7. History of study of binucleated neurons 
The binucleated nerve cells were first revealed by I. Remak [57]. He was a pupil of the 
famous physiologist I. Müller who was the fist to describe the binucleated non-nerve cells. 
Since then the binucleated neurons were studied hundred times by numerous well-known 
histologists, such as Ranvier, Schtër, Dogiel, Schpielmayer, Bielschowski, Këliker, 
Alzheimer, and others [58, 59]. Their description had been included into previous textbooks 
and manuals past [60-62].  
This problem has also been studied at present [63-65]. The binucleated and polynucleated 
neurons have been revealed in various central and peripheral parts of the nervous system 
[66, 67]: in large hemisphere cortex, hippocampus, globus pallidus, brainstem, cerebellum, 
pituitary, spinal cord, spinal ganglia, boundary sympathetic trunk, prevertebrate ganglia. 
The binucleated neurons were studied in human, monkey, horse, pig, sheep, rabbit, cat, dog, 
rat, mouse, guinea pig, frog, cod. In investigation of our Laboratory, they have been 
detected in intramural nerve plexuses of the normal cat gut (Fig. 17) and in dog [68] in 
toxicosis on the background of the portal vein (Fig. 18). More than a half of the authors 
studied the normal material.  
In pathology there has also been described a great number of bi- and polynucleated neurons 
[69-74]. 
In the monograph of N.E. Yarygin and V.N. Yarygin [75] as well as in works of Ehlers [76], 
Shabadash and Zelikina [77] there are presented counts of binuclear neurons in norm. Their 
number in peripheral ganglia varies in different animals from 13 to 89%.  
The issue of binucleated cells involves the problem of syncytial connection in the nervous 
system and the problem of non-divisibility of highly differentiated neurons. The most 
important is the issue of mechanism of formation of phenomenon of neuron binuclearity. 
The point is that from the very beginning of the studies and till now the appearance of 
binucleated neurons has been explained by division of mononucleated nerve cells. But since 
mitosis in differentiated neurons of adult animals is impossible, the hypothesis of the so-
called amitosis was proposed, when the neuron nucleus is divided by direct perecording, 
without mitotic division figures. Since nobody has seen cytokinesis (the process of division 
of the cell body proper), there was formulated the additional hypothesis of the possibility of 
the incomplete amitosis restricted only by division of the nucleus. But division of the 
neuronal nucleus also was seen by nobody. All suggestions are based on voluntary selection 
of static fixed histological preparations. 
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This construction looks schematically like in Fig. 19, а. But the point is that in static 
histological  preparations it is impossible to determine direction of vector of the process [78]. 
It is selected arbitrarily, based on the beforehand suggested hypothesis. Based on the same 
preparations it is also possible to model the process of the opposite direction: two neighbor 
cells are touched, form membrane contact, establish syncytial connection, and then are fused 
into one binucleated cell (Fig. 19, b).  
However, for strange reason, almost all authors chose hypothesis of amitosis as mechanism 
of binuclearity and even do not discuss the possibility of mechanism of syncytial 
cytoplasmic fusion of neurons. 
True, H. Apolant [79] mentions such possibility, but thinks it to be incompatible with 
physiological data. Indeed, the neuronal doctrine negates completely the possibility of 
interneuronal syncytium and, hence, does not accept the possibility of syncytial fusion. But 
in the culture of isolated neurons we have shown the binucleated neurons to be formed by 
syncytial fusion of usual mononucleated cells. 
       
Figure 17. Binucleated neurons from intramural plexus of normal gut. 
а – binucleated neuron with independent neurocytes; b – binucleated bipolar neuron with the generalized processes; c 
– a variant of binucleated neuron. Impregnation by Bielshowski-Gros. Obj. 40, eyep. 10. 
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Figure 18. Polynucleated neurocytes in the node of submucosal plexus of the dog jejunum. The 15th 
day after the operation of the portal vein stenosing (by Chepur [68]). Procedures of Gomori in 
modification of Chilingaryan (a) and Einarson (b). Obj. 40, eyep. 10. 
 
Figure 19. Schematic presentation of suggested mechanisms of formation of binucleated cells. 
а – formation of binuclearity of neurons by amitotic cell division; b – formation of binuclearity by syncytial fusion of 
neurons. 
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modification of Chilingaryan (a) and Einarson (b). Obj. 40, eyep. 10. 
 
Figure 19. Schematic presentation of suggested mechanisms of formation of binucleated cells. 
а – formation of binuclearity of neurons by amitotic cell division; b – formation of binuclearity by syncytial fusion of 
neurons. 
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8. Physiological proofs of interneuronal syncytial connection and of 
formation of binuceated neurons 
The first electrophysiological study of neurons after their syncytial fusion with the 
neuroblasoma C 1300 neuroid cells seems to have been performed by A. Chalazonitis and 
coauthors [80]. The cells of the obtained hybrid line reminded the initial sympathetic 
neurons, were electroexcitable, sensitive to acetylcholine, and able to generate action 
potential. It is not necessary to prove that the hybrids are obtained by the cytoplasmic 
syncytial fusion. There also exist other examples that the presence of syncytial connection of 
neurons follows indirectly from physiological experiments. 
In our work there remains one more uncovered point: whether there are physiological 
proofs of the existence of the syncytial interneuronal connection and what is the 
physiological effect of formation of syncytium in tissue culture.  
In several experiments it was shown that such stains as Fura-2 and Calcium Green that are 
too large to overcome gap junction pores sometimes do penetrate across the boundary 
membranes. After injection into one cell they turned out to appear in the adjacent cell [81] as 
if the cleft contact would be converted into the syncytium. When studying the neuronal 
coupling only by the electrophysiological method, it is always difficult to distinguish the 
cleft contact from the electrical syncytial interconnection of neurons [82]. 
For the last few years there was intensively studied the role of interneuronal cleft contacts in 
hippocampus and cerebral cortex [83-85]. The electropermeable contacts were found to be 
the cause of formation of the high-frequency synchronization of the spike activity [63, 86]. It 
was shown that the “connexin-specific” blockators of cleft contacts: octanol, halotan, and 
carbenoxolen [87] cannot prevent completely effects of the presence of intercellular electrical 
connection. Suggestion of electrical connection of the “non-connexin type” appeared [88, 
89]. This form of connection can be syncytium, as it is known that it is the syncytial 
perforations by their nature, which cannot be blocked by chemical agents.  
It is also proven that the main protein providing intercellular connections in hippocampal 
cleft contact is connexin-36. It also serves the 100% marker of these contacts in vertebrates. 
However, in special studies of knockout animals deprived of connexin-36 and hence of cleft 
contacts [90, 91], the capability of hippocampus for synchronization of spikes as well as 
other effects are partly preserved [81, 92, 93]. Hence, apart from the cleft contact pores, 
hippocampus contains some intercellular connections between neurons, i.e., possibly the 
cytoplasmic syncytium. 
Further. As long ago as in the 1990s a mysterious phenomenon was detected: the 
pseudorabies virus in the tissue culture was able to penetrate from neuron to neuron and to 
other cells by passing the intercellular medium [94-96]. This allowed suggesting formation 
of membranous perforations between cells. This virus was shown to be able to fuse neurons 
with the surrounding glia by forming binucleated cells and multinucleated hybrid 
symplasts [97]. 
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Lastly, a work was published [51] whose authors infected culture of isolated neurons of rat 
sympathetic ganglion with the low pathogenic pseudorabies virus (PRV-151) and produced 
a massive formation of cleft contacts between adjacent neurons. The authors were able to 
demonstrate the ability of the dye with low molecular weight, Lucifer yellow (457 MW) to 
penetrate across the cleft contact membranous pores 9-12 h after infection of the culture. The 
dyes with the higher molecular weight could not be translocated from neuron to neuron. 
However, 24-26 h later, the dextran Texas red, the dye with the higher molecular weight  
(3000-40000 MW) began to penetrate from one neuron into the other one. This means that 
the cleft contact pores were transformed into syncytial cytoplasmic perforations; in other 
words, the neurons fused and acquired the dumbbell-like shape. The waist angle between 
fused neurons became more than 125° and several contacting neurons actually formed 
binucleated cells or the multinucleated symplast. Thus, with aid of the electrophysiological 
procedure there were shown the morphological equivalent and the physiological 
manifestation of the syncytial fusion of neurons. 
It is important to emphasize that 18-20 h after infection of culture the incomplete electrical 
coupling (interneuronal electrical connection) was still observed, although a weak ability of 
the Lucifer yellow to penetrate from one cell into the other already was obvious. There were 
noted the incomplete coincidence of rhythms of adjacent cells, deletion of spikes or their 
conversion into spikelets (the noise-like spikes). But after 24-26 h the paired neurons became 
completely connected. They reproduced synchronously both spikes and spikelets, i.e., 
worked as the single binucleated cell. 
Thus, these authors have managed to: first to obtain a model of the massive goal-seeking 
formation of gap junctions; second, with aid of microelectrode electrophysiological 
procedures to demonstrate conversion of small membranous pores of these contacts into 
syncytial perforations, i.e., to fuse neurons in the same way as we managed to do this in 
tissue culture without using virus.  
In our work, by morphological methods it was also shown that syncytial perforations 
appeared in the place of gap junctions as a result of their perforation [25]. Hence, apart from 
the existing static concepts of structure of gap junctions there should be formulated a novel 
concept of transformation of cleft contacts from perforation of contacting membranes up to 
the complete fusion of neurons.  
Some consequences of fusion of neuronal bodies can be revealed with aid of mathematical 
modeling [98, 99]. Due to development of the process of the neuronal body fusion and a rise 
of fusion pores between these neurons, the degree of synchronization of impulses of this 
pair of neurons increased. In the end of the fusion process the impulse activity of these 
neurons became practically synchronous. Besides, after fusion of two identical spherical 
neurons and at their transition to the shape of one sphere with preservation of the total 
cytoplasm volume the dikaryon surface will be reduced by approximately 20% as compared 
with that prior to fusion. Also reduced was the capacity of the cell body membrane. The 
newly fused nerve cell should be more sensitive to controlling signals of synapses.  
Also attention is to be paid to data of study of neocortex of the 14-day rat embryos [12]. 
The syncytial cytoplasmic connections in these embryos were detected at the time when 
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the developed chemical synapses still were absent. Besides, it is known that in pathology, 
when chemical synapses are damaged for the first time, a clear increase of the number and 
size of syncytial perforations is noted [35]. Possibly, in these cases, when the fine 
procession of information in chemical synapses is absent or attenuated, brain uses rough, 
but simple and stable form of impulse transduction between neurons with aid of syncytial 
pores and perforations. This primitive way is resistant to chemical actions and pessimal 
impulse activation and hence can have certain compensatory significance. Besides, the 
presence of the syncytial cytoplasmic connection between neurons allows the direct 
exchange with energetically important substances and proteins between the relatively 
preserved and the damaged neurons. This also can be considered as compensatory 
phenomenon. 
In our neurohistological studies, on many objects there were recorded syncytial cytoplasmic 
interneuronal connections [100]; however, studies on living neurons in the tissue culture 
were necessary to demonstrate kinetics of their formation and transformation into fusion of 
cells and multinuclearity; it was necessary to develop the way of massive artificial obtaining 
in the tissue culture of interneuronal syncytial connections in experiment. Such way was 
developed [54]. We have managed to obtain fusion of two or several neurons, i.e., to model 
formation of bi- and multinucleated neurons and to confirm fusion of cells with aid of 
electron microscope. 
The fact that syncytial perforations are formed on the basis of cleft contacts, while individual 
perforations are transformed with time into the total fusion of neurons with formation of 
binucleated cells allows formulating notion about the single process of readjustment of 
paired membranes. The process begins with formation of dotted and expanded 
membranous contacts, their fusion, formation of small pores and large perforations. 
Enlargement of perforations leads to fusion of neuronal bodies and formation of binucleated 
cells. 
Acceptance of cytoplasmic syncytial connections in the nervous system as the 
morphological and physiological reality removes contradiction of the neuronal theory and 
cellular theory. Similarity of the main properties of all cells including their ability to form 
the cytoplasmic syncytium and fusion has been confirmed. 
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1. Introduction 
The placenta is a transient organ responsible for maternal fetus nutrient and oxygen 
exchange. It is important to the modulation of the maternal immune response to antigens of 
paternal and fetal origin and a source of a great variety of hormones that ensure the 
maintenance of gestation. Pathological conditions of pregnancy, fetal growth and delivery, 
abnormal placentation and surgical problems always attracted the medical sciences 
attention. The diversity of placental types among eutherian mammals has often raised 
important questions about phylogeny. In vitro culture of placental cells is an approach that 
allows the investigation of hormonal production and metabolic process as well as 
pathological disorders of common occurrence in human beings and animals. This chapter 
aims to show the most important features on culturing placenta derived cells and cell 
populations with properties of progenitor/stem cells: identification of the structures, 
isolation of the cells, maintenance of the cell culture, and applicability in research trends. 
2. The placenta 
Retention and development of the fertilized egg within the maternal body (histotrophic and 
hemotrophic viviparity) are observed in most mammals, reptiles and a few lower 
organisms. The growing embryo is nourished by the mother, usually through a placenta or 
similar structure. Vertebrate viviparity with the development of a placenta in the uterus 
evolved 150-100 million years ago and is responsible for the adaptability and dispersion of 
eutherian mammalians all over the diverse habitats.  
The Mammalian class is divided into two subclasses, Prototheria and Theria, which includes 
the two major groups of viviparous mammals, the marsupials and placentals.  
Four superorders of eutherian mammals were identified by techniques of molecular 
phylogenetics. The two oldest superorders Afrotheria (elephants and others) and Xenarthra 
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1. Introduction 
The placenta is a transient organ responsible for maternal fetus nutrient and oxygen 
exchange. It is important to the modulation of the maternal immune response to antigens of 
paternal and fetal origin and a source of a great variety of hormones that ensure the 
maintenance of gestation. Pathological conditions of pregnancy, fetal growth and delivery, 
abnormal placentation and surgical problems always attracted the medical sciences 
attention. The diversity of placental types among eutherian mammals has often raised 
important questions about phylogeny. In vitro culture of placental cells is an approach that 
allows the investigation of hormonal production and metabolic process as well as 
pathological disorders of common occurrence in human beings and animals. This chapter 
aims to show the most important features on culturing placenta derived cells and cell 
populations with properties of progenitor/stem cells: identification of the structures, 
isolation of the cells, maintenance of the cell culture, and applicability in research trends. 
2. The placenta 
Retention and development of the fertilized egg within the maternal body (histotrophic and 
hemotrophic viviparity) are observed in most mammals, reptiles and a few lower 
organisms. The growing embryo is nourished by the mother, usually through a placenta or 
similar structure. Vertebrate viviparity with the development of a placenta in the uterus 
evolved 150-100 million years ago and is responsible for the adaptability and dispersion of 
eutherian mammalians all over the diverse habitats.  
The Mammalian class is divided into two subclasses, Prototheria and Theria, which includes 
the two major groups of viviparous mammals, the marsupials and placentals.  
Four superorders of eutherian mammals were identified by techniques of molecular 
phylogenetics. The two oldest superorders Afrotheria (elephants and others) and Xenarthra 
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(armadillos, anteaters and sloths) have either endothelial or hemochorial placentas. 
Members of the superorder Euarchontoglires exhibit hemochorial placentas (Glires – 
rodents and lagomorphs) and endotheliochorial placentation (Euarchonta – tree shrews). 
Epitheliochorial placentas are observed in the last superorder to arise, the Laurasiatheria 
(horses, ruminants and various other species). It seems that the likely path of evolution in 
Afrotheria was from endotheliochorial to hemochorial placentation and the same condition 
apparently occurs with the Xenarthra and the bats. It is possible that endotheliochorial 
placentation was the more primitive and that epitheliochorial placenta evolved twice, once 
in the Laurasiatheria and once in Euarchontoglires. Mammalian phylogeny has been 
extensively studied (1–4). 
The placenta should be considered as an apposition of the fetal membranes to the uterine 
tissue for physiological exchange, and in mammals the definitive placentation is of the 
chorio-allantoic type, in which mesodermal blood vessels, from the allantoids external layer, 
form a vascular bridge between the embryo and the chorion, allowing a broad 
vascularization, and increasing efficiency in the mother-fetus exchange (5). In this situation, 
the maternal-fetal interface is enlarged, because chorionic villous fills the uterine crypts. In 
the chorion-vitelline placenta, there is a fusion between the yolk sac and its blood vessels 
network with the chorion. Here the allantois is never in contact with the chorion and it is 
observed in some non-mammalian vertebrates. In mammalian species, however, it occurs 
temporarily, while the allantois is developing from the intestine, to constitute the chorio-
allantoic placenta.  
Despite of all the work to develop systems of classification and to use placental structure to 
aid in the investigation of phylogenetic relationships among species of different orders, 
there is a lack of morphological and electron microscopic studies of the placenta in a great 
number of organisms, limiting the efforts to generalizations. The classical systems of 
classification of the placenta, based on structure, are of limited significance. Considering 
that the trophoblast could be apposed to uterine ephithelium, to the endothelium of 
maternal vessels or directly to maternal blood, the placenta is classified as epitheliochorial, 
endotheliochorial or hemochorial, respectively. However, electron microscopy studies have 
been shown that a continuous fetal endothelium and chorion always persist, although very 
thin in some tissue extensions, reducing the diffusion distance between fetal and maternal 
circulation, even in epitheliochorial placentas. 
It is now well recognized that the number of layers between fetal and maternal circulation 
do not have any relationship to the placenta’s ability to supply oxygen to the fetus. 
Interhaemal area is reduced in many ways in the different types of placentation. In the 
ruminant’s placenta (epitheliochorial and synepitheliochorial) the indentation of trophoblast 
and uterine epithelium by blood vessels decreases the interhaemal distance; in the 
endotheliochorial placentae this reduction is achieved by the indentation of trophoblast by 
fetal capillaries within the labyrinth. In the haemochorial placentation several features occur 
to reduce the thickness of the trophoblast, like alternation of thick and thin regions in the 
rabbit placenta (See (6) for detailed information).  
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The placenta developed as an organ to nutrient and oxygen exchange between the mother 
and fetus and also to avoid immunological rejection by the maternal immune system. Cells 
from the mother and the fetus intermingle throughout gestation and the extension of 
trophoblast invasion apparently is related to the modulation of maternal immune response 
against the allogenic conceptus (7). In the epithelialchorion placentation there are minimal 
changes in the uterine mucosa during gestation, whereas in the haemochorial placentation 
the endometrium is differentiated into decidua. These changes allow the establishment and 
maintenance of pregnancy and fetal survival with great diversity among different species. 
2.1. Organogenesis 
At the beginning of the mammalian development, the conceptus differentiates into an inner 
cell mass and an outer layer of cells, the trophoblast, which solely contributes to extra-
embryonic membranes formation (4,8). The tissue on the maternal component of the 
placenta usually is of epithelial or connective tissue origin of the ovary, oviduct or uterus. 
The fetal component is a derivate of ectodermal epithelium, the trophoblast or 
trophectoderm. 
Diverse populations of trophoblasts, all derived from the embryonic trophectoderm, have 
morphological, functional and molecular diversity within and across species. The extra-
embryonic membranes of the vertebrate conceptus form from the three germ layers of the 
embryo - the endoderm, mesoderm and ectoderm. These germ layers form the yolk sac, 
initially a single layer of ectoderm that is progressively transformed in a bilaminar and 
trilaminar structure, after the migration of a layer of endoderm internal to the ectoderm, and 
a growth of mesoderm between these two first layers. In mammals, the growth of mesoderm 
transforms only the superior part of the bilaminar yolk sac into the trilaminar vascularized 
structure, which is the basis for development of the chorion, amnion and allantois. Fusion of 
mesoderm and endoderm vascularizes promptly, whereas mesoderm and trophectoderm 
rarely form bloof vessels. The vascularized yolk sac fused with the ectoderm form the fetal 
component of the choriovitelline placenta, and the vascularized allantois plus chorion forms 
the fetal part of the chorioallantoic placenta. 
The trophectoderm and the inner cell mass become separate during early gestation and non 
interconvertible cell lineages. In mouse, for instance, Cdx2 is expressed predominantly in the 
trophoblast and Oct3/4 only in the inner cell mass (6). In the human placenta (9), the cell types 
that constitute placental villi are different populations of trophoblasts, the 
syncytiotrophoblasts and cytotrophoblasts that cover the surface of villi and bathe in maternal 
blood within intervillous space. Trophoblasts are formed during the first stage of pregnancy 
and are the first cells to differentiate from the fertilized egg. They have two cell populations, 
the undifferentiated cytotrophoblasts and fully differentiated syncytiotrophoblasts. The 
syncytiotrophoblasts are a continuous, specialized layer of epithelial cells.  
Mesenchymal cells, Hofbauer cells (mesenchymal derived macrophages) and fibroblasts are 
found between fetal vessels and trophoblasts in human species. The last group of cells is 
fetal vascular cells (vascular smooth muscle cells, endothelial and perivascular cells 
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(armadillos, anteaters and sloths) have either endothelial or hemochorial placentas. 
Members of the superorder Euarchontoglires exhibit hemochorial placentas (Glires – 
rodents and lagomorphs) and endotheliochorial placentation (Euarchonta – tree shrews). 
Epitheliochorial placentas are observed in the last superorder to arise, the Laurasiatheria 
(horses, ruminants and various other species). It seems that the likely path of evolution in 
Afrotheria was from endotheliochorial to hemochorial placentation and the same condition 
apparently occurs with the Xenarthra and the bats. It is possible that endotheliochorial 
placentation was the more primitive and that epitheliochorial placenta evolved twice, once 
in the Laurasiatheria and once in Euarchontoglires. Mammalian phylogeny has been 
extensively studied (1–4). 
The placenta should be considered as an apposition of the fetal membranes to the uterine 
tissue for physiological exchange, and in mammals the definitive placentation is of the 
chorio-allantoic type, in which mesodermal blood vessels, from the allantoids external layer, 
form a vascular bridge between the embryo and the chorion, allowing a broad 
vascularization, and increasing efficiency in the mother-fetus exchange (5). In this situation, 
the maternal-fetal interface is enlarged, because chorionic villous fills the uterine crypts. In 
the chorion-vitelline placenta, there is a fusion between the yolk sac and its blood vessels 
network with the chorion. Here the allantois is never in contact with the chorion and it is 
observed in some non-mammalian vertebrates. In mammalian species, however, it occurs 
temporarily, while the allantois is developing from the intestine, to constitute the chorio-
allantoic placenta.  
Despite of all the work to develop systems of classification and to use placental structure to 
aid in the investigation of phylogenetic relationships among species of different orders, 
there is a lack of morphological and electron microscopic studies of the placenta in a great 
number of organisms, limiting the efforts to generalizations. The classical systems of 
classification of the placenta, based on structure, are of limited significance. Considering 
that the trophoblast could be apposed to uterine ephithelium, to the endothelium of 
maternal vessels or directly to maternal blood, the placenta is classified as epitheliochorial, 
endotheliochorial or hemochorial, respectively. However, electron microscopy studies have 
been shown that a continuous fetal endothelium and chorion always persist, although very 
thin in some tissue extensions, reducing the diffusion distance between fetal and maternal 
circulation, even in epitheliochorial placentas. 
It is now well recognized that the number of layers between fetal and maternal circulation 
do not have any relationship to the placenta’s ability to supply oxygen to the fetus. 
Interhaemal area is reduced in many ways in the different types of placentation. In the 
ruminant’s placenta (epitheliochorial and synepitheliochorial) the indentation of trophoblast 
and uterine epithelium by blood vessels decreases the interhaemal distance; in the 
endotheliochorial placentae this reduction is achieved by the indentation of trophoblast by 
fetal capillaries within the labyrinth. In the haemochorial placentation several features occur 
to reduce the thickness of the trophoblast, like alternation of thick and thin regions in the 
rabbit placenta (See (6) for detailed information).  
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The placenta developed as an organ to nutrient and oxygen exchange between the mother 
and fetus and also to avoid immunological rejection by the maternal immune system. Cells 
from the mother and the fetus intermingle throughout gestation and the extension of 
trophoblast invasion apparently is related to the modulation of maternal immune response 
against the allogenic conceptus (7). In the epithelialchorion placentation there are minimal 
changes in the uterine mucosa during gestation, whereas in the haemochorial placentation 
the endometrium is differentiated into decidua. These changes allow the establishment and 
maintenance of pregnancy and fetal survival with great diversity among different species. 
2.1. Organogenesis 
At the beginning of the mammalian development, the conceptus differentiates into an inner 
cell mass and an outer layer of cells, the trophoblast, which solely contributes to extra-
embryonic membranes formation (4,8). The tissue on the maternal component of the 
placenta usually is of epithelial or connective tissue origin of the ovary, oviduct or uterus. 
The fetal component is a derivate of ectodermal epithelium, the trophoblast or 
trophectoderm. 
Diverse populations of trophoblasts, all derived from the embryonic trophectoderm, have 
morphological, functional and molecular diversity within and across species. The extra-
embryonic membranes of the vertebrate conceptus form from the three germ layers of the 
embryo - the endoderm, mesoderm and ectoderm. These germ layers form the yolk sac, 
initially a single layer of ectoderm that is progressively transformed in a bilaminar and 
trilaminar structure, after the migration of a layer of endoderm internal to the ectoderm, and 
a growth of mesoderm between these two first layers. In mammals, the growth of mesoderm 
transforms only the superior part of the bilaminar yolk sac into the trilaminar vascularized 
structure, which is the basis for development of the chorion, amnion and allantois. Fusion of 
mesoderm and endoderm vascularizes promptly, whereas mesoderm and trophectoderm 
rarely form bloof vessels. The vascularized yolk sac fused with the ectoderm form the fetal 
component of the choriovitelline placenta, and the vascularized allantois plus chorion forms 
the fetal part of the chorioallantoic placenta. 
The trophectoderm and the inner cell mass become separate during early gestation and non 
interconvertible cell lineages. In mouse, for instance, Cdx2 is expressed predominantly in the 
trophoblast and Oct3/4 only in the inner cell mass (6). In the human placenta (9), the cell types 
that constitute placental villi are different populations of trophoblasts, the 
syncytiotrophoblasts and cytotrophoblasts that cover the surface of villi and bathe in maternal 
blood within intervillous space. Trophoblasts are formed during the first stage of pregnancy 
and are the first cells to differentiate from the fertilized egg. They have two cell populations, 
the undifferentiated cytotrophoblasts and fully differentiated syncytiotrophoblasts. The 
syncytiotrophoblasts are a continuous, specialized layer of epithelial cells.  
Mesenchymal cells, Hofbauer cells (mesenchymal derived macrophages) and fibroblasts are 
found between fetal vessels and trophoblasts in human species. The last group of cells is 
fetal vascular cells (vascular smooth muscle cells, endothelial and perivascular cells 
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(pericytes). Hofbauer cells are the macrophages in the placenta villous stroma. These cells 
are of mesenchymal origin and expand during the first and second trimesters in placental 
villous tissues mesenchymal stem cells are differentiated by vasculogenesis and 
angiogenesis, transform into hemangioblastic cell cords, which are believed to be the 
precursors of capillary endothelial cells and hematopoietic stem cells. Mesenchymal stem 
cells can also differentiate into perivascular cells, which are considered predecessors of 
capillary endothelial cells. Pericytes (perivascular cells with dendritic processes) are found 
surrounding capillary endothelium and venules. They support endothelial cells and are 
important for maintaining vessel stability and microvascular integrity. 
In mouse, the trophectoderm differentiates in two pathways: rapid proliferation of polar 
trophoblastic cells originate the extraembrionic ectoderm and the ectoplacental cone; and 
the mural trophoblastic cells that originate the primary giant trophoblastic cells by 
endoreplicating their DNA but not dividing, like in other rodent giant cells. These cells, 
however, are not analogous to that observed in the human placenta, despite bearing the 
same name. 
Chorionic binucleate cells are observed in the ruminant and horse placentas (6). In the mare, 
these are migratory transient cells and never fuse with maternal cells. In the cow and ewe, 
nevertheless, this population of fetal cells migrates through the chorionic tight junction to 
fuse with uterine epithelial cells throughout gestation. These cells are derived from 
uninucleate trophectoderm cells by consecutive nuclear divisions, the second without 
subsequent cytokinesis. The chorionic binucleate cells comprise 15 to 20 per cent of the 
trophectoderm epithelial cells and produce a great variety of hormones. This is a unique 
feature of the ruminant placenta. 
2.2. Structure and classification  
Placenta has been described in the early studies (5) as more variable in structure than any 
other mammalian organ, and consequently it is classified in different ways, but other 
classification (10), which distinguishes the layers between fetal trophoblast and maternal 
endometrial surface, is considered the most useful, despite its limitations regarding 
biological and evolutionary aspects, as it was mentioned before.  
Morphologically, the placenta is classified according to the configuration of the maternal-
fetal interface. The area of fetomaternal exchange is increased by the formation of placental 
folds (villi) which is characteristic among families. Four types of placenta are described: in 
the diffuse placenta (horse and pig) the allantochorion is involved in the formation of the 
organ and it is almost entirely in contact with the endometrium; the cotyledonary placenta, 
observed in ruminants, shows multiple and discrete areas of attachment to the 
endometrium. The fetal portion is called cotyledon and the maternal contact sites are the 
caruncles. The hemotrophic structures formed by this fusion are called placentomes.  
The placenta seen in carnivores like dogs and cats is called zonary, and the chorionic villi 
occupy the equatorial region of the chorionic sac, where they attach to the endometrium; 
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finally, a discoid placenta is present in rodents and primates, in which an area of the chorion 
(discoid in shape) adhere to the endometrial stroma.  
Regarding to its internal structure, the placenta is classified in villous and labyrinthine; in 
the former, chorionic villi are present and they penetrate into uterine crypts; fetal blood is 
transported in vessels through these structures. In the labyrinthine placenta, maternal blood 
circulates through channels within the fetal syncytiotrophoblast.  
Histologically, the placenta is classified according to the layers between fetal and maternal 
blood, examined by light microscopy. The fetal components are endothelium, mesenchyma 
and trophoblast; maternal tissues are uterine epithelium, connective tissue and 
endothelium. When the uterine epithelium is in contact with the chorion (pig and horse) the 
placenta is called epitheliochorial; in ruminants, the uterine epithelium is removed and the 
maternal connective tissue is in contact with the chorion (Syndesmochorial placenta); 
uterine epithelium and connective tissue could be absent, and so the maternal endothelial 
basement membrane is in contact with the chorion, like in the carnivores placenta, and 
finally, in the haemochorial placenta, all the maternal tissue layers are removed, the chorion 
is in direct contact with the maternal circulation and such situation is observed in 
anthropoids and rodents. 
Some other criteria of classification have been proposed, like capillary position, regional 
specialization, tissue lost at parturition and accessory placental structures. For the classical 
criteria see (11) and for updates, see (6). 
2.3. Physiology 
The placenta is related to the production and metabolism of gonadotropins, steroids and 
prostaglandins hormones that are responsible for the pregnancy establishment and 
maintenance, placental maturation and parturition. Throughout gestation uterine 
environment shows great plasticity, which is necessary for fetal growth, being mediated by 
hormonal production of the placenta. This organ produces a great variety of hormones, 
including steroid hormones, peptides and insulin-like growth factors. In the human species, 
these factors are related to proliferation, invasion and differentiation of the trophoblast. 
Progesterone (P4) secretion in mammals is necessary to prepare the uterine environment to 
receive the developing conceptus. Embryonic signals, in the absence of P4, are inefficient to 
rescue the corpus luteum from the uterus luteolytic mechanisms, like in the ungulates, or to 
extend the luteal lifespan, as it occurs in the human species. In the ewe, hypophysectomy 
before day 50 of gestation causes corpus luteum regression and abortion. After this, the 
placenta produces P4 in sufficient concentrations to maintain pregnancy, even in the 
absence of ovaries and hypophysis.  
In ruminants, binucleate cells (BNC) are present in the trophoblast since the pre-
implantation period until parturition and these cells are found in the endometrium by day 
22 of pregnancy. BNC produce placental lactogen, P4, and prostaglandins E-2 and I-2. In the 
mare these cells produce the equine chorionic gonadotropin during their migration by the 
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(pericytes). Hofbauer cells are the macrophages in the placenta villous stroma. These cells 
are of mesenchymal origin and expand during the first and second trimesters in placental 
villous tissues mesenchymal stem cells are differentiated by vasculogenesis and 
angiogenesis, transform into hemangioblastic cell cords, which are believed to be the 
precursors of capillary endothelial cells and hematopoietic stem cells. Mesenchymal stem 
cells can also differentiate into perivascular cells, which are considered predecessors of 
capillary endothelial cells. Pericytes (perivascular cells with dendritic processes) are found 
surrounding capillary endothelium and venules. They support endothelial cells and are 
important for maintaining vessel stability and microvascular integrity. 
In mouse, the trophectoderm differentiates in two pathways: rapid proliferation of polar 
trophoblastic cells originate the extraembrionic ectoderm and the ectoplacental cone; and 
the mural trophoblastic cells that originate the primary giant trophoblastic cells by 
endoreplicating their DNA but not dividing, like in other rodent giant cells. These cells, 
however, are not analogous to that observed in the human placenta, despite bearing the 
same name. 
Chorionic binucleate cells are observed in the ruminant and horse placentas (6). In the mare, 
these are migratory transient cells and never fuse with maternal cells. In the cow and ewe, 
nevertheless, this population of fetal cells migrates through the chorionic tight junction to 
fuse with uterine epithelial cells throughout gestation. These cells are derived from 
uninucleate trophectoderm cells by consecutive nuclear divisions, the second without 
subsequent cytokinesis. The chorionic binucleate cells comprise 15 to 20 per cent of the 
trophectoderm epithelial cells and produce a great variety of hormones. This is a unique 
feature of the ruminant placenta. 
2.2. Structure and classification  
Placenta has been described in the early studies (5) as more variable in structure than any 
other mammalian organ, and consequently it is classified in different ways, but other 
classification (10), which distinguishes the layers between fetal trophoblast and maternal 
endometrial surface, is considered the most useful, despite its limitations regarding 
biological and evolutionary aspects, as it was mentioned before.  
Morphologically, the placenta is classified according to the configuration of the maternal-
fetal interface. The area of fetomaternal exchange is increased by the formation of placental 
folds (villi) which is characteristic among families. Four types of placenta are described: in 
the diffuse placenta (horse and pig) the allantochorion is involved in the formation of the 
organ and it is almost entirely in contact with the endometrium; the cotyledonary placenta, 
observed in ruminants, shows multiple and discrete areas of attachment to the 
endometrium. The fetal portion is called cotyledon and the maternal contact sites are the 
caruncles. The hemotrophic structures formed by this fusion are called placentomes.  
The placenta seen in carnivores like dogs and cats is called zonary, and the chorionic villi 
occupy the equatorial region of the chorionic sac, where they attach to the endometrium; 
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finally, a discoid placenta is present in rodents and primates, in which an area of the chorion 
(discoid in shape) adhere to the endometrial stroma.  
Regarding to its internal structure, the placenta is classified in villous and labyrinthine; in 
the former, chorionic villi are present and they penetrate into uterine crypts; fetal blood is 
transported in vessels through these structures. In the labyrinthine placenta, maternal blood 
circulates through channels within the fetal syncytiotrophoblast.  
Histologically, the placenta is classified according to the layers between fetal and maternal 
blood, examined by light microscopy. The fetal components are endothelium, mesenchyma 
and trophoblast; maternal tissues are uterine epithelium, connective tissue and 
endothelium. When the uterine epithelium is in contact with the chorion (pig and horse) the 
placenta is called epitheliochorial; in ruminants, the uterine epithelium is removed and the 
maternal connective tissue is in contact with the chorion (Syndesmochorial placenta); 
uterine epithelium and connective tissue could be absent, and so the maternal endothelial 
basement membrane is in contact with the chorion, like in the carnivores placenta, and 
finally, in the haemochorial placenta, all the maternal tissue layers are removed, the chorion 
is in direct contact with the maternal circulation and such situation is observed in 
anthropoids and rodents. 
Some other criteria of classification have been proposed, like capillary position, regional 
specialization, tissue lost at parturition and accessory placental structures. For the classical 
criteria see (11) and for updates, see (6). 
2.3. Physiology 
The placenta is related to the production and metabolism of gonadotropins, steroids and 
prostaglandins hormones that are responsible for the pregnancy establishment and 
maintenance, placental maturation and parturition. Throughout gestation uterine 
environment shows great plasticity, which is necessary for fetal growth, being mediated by 
hormonal production of the placenta. This organ produces a great variety of hormones, 
including steroid hormones, peptides and insulin-like growth factors. In the human species, 
these factors are related to proliferation, invasion and differentiation of the trophoblast. 
Progesterone (P4) secretion in mammals is necessary to prepare the uterine environment to 
receive the developing conceptus. Embryonic signals, in the absence of P4, are inefficient to 
rescue the corpus luteum from the uterus luteolytic mechanisms, like in the ungulates, or to 
extend the luteal lifespan, as it occurs in the human species. In the ewe, hypophysectomy 
before day 50 of gestation causes corpus luteum regression and abortion. After this, the 
placenta produces P4 in sufficient concentrations to maintain pregnancy, even in the 
absence of ovaries and hypophysis.  
In ruminants, binucleate cells (BNC) are present in the trophoblast since the pre-
implantation period until parturition and these cells are found in the endometrium by day 
22 of pregnancy. BNC produce placental lactogen, P4, and prostaglandins E-2 and I-2. In the 
mare these cells produce the equine chorionic gonadotropin during their migration by the 
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uterine connective tissue. In the cow steroid production are altered throughout gestation. 
Two to three days before parturition, P4 levels decrease, and estradiol, in contrast, increase, 
and high levels are observed in the last week of gestation.  
BNC produce prostaglandins and it is possible that they are related to the maternal 
recognition of pregnancy in some species, like swine. It has been suggested that estrogens 
and prostaglandins have a physiological role in normal expulsion of the placenta in cattle.  
In the ruminant placenta, the trophoblast produces interferons that are responsible by the 
maternal recognition of pregnancy. Interferon tau has been recognized, in ungulates, as an 
inhibitor of luteolysis. Atypical interferons are produce by the swine blastocyst and its 
relationship with the maternal recognition of pregnancy is less clear. Type I interferons are 
produced by the human placenta and it is accepted that they are hormones related to the 
establishment of gestation in this species. For details see (12,13). 
3. In vitro culture of placental tissues 
3.1. Primary culture  
Basically the source of tissues to primary culture is human term placentas or animal 
placentas obtained in abattoirs. Cells can be obtained by mechanical disaggregation of 
placental tissues (amniochorion and allantochorion membranes, cotyledons, caruncles and 
the endometrium itself). Usually tissues are rinsed in Hank’s balanced salt solution (HBSS) 
or in phosphate-buffered saline (PBS) enriched with antibiotics (gentamicin, penicillin, 
streptomycin), to avoid bacterial contamination, and they are progressively dispersed with 
surgical scissors in at least six baths. After rinsed, tissues are cultured in suspension in 
Minimum Essential Medium (EMEM) with Earle’s salts. Disaggregate tissues contain 
different cell types and it may be necessary to go through a separation process. Amniocytes 
may be aspirated directly from placental fetal fluid and cultured in specialized medium 
such as Amniomax. These cells have adherent properties and form small aggregates in 
culture plastic flasks, being ideal for cariotypying. Basic culture conditions are 37º C and 5% 
CO2 atmosphere. Briefly, a protocol of cell separation is described. First, remove fat and 
dead tissues. Wash it with PBS twice. Slice placenta in trophoblast regions and transfer to a 
sterilized conical tube with cold PBS (10%) on ice. Release trophoblasts from chorionic villi 
by trypsin digestion. Plate the cells. Deplete macrophages by adherence to plastic. Freshly 
isolated cells are predominantly trophoblast villous that can be identified by verifying the 
expression of epidermal growth factor receptor (EGFR). Tissues and cells cultured primarily 
can be induced, by different ways, to produce proteins, hormones and other metabolites. 
The cell genome can be altered under experimental conditions in order to achieve research 
purposes, and different systems of tissue culture and cell manipulation could be assembly to 
diagnostic techniques and intracellular information flow investigation. 
Primary cultures are obtained by disaggregation of a tissue sample, either mechanically or 
enzymatically. The resulting suspension contains a proportion of cells capable of attaching 
to a surface, as in tissue culture flasks and dishes, forming a monolayer. Another type of cell 
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culture, the primary explants, consists of cells that migrate out from small fragments of 
tissue and adhere to the growth surface. Tissue disaggregation is capable of generating 
larger cultures in short periods of time, but explants culture may still be preferable where 
only small fragments of tissue are available or the fragility of the cells precludes survival 
after disaggregation.  
Generally, from human beings and large animals, placentae are obtained at term of normal 
pregnancies and after caesarean section or vaginal delivery. Amnion and chorion 
membranes are manually separated from each other. The membranes and other placental 
tissues as well, are washed extensively in PBS or HBSS containing 100 U/ml penicillin and 
100 µg/ml streptomycin to avoid bacterial contamination. Blood clots present in the 
cotyledons may be mechanically removed. 
In small animals like rats and mouse (Rattus norvegicus and Mus musculus), it is a common 
practice to excise the uteri from pregnant animals, transfer them to Petri dishes with cold 
PBS, and then, collect and pool the placentae in a new Petri dish. Harvested placentae are 
washed thoroughly with PBS containing antibiotics. Rat amnion may become 
distinguished as almost transparent, and may be peeled off from chorion and dissected 
(14). Otherwise, both membranes are processed together in order to obtain the fetal 
membrane-derived cells.   
Samples are cut into small fragments (3 x 3 or 5 x 5 cm) and may be stored in 50 ml vials 
filled with serum-free and phenol red-free Dulbecco’s Modified Eagle Medium (DMEM) in 
sterile conditions. The number of cells and their viability, either when stored at room 
temperature and processed within 24 hours or when stored at 4°C and processed within 28 
days, are the same as in fresh membranes, as previously reported (15,16). Those fragments 
may be either used as primary explants or submitted to enzymatic disaggregation. 
Small fragments of amniotic membrane may be directly engrafted to a site of injury, as focal 
ischemic regions in the heart, lung fibrosis, skin wounds, chronic leg ulcers, and liver fibrosis. 
The benefits of such therapeutic approaches as the ability to promote re-epithelialization have 
been shown to reduce inflammation and fibrosis and to modulate angiogenesis (16–19). 
Explants culture may also be done using fetal placental villi. Bundles of chorionic anchoring 
(stem) villi are separated from the chorionic plate and spread out using forceps to separate 
individual villi from each other. The villi are washed multiple times in PBS, cut into small 
pieces (1 x 1 mm) and cultured intact. When outgrowing cells reach 80% to 90% confluence, 
the villi pieces remaining intact are carefully removed, transferred into, and subsequently 
cultured on new plates to get a sufficient amount of cells for the experimental procedures. 
Recently it was reported that abundant vasculature present in the human placenta can serve 
as a source of myogenic cells able to migrate within dystrophic muscle and regenerate 
myofibers (20).  
Instead of using an entire fragment, fetal membranes may be subjected to enzymatic 
disaggregation, as reported in literature by various different protocols, which differ from 
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Basically the source of tissues to primary culture is human term placentas or animal 
placentas obtained in abattoirs. Cells can be obtained by mechanical disaggregation of 
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or in phosphate-buffered saline (PBS) enriched with antibiotics (gentamicin, penicillin, 
streptomycin), to avoid bacterial contamination, and they are progressively dispersed with 
surgical scissors in at least six baths. After rinsed, tissues are cultured in suspension in 
Minimum Essential Medium (EMEM) with Earle’s salts. Disaggregate tissues contain 
different cell types and it may be necessary to go through a separation process. Amniocytes 
may be aspirated directly from placental fetal fluid and cultured in specialized medium 
such as Amniomax. These cells have adherent properties and form small aggregates in 
culture plastic flasks, being ideal for cariotypying. Basic culture conditions are 37º C and 5% 
CO2 atmosphere. Briefly, a protocol of cell separation is described. First, remove fat and 
dead tissues. Wash it with PBS twice. Slice placenta in trophoblast regions and transfer to a 
sterilized conical tube with cold PBS (10%) on ice. Release trophoblasts from chorionic villi 
by trypsin digestion. Plate the cells. Deplete macrophages by adherence to plastic. Freshly 
isolated cells are predominantly trophoblast villous that can be identified by verifying the 
expression of epidermal growth factor receptor (EGFR). Tissues and cells cultured primarily 
can be induced, by different ways, to produce proteins, hormones and other metabolites. 
The cell genome can be altered under experimental conditions in order to achieve research 
purposes, and different systems of tissue culture and cell manipulation could be assembly to 
diagnostic techniques and intracellular information flow investigation. 
Primary cultures are obtained by disaggregation of a tissue sample, either mechanically or 
enzymatically. The resulting suspension contains a proportion of cells capable of attaching 
to a surface, as in tissue culture flasks and dishes, forming a monolayer. Another type of cell 
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culture, the primary explants, consists of cells that migrate out from small fragments of 
tissue and adhere to the growth surface. Tissue disaggregation is capable of generating 
larger cultures in short periods of time, but explants culture may still be preferable where 
only small fragments of tissue are available or the fragility of the cells precludes survival 
after disaggregation.  
Generally, from human beings and large animals, placentae are obtained at term of normal 
pregnancies and after caesarean section or vaginal delivery. Amnion and chorion 
membranes are manually separated from each other. The membranes and other placental 
tissues as well, are washed extensively in PBS or HBSS containing 100 U/ml penicillin and 
100 µg/ml streptomycin to avoid bacterial contamination. Blood clots present in the 
cotyledons may be mechanically removed. 
In small animals like rats and mouse (Rattus norvegicus and Mus musculus), it is a common 
practice to excise the uteri from pregnant animals, transfer them to Petri dishes with cold 
PBS, and then, collect and pool the placentae in a new Petri dish. Harvested placentae are 
washed thoroughly with PBS containing antibiotics. Rat amnion may become 
distinguished as almost transparent, and may be peeled off from chorion and dissected 
(14). Otherwise, both membranes are processed together in order to obtain the fetal 
membrane-derived cells.   
Samples are cut into small fragments (3 x 3 or 5 x 5 cm) and may be stored in 50 ml vials 
filled with serum-free and phenol red-free Dulbecco’s Modified Eagle Medium (DMEM) in 
sterile conditions. The number of cells and their viability, either when stored at room 
temperature and processed within 24 hours or when stored at 4°C and processed within 28 
days, are the same as in fresh membranes, as previously reported (15,16). Those fragments 
may be either used as primary explants or submitted to enzymatic disaggregation. 
Small fragments of amniotic membrane may be directly engrafted to a site of injury, as focal 
ischemic regions in the heart, lung fibrosis, skin wounds, chronic leg ulcers, and liver fibrosis. 
The benefits of such therapeutic approaches as the ability to promote re-epithelialization have 
been shown to reduce inflammation and fibrosis and to modulate angiogenesis (16–19). 
Explants culture may also be done using fetal placental villi. Bundles of chorionic anchoring 
(stem) villi are separated from the chorionic plate and spread out using forceps to separate 
individual villi from each other. The villi are washed multiple times in PBS, cut into small 
pieces (1 x 1 mm) and cultured intact. When outgrowing cells reach 80% to 90% confluence, 
the villi pieces remaining intact are carefully removed, transferred into, and subsequently 
cultured on new plates to get a sufficient amount of cells for the experimental procedures. 
Recently it was reported that abundant vasculature present in the human placenta can serve 
as a source of myogenic cells able to migrate within dystrophic muscle and regenerate 
myofibers (20).  
Instead of using an entire fragment, fetal membranes may be subjected to enzymatic 
disaggregation, as reported in literature by various different protocols, which differ from 
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each other mainly regarding the enzyme employed and the digestion length. However, all 
of them include an incubation step at 37°C with some enzyme (dispase, trypsin/EDTA, 
collagenase) followed by collection of the cells through filtration and centrifugation. 
Different strategies employing diverse enzymes will be presented. Moreover, it is important 
to have in mind the kind of cells going to be isolated and the possibility of separating the 
fetal membranes. Chorion, cotyledons, and especially the amnion are rich sources of 
mesenchymal stromal/stem cells. The amnion is also comprised of an epithelial layer from 
which amnion epithelial cells are obtained. 
In order to isolate the amniotic mesenchymal stromal cells, first incubate membrane 
fragments with dispase (2.4 U/ml in PBS) for 9 minutes, followed by collagenase I (0.75 
mg/ml) + DNAse (20 µg/ml) solution in PBS for 150 minutes. An alternative option is only 
one digestion step using 1 mg/ml collagenase I for 120 minutes. Chorionic mesenchymal 
stromal cells may be isolated by performing two 9-minute dispase digestions, separated by 
one 9-minute wash step in RPMI-1640 containing 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 10% heat-inactivated fetal bovine serum (FBS). Another way is to replace 
the dispase of the first digestion step by collagenase IV. After gentle centrifugation (150 x g 
for 3 minutes), filtrate each supernatant containing amniotic or chorionic mesenchymal 
stromal cells in a 100 µm cell strainer. However, mesenchymal stromal cells may be isolated 
from the placenta without previously separation of its components. In such situation, mince 
pieces from fetal membranes and incubate for 10 minutes in DMEM with 0.25% 
trypsin/EDTA, 10 U/ml DNase I, and 0.1% collagenase. Tissues should be pipetted 
vigorously up and down, avoiding foam, for 5 minutes. Allow large pieces of tissue to settle 
under gravity for 5 minutes. Transfer the supernatant to a fresh tube, neutralize with FBS, 
and then spin at 1500 rpm for 10 minutes. 
Amniotic undigested pieces (when amnion is incubated either with dispase and collagenase 
I or collagenase I only, as previously described) may be submitted to another digestion step 
with trypsin (0.25% in PBS) for 2 minutes, in order to obtain epithelial cells. 
Moreover, epithelial cells may be harvested from amniotic membrane fragments after 
digestion only with trypsin/EDTA, at 37°C. One way is to use the enzyme at 0.125% and 
incubate three times at 20 minutes each. Alternatively, two digestion steps of 30 minutes 
each, shaking (0.20% trypsin/EDTA) or two steps of 20 minutes (0.25% trypsin/EDTA) are 
considered. Trypsin should be inactivated by adding FBS. Collect the cells after 
centrifugation (1000 rpm for 5 minutes). It is important to highlight that, in all situations, the 
amniotic epithelial cell layer must be scraped out to remove the underlying tissues, such as 
the spongy and fibroblast layers, to obtain a pure epithelial layer. 
In addition to all disaggregation protocols for amniotic membrane, to achieve different 
populations of cells (amniotic mesenchymal stromal and amniotic epithelial), the whole 
membrane may be digested giving a mix of cells, known as amniotic derived cells. 
Membrane fragments are digested with 0.25% trypsin/EDTA for 30 minutes at 37°C. Cells 
are collected after filtration in 100 µm cell strainer and three wash steps in cold PBS. 
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Another protocol requires three digestion steps (1x15 minutes; 2x30 minutes) in 0.05% 
trypsin at 37°C. Wash cells three times in PBS and collect after centrifugation (1000 rpm for 5 
minutes). 
Another placental tissue used for cell isolation is cotyledon. Minced cotyledon is digested 
with 0.25% trypsin for 60 minutes at 37°C. Incubate the undigested fragments with 12.5 
U/ml collagenase I for 60 minutes at 37°C. Collect cells by filtration (100 µm cell strainer) 
and centrifugation (300 x g for 10 minutes).    
Finally, when fetal membranes are difficult to distinguish (i.e. small animals as mouse) 
incubate the placenta with dispase (2.4 U/ml in PBS) for 5 minutes at 37°C, followed by 
collagenase (0.75 mg/ml) + DNAse (20 µg/ml) in PBS for 90 minutes at 37°C. After filtration 
(100 µm cell strainer) and centrifugation (300 x g for 5 minutes) a mix of amniotic and 
chorionic cells are obtained. Alternatively, digest placenta fragments with 300 U/ml 
collagenase II for 1 hour at 37°C in water shaker. Neutralize enzyme activity with ɑ-minimal 
essential medium (ɑ-MEM) containing 10% FBS. Collect the cells after filtration and 
centrifugation. 
Cells obtained after any of the procedures mentioned above must be plate onto noncoated 
tissue culture dishes or flasks. Cells may be seeded at 7x103/cm2 (amniotic mesenchymal 
stromal cells) and 14-21x103/cm2 (amniotic epithelial cells). The medium should be 
supplemented with serum, mainly FBS. There is a common practice, in some research 
centers, to use 20% of serum for the primary culture, and then, replace it for 10% in further 
passages. However, such cells are perfectly capable to survive and proliferate when incubate 
with 10% serum from the first passage. The most commonly used media are Roswell Park 
Memorial Institute (RPMI)-1640, DMEM, ɑ-MEM, and DMEM/F12. It is also important to 
supplement the medium with antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin or 
1% antibiotic-antimycotic solution), L-glutamine (2 mM), nonessential amino acids (1%), β-
mercaptoethanol (55 µM), and sodium pyruvate (1 mM). Cells are incubated at 37°C in a 
humid atmosphere (5% CO2).  
Morphological characterization of the cells, by light microscopy, indicates that amniotic 
epithelial cells show ground or oval shapes, cluster formation, relatively big nucleus (some 
can reach half of the cell diameter) and many fat drops in the cytoplasm. Both amniotic and 
chorionic mesenchymal stromal cells show the fibroblast-like appearance and very high 
proliferation rate, reaching 70-80% confluence after one to three weeks from harvesting.  
Cells may either be used in experimental procedures just right after culturing or be frozen 
in 10% dimethyl sulfoxide (DMSO) and 90% FBS. An alternative freezing media is 10% 
DMSO, 40% DMEM, 50% FBS. Prior to using these cells, it is recommended to analyze the 
viability, which may be determined by use of trypan blue dye, and cell number in a 
hemocytometer. 
In addition, it is important to highlight that all experimental procedures must have ethics 
committee’s approval and, regarding human placental tissues, the previous donor consent. 
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each other mainly regarding the enzyme employed and the digestion length. However, all 
of them include an incubation step at 37°C with some enzyme (dispase, trypsin/EDTA, 
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Different strategies employing diverse enzymes will be presented. Moreover, it is important 
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fetal membranes. Chorion, cotyledons, and especially the amnion are rich sources of 
mesenchymal stromal/stem cells. The amnion is also comprised of an epithelial layer from 
which amnion epithelial cells are obtained. 
In order to isolate the amniotic mesenchymal stromal cells, first incubate membrane 
fragments with dispase (2.4 U/ml in PBS) for 9 minutes, followed by collagenase I (0.75 
mg/ml) + DNAse (20 µg/ml) solution in PBS for 150 minutes. An alternative option is only 
one digestion step using 1 mg/ml collagenase I for 120 minutes. Chorionic mesenchymal 
stromal cells may be isolated by performing two 9-minute dispase digestions, separated by 
one 9-minute wash step in RPMI-1640 containing 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 10% heat-inactivated fetal bovine serum (FBS). Another way is to replace 
the dispase of the first digestion step by collagenase IV. After gentle centrifugation (150 x g 
for 3 minutes), filtrate each supernatant containing amniotic or chorionic mesenchymal 
stromal cells in a 100 µm cell strainer. However, mesenchymal stromal cells may be isolated 
from the placenta without previously separation of its components. In such situation, mince 
pieces from fetal membranes and incubate for 10 minutes in DMEM with 0.25% 
trypsin/EDTA, 10 U/ml DNase I, and 0.1% collagenase. Tissues should be pipetted 
vigorously up and down, avoiding foam, for 5 minutes. Allow large pieces of tissue to settle 
under gravity for 5 minutes. Transfer the supernatant to a fresh tube, neutralize with FBS, 
and then spin at 1500 rpm for 10 minutes. 
Amniotic undigested pieces (when amnion is incubated either with dispase and collagenase 
I or collagenase I only, as previously described) may be submitted to another digestion step 
with trypsin (0.25% in PBS) for 2 minutes, in order to obtain epithelial cells. 
Moreover, epithelial cells may be harvested from amniotic membrane fragments after 
digestion only with trypsin/EDTA, at 37°C. One way is to use the enzyme at 0.125% and 
incubate three times at 20 minutes each. Alternatively, two digestion steps of 30 minutes 
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amniotic epithelial cell layer must be scraped out to remove the underlying tissues, such as 
the spongy and fibroblast layers, to obtain a pure epithelial layer. 
In addition to all disaggregation protocols for amniotic membrane, to achieve different 
populations of cells (amniotic mesenchymal stromal and amniotic epithelial), the whole 
membrane may be digested giving a mix of cells, known as amniotic derived cells. 
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Another protocol requires three digestion steps (1x15 minutes; 2x30 minutes) in 0.05% 
trypsin at 37°C. Wash cells three times in PBS and collect after centrifugation (1000 rpm for 5 
minutes). 
Another placental tissue used for cell isolation is cotyledon. Minced cotyledon is digested 
with 0.25% trypsin for 60 minutes at 37°C. Incubate the undigested fragments with 12.5 
U/ml collagenase I for 60 minutes at 37°C. Collect cells by filtration (100 µm cell strainer) 
and centrifugation (300 x g for 10 minutes).    
Finally, when fetal membranes are difficult to distinguish (i.e. small animals as mouse) 
incubate the placenta with dispase (2.4 U/ml in PBS) for 5 minutes at 37°C, followed by 
collagenase (0.75 mg/ml) + DNAse (20 µg/ml) in PBS for 90 minutes at 37°C. After filtration 
(100 µm cell strainer) and centrifugation (300 x g for 5 minutes) a mix of amniotic and 
chorionic cells are obtained. Alternatively, digest placenta fragments with 300 U/ml 
collagenase II for 1 hour at 37°C in water shaker. Neutralize enzyme activity with ɑ-minimal 
essential medium (ɑ-MEM) containing 10% FBS. Collect the cells after filtration and 
centrifugation. 
Cells obtained after any of the procedures mentioned above must be plate onto noncoated 
tissue culture dishes or flasks. Cells may be seeded at 7x103/cm2 (amniotic mesenchymal 
stromal cells) and 14-21x103/cm2 (amniotic epithelial cells). The medium should be 
supplemented with serum, mainly FBS. There is a common practice, in some research 
centers, to use 20% of serum for the primary culture, and then, replace it for 10% in further 
passages. However, such cells are perfectly capable to survive and proliferate when incubate 
with 10% serum from the first passage. The most commonly used media are Roswell Park 
Memorial Institute (RPMI)-1640, DMEM, ɑ-MEM, and DMEM/F12. It is also important to 
supplement the medium with antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin or 
1% antibiotic-antimycotic solution), L-glutamine (2 mM), nonessential amino acids (1%), β-
mercaptoethanol (55 µM), and sodium pyruvate (1 mM). Cells are incubated at 37°C in a 
humid atmosphere (5% CO2).  
Morphological characterization of the cells, by light microscopy, indicates that amniotic 
epithelial cells show ground or oval shapes, cluster formation, relatively big nucleus (some 
can reach half of the cell diameter) and many fat drops in the cytoplasm. Both amniotic and 
chorionic mesenchymal stromal cells show the fibroblast-like appearance and very high 
proliferation rate, reaching 70-80% confluence after one to three weeks from harvesting.  
Cells may either be used in experimental procedures just right after culturing or be frozen 
in 10% dimethyl sulfoxide (DMSO) and 90% FBS. An alternative freezing media is 10% 
DMSO, 40% DMEM, 50% FBS. Prior to using these cells, it is recommended to analyze the 
viability, which may be determined by use of trypan blue dye, and cell number in a 
hemocytometer. 
In addition, it is important to highlight that all experimental procedures must have ethics 
committee’s approval and, regarding human placental tissues, the previous donor consent. 
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3.2. Established (transformed) cell lines 
There are a lot of cell lines derived from placenta. These cells are cultured with subtle 
differences, for research purposes and some of them are able to secret hormones and other 
molecules. Some examples will be present.  
BeWo (ATCC® number CCL-98™) is a human epithelial cell line, derived from 
choriocarcinoma, that produces progesterone, human chorionic gonadotropin (hCG), 
placental lactogen, estrogen and other reproductive hormones. BeWo is cultured in F-12K 
medium enriched with 10% FBS. This cell is sensible to human poliovirus 3 and the 
vesicular stomatitis virus. Other human epithelial cell lines derived from choriocarcinoma 
are JEG-3 (ATCC® number HTB-36™) and JAR (ATCC® number HTB-144™). JEG-3 
produces hCG, progesterone and placental lactogen. The cells are able to transform steroid 
precursors to estrone and estradiol. The line is cultured with EMEM supplemented with 
10% FBS. JAR cells produce estrogen, progesterone, hCG, and placental lactogen and are 
cultured in RPMI 1640 supplemented with 10% FBS.   
The M. musculus mast cells 10P2 (ATCC® number CRL-2034™) and 10P12 (ATCC® number 
CRL-2036™) were established by transformation of placental cells from a 10 day mouse 
embryo, and are cultured in suspension with RPMI 1640 medium supplemented with 0.05 
mM 2-mercaptoethanol and 10% FBS. These cells possess receptors for IgE. Both lines 
represent a transformed stage of a very early hematopoietic precursor and share surface 
antigens with multipotent stem cells. The 11P0-1 (ATCC® number CRL-2037™) cell line is 
similar with the others except for being derived from a 11 day mouse embryo. 
The FC-47 (ATCC® number CRL-6094™) is a fibroblast derived from the cat (Felis catus) 
normal placenta, with adherent properties and cultured in DMEM supplemented with 10% 
FBS. 
The 3A-(tPA-30-1) (ATCC® number CRL-1583™) is a human SV40 transformed cell line, 
derived from placenta, showing an epithelial morphology. When incubate at 40°C, these 
cells are able to synthesize hCG and alkaline phosphatase. The cells express the transformed 
phenotype at the permissive temperature (33°C) and the non- transformed phenotype at the 
non- permissive temperature (40°C). The line has a limited life expectancy of 15 to 18 
passages before entering the crisis stage. Medium required for incubation is ɑ-MEM 
supplemented with 10% FBS. 
ChaGo-K-1 (ATCC® number HTB-168™) is a human epithelial cell line, derived from 
bronchogenic carcinoma, that produces hCG alpha subunit only, estradiol, progesterone, 
and mucin (apomucin, MUC-1, MUC-2). The cells are cultured in RPMI 1640 supplemented 
with 10% FBS. 
There are several cell lines derived from normal human placenta, which are available for 
research purposes, such as Hs 726.PI (ATCC® number CRL-7460™), Hs 730.PI (ATCC® 
number CRL-7464™), Hs 795.PI (ATCC® number CRL-7526™), Hs 798.PI (ATCC® number 
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CRL-7529™), Hs 799.PI (ATCC® number CRL-7530™), Hs 815.PI (ATCC® number CRL-
7548™). All of them are cultured in DMEM supplemented with 10% FBS, at 37°C, in 
humidity atmosphere (5% CO2).  
3.3. Placenta-derived stem/progenitor cells 
Various undifferentiated stem cell sources have been proposed for regenerative medicine, 
each having their advantages and drawbacks. Embryonic stem cells (ESCs) are characterized 
by pluripotency and an unlimited self-renewal capacity, but they may present high 
tumorigenic potential and their use is associated with major ethical concerns. In contrast, 
mesenchymal stem cells (MSCs) are not ethically restricted, but show limited capacity to 
proliferate and differentiate into different cell lineages (multipotency). MSCs reside within 
bone marrow, adipose tissue, dental pulp, and many other tissues. Although bone marrow 
MSCs are the most studied and the best established, there are some limitations of their use 
due to invasive nature of bone marrow aspiration, donor site morbidity, inadequate cell 
numbers, and the limited capacity of proliferation and differentiation. Thus, researchers 
started looking for alternative sources of MSCs that can be obtained noninvasively and in 
sufficient quantity. Studies have shown that MSCs may be isolated from placenta (either 
from maternal or fetal components, especially from the amnion), which are generally 
discarded as medical waste after delivery, and are therefore without ethical concerns 
associated with their use. Placenta-derived MSCs have been described to combine 
characteristics from both embryonic and mesenchymal stem cells: the ability to differentiate 
into all three germ layers and lack of tumorigenicity. Although specific fetal membrane 
components have already been considered in the above section “primary culture” of this 
chapter, here aspects of placenta MSCs will be discussed, without distinction between any 
fetal membranes as a specific source of cells, even though the amniotic MSCs are the most 
studied. It should be highlighted that efforts toward standardization of the terminologies 
used have been made (21) in the First International Workshop on placenta-derived stem 
cells, who proposed the following nomenclature: aminiotic epithelial cells, aminiotic 
mesenchymal stromal cells, chorionic mesenchymal stromal cells, and chorionic 
trophoblastic cells. 
One way to identify a population of cells is by performing its immunophenotype 
characterization, mainly for surface marker expression. Current methodologies employed 
are immunocytochemistry, immunofluorescence, and flow cytometry. Placenta MSCs 
reveal profiles in between embryonic and adult stem cells, as summarized in Table 1 
where it is shown some of the most used surface markers, as cluster of differentiation 
(CD), for categorizing stem cell populations. It is important to note that neither embryonic 
nor mesenchymal cells (and placenta-derived MSC as well) express the hematopoietic 
stem cell markers CD11b, CD34, and CD45. Placenta MSCs show a positive expression 
profile for CD29, CD73, CD166, and major histocompatibility complex (MHC) class I 
molecules (human leucocyte antigen (HLA) -A, -B, -C) and a negative expression profile 
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There are a lot of cell lines derived from placenta. These cells are cultured with subtle 
differences, for research purposes and some of them are able to secret hormones and other 
molecules. Some examples will be present.  
BeWo (ATCC® number CCL-98™) is a human epithelial cell line, derived from 
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placental lactogen, estrogen and other reproductive hormones. BeWo is cultured in F-12K 
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are JEG-3 (ATCC® number HTB-36™) and JAR (ATCC® number HTB-144™). JEG-3 
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precursors to estrone and estradiol. The line is cultured with EMEM supplemented with 
10% FBS. JAR cells produce estrogen, progesterone, hCG, and placental lactogen and are 
cultured in RPMI 1640 supplemented with 10% FBS.   
The M. musculus mast cells 10P2 (ATCC® number CRL-2034™) and 10P12 (ATCC® number 
CRL-2036™) were established by transformation of placental cells from a 10 day mouse 
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CRL-7529™), Hs 799.PI (ATCC® number CRL-7530™), Hs 815.PI (ATCC® number CRL-
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are immunocytochemistry, immunofluorescence, and flow cytometry. Placenta MSCs 
reveal profiles in between embryonic and adult stem cells, as summarized in Table 1 
where it is shown some of the most used surface markers, as cluster of differentiation 
(CD), for categorizing stem cell populations. It is important to note that neither embryonic 
nor mesenchymal cells (and placenta-derived MSC as well) express the hematopoietic 
stem cell markers CD11b, CD34, and CD45. Placenta MSCs show a positive expression 
profile for CD29, CD73, CD166, and major histocompatibility complex (MHC) class I 
molecules (human leucocyte antigen (HLA) -A, -B, -C) and a negative expression profile 
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for CD11b, CD31 (endothelial marker), CD34, CD45, and MHC class II molecules (HLA-
DR, -DP, -DQ).  
Although there are common properties between placenta and bone marrow derived MSCs, 
flow cytometric analyses performed by different research groups report that placenta MSCs 
do not express CD271 (22) and show different patterns for CD90 expression: either low 
[4.7% (14)], moderate [22.5% (23)], or high expression [> 95% (22)] and even the presence of 
two distinct subpopulations of placenta MSCs positive for CD90 (24). 
Taken together, placenta MSCs satisfy the minimal criteria for identifying multipotent 
mesenchymal stromal cells (27). Furthermore placenta MSCs, different from other 
mesenchymal cells, are able to differentiate into ectodermal (neural and retinal cells), 
endodermal (pancreatic beta cells), and mesodermal (adipocytes, osteocytes, and 
chondrocytes along with myotubule formation and endothelial cells) lineages in vitro 
(24,25). 
Moreover, placenta MSCs are positive for surface markers that are expressed by embryonic 
stem cells but not by mesenchymal cells. Among them are octamer binding protein 4 (Oct-4), 
Sox2, Nanog, stage-specific embryonic antigen (SSEA)-1, SSEA-4, GCTM2, Tra-1-60, and 
Tra-1-80 which are routinely evaluated by immunocytochemistry or flow cytometry 
(14,23,26). Even when analyzing such expression using more sensitive assays, as in real time 
polymerase chain reaction (q-PCR), it is observed that placenta MSCs significantly express 
high levels of Oct-4, Nanog and Sox2 (25). In addition, it was detected by 
immunofluorescence analysis that human amniotic stem cells, different from other MSCs, 
are positive for the neural stem cell markers Nestin, Vimentin, Musashi-1, and PSA-NCAM 
(28). However, all of these data should be analyzed carefully. Some studies indicate variable 
percentages of positive cells for different pluripotent markers, indicating that more studies 
are need.  
Besides the pluripotency potential of placenta MSCs and the lack of ethical concerns, an 
important characteristic that lead placenta MSCs to a great importance for clinical 
application is their low immunogenicity. This property is partially explained by the fact that 
placenta MSCs do not express MHC class II molecules (HLA-DR, -DP, -DQ) and co-
stimulatory molecules in vitro, as reported by different research groups and using different 
methodologies (flow cytometry, qPCR, western blotting), indicating that such cells can be 
effectively used for both autologous and allogenic transplantations. It was recently 
demonstrated that fetal membrane MSCs are capable of suppressing proliferation in a mix 
lymphocyte reaction, decreasing interferon (IFN)-ɣ and interleukin (IL)-17 production, 
stimulating IL-10 secretion, and increasing levels of adhesion markers CD54, CD29, and 
CD49d (29). In addition, placenta MSCs are able to engraft and survive long-term in various 
organs and tissues without evidence of inflammation or rejection after transplantation into 
neonatal animals and after in utero transplantation into pregnant rats (30,31). Therefore, 
placenta MSCs are viable candidates for cell-based therapeutic approaches.  
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Surface marker Cell types References 
 ESC MSC Placenta – MSC  
CD11b - - - (24) 
CD34 - - - (14,22–27) 
CD45 - - - (14,22–24,26,27) 
CD29 - + + (14,22,24–27) 
CD73 - + + (22–26) 
CD90 - + ND (14,22–25,27) 
CD105 - + - (23,25,27) 
CD166 - + + (23,26) 
CD271 - + - (22) 
Nanog + - + (25,26) 
Oct-4 + - + (14,23,25,26) 
Sox-2 + - + (23,25,26) 
SSEA-1 + - + (14) 
SSEA-4 + - + (23,26) 
GCTM-2 + - + (23,26) 
Tra-1-60 + - + (26) 
Tra-1-80 + - + (26) 
(+): presence; (-): absence; ND: not defined 
Table 1. Surface marker expression from embryonic stem cells (ESC), adult mesenchymal stem cells 
(MSC), and placenta derived mesenchymal stem cells (placenta-MSC). 
When considering cellular therapy it is important to keep in mind that a great number of 
cells will be needed and cell banking may be required. As a result, it is imperative that cells 
possess some important characteristics: abundant source, high proliferation rate, stability 
over further passages, efficient freezing, and high viability after thawing. Placenta MSCs 
have been demonstrated to fulfill such requirements. It was recently reported that placenta 
MSCs at passage 30 are still able to proliferate in normal rates and keep a stable karyotype 
(25). Such characteristics are observed in ESCs but not in other types of MSCs, such as those 
derived from bone marrow or adipose tissue, which don’t proliferate well and go to 
senescence around passages 8-10. Compared to ESCs, MSCs are more resistant to 
cryopreservation. Whilst ESCs require complex and expansive reagents to be frozen and 
great number of cells die, placenta MSCs are successfully frozen in 40% DMEM, 50% FBS, 
10% DMSO, as well as bone marrow and adipose tissue MSCs, with high recovery rates after 
thawing. Among many different assays to evaluate cellular viability, the measurement of 
mitochondrial metabolic rate using MTT (3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-
tetrazolium bromide) to indirectly reflect viable cell numbers has been widely applied. 
However, if the purpose is to evaluate the viability and the number of cells immediately 
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before their transplantation to human or animals, trypan blue dye exclusion assay is 
preferable because only the unavailable cells are dyed, while the desired cells are 
maintained viable, ready to use. 
Before considering using placenta MSCs for clinical purposes, preclinical studies may be 
performed and the results must be carefully interpreted in order to assure safety for the 
patient and success in the therapy. Many preclinical studies on placenta-derived cells and 
amniotic membrane were reviewed (32), considering a wide range of diseases as 
neurological, pancreatic, muscle, vascular, cardiac, and pulmonary disorders along with 
liver fibrosis and applications for tissue engineering. Overall the results are promising 
and, although differentiation of placenta MSCs to specific lineages has been considered 
the first necessity for therapeutic applications in vivo, it seems that the beneficial effects 
reside on paracrine effects. However, both mechanisms (differentiation or paracrine) are 
not mutually exclusive and can account for the promising results reported in the 
literature.  
As placenta MSCs share with ESCs some common characteristics such as surface marker 
expression and plasticity in vitro, it was assumed that placenta cells could regenerate 
damaged tissues due to pluripotency potential. To date, however, preclinical studies have 
failed to demonstrate the differentiation of engrafted cells. Most of the time the success of 
the cell transplantation may more likely be due to the secretion of bioactive molecules that 
could act on other cells and on the microenvironment which they occupy thereby promoting 
endogenous tissue repair or eliciting other beneficial effects (anti-inflammatory, anti-
scarring, angiogenic effects) through paracrine actions.  
The abundance of pluripotent cells, high yield, rapid proliferation rates, stable karyotype, 
plasticity and immunomodulatory properties make placenta MSCs an ideal choice for 
clinical and tissue engineering applications. Nevertheless, further studies are needed to 
demonstrate the pluripotency ability of placenta MSCs in vivo and to elucidate the 
mechanisms by which these cells promote physiological and clinical improvements.  
4. Conclusion 
Eutherian mammalian fetus growth is characterized by the early development of fetal 
membranes, specially the trophoblast, which produces hormones for the establishment, 
maintenance and end of pregnancy. The fetomaternal interface varies among species and is 
a basis for placental structure classification. Primary cultures from placenta are obtained in 
an easy and not consuming fashion allowing a great number of research applications. 
Various undifferentiated stem cell sources have been proposed for regenerative medicine. In 
this setting placenta-derived cells show some advantages as potential to differentiate into 
the three germ layers, lack of tumorigenicity, low immunogenicity, and more importantly 
that they are isolated in high yields from sources generally considered medical waste, 
avoiding ethical concerns. 
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1. Introduction
Vertebrates have multiple synovial joints, and these joints in humans enable a number of
activities of daily life. In particular, the hip, knee, shoulder, elbow, and ankle are all synovial
joints with synovium in which the secretes synovial fluid. The articular surface is covered with
smooth hyaline cartilage, which forms the part of the skeletal system that is notably different
from mineralized bone in both function and histological composition [1]. The formation of
animal cartilage from mesenchyme occurs in numerous areas of the embryo, such as the
skull, limbs, and spine. This tissue contains chondrocytes which synthesize and maintain
extracellular matrix (ECM), which is composed of a dense network of collagen molecules
and proteoglycans [2]. There are three types of cartilage; fibrocartilage, elastic cartilage, and
hyaline cartilage. Fibrocartilage contains regions of organized fibrous tissue, containing type
I collagen in addition to the normal type II collagen. It is found in the annulus fibrosus of
the intervertebral discs, meniscus and temporomandibular joints. Elastic cartilage contains
additional elastin fibers and is a type of cartilage present in the ear, larynx, and epiglottis.
Finally, hyaline cartilage coats the articular surfaces of bone epiphyses and is composed of
individual chondrocytes bound together by the ECM. The major constituent of the hyaline
cartilage is held in place by proteoglycan (about 10 % of wet weight) and type II collagen
(10–20 % of wet weight), which forms a meshwork with high tensile strength [3–5].
Steric and electrostatic interactions of these ECM molecules in the hyaline cartilage occur
between the cationic collagen fibers and the anionic proteoglycans to provide a highly charge
in a neutral pH environment. In particular, since the proteoglycan is highly negatively
charged, it is not only cross-liked between collagen, but also combined with many water
molecules, leading to high extracellular osmolality within the cartilage. Consequently,
cartilage is as formed as a soft-tissue-bearing element with high viscoelasticity [6]. The
mechanical function of the hyaline cartilage is joint lubrication and shock absorption, and
articular cartilage has a very low friction coefficient (0.02) [7] with smoother movement than
most modern artificial joint replacements.
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2 Will-be-set-by-IN-TECH
Although adult articular cartilage is a remarkable load bearing system, it lacks the ability to
repair itself under conditions of wear and tear or traumatic injury, leading to osteoarthritis
(OA). This lack of self-maintenance is due to its avascular, aneural, alymphatic and almost
nonimmunogenic properties, as well as its nourishment entirely via diffusion from synovial
fluid. Diseases of the cartilage are a major health problems, especially in industrialized
countries with long life expectancy. At present, there is no established therapy of cell-assisted
tissue regeneration for sufficiently reliable and durable replacement of damaged articular
cartilage [8–11]. In recent years, however, tissue engineering has shown promise toward
the treatment of OA, enabling researchers to produce functional replacements for diseased
cartilage [12, 13]. Developments in therapeutic strategies for damaged cartilage treatment
have increasingly focused on the promising technology of cell-assisted repair and proposing
the use of autologous chondrocytes or other cell types to regenerate articular cartilage [10, 11].
Little knowledge is available for establishing a suitable design strategy for reconstructing
cartilage by tissue engineering to match the mechanical properties of natural tissue. It
is therefore necessary to understand the relationship between degree of development of
the ECM network and the macroscopic mechanical properties of the cultured construct for
producing regenerated cartilage. Because the ECM meshwork is formed chiefly by type
II collagen, growth of the collagen network likely plays the most important role in the
mechanical characteristics of the overall three-dimensional construct (e.g., Young’s modulus
and compressive strength). If ECM network does not interconnect among chondrocytes in
the cell-scaffold material, it is no relevant to entire mechanical property of the construct. In
such a case, this mechanical property will be the same as that of the scaffold material without
chondrocytes. This means that less mechanical property increases if the ECM synthesizes a
lot. We therefore investigated the relationship between development of the ECM network
and the macroscopic mechanical property of the cultured construct using vitamin C (VC) to
control collagen synthesis [14].
VC is an important water-soluble antioxidant and enzyme cofactor of collagen synthesis in
plants and animals [15] and the importance of VC in collagen synthesis is well-known as
described below [16–18]. Procollagen molecules, which are collagen precursors, undergo
multiple steps of post-translational modification. After translocation of the growing
polypeptide chains of procollagens into the rough endoplasmic reticulum, hydroxylation of
proline residues is catalyzed by prolyl 4-hydroxylase (P4H). This catalytic reaction requires
ferrous ions, 2-oxoglutarate, molecular oxygen, and ascorbic acid (AsA), a kind of VC,
as cofactors. The hydroxylation of proline residues increases the stability of the triple
helix and is a key element in its folding. P4H requires an unfolded chain as a substrate.
The C-propeptides have an essential function in the assembly of the three α-chains into
trimeric collagen monomers. The formation of triple helices starts from the alignment of
the C-terminal domains of the three α-chains and proceeds to the N-terminal. Premature
association between procollagen is thought to be prevented by heat shock protein 47 [18]
and by collagen-modifying enzymes until biosynthesis of the individual chain is complete.
In the collagen-secretion process, proline hydroxylation is caused by oxidation of P4H-bound
ferrous iron, which must be reduced to P4H-bound ferric iron by AsA to reinvigorate P4H
activity for maintaining the proline hydroxylation process. Thus, the collagen biosynthesis
needs AsA to reduce oxidized P4H-bound iron.
Many studies have reported the relationship between collagen content in the tissue and
mechanical properties [19–21] and the effects of VC on several cell functions (e.g., cytotoxicity
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and redox) [15, 22–25]; however, little knowledge is available on the development of the ECM
network in relation to the mechanical properties of the cultured construct. In this chapter,
we demonstrate the influence of collagen network growth on the macroscopic mechanical
properties of regenerated cartilage using a chondrocyte-agarose construct, and we briefly
explain how expansion of the network within a tissue affects to the mechanical properties.
Here we used two types of VC: AsA, the acidic form; and ascorbic acid 2-phosphate (A2P), the
non-acidic form. In addition, after applying uniaxial compressive strain to the tissue model
using a purpose-built bioreactor, we described the different ways of developing the ECM in
the construct by dosing the culture medium with AsA or A2P.
2. Materials & methods
2.1. Sample preparation and culturing
Primary bovine chondrocytes were isolated from metacarpophalangeal joints of steers
purchased from a meat center in Fukuoka city, Japan using a sequential enzyme digestion
method [26]. Full-thickness articular cartilage tissue was harvested from the proximal
articular surface of the metatarsal bone and finely diced with a scalpel. The finely diced
cartilage was enzymatically digested with 25 unit/mL protease solution (P8811, Sigma, St
Louis, MO) for 3 hours, and subsequently with 200 unit/mL collagenase solution (C7657,
Sigma) for 18 hours at 37 degree C. Both enzyme solutions were prepared in sterile tissue
culture medium, consisting of Dulbecco’s modified Eagle’s medium (DMEM; D5921, Sigma)
supplemented with 20 v/v% Fetal Bovine Serum (FBS; 10437-028, Gibco, CA), 2 mM
L-glutamine (G7513, Wako Pure Chemical Industries, Ltd., Osaka, Japan), 100 unit/mL
penicillin, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B (161-23181, Wako), 20 mM
hepes (H0887, Sigma), and 0.85 mM L-ascorbic acid (AsA; A5960, Sigma). The supernatant
of the resultant solution was centrifuged to separate chondrocytes at 40×g for 5 min. The
resultant cell pellet was washed twice with fresh culture medium, and cell number and
cell viability were determined by trypan blue assay. In this study, Sigma Type VII agarose
(A6560, Sigma) was used to prepare a chondrocyte-agarose construct. The agarose powder
was dissolved in Earle’s balanced salts solution (EBSS; Sigma) at twice the required final
concentration (1 w/v%) and mixed with an equal volume of the cell suspension to yield
the desired agarose concentration with a final cell density of 1 × 107 cells/mL. The molten
cell-agarose solution was poured into an acrylic mold and quenched to gel at 4 degree C for
30 min to create cylindrical constructs with a diameter of 4 mm and a height of 2.5 mm. The
resultant cell-agarose constructs were placed into a 24-well culture plate and subsequently
cultured with 1 mL culture medium in a humidified tissue culture incubator controlled at 37
degree C and 5 % CO2. The culture medium was exchanged every two days. Several culture
media with different VC concentrations, from 0.64 to 6.4 pmol/109 cells were prepared and
used to evaluate the effect of AsA and A2P Salt (Wako) concentrations. The culture medium
without VC was also used as a control. Media are denoted abbreviated as AsA(0.64), AsA(2.2),
AsA(3.2), A2P(3.2), and A2P(6.4) hereafter in this paper.
2.2. Mechanical stimulation
After 1 day of free-swelling culture, the constructs in the experiment group were subjected to
uniaxial compression within a purpose-built bioreactor system as shown in Fig. 1. The system
enables the application of strain independently in each vertical and horizontal direction to
135Tissue Development and Mechanical Property in the Regenerated-Cartilage Tissue
2 Will-be-set-by-IN-TECH
Although adult articular cartilage is a remarkable load bearing system, it lacks the ability to
repair itself under conditions of wear and tear or traumatic injury, leading to osteoarthritis
(OA). This lack of self-maintenance is due to its avascular, aneural, alymphatic and almost
nonimmunogenic properties, as well as its nourishment entirely via diffusion from synovial
fluid. Diseases of the cartilage are a major health problems, especially in industrialized
countries with long life expectancy. At present, there is no established therapy of cell-assisted
tissue regeneration for sufficiently reliable and durable replacement of damaged articular
cartilage [8–11]. In recent years, however, tissue engineering has shown promise toward
the treatment of OA, enabling researchers to produce functional replacements for diseased
cartilage [12, 13]. Developments in therapeutic strategies for damaged cartilage treatment
have increasingly focused on the promising technology of cell-assisted repair and proposing
the use of autologous chondrocytes or other cell types to regenerate articular cartilage [10, 11].
Little knowledge is available for establishing a suitable design strategy for reconstructing
cartilage by tissue engineering to match the mechanical properties of natural tissue. It
is therefore necessary to understand the relationship between degree of development of
the ECM network and the macroscopic mechanical properties of the cultured construct for
producing regenerated cartilage. Because the ECM meshwork is formed chiefly by type
II collagen, growth of the collagen network likely plays the most important role in the
mechanical characteristics of the overall three-dimensional construct (e.g., Young’s modulus
and compressive strength). If ECM network does not interconnect among chondrocytes in
the cell-scaffold material, it is no relevant to entire mechanical property of the construct. In
such a case, this mechanical property will be the same as that of the scaffold material without
chondrocytes. This means that less mechanical property increases if the ECM synthesizes a
lot. We therefore investigated the relationship between development of the ECM network
and the macroscopic mechanical property of the cultured construct using vitamin C (VC) to
control collagen synthesis [14].
VC is an important water-soluble antioxidant and enzyme cofactor of collagen synthesis in
plants and animals [15] and the importance of VC in collagen synthesis is well-known as
described below [16–18]. Procollagen molecules, which are collagen precursors, undergo
multiple steps of post-translational modification. After translocation of the growing
polypeptide chains of procollagens into the rough endoplasmic reticulum, hydroxylation of
proline residues is catalyzed by prolyl 4-hydroxylase (P4H). This catalytic reaction requires
ferrous ions, 2-oxoglutarate, molecular oxygen, and ascorbic acid (AsA), a kind of VC,
as cofactors. The hydroxylation of proline residues increases the stability of the triple
helix and is a key element in its folding. P4H requires an unfolded chain as a substrate.
The C-propeptides have an essential function in the assembly of the three α-chains into
trimeric collagen monomers. The formation of triple helices starts from the alignment of
the C-terminal domains of the three α-chains and proceeds to the N-terminal. Premature
association between procollagen is thought to be prevented by heat shock protein 47 [18]
and by collagen-modifying enzymes until biosynthesis of the individual chain is complete.
In the collagen-secretion process, proline hydroxylation is caused by oxidation of P4H-bound
ferrous iron, which must be reduced to P4H-bound ferric iron by AsA to reinvigorate P4H
activity for maintaining the proline hydroxylation process. Thus, the collagen biosynthesis
needs AsA to reduce oxidized P4H-bound iron.
Many studies have reported the relationship between collagen content in the tissue and
mechanical properties [19–21] and the effects of VC on several cell functions (e.g., cytotoxicity
134 Biomedical Tissue Culture Tissue Development and Mechanical Property in the Regenerated-Cartilage Tissue 3
and redox) [15, 22–25]; however, little knowledge is available on the development of the ECM
network in relation to the mechanical properties of the cultured construct. In this chapter,
we demonstrate the influence of collagen network growth on the macroscopic mechanical
properties of regenerated cartilage using a chondrocyte-agarose construct, and we briefly
explain how expansion of the network within a tissue affects to the mechanical properties.
Here we used two types of VC: AsA, the acidic form; and ascorbic acid 2-phosphate (A2P), the
non-acidic form. In addition, after applying uniaxial compressive strain to the tissue model
using a purpose-built bioreactor, we described the different ways of developing the ECM in
the construct by dosing the culture medium with AsA or A2P.
2. Materials & methods
2.1. Sample preparation and culturing
Primary bovine chondrocytes were isolated from metacarpophalangeal joints of steers
purchased from a meat center in Fukuoka city, Japan using a sequential enzyme digestion
method [26]. Full-thickness articular cartilage tissue was harvested from the proximal
articular surface of the metatarsal bone and finely diced with a scalpel. The finely diced
cartilage was enzymatically digested with 25 unit/mL protease solution (P8811, Sigma, St
Louis, MO) for 3 hours, and subsequently with 200 unit/mL collagenase solution (C7657,
Sigma) for 18 hours at 37 degree C. Both enzyme solutions were prepared in sterile tissue
culture medium, consisting of Dulbecco’s modified Eagle’s medium (DMEM; D5921, Sigma)
supplemented with 20 v/v% Fetal Bovine Serum (FBS; 10437-028, Gibco, CA), 2 mM
L-glutamine (G7513, Wako Pure Chemical Industries, Ltd., Osaka, Japan), 100 unit/mL
penicillin, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B (161-23181, Wako), 20 mM
hepes (H0887, Sigma), and 0.85 mM L-ascorbic acid (AsA; A5960, Sigma). The supernatant
of the resultant solution was centrifuged to separate chondrocytes at 40×g for 5 min. The
resultant cell pellet was washed twice with fresh culture medium, and cell number and
cell viability were determined by trypan blue assay. In this study, Sigma Type VII agarose
(A6560, Sigma) was used to prepare a chondrocyte-agarose construct. The agarose powder
was dissolved in Earle’s balanced salts solution (EBSS; Sigma) at twice the required final
concentration (1 w/v%) and mixed with an equal volume of the cell suspension to yield
the desired agarose concentration with a final cell density of 1 × 107 cells/mL. The molten
cell-agarose solution was poured into an acrylic mold and quenched to gel at 4 degree C for
30 min to create cylindrical constructs with a diameter of 4 mm and a height of 2.5 mm. The
resultant cell-agarose constructs were placed into a 24-well culture plate and subsequently
cultured with 1 mL culture medium in a humidified tissue culture incubator controlled at 37
degree C and 5 % CO2. The culture medium was exchanged every two days. Several culture
media with different VC concentrations, from 0.64 to 6.4 pmol/109 cells were prepared and
used to evaluate the effect of AsA and A2P Salt (Wako) concentrations. The culture medium
without VC was also used as a control. Media are denoted abbreviated as AsA(0.64), AsA(2.2),
AsA(3.2), A2P(3.2), and A2P(6.4) hereafter in this paper.
2.2. Mechanical stimulation
After 1 day of free-swelling culture, the constructs in the experiment group were subjected to
uniaxial compression within a purpose-built bioreactor system as shown in Fig. 1. The system
enables the application of strain independently in each vertical and horizontal direction to
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Figure 1. Photograph (left) and Schematic drawing (center) of the mechanical loading system mounted
within tissue culture incubator and appearance of the loading platen with 22 plungers coupled with a 24
well culture plate (right).
individual constructs using a 24-well plate in a commercially available incubator. Movements
was controlled with respective linear variable displacement transducers and linear guide
actuators. Strain was applied to the individual constructs through a loading plate, which was
attached to the actuator via a jig. Uniaxial cyclic compression up to a maximum amplitude
of 15 % was applied with a triangular waveform at a frequency of 1 Hz for 6 hours and
subsequently off-loaded with the platen resting on each construct for the subsequent 18 hours.
Control constructs were cultured in contrast with both upper- and lower-platens to diffusion
through its sides alone.
2.3. Mechanical testing
To examine the influence of chemical and physical stimulation on the mechanical properties
of the constructs, cell-agarose constructs were subjected to unconfined compression while
immersed in culture medium at room temperature. Individual constructs were tested after
culture periods of 1, 8, 15, and 22 days. Mechanical tests were performed with an impermeable
stainless steel plunger at a strain rate of 0.5 mm/min up to a strain of 10%, while the load was
recorded with a 10-N load sensor, as shown in Fig. 2. The tangent modulus of the construct
was calculated from the slope of a straight-line approximation of the stress-strain curve with
a range of 0–15 % strain using the least-square method.
2.4. Immunohistology
Separate constructs were used for trichrome immunofluorescence observation to examine
the morphological characteristics of the elaborated ECMs, in particular type I collagen, type
II collagen, and chondroitin sulphate. After the prescribed culture periods, representative
constructs were cut into slices with a thickness of approximately 1 mm using a knife.
The slices were washed in Ca2+ and Mg2+ free phosphate-buffered saline (PBS(–)) and
subsequently incubated in PBS(–) + 1 w/v% bovine serum albumin (BSA; Wako) for 30 min at
37 degree C. These slices were incubated in PBS(–) containing the three monoclonal antibodies
(bovine IgG1 isotype anti-type I collagen, Funakoshi, Tokyo, Japan; embryonic chicken IgG2a
isotype anti-type II collagen, Funakoshi; mouse IgM isotype anti-chondroitin sulphate, Sigma)
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Figure 2. Photograph of compression test for determining the tangent modulus
for 90 min at 37 degree C to primarily label the collagens and the proteoglycan at once.
The slices were then washed three times in PBS(–) for 10 min and incubated in PBS(–)
containing the three secondary antibodies corresponding to each of the primary antibodies
(Alexafluor 350-conjugated anti-mouse IgG1 antibody, A21120; Alexafluor 488-conjugated
anti-mouse IgG2a antibody, A11001; Alexafluor 568-conjugated anti-mouse IgM antibody,
A21043, Invitrogen) for 60 min at 37 degree C to fluorescently visualize the labeled ECM
molecules within the cultured cell-agarose construct. The fluorescently stained specimen was
mounted on the coverslip and observed using a confocal laser scanning microscope (CLSM;
Eclipse; Nikon Corp., Tokyo, Japan).
2.5. Statistical analysis
Result of the tangent modulus were expressed as the mean ± sample standard deviation (SD).
The significance of the difference between each experimental group was assayed using the
two-tailed Welch’s t-test. The degree of freedom is abbreviated as d f . If the results of pairwise
comparisons between two groups were P < 0.01, d > 1 and (1 − β) > 0.8 simultaneously, we
judged the difference in the tangent modulus as significant, where P: level of significance; d:
Cohen’s d, a kind of the effect size [27]; (1 − β): the power of test as calculated usigng the R
language.
3. Results
3.1. Effect of VC on mechanical properties of the tissue under free-swelling
culture conditions when added to the medium
3.1.1. Influence on mechanical properties
The tangent modulus (E) of the four experiment groups (without VC, AsA(0.64), AsA(2.2), and
AsA(3.2)) was determined at 22 days of culture in Fig. 3. The tangent moduli of the high AsA
dose groups, AsA(2.2) and AsA(3.2), were significantly higher than those of the without AsA
group. Moreover, we measured the temporal growth of the construct’s tangent modulus to
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A21043, Invitrogen) for 60 min at 37 degree C to fluorescently visualize the labeled ECM
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mounted on the coverslip and observed using a confocal laser scanning microscope (CLSM;
Eclipse; Nikon Corp., Tokyo, Japan).
2.5. Statistical analysis
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The significance of the difference between each experimental group was assayed using the
two-tailed Welch’s t-test. The degree of freedom is abbreviated as d f . If the results of pairwise
comparisons between two groups were P < 0.01, d > 1 and (1 − β) > 0.8 simultaneously, we
judged the difference in the tangent modulus as significant, where P: level of significance; d:
Cohen’s d, a kind of the effect size [27]; (1 − β): the power of test as calculated usigng the R
language.
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3.1. Effect of VC on mechanical properties of the tissue under free-swelling
culture conditions when added to the medium
3.1.1. Influence on mechanical properties
The tangent modulus (E) of the four experiment groups (without VC, AsA(0.64), AsA(2.2), and
AsA(3.2)) was determined at 22 days of culture in Fig. 3. The tangent moduli of the high AsA
dose groups, AsA(2.2) and AsA(3.2), were significantly higher than those of the without AsA
group. Moreover, we measured the temporal growth of the construct’s tangent modulus to
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determine the relationship between development of the ECM and mechanical properties. The
tangent moduli of all experiment groups after 1 day of culture were almost identical (results
not shown) and were equivalent to the tangent modulus of cell-free agarose gel (12.5± 0.9 kPa,
n = 10). The measured tangent modulus (E) was normalized with the tangent modulus at day
1 (E0) and plotted against the culture periods in Fig. 4. It was evident that the tangent modulus
increased with increasing culture period. These results clearly indicate that the growth rate
of the tangent modulus is dependent on the AsA concentration of the culture medium. Thus,
the tangent modulus of the high AsA dose groups, AsA(2.2), and AsA(3.2), increased faster
than that of the low AsA dose group, AsA(0.64).
3.1.2. Histological observation
Typical immunofluorescence images of elaborated ECMs (type I collagen, type II collagen and
chondroitin sulfate) after 22 days of culture were compared as shown in Fig. 5. It is clear
that in the low-VC concentration groups (without VC and AsA(0.64)), only a small amount
of ECM which is consisting of chondroitin sulfate was present, as indicated in Fig. 5(A) and
5(B). By contrast, abundant ECM, chiefly type II collagen, was observed in the constructs
of AsA(2.2) and AsA(3.2), as indicated by the arrow-heads in Fig. 5(C) and 5(D). Then, the
broadened collagen network interconnected the chondrocytes to create an extended network
which exceeded the field of view in the photograph.
3.2. Influence of mechanical stimulation on the development of the ECM and
mechanical properties
3.2.1. Measurement of mechanical properties
To evaluate the influence of mechanical stimulation on the cultured constructs, the tangent
moduli of each group after 22 days of culture was measured in Fig. 6. A significant
difference was noted between the without VC and AsA(2.2) groups compared with the three
free-swelling groups, the latter revealing an increased tangent modulus. When applying
cyclic compression to the construct with dosing the culture medium with VC, no clear
difference was observed between free-swelling and compression AsA groups. By contrast,
both tangent moduli of compression A2P dose group (A2P(6.4)) were higher than those of the
free-swelling A2P(6.4) group. Each tangent modulus of control groups with A2P was ranked
between free-swelling and compression groups. No differences were evident between the
three compression groups (d f = 16, P = 0.47, d = 0.32, (1 − β) = 0.030).
3.2.2. Histological observation
Figs. 7 and 8 show immunofluorescent images at low- and high-magnification and reveal the
ECM distribution (type I and II collagen and chondroitin sulfate) after 22 days of culture, with
the high-magnification images taken near the center of the construct. It is clear that in the
absence of VC in the culture medium, there was only a limited quantity of ECM, as indicated
in Fig. 7(A) and 8(A). By contrast, in the free-swelling group (AsA(2.2)), there was fairly
uniform distribution of ECM across the construct (Fig. 7(B)) which, at high magnification,
revealed a collagen network that interconnected between chondrocytes, as indicated by the
arrows in Fig. 8(B). The low-magnification images for each of the A2P dose groups revealed
similar distribution in ECM across the constructs (Figs. 7(C)–(E)). In the high-magnification
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Figure 3. Comparison of tangent modulus after 22 days culture period. Each number in a column is
cultured sample number, and each sample represents an individual culture. Error bar means SD. Sharps
(#) was shown statistical significant respective as compared to control group and between each groups.
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Figure 4. Comparison of normalized tangent modulus with the tangent modulus at day 1 (E0).
images, type II collagen molecules were appeared to interconnect between chondrocytes, as
indicated by arrows in Fig. 8(E). These results demonstrate that the compression group of
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difference was noted between the without VC and AsA(2.2) groups compared with the three
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3.2.2. Histological observation
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ECM distribution (type I and II collagen and chondroitin sulfate) after 22 days of culture, with
the high-magnification images taken near the center of the construct. It is clear that in the
absence of VC in the culture medium, there was only a limited quantity of ECM, as indicated
in Fig. 7(A) and 8(A). By contrast, in the free-swelling group (AsA(2.2)), there was fairly
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images, type II collagen molecules were appeared to interconnect between chondrocytes, as
indicated by arrows in Fig. 8(E). These results demonstrate that the compression group of
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Figure 5. Fluorescence images of ECMs: blue: type I collagen; green: type II collagen; red: chondroitin
sulphate. Culture period was 22 days. (A): without VC; (B): AsA(0.64); (C): AsA(2.2); (D): AsA(3.2). Each
trichrome stained sample represents an individual culture. Scale bar represents 50 μm.
A2P(6.4) is associated with more of the collagen network than the corresponding free-swelling
group. In addition, the distribution of chondroitin sulfate was clearly observed to be restricted
to the peripheral regions of the chondrocytes.
4. Discussion
4.1. Effect of VC on mechanical properties of the tissue under free-swelling
culture conditions when added to the medium
Collagen synthesis is enhanced by increasing VC concentration [23, 24, 28, 29]. In addition, the
immunofluorescent images in Fig. 5 indicate that the synthesized collagen fibrils, as the chief
reinforcing fiber in the elaborated tissue, are upregulated by increasing AsA concentration.
Moreover, the self-assembled collagen network was spread out spatially in the construct and
interconnected among chondrocytes. As shown in Fig. 5, the elaborated ECM is forms into
a large network which spreads infinitely. This means that entanglements between opposite
sides of a cube in three-dimension exist, and that the entire construct is percolated by
interconnecting the ECM network, as shown in Fig. 9. Therefore, the mechanical property
of the developed ECM network appeared as that of the whole construct.
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Figure 6. Comparison of the tangent modulus after 22 day culture period. Cultures were terminated
following either a free-swelling (white column), control (gray column) or compression (black column)
condition. Each number in a column is cultured sample number and each sample represents an
individual culture. Error bar means SD. Sharps (# and ##) and asterisks (∗ and ∗∗) were shown statistical
significant respective as compared to control group and between each groups in Welch’s t-test. #, ∗:
d > 1, P < 0.01, (1 − β) > 0.8; ##, ∗∗: d > 2, P < 0.01, (1 − β) > 0.8.
The observed mechanical behavior of the cultured constructs, in which the elastic modulus
changed non-linearly with the culture period, was similar to the mechanical characteristics
of the gel at the vicinity of the sol-gel transition point [30]. In particular, the elasticity of the
gel in the vicinity of the sol-gel transition point is exponentially proportional to the molecular
concentration of polymer solution [31]. It was widely alleged that the gel had been formed by
the very tenuous network irrespective of the mechanism of cross-linking formation process
and had been dominated by entropic elasticity in the vicinity of the gelation point Several
studied several researches with experiments [31, 32] and numerical simulations [33–35].
On the basis of the above, the chondrocytes synthesize collagen fibrils around themselves,
and reinforced polymer concentration (ρ) in the cultured construct is enhanced by increasing
collagen density. Then, the elasticity was increased exponentially by culture period (t) as
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A2P(6.4) is associated with more of the collagen network than the corresponding free-swelling
group. In addition, the distribution of chondroitin sulfate was clearly observed to be restricted
to the peripheral regions of the chondrocytes.
4. Discussion
4.1. Effect of VC on mechanical properties of the tissue under free-swelling
culture conditions when added to the medium
Collagen synthesis is enhanced by increasing VC concentration [23, 24, 28, 29]. In addition, the
immunofluorescent images in Fig. 5 indicate that the synthesized collagen fibrils, as the chief
reinforcing fiber in the elaborated tissue, are upregulated by increasing AsA concentration.
Moreover, the self-assembled collagen network was spread out spatially in the construct and
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Figure 6. Comparison of the tangent modulus after 22 day culture period. Cultures were terminated
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condition. Each number in a column is cultured sample number and each sample represents an
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of the gel at the vicinity of the sol-gel transition point [30]. In particular, the elasticity of the
gel in the vicinity of the sol-gel transition point is exponentially proportional to the molecular
concentration of polymer solution [31]. It was widely alleged that the gel had been formed by
the very tenuous network irrespective of the mechanism of cross-linking formation process
and had been dominated by entropic elasticity in the vicinity of the gelation point Several
studied several researches with experiments [31, 32] and numerical simulations [33–35].
On the basis of the above, the chondrocytes synthesize collagen fibrils around themselves,
and reinforced polymer concentration (ρ) in the cultured construct is enhanced by increasing
collagen density. Then, the elasticity was increased exponentially by culture period (t) as
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Figure 7. Low-magnified immunofluorescence images of ECMs under either free-swelling (A, B, C),
control (D) or compression (E) culture condition: A: without VC; B: AsA(2.2); C–E: A2P(6.4). Blue: type I
collagen; green: type II collagen; red: chondroitin sulphate. Culture period was 22 days. Each trichrome
stained samples represents an individual culture. Scale bar represents 1 mm.
follow,
E ∝| ρ − ρc |λ∝ tν, (1)
where ρc is polymer density at gelation point. We considered that the elastic modulus
of the regenerated cartilage is expected to exponentially proportionate with the culture
period. Therefore, we hypothesised that the tangent modulus of cultured construct increases
exponentially with the culture period because the ECM content of the cultured constructs




where E0 is tangent modulus at day 1 of the culture period and exponent ν is the growth
rate of the tangent modulus. To investigate the relationship between AsA concentration and
the growth rate of the tangent modulus, we applied equation (2) to the tangent moduli of all
experimental groups in Fig. 4 and described these exponents (ν) into Fig. 10. As shown in Fig.
10, the exponent (ν) was linearly proportional to the AsA concentration with 3.2 pmol/109
cells as follows,
ν ∝ (AsA concentration) . (3)
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Figure 8. High-magnified immunofluorescence images of ECMs in the vicinity of the tissue model under
either free swelling (A, B, C), control (D) or compression (E) culture condition: A: without VC; B:
AsA(2.2); C–E: A2P(6.4). Blue: type I collagen; green: type II collagen; red: chondroitin sulphate. Culture
period was 22 days. Each trichrome stained samples represents an individual culture. Scale bar
represents 50 μm. Arrows indicate to interconnect among chondrocytes by type II collagen net work.
To establish a suitable design method for regenerating tissue-engineered cartilage, we studied
the effect of two types of chemical and physical stimulation on the mechanical properties
of the chondrocyte-agarose construct as a regenerated cartilage model. One is to add a
high quantity of VC to the culture medium to effectively enhance collagen synthesis. The
other is to apply a compressive strain to the construct using a purpose-built bioreactor. Our
results showed that the compressive strain led to an increase in the tangent modulus because
it was clear that the collagen network had increased its density and had interconnected
chondrocytes.
4.2. Influence of mechanical stimulation on the development of the ECM and
mechanical properties
To establish a suitable design method for regenerating tissue-engineered cartilage, we studied
the effect of two types of chemical and physical stimulations on the mechanical property of
the chondrocyte-agarose construct, as a regenerated-cartilage tissue model. One is to add high
VC concentration into culture medium for effectively enhancing the collagen synthesis. The
other is to apply a compressive strain to the construct using a purpose-built bioreactor. Our
results showed that compressive strain had leaded to increase tangent modulus because it
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of the chondrocyte-agarose construct as a regenerated cartilage model. One is to add a
high quantity of VC to the culture medium to effectively enhance collagen synthesis. The
other is to apply a compressive strain to the construct using a purpose-built bioreactor. Our
results showed that the compressive strain led to an increase in the tangent modulus because
it was clear that the collagen network had increased its density and had interconnected
chondrocytes.
4.2. Influence of mechanical stimulation on the development of the ECM and
mechanical properties
To establish a suitable design method for regenerating tissue-engineered cartilage, we studied
the effect of two types of chemical and physical stimulations on the mechanical property of
the chondrocyte-agarose construct, as a regenerated-cartilage tissue model. One is to add high
VC concentration into culture medium for effectively enhancing the collagen synthesis. The
other is to apply a compressive strain to the construct using a purpose-built bioreactor. Our
results showed that compressive strain had leaded to increase tangent modulus because it
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Figure 9. Developing process of ECM and increasing connectivity. Elaborated ECM forms large network
which is spreaded infinitly. This means a entanglement between opposite sides of a cube in three
dimensions, and that entire mechanical property was percolated by of interconnected ECM network.
had been clear that collagen network had become dense and had been interconnected among
chondrocytes. We already described in last section (4.1) that it had definitely important that
chondrocytes had been linked by ECM for development of the elasticity of the construct.
It is well-known that A2P has no physiological activity but can produce the same as that
of effect of VC activity after dephosphorylation by an alkaline phosphatase (ALP) [36].
Dephosphorylated A2P, this is AsA, penetrates into chondrocyte through a VC transporter,
chiefly the sodium-dependent VC transporter 2 (SVCT2), and supports the collagen synthesis
as a cofactor in the rough endoplasmic reticulum [37]. Under free-swelling culture conditions,
we observed few collagen molecules distributed in the construct and found that the tangent
modulus of the A2P group was lower than that of the AsA(2.2) group. We should also consider
reaction rates, one of A2P dephosphorylation by ALP, the other of AsA transport into the
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y = 0.10 + 0.96 * x
  R2 = 0.91
Figure 10. Relationship of AsA concentration and exponent. Line shows a linear regression in AsA
concentration interval of 0 to 3.2 pmol/109 cells. R is the coefficient of determination.
cytosol by SVCT2. The Michaelis constants of both ALP and SVCT2 of bovine chondrocyte is
1–10 and 62 ± 25μM [38, 39]. Since the affinity of the substrate for ALP is slightly higher than
for SVCT2, AsA concentration around chondrocyte in A2P group was lower unlike cultivation
of high AsA concentration, the also rate of collagen synthesis was relatively decreased by
comparison with AsA dose group. Then, the tangent modulus of the free-swelling groups
with the A2P was suppressed with restraining cytotoxicity of AsA.
When applying compressive strain to the construct, the tangent modulus of A2P(6.4) was
higher than that of the respective free-swelling groups. This is because the collagen
fibers interconnected chondrocytes and because the collagen network of these groups
was expanded. We think this mechanical stimulation enhanced the diffusion of both
A2P and nutrients, homogenizing A2P in the construct. In addition, the stimulation
probably excited a mechanosensor on the cell surface, activating cell-signaling pathways,
namely the mechanotransduction pathway. It is well-known that mechanical stimulation
causes chondrocytes to several biological responses in cartilage remodeling strategies which
are based on the implantation of a cultured tissue [40]; for example, activation of the
mitogen-activated protein kinase (MAPK) pathway, a kind of cell signaling pathway [41, 42],
increase in GAG biosynthesis [43] and regulation of inflammatory species synthesis [44].
These chondrocyte responses were followed presently after loading mechanical stimulation
and sustained the activity of MAPK pathway for 5–60 min [41, 42]. BY synthesizing ECM with
mechanical stimulation, chondrocytes built up the collagen network and adapted to changes
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in the deformation around the cells. Therefore, the tangent modulus of the compression group
with A2P was higher than that of the free-swelling group.
Homogenously developing ECM under a free-swelling culture condition for expansive
regeneration of cartilage is a complex process. Our results provide evidence that it is necessary
to subject the construct to mechanical strain because nutrients should be supplied uniformly
to the construct. We also think that a diffusion of nutrients exists under free-swelling culture
conditions. The diffusion coefficient of water in agarose gel is about 10 × 10−10m2s [45, 46].
This means that a water molecule diffuses 10 mm per a day in the gel when applying the
Fick’s law. Pluen et al. reported that the diffusion coefficients of the proteins, lactalbumin and
ovalbumin, in 0.1 M PBS(–) solution into agarose gel was 0.8–1 ×10−10m2s [47]. This means
that the nutrient particles of diffuse 3 mm per a day in the gel. Moreover, if the ECM of the
cultured construct is more densely synthesized, it is hard to diffuse nutrients in the tissue; and
consequently, the diffusion coefficient will be decreased. Thus, if a medical doctor would like
to implant a large quantity of regenerated cartilage to treat the cartilage defect, the construct
should be subjected to mechanical stimulation to homogenously develop the ECM network.
5. Summary
This chapter demonstrates the relationship between the development of the ECM in the
construct and the mechanical properties of the construct for establishing a suitable design
method to reconstruct the regenerated cartilage by using a chondrocyte-agarose construct
as a tissue model. First, we revealed the influence of VC concentration in the culture
medium on the mechanical properties of the regenerated cartilage model. The present
findings suggest that the mechanical characteristic of the construct depend clearly on the
AsA concentration in the culture medium. The tangent modulus of the cultured construct
was exponentially increased according to cultivation duration. The growth rate of the
tangent modulus was accelerated to upregulate ECM secretion in the high AsA concentration.
This study strongly suggests, therefore, that the mechanical properties of the regenerated
cartilage depend on the interconnections created by the ECM between cells which are mainly
those of the three-dimensional collagen network. Second, we investigated the influence of
mechanical properties on the development of the ECM network as well as the regulation
of the chondrocyte-agarose constructs using two types of VCs, AsA and A2P. Neither the
collagen network nor the tangent modulus of the A2P dose groups was improved compared
with the AsA group under the free-swelling culture condition. Moreover, it is clear that the
free-swelling culture condition suppresses the development of the ECM of the inner tissue
compared with the ECM of outer tissue. W hen applying compressive strain to the construct,
the tangent modulus of the A2P dose group was increased because the ECM networks of the
inner tissue had been upregulated and had interconnected chondrocytes. We can additionally
consider that mechanical stimulation enhanced the diffusion of nutrients and improved the
synthesis of the ECM via the mechanotransduction pathway. Moreover, we revealed that it is
necessary to apply mechanical stimulation to a large engineered tissue when treating articular
cartilage defects.
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1. Introduction 
In virology, cell culture usually refers to the in vitro growth and manipulation of cells from a 
tissue obtained from a multicellular organism. The term “cell culture” is often used 
interchangeably with “tissue culture”. Cell culture remains integral with virology, as viruses 
are obligate intracellular parasites that require replication within a living cell to produce 
copies of themselves (i.e., to form progeny virions). Both animal and plant cells are 
propagated in cell cultures. The only other practical alternatives to cell culture are to 
propagate the viruses in susceptible animal or plant hosts. This review covers only cell 
culture for animal viruses. Since the literal meaning of tissue culture is the culturing of 
tissue pieces, i.e. explant culture, the term “cell culture” is used in this review instead of 
“tissue culture”. 
Cell cultures can be prepared from unicellular cells (e.g., white blood cells) or from a piece 
of “tissue”. We define tissue as an aggregate of similar cells forming a definite kind of 
structural material with a specific function in a multicellular organism. Tissues are first 
dissociated into smaller pieces by mechanical disruption (such as by cutting into smaller 
pieces using scissors). Next, the tissue pieces are subjected to treatment with agents that 
disrupt the extracellular matrix that holds cells together. The cell-dissociating agents usually 
are proteolytic enzymes such as collagenase and trypsin (to digest proteins) in combination 
with cation chelators such as ethylenediaminetetraacetic acid (EDTA) that bind, or chelate, 
the Ca2+ and other divalent cations on which cell-cell adhesion depends. The cells are then 
gently teased apart, suspended in cell growth medium and placed in sterile growth vessels. 
In the past, glass bottles or petri dishes were used. Indeed, in the context of virology, the 
term “in vitro” originally referred to cells grown “in glass”; this term was used to contrast them 
experiments carried out on cells grown in glass vessels as opposed to experiments using living 
organisms. Nowadays, polystyrene (plastic) vessels are most commonly used for cell culture. 
A majority of cell culture is still performed using techniques wherein the cells are grown in 
two dimensions. Newer technologies are available that permit cell growth in three dimensions; 
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using such techniques, it has been able to induce some cells to differentiate into into forms that 
are not observed during two-dimensional growth. Such technology is still relatively new in the 
field of virology, and are not discussed in this review.  
Since tissues are generally composed of different cell types, a heterogeneous population of 
cells is usually isolated during the first (“primary”) attempt to isolate cells for cell culture. 
Therefore, subsequent efforts are made to separate the cells into the various types, with the 
goal of obtaining homogenous populations of cells. The genetic uniformity of a batch of cells 
can be attained through a process termed “cloning”, wherein one cell is isolated and 
allowed to proliferate to form a “colony” or “clone”. All the cells in a colony derive from a 
common ancestor, and are thus “clones” of each other. 
Cells obtained from tissues tend to be “adherent”, meaning they attach to the growing 
surface (of the flask or other vessel) then spread out to form a monolayer. On the other 
hand, white blood cells settle but do not adhere, and are maintained as “suspension” 
cultures. As such, they are usually constantly stirred by a spinning magnet in a type of 
growth vessel termed “spinner flask”. Adherent cells growing as flat monolayers are 
generally of two types: fibroblast and epithelial. Fibroblasts are the most common cells of 
connective tissue, and synthesize collagen and the extracellular matrix. Epithelial cells line 
the cavities and surfaces of structures throughout a body, and also form many glands. In 
culture, they tend to appear rectangular and pack into tight monolayers that look like “brick 
pavements”. 
The art of cell culture for virus isolation has entered a renaissance in recent years. Significant 
improvements have been made in the quality of available reagents, plasticware, and in basic 
methodologies. For example, disposable platicware has largely supplanted the use of glass 
vessels. This has reduced the costs of culturing cells in many ways: (a) glass bottles do not 
have to be washed and sterilized between uses, (b) cell culture plasticware can be purchased 
ready-made with growth surface coatings or electrostatic “treatments” that promote cell 
attachment to the growing surface, (c) plasticware is inherently safer in that it is relatively 
shatterproof. Other sterile disposable plasticware has significantly reduced work burdens. 
For example, disposable pipettes have made obsolete the task of washing glass pipettes, and 
the subsequent tasks necessary to prepare them for virology work. In the past, such tasks 
required the use of multiple detergent and acid washes, which created potential biological 
and chemical hazards, and required large amounts of distilled water. Apart from 
improvements in materials used for virology work, many new instruments are available that 
simplify cell culture technology and at the same time improve precision between 
experiments. For example, various cell counters are now available that make cell counting 
easy and reproducible in a intra- and inter-laboratory manner. Moreover, various new or 
engineered cell lines and primary cells are available for the propagation of viruses once 
considered very difficult to study in vitro. Unfortunately, along with material improvements 
and technological progress, less emphasis is usually placed on teaching the art of cell culture 
compared to molecular technology relevant to virus detection. This is a recipe for disaster, 
as cell culture is neither simple nor a thoughtless process. To paraphrase recent statements 
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by a colleague, “All cells cultured in vitro are angry; they are outside of their normal 
environment and maintained under artificial conditions, surrounded by physiologically 
incorrect concentrations of all things important to their well-being. No wonder it is so 
difficult to have well-behaved cell cultures”! Without adequate training and preparation, 
cell culture as an art and science becomes sloppy, and data generated by such practices are 
questionable. We have often not been able to repeat the results of others, and they have not 
been able to repeat ours, due to a difference in the cells used in our experiments. In some 
cases, the cells are not what they should be, in other cases, the cells are contaminated with 
adventitious agents that confound the results, and sometimes, the cells have changed, either 
through differentiation or genetic instability.  
Due to the number of different disciplines now engaged in cell culture, the terminology 
used to describe the work varies substantially. This makes it difficult to communicate 
effectively using language salient to virology. For this review, eight key terms used for cell 
culture work and their definitions are presented in Table 1. The definitions given in Table 1 
are from the Society for In Vitro Biology (SIVB), as in reference [1]. We strongly recommend 
adaption of SIVB terminology for inter-laboratory communications of cell culture work. 
Their definitions are well-thought out, and intuitively understandable. 
In this chapter, we provide a review of some contemporary cell culture issues relevant to 
virus isolation. Some practical guidelines for virus isolation and the maintenance of cell lines 
are provided. The information we present should provide useful insights for virologists, and 
may be a useful review of some forgotten principles of virus isolation. This review is not 
meant to be comprehensive, as each topic would require substantial and detailed treatment, 
historic and contemporary. It should be noted that the terms “cell strain” and “cell line” 
(Table 1) are sometimes used interchangeably by other authors. Others also define “cell 
strain” as a culture of a single type of cell, and “cell line” as an immortalized culture of a 
single type of cell.  
2. Basic validation of animal cells used for the isolation of viruses 
Cell lines or primary cell cultures derived from vertebrates and invertebrates are used for the 
isolation of animal viruses. Animal cell lines can be purchased from well-known suppliers, 
including those listed in Table 2, and primary cells from suppliers such as those listed in Table 
3. Alternatively, primary cell cultures can be established de novo from live animal cells, tissues 
or organs. Cells for virology work can also be obtained from university collections or from 
individual laboratories. In general, the best practice is to obtain cells at the lowest possible 
population doubling level (Table 1) from reputable suppliers that can provide documentation 
relevant to traceability. A problem we encounter repeatedly is that a majority of academic 
research laboratories totally lack or do not have an adequate “Quality System” or “Quality 
Practices” process, and traceability is problematic. For example, it has been nearly impossible 
to estimate the population doubling level (“true age of the culture”) of cells obtained from 
most research laboratories due to inconsistencies not only in record keeping but also due to 
lack of standardization of practices. The major problem encountered with cells that have been 
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highly passaged is that their phenotype can be quite different from their progenitors. This 
often makes it difficult to reproduce experiments performed in past years using the cells. 
 
Terms Definitionsa
Adventitious Agents which contaminate cell cultures. 
Cell line A cell line arises from a primary culture at the time of the first 
successful subculture. The term cell line implies that cultures from it 
consist of lineages of cells originally present in the primary culture. The 
terms finite or continuous are used as prefixes if the status of the culture 
is known. The term "continuous line" replaces the term "established 
line". 
Cell strain A cell strain is derived either from a primary culture or a cell line by the 
selection or cloning of cells having specific properties or markers. In 
describing a cell strain, its specific features must be defined. The terms 
finite or continuous are to be used as prefixes if the status of the culture is 
known. If not, the term strain will suffice. 
Passage The transfer or transplantation of cells, with or without dilution,  
from one culture vessel to another. It is understood that any  
time cells are transferred from one vessel to another, a certain  
portion of the cells may be lost and, therefore, dilution of cells,  
whether deliberate or not, may occur. This term is synonymous  
with the term "subculture". 
Passage 
number 
The number of times the cells m the culture have been subcultured or 
passaged. In descriptions of this process, the ratio or dilution of the cells 




The total number of population doublings of a cell line or strain since its 
initiation in vitro. A formula to use for the calculation of "population 
doublings" in a single passage is: number of population doublings = Log 
(N/No ) X 3.33 where: N=number of cells in the growth vessel at the end 
of a period of growth. No=number of cells plated in the growth vessel. It 
is best to use the number of viable cells or number of attached cells for 
this determination. Population doubling level is synonymous with 
"cumulative population doublings". 
Population 
doubling time 
The interval, calculated during the logarithmic phase of growth in 
which, for example, 1.0 X 106 cells increase to 2.0 X 106 cells. This term is 
not synonymous with "cell generation time". 
Primary cell 
culture 
A culture started from cells, tissues or organs taken directly from 
organisms. A primary culture may be regarded as such until it is 
successfully subcultured for the first time. It then becomes a "cell line". 
A primary culture may contain multiple types of cells such as 
fibroblasts, epithelial, and endothelial cells. 
aPublished in reference [1] and also available though: http://www.sivb.org/edu_terminology.asp.  
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4 Cell Applications, Inc. 
5 Invitrogen 
6 Lifeline Cell Technology 
7 Lonza 
8 QBM Cell Science 
9 ReachBio 
10 Science Biosystems 
11 ScienCell Research Laboratories 
Table 3. Partial list of suppliers of primary cell cultures. 
Whereas the terminology differs between laboratories and in different countries, many 
virologists use terminology coined by the ATCC and refer to continuous (previously termed 
“established”) cells as either: CCL (Certified Cell Lines), CRL (Certified Repository Lines), 
HB (Hybridomas), TIB (Cell Lines in Tumor Immunology Banks), and HTB (Cell Lines in 
Tumor Cell Banks). In general, cells designated as CCL by the ATCC are the most 
thoroughly characterized and have been certified by the National Institutes of Health 
American Cell Culture Collection Committee [2].  
Prior to use for virus isolation or detection, cells should be “validated” for their intended 
purpose. A valid batch of cells implies they have been tested and confirmed suitable for the 
isolation or detection of the target virus. Three general questions must be asked and 
answered during the validation process: 
a. Has authenticity been confirmed (are the cells what they should be)? 
b. Do the cells behave as expected before we use them? 
c. When the task is virus isolation (or propagation): Will a wild-type virus similar to the 
target virus effectively infect the cells, replicate in them, and form progeny virions? If 
the task is virus detection: Will a wild-type virus similar to the target virus effectively 
infect the cells and form a virus-encoded product that can be detected by 
immunochemistry, PCR, or other relevant methods? 
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Ideally, each laboratory would have the capability of fully “characterizing” each cell line 
prior to its use for virus isolation. Nominally, this would include some sort of authentication 
of host cell species, verification that the cells are free of microbial contaminants, 
confirmation of cell phenotype and growth kinetics, and importantly, the cells should be 
tested using a contemporary wild-type isolate of the virus that is targeted for detection or 
isolation. In practice, in-house cell authentication is usually neither cost-effective nor 
practical for small diagnostic laboratories. For routine/general virology work, we have 
found that the following practices to be useful for the validation of cells for virus isolation:  
a. Obtain cells from a reputable source or laboratory – Resources such as the ATCC 
provide a certificate that details authenticity, and that the cells are not contaminated 
with mycoplasma, bacteria, or fungi. Furthermore, cell lines obtained from the ATCC 
are currently confirmed for species identity using a Cytochrome C subunit I (COI) PCR 
assay, and Short Tandem Repeat profiling (STR) [3], a PCR-based DNA profiling 
method for intraspecies identification. Particular attention should be focused on cells 
obtained through inter-laboratory transfer, as many are cross-contaminated with 
different cells or have been misidentified altogether [4]. Our experience is they are also 
often contaminated with adventitious agents. 
b. Use a pay-for-service provider to verify cell identity. Whereas we do not necessarily 
endorse any, examples of commercial service providers that authenticate animal cells 
are given in Table 4. Many universities also have excellent cell-authentication services. 
 
1 ATCC 
2 Bio-Synthesis, Inc. 
3 CellBank Australia 
4 DNA Diagnostics Center 
5 ECACC 
6 Genetica DNA Laboratories, Inc. 
7 IDEXX RADIL 
8 i Life Discoveries 
9 Johns Hopkins Genetic Resources Core Facility 
10 LGC Standards 
11 MicroSynth 
12 Orchid Cellmark 
13 SeqWright 
Table 4. Partial list of cell-identification service providers. 
c. Observe the cell morphology at low and high cell densities, and verify they conform to 
expectations. Aberrant cell shapes may be an indication that the wrong cells were 
obtained, or that the cells are contaminated with mycoplasma or other infectious agents. 
d. Verify the cells are mycoplasma-free. We have obtained mycoplasma contaminated 
cells from even the most prestigious laboratories; in one instance, 15/20 cancer cell lines 
were contaminated, and upon genetic analysis, five different mycoplasma species were 
uncovered in the cells. Each laboratory should have a mycoplasma test, suitable for the 
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detection of a wide variety of mycoplasma, of which there are over 100 species. Many 
PCR tests for mycoplasma have been described, and various kits are available 
commercially. We have found through experience that PCR tests should be carefully 
evaluated, as many of the older tests do not detect some of the more recently discovered 
mycoplasma species. In concert with PCR, mycoplasma isolation is recommended as a 
second test, especially if the PCR tests have not been updated. We specifically 
recommend culturing cells for a minimum of two weeks in the absence of antibiotics 
prior to performing mycoplasma tests, as some mycoplasma species are inhibited but 
not killed by antibiotics added to cell growth media. It is a good practice, however, to 
isolate any incoming cell lines and automatically treat as if they contain mycoplasma 
through the incorporation of plasmocin in the growth medium. Some of the other non-
PCR based tests for mycoplasma include detection of live organisms using the Barile 
culture method [5], staining of cell cultures with fluorescent dye Hoeschst 33258 [6], 
and use of PlasmoTest (InvivoGen), which is a cell-based assay. PlasmoTest is 
performed using HEK-Blue™ -2 cells, which are HEK293 cells that are engineered with 
multiple genes from the toll-like receptor 2 (TLR2) pathway. In the presence of 
mycoplasma, HEK-Blue-2 cells secrete embryonic alkaline phosphatase, which then 
reacts with a specific substrate in the cell media to produce a blue color.    
Apart from university testing facilities, service providers can also perform mycoplasma 
tests. Whereas we do not necessarily endorse any, examples of service providers that 
perform mycoplasma tests are listed in Table 5: 
 
 ATCC 
1 Bionique Testing Laboratories, Inc. 
2 BioOutsource 
3 Bioreliance 
4 Charles River Laboratories 
5 Clongen Laboratories, LLC 
6 Invivogen 
7 Lonza 
8 Microtest Laboratories, Inc. 
9 Minerva Biolabs 
10 Mycosafe 
11 Nucro Technics 
12 Paragon Bioservices 
13 Q Laboratories, Inc. 
14 Quadscience 
15 Wuxiapptech 
Table 5. Partial list of mycoplasma testing services 
e. Evaluate the cells for contamination with agents other than mycoplasma [7]. Often 
times, laboratories assume that bacterial contaminants are easy to detect through the 
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color of the pH indicator dye in the growth medium. In particular, many growth media 
formulations incorporate phenol red, and a rapid conversion from red to yellow is used 
as evidence for the presence of bacterial contamination. Whereas the former is often 
true for bacteria that are fermenters or facultative anaerobes, it should be noted that 
obligate aerobes tend to make the media more basic. Moreover, some bacterial 
contaminants are missed during cursory inspection by microscopy because they are 
non-motile, replicate slowly, and are often present attached to the surfaces of the 
cultured cells. We have found Propionibacterium acnes (which is an aerotolerant 
anaerobe), various actinomycete species, and both gram positive and negative 
anaerobes in contaminated cell cultures. Often, the bacteria are resistant to antibiotics 
commonly used for cell culture, and worse, some are multiple-drug resistant and nearly 
impossible to eradicate. 
f. As a final validation step, verify the cells are suitable for the target virus. This is 
especially true for cancer cell lines, which are karyotypically abnormal or genetically 
unstable. Where possible, we examine the susceptibility of the cells to a contemporary, 
wild-type version of the target virus, as well as to a known laboratory strain of the same 
virus that serves as a reference standard. This comparison is made because viruses tend 
to mutate, and in the process, the affinity for the particular cellular receptor may 
change. Moreover, the quantity of cellular receptors on the cell may change, and this 
can affect the avidity of the virus for its receptor.  
3. Complications arising from the use of primary cells for virus isolation 
Primary cells (Table 1), which are non-immortalized cells taken directly from a living 
organism, are often used in clinical laboratories for the isolation of various viruses. For 
example, primary monkey kidney cells, which in the USA are obtained from rhesus or other 
macaques or from various African “green” monkey species, are used for the isolation of 
echo and other picorna viruses, and human parainfluenza and other paramyxoviruses. 
Primary cells are especially useful for diagnostic virology because some viruses are easier to 
isolate (or can only be isolated) in them. However, primary cells often harbor latent viruses 
that become reactivated once the cells are separated from kidneys and propagated in vitro, 
or, contain viruses that produce a persistent but subclinical infection of the host. The latter 
viruses may not cause significant (if any) pathology in vivo, where the cells exist in an 
environment with a functional immune system. But outside of the host and away from the 
immune system, the cells may be fully permissive and the same virus cause highly 
cytopathic effects (CPE). Unfortunately, some primary cells may also harbor viruses that can 
replicate in the host cells without causing easily recognized CPE, and also in the indicator 
cells used for their isolation (or detection) in vitro. Unwanted viruses in primary cells cause 
various complications relevant to the isolation of a target virus, including: 
a. They might quickly overtake a cell culture, reducing the chances of isolating the target 
virus. 
b. They may cause CPE identical to those of the target virus, thus causing a false positive 
preliminary assessment. 
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c. They are obvious sources of contamination that complicate the isolation of the target 
virus in “pure” form. 
d. They may pose a biosafety risk to laboratory workers. 
Noteworthy, primary cells can harbor contaminating agents other than viruses. For 
example, mycoplasma species are present in most animals, and are prevalent on the surfaces 
of the respiratory tract. Moreover, mycoplasma species exist as intracellular and 
extracellular varieties. For reasons not yet entirely clear, kidneys are “sanctuaries” for 
viruses. For this reason, we often hunt for new viruses in kidney cells sourced from exotic 
species (J. Lednicky, unpublished).  
Some of the adventitious agents we have encountered in primary cells include: 
• Human cytomegalovirus in human kidney cells 
• Lymphocytic choriomeningitis virus in mouse kidney cells 
• Murine polyomavirus in the kidneys of mice from a university rodent colony 
• Parainfluenza virus 5 (formerly Simian virus 5) in rhesus monkey kidney cells 
• Simian cytomegalovirus in simian (various species) kidney cells  
• Simian foamy retrovirus in rhesus and green monkey kidney cells 
Primary cells also have a finite lifespan, and should be used with minimal passages in vitro. 
Otherwise, senescence of the cells can be mistaken for CPE caused by viruses. Various 
commercial suppliers currently provide primary cells from various tissues and species. 
These cells should be used judiciously for virus propagation or isolation. A common 
mistake is to assume that primary cells obtained from the suppliers are certified to be virus 
free. In reality, this is not the case. For example, the donors of primary human cells sold in 
the USA are examined (by serology) for antibodies to Hepatitis B and C viruses, and to HIV, 
following United States Food and Drug Administration (USFDA) guidelines, and if that 
information is not available, the cells are checked by PCR or other methods for the same 
viruses. [The USFDA is an agency of the United States Department of Health and Human 
Services responsible for protecting and promoting public health through the regulation and 
supervision of biopharmaceuticals, blood transfusions, cosmetics, dietary supplements, 
electromagnetic radiation emitting devices (ERED), food safety, medical devices, over-the-
counter pharmaceutical drugs (medications), tobacco products, prescription, vaccines and 
veterinary products]. However, additional tests for other adventitious agents have not been 
mandated by the USFDA, and it may be impractical to check for the presence of many other 
agents with regard to cost and representative sampling reasons. Thus, commercially 
supplied human primary cells are sold with an advisory statement indicating the cells 
should be considered as potentially infected, and that biosafety practices be used when 
working with the cells. 
Cell deterioration in primary cells due to improper cell growth media formulation can also 
be confused for CPE caused by viruses. It is important to maintain non-infected controls 
along with cells used for virus isolation for comparison. We have noted cell deterioration 
due to L-glutamine deficiency, and to improper dosage of antifungal agents in the growth 
media, among a few batches of commercially bought primary cells. Similarly, commercial 
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media formulations for primary human cells often include additives such as epinephrine, 
human recombinant epidermal growth factor, hydrocortisone, insulin, transferrin, and 
others; a mistake in the amount of some of these biomolecules added to the cell growth 
media can adversely affect cell viability.  
Thus, primary cells are useful for the isolation of some viruses, but should be used with 
caution because: (a) they can contain adventitious agents, and (b) cell deterioration due to 
one of many different reasons can be mistaken for virus-induced CPE.  
4. Serum vs. serum-free cell culture media 
Serum has been a mandatory additive in cell growth media for much of the history of tissue 
culture, and is essential for cell growth, metabolism, and to stimulate proliferation 
(“mitogenic effect”). This is because serum in a complex mixture that provides (a) hormonal 
factors for stimulating cell growth and proliferation and promoting differentiated functions, 
(b) transport proteins carrying hormones (e.g. transcortin), minerals and trace elements and 
lipids, (c) attachment and spreading factors, and (d) stabilizing and detoxifying factors 
needed to maintain pH or to inhibit proteases either directly (e.g., α-antitrypsin inhibitor in 
serum is an important inhibitor of the protease trypsin), or indirectly, by acting as an 
unspecific sink for proteases and other (toxic) molecules [8]. 
Previously, human and horse serum, collected aseptically through venipuncture, was the 
source of serum for tissue culture. This was later supplanted by less expensive bovine serum 
sourced from blood taken from slaughterhouse bovines. The bovine blood is collected using 
somewhat crude methodology, the blood clotted, serum separated, then usually filtered 
using 0.1 µm filters. Both calf and fetal bovine serum (FBS) are used for cell culture media. 
However, primarily because of its rich content of growth factors and its low γ-globulin 
(antibody) content, FBS has been adopted as the standard supplement of cell culture media 
[8]. Unfortunately, filtration using smaller pore filters is technically difficult due to the 
complex composition of serum. Moreover, mycoplasma and viruses are not always retained 
by the filters; mycoplasma presumably due to small size and their inherent flexibility, and 
viruses due to their small dimensions and often pleomorphic nature. Thus, serum itself has 
often been the source of mycoplasma and virus contamination [9-14]. Viruses that may be 
common contaminants of bovine calf or FBS include: bovine viral diarrhea virus (BVDV) 
[15-19], bovine polyomavirus [20, 21], bovine parvovirus [22-24] (J. Lednicky, unpublished), 
and bovine herpes viruses [25-28]. Inadvertent contamination of cultured cells by these 
serum-derived viruses has obvious repercussions not only with regard to data generation, 
but also because it exerts a toll on time wasted in the performance of laboratory work, and 
the costs thereof. And it is usually the case that problems are noted many months 
afterwards (in common language, the problems occur “downstream”). 
Whenever economically feasible, we suggest using gamma-irradiated low antibody FBS or 
calf serum for tissue culture media. Low antibody sera are desirable to reduce the chances of 
antibody neutralization of the target virus, thus improving chances of virus isolation.  
 
The Art of Animal Cell Culture for Virus Isolation 
 
161 
Gamma-irradiation is generally performed after filtration, and acts as a secondary safeguard 
[29-31]. The irradiation process purportedly inactivates viruses and live microorganisms 
with minimal damage to product integrity [32, 33]. Gamma-irradiation should be performed 
using a validated process; we have occasionally encountered batches of gamma-irradiated 
sera replete with filamentous carbonaceous material that to the untrained eye may be 
mistaken for fungal mycelia. The presence of filamentous material is due to protein 
degradation resulting from improper handling during the gamma-irradiation process. A 
word of caution: We have noted that small DNA viruses such as parvo- and polyomaviruses 
in sera are not effectively inactivated by gamma-irradiation (Lednicky and Wyatt, 
unpublished observations). Similar observations were recently published by others [34, 35]. 
Knowledge over the susceptibility of cell lines to bovine parvoviruses and polyomaviruses 
is relatively scant.  
Another important consideration when purchasing calf serum or FBS is the level of 
endotoxin [36]. Failure of some cell culture attempts can sometimes be traced to the level of 
endotoxin in the sera. When presented with the choice, it is always best to purchase sera 
with the lowest possible endotoxin levels. Industry standards for serum sold at present 
specify < 10.0 EU/ml, where 1 EU/ml ~ 0.1 ng/ml (EU = endotoxin unit). Endotoxin is 
detected by the limulus amebocyte lysate assay, which can detect down to 0.01 EU/ml. 
Risks associated with the use of animal-sourced components in the culture milieu have led 
to the quest for protein-free, animal-free cell growth media. To-date, various cell lines have 
been adapted to grow in serum-free media. And numerous defined serum-free media 
formulations are available for some of the cell lines commonly used for virus isolation, such 
as for the African green monkey kidney cell line termed Vero, and for Madin Darby Canine 
Kidney (MDCK) cells. The use of serum-free cell growth media has been validated for the 
isolation or propagation of many viruses [37], including those used for vaccines. As an 
example, a chimeric parainfluenza virus type 3 - respiratory syncytial virus was propagated 
to 100-fold higher titers in Vero cells grown in serum free cell growth media than could be 
attained with a serum-containing media formulation [38]. Vero cells grown in serum-free 
media has been used for the production of reovirus [39]. MDCK cells grown in serum-free 
media was used for the production of Influenza H5N1 virus used as a vaccine [40]. Rabies 
virus used for vaccine production was grown to higher titers in Vero cells in serum free than 
in serum-containing cell growth media [41]. 
Thus, serum free media should be considered for virology applications that entail routine 
virus propagation or vaccine virus production. Less explored is the use of serum free media 
for the isolation of viruses from clinical specimens. To-date, many laboratories have not 
experimented with this option, probably because many serum-free media formulations are 
used without the addition of antibiotics and antifungals, or with their use at 1/5 to 1/10 the 
concentrations that would normally be used in serum-containing media. At lower 
concentrations, the antibiotics and antifungals might not effectively suppress contaminating 
microorganisms that are often present in clinical specimens. However, we have found most 
cells that have been adapted to growth in serum-free media do tolerate antibiotics. For 
 
Biomedical Tissue Culture 
 
160 
media formulations for primary human cells often include additives such as epinephrine, 
human recombinant epidermal growth factor, hydrocortisone, insulin, transferrin, and 
others; a mistake in the amount of some of these biomolecules added to the cell growth 
media can adversely affect cell viability.  
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one of many different reasons can be mistaken for virus-induced CPE.  
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culture, and is essential for cell growth, metabolism, and to stimulate proliferation 
(“mitogenic effect”). This is because serum in a complex mixture that provides (a) hormonal 
factors for stimulating cell growth and proliferation and promoting differentiated functions, 
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by the filters; mycoplasma presumably due to small size and their inherent flexibility, and 
viruses due to their small dimensions and often pleomorphic nature. Thus, serum itself has 
often been the source of mycoplasma and virus contamination [9-14]. Viruses that may be 
common contaminants of bovine calf or FBS include: bovine viral diarrhea virus (BVDV) 
[15-19], bovine polyomavirus [20, 21], bovine parvovirus [22-24] (J. Lednicky, unpublished), 
and bovine herpes viruses [25-28]. Inadvertent contamination of cultured cells by these 
serum-derived viruses has obvious repercussions not only with regard to data generation, 
but also because it exerts a toll on time wasted in the performance of laboratory work, and 
the costs thereof. And it is usually the case that problems are noted many months 
afterwards (in common language, the problems occur “downstream”). 
Whenever economically feasible, we suggest using gamma-irradiated low antibody FBS or 
calf serum for tissue culture media. Low antibody sera are desirable to reduce the chances of 
antibody neutralization of the target virus, thus improving chances of virus isolation.  
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media was used for the production of Influenza H5N1 virus used as a vaccine [40]. Rabies 
virus used for vaccine production was grown to higher titers in Vero cells in serum free than 
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Thus, serum free media should be considered for virology applications that entail routine 
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for the isolation of viruses from clinical specimens. To-date, many laboratories have not 
experimented with this option, probably because many serum-free media formulations are 
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microorganisms that are often present in clinical specimens. However, we have found most 
cells that have been adapted to growth in serum-free media do tolerate antibiotics. For 
 
Biomedical Tissue Culture 
 
162 
example, we have used MDCK cells in serum-free media with antibiotics for the isolation of 
influenza viruses. As there are now many different serum-free cell media formulations, it is 
likely that successful methodologies using these for diagnostic virology will be developed. 
A particularly important aspect of such work would be the reduction of costs for diagnostic 
virology laboratories in less privileged nations, since serum is expensive. 
As pointed out above, serum is a complex mixture and lot to lot variation and inconsistency 
is common. This is because the source animals themselves differ, and their nutrition status, 
hydration, over-all wellbeing, etc. have direct effects on the quality of the serum. Hormone 
and vitamins levels in the sera can vary, and all things taken together, can have a significant 
impact on cell culture. Thus, another argument for using serum-free cell growth media, 
where possible, is there is potentially better process control. Prior to the development of 
serum-free cell growth media, many researchers would test multiple serum lots for a 
particular application, then purchase a large lot of the best performing batch of serum. This 
is still an advisable practice when serum must be used for long-term projects, and for high-
throughput work, but imposes large cost and storage burdens.   
5. Remediation of mycoplasma contamination 
Mycoplasma are bacteria (class Mollicutes) that are among the most common and serious 
contaminants of cell cultures. There are two genera of mycoplasma that are relevant to cell 
culture, Acholeplasma and Mycoplasma, and they have several unique properties that 
distinguish them from other prokaryotes. In particular, they lack a cell wall, instead using 
sterols to maintain their plasma membrane. Mycoplasma require cholesterol or similar sterols 
derived from vertebrate hosts, which they incorporate into their cell membranes, whereas 
Acholeplasma grows in the absence of sterols (but incorporates them if present). Since they 
lack cell walls, mycoplasma are unaffected by antibiotics that interfere with murein 
(peptidoglycan) formation of cell walls, such as penicillin and other beta-lactam antibiotics. 
They are also resistant to streptomycin. In the early 1990’s, it was estimated that about 15% 
of cell cultures in the USA were contaminated with mycoplasma [42]. The most likely 
sources of mycoplasma for laboratories engaged in cell culture are: (a) previously 
contaminated cell cultures (which can include new cultures from unknown sources or some 
obtained from cell banks), (b) laboratory equipment, media, reagents that came into contact 
with contaminated cultures, and sera used for cell cultivation [43], and (c) personnel 
involved in cell maintenance [44].  
Because they are relatively small (0.15–0.3 µm), it is difficult to filter them out of suspension. 
Both intracellular and extracellular types of mycoplasma exist. Mycoplasma replicate 
relatively slowly as they spread through a cell culture. A few mycoplasma species comprise 
95% of cell culture isolates: Acholeplasma laidlawii, Mycoplasma arginini, M. fermentans, M. 
hominis, M. hyorhinis, M. orale, M. pirum, and M. salivarium [42, 44-46]. It should be noted that 
by definition, members of the genus Mycoplasma are restricted to vertebrate hosts. For this 
reason, many researchers assume plant-based materials are free of mycoplasma that infect 
cells derived from vertebrates. However, we suggest caution against such notions; as 
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contamination of plant-based media components by A.laidlawii has recently been reported 
[47]. The consequences of mycoplasma contamination of cultured cells may vary from subtle 
to severe. The overall effects of mycoplasma on a cell culture vary according to the 
mycoplasma species infecting the cells, the mycoplasma burden (titer), the type of cells 
infected, and the duration of the infection [48]. Mycoplasma attach to cell membranes in 
order to obtain nutrients, and in the process can damage the host cell’s membranes, DNA 
and RNA, and intracellular organelles. Their presence can exert profound effects ranging 
from unexpected alterations of growth patterns and host gene expression to modulation of 
host metabolism (e.g., produce pH-altering metabolites), induction of chromosomal 
aberrations, depletion of media, alteration of product yields (such as virus titer), and 
alteration of cytokine production and other functions of cells of the immune system [44, 48-
50]. It goes without saying that efforts must be exerted at preventing mycoplasma 
contamination of cell cultures, following good cell culture practices [44]. 
If a cell culture is contaminated with mycoplasma, there are two remediation solutions: (a) 
Destroy (autoclave) the culture and dispose of it, and start with a new culture, or (b) Treat 
the culture with specific antibiotics or other biochemicals that are toxic to mycoplasma but 
safe for cells. Most commonly used cell culture antibiotics are not effective against 
mycoplasma contamination but other antibiotics have shown success in eliminating 
mycoplasma from cell cultures. In the near past, the following treatments were used to clear 
mycoplasma-contaminated cell cultures: (a) one to two week treatment with the 
fluoroquinolone Mycoplasma Removal Agent (MRA, from ICN Biochemicals [now MP 
Biochemicals]), (b) two week treatment with the fluoroquinolone ciprofloxacin (which is 
better known by many as Ciprobay), and (c) three rounds of sequential one-week treatment 
with BMCyclin (Roche), which contains a pleuromutilin and a tetracycline derivative [51, 
52]. Prior to the use of the aforementioned mycoplasma eradication products, long-term 
treatments with tetracyclines were common. We and others have found such mycoplasma 
eradication treatments to be of limited efficacy. Instead, when necessary, we favor the use of 
plasmocin (InvivoGen) treatment (for a minimum of two weeks). Plasmocin is an antbiotic 
mixture that consists of a combination of a macrolide and a quinolone, and it is active 
against both intra- and extracellular mycoplasma. No permanent alterations were detected 
in eukaryotic cells treated with plasmocin [53], suggesting the product may be generally safe 
for most cell lines. This has been our experience so far with the many cell lines we have 
treated upon receipt as a prophylactic measure (J. Lednicky and D. Wyatt, unpublished). 
Plasmocure, a newer antibiotic mixture for the eradication of mycoplasma from cell cultures, 
is now also available from Invivogen; however we have not tested this product, and cannot 
comment on its efficacy. 
One last important consideration is some cultures may be infected by more than one 
mycoplasma species [54; J. Lednicky and D. Wyatt, unpublished data]. Failure to rid a 
culture of mycoplasma may arise if one (or more) of the species in a contaminated culture is 
resistant to the antibiotics being used to eradicate the mycoplasma. Because mycoplasma 
biology varies among the species, it is not correct to generalize the effect of a certain 
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example, we have used MDCK cells in serum-free media with antibiotics for the isolation of 
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antibiotic or mixture of antibiotics for all (i.e., an antibiotic or antibiotic mix that works for 
the eradication of one may not work for a different mycoplasma species) [55]. 
In the last few years, we have not detected mycoplasma in cell lines that we have validated 
in our respective laboratories. And we have noted a decrease in the percentage of 
mycoplasma-contaminated cells obtained from reputable laboratories. However, we still 
frequently detect mycoplasma in virus preparations obtained from commercial suppliers, 
clinical laboratories, and other sources. Thus, it is advisable to assess virus stocks for 
mycoplasma contamination. This is particularly important for cell culture-produced virus 
stocks that are intended for animal studies. Especially so if the virus must be injected into 
the animals through intracerebral, subcutaneous, or intraperitoneal routes. In animal 
studies, it is rarely the case that researchers examine whether inter-laboratory discrepancies 
might be due to the presence or absence of mycoplasma in the challenge virus. Related to 
this, it is also worthwhile to verify that hybridoma antibodies used for animal studies are 
mycoplasma free. 
6. Microscopy for cell culture 
We have noted that many laboratories engaged in cell culture, including virology 
laboratories, are up to now only equipped with microscopes that use transmitted brightfield 
illumination. And many of these laboratories use microscope objectives that in combination 
with the eyepiece lenses produce a magnified image of only 200X or so. A big problem is 
that cells in culture appear virtually transparent when observed with an optical microscope 
under brightfield illumination. To improve visibility and contrast, analysts must then 
reduce the opening size of the substage condenser iris diaphragm, but this usually results in 
a serious loss of resolution and the introduction of diffraction artifacts. Moreover, subtle 
morphological changes are impossible to observe when cells are viewed using low-
magnification using transmitted brightfield illumination. Thus, it is easy to miss telltale 
signs of cell deterioration or “stress”, and also of CPE, when cultured cells are viewed using 
transmitted brightfield illumination at relatively low magnification. The images of cells 
photographed using transmitted brightfield illumination under low magnification tend to 
lack adequate resolution for teaching purposes and are less desirable for data capture. 
Indeed, laboratories that utilize transmitted brightfield illumination often resort to the use of 
various cell-staining procedures so that features of virus-infected cells can be more readily 
visualized. This adds costs and often presents biosafety hazards, and also kills the cells 
being studied. When cell staining must be used as an adjunct for microscopy, the following 
are useful: 
1. May-Grüenwald-Giemsa stain, used to visualize cytopathology. Stained infected cell 
monolayers are compared to those of non-infected controls. The May-Grüenwald-
Giemsa stain will differentially stain DNA nucleoproteins (red/purple) and RNA 
nucleoproteins (blue). The stained cells are also examined for the presence of syncytia 
or giant cells, inclusion bodies, and other viral CPE.  
 
The Art of Animal Cell Culture for Virus Isolation 
 
165 
2. Modified Wright-Giemsa stain for white blood cells, suspension cells, or cells grown as 
monolayers on coverslips. Available commercially as Diff-Quick test, we have found 
this staining process useful for the detection of coxiella- or chlamydia-infected cells, 
viral inclusion bodies, and similar applications. Chromatin margination, cytoplasmic 
stranding, vacuoles, and the shape of viral inclusion bodies are easily visualized, giving 
clues on which virus may be in a cell.  
3. Gimenez stain. This stain is useful for intracellular bacteria that stain poorly using a 
Gram stain. We have used this stain to detect bacteria growing attached to the outside 
of cells grown as monolayers in cell culture. 
A better way to visualize cultured cells is to use an inverted microscope that is set up for 
phase contrast microscopy. With phase contrast, relatively thin objects such as flat cells 
become visible under the light microscope. Differences in cell structure are amplified during 
phase contrast, resulting in an image that can be regarded as an optical density map. Fine 
structures in the cells not easily detected by brightfield microscopy are clearly visualized, 
facilitating assessment of cell “condition”, and CPE are easier to detect. Phase contrast 
microscopy is especially advantageous because living cells can be observed without being 
killed, “fixed” (preserved), and stained. We equip our phase contrast microscopes with 
objectives that provide a wide, flat view, and recommend magnification of up to at least 
400X. Economical, high-quality digital cameras are now widely available and highly 
recommended for image capture. There are various microscopes on the open market that are 
affordable, rugged, and suitable for most virology applications using cells grown as 
monolayers. The authors of this manuscript use microscopes made by Leitz, Nikon, and 
Olympus in their laboratories. For high containment laboratories wherein face shields must 
be used [e.g., face shield that is a component of a powered air purifying respirator (PAPR) 
assembly], a focusing screen in LCD format is convenient. Otherwise focusing is difficult, 
especially when the face-shield is scratched from everyday “wear and tear”, or has turned 
somewhat opaque from repeated decontamination with sodium hypochlorite or similar 
harsh decontaminating solutions). 
Within the last few years, the concept of using digital inverted microscopes has generated 
much interest among virologists. We have tested the EVOS-x1 brightfield and phase contrast 
microscope (AMG, Germany) and find it easy to use. These microscopes have a high 
resolution LCD viewing screen that is useful for instruction purposes, as it can be 
simultaneously be viewed by many people. These microscopes are portable and have a 
relatively compact overall dimension that makes them facile to install within biosafety 
cabinets or class III gloveboxes. Focusing on the image by viewing the LCD screen is 
convenient in high-containment biosafety laboratories wherein work is performed using 
protective face masks such as work with PAPR. 
7. Maintenance of virus-infected cell cultures over a few months 
The isolation of some viruses may take weeks to two months or more. There are many 
reasons for this. In many cases, the indicator cells are sub-optimal for high-titer replication 
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antibiotic or mixture of antibiotics for all (i.e., an antibiotic or antibiotic mix that works for 
the eradication of one may not work for a different mycoplasma species) [55]. 
In the last few years, we have not detected mycoplasma in cell lines that we have validated 
in our respective laboratories. And we have noted a decrease in the percentage of 
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frequently detect mycoplasma in virus preparations obtained from commercial suppliers, 
clinical laboratories, and other sources. Thus, it is advisable to assess virus stocks for 
mycoplasma contamination. This is particularly important for cell culture-produced virus 
stocks that are intended for animal studies. Especially so if the virus must be injected into 
the animals through intracerebral, subcutaneous, or intraperitoneal routes. In animal 
studies, it is rarely the case that researchers examine whether inter-laboratory discrepancies 
might be due to the presence or absence of mycoplasma in the challenge virus. Related to 
this, it is also worthwhile to verify that hybridoma antibodies used for animal studies are 
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We have noted that many laboratories engaged in cell culture, including virology 
laboratories, are up to now only equipped with microscopes that use transmitted brightfield 
illumination. And many of these laboratories use microscope objectives that in combination 
with the eyepiece lenses produce a magnified image of only 200X or so. A big problem is 
that cells in culture appear virtually transparent when observed with an optical microscope 
under brightfield illumination. To improve visibility and contrast, analysts must then 
reduce the opening size of the substage condenser iris diaphragm, but this usually results in 
a serious loss of resolution and the introduction of diffraction artifacts. Moreover, subtle 
morphological changes are impossible to observe when cells are viewed using low-
magnification using transmitted brightfield illumination. Thus, it is easy to miss telltale 
signs of cell deterioration or “stress”, and also of CPE, when cultured cells are viewed using 
transmitted brightfield illumination at relatively low magnification. The images of cells 
photographed using transmitted brightfield illumination under low magnification tend to 
lack adequate resolution for teaching purposes and are less desirable for data capture. 
Indeed, laboratories that utilize transmitted brightfield illumination often resort to the use of 
various cell-staining procedures so that features of virus-infected cells can be more readily 
visualized. This adds costs and often presents biosafety hazards, and also kills the cells 
being studied. When cell staining must be used as an adjunct for microscopy, the following 
are useful: 
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2. Modified Wright-Giemsa stain for white blood cells, suspension cells, or cells grown as 
monolayers on coverslips. Available commercially as Diff-Quick test, we have found 
this staining process useful for the detection of coxiella- or chlamydia-infected cells, 
viral inclusion bodies, and similar applications. Chromatin margination, cytoplasmic 
stranding, vacuoles, and the shape of viral inclusion bodies are easily visualized, giving 
clues on which virus may be in a cell.  
3. Gimenez stain. This stain is useful for intracellular bacteria that stain poorly using a 
Gram stain. We have used this stain to detect bacteria growing attached to the outside 
of cells grown as monolayers in cell culture. 
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phase contrast microscopy. With phase contrast, relatively thin objects such as flat cells 
become visible under the light microscope. Differences in cell structure are amplified during 
phase contrast, resulting in an image that can be regarded as an optical density map. Fine 
structures in the cells not easily detected by brightfield microscopy are clearly visualized, 
facilitating assessment of cell “condition”, and CPE are easier to detect. Phase contrast 
microscopy is especially advantageous because living cells can be observed without being 
killed, “fixed” (preserved), and stained. We equip our phase contrast microscopes with 
objectives that provide a wide, flat view, and recommend magnification of up to at least 
400X. Economical, high-quality digital cameras are now widely available and highly 
recommended for image capture. There are various microscopes on the open market that are 
affordable, rugged, and suitable for most virology applications using cells grown as 
monolayers. The authors of this manuscript use microscopes made by Leitz, Nikon, and 
Olympus in their laboratories. For high containment laboratories wherein face shields must 
be used [e.g., face shield that is a component of a powered air purifying respirator (PAPR) 
assembly], a focusing screen in LCD format is convenient. Otherwise focusing is difficult, 
especially when the face-shield is scratched from everyday “wear and tear”, or has turned 
somewhat opaque from repeated decontamination with sodium hypochlorite or similar 
harsh decontaminating solutions). 
Within the last few years, the concept of using digital inverted microscopes has generated 
much interest among virologists. We have tested the EVOS-x1 brightfield and phase contrast 
microscope (AMG, Germany) and find it easy to use. These microscopes have a high 
resolution LCD viewing screen that is useful for instruction purposes, as it can be 
simultaneously be viewed by many people. These microscopes are portable and have a 
relatively compact overall dimension that makes them facile to install within biosafety 
cabinets or class III gloveboxes. Focusing on the image by viewing the LCD screen is 
convenient in high-containment biosafety laboratories wherein work is performed using 
protective face masks such as work with PAPR. 
7. Maintenance of virus-infected cell cultures over a few months 
The isolation of some viruses may take weeks to two months or more. There are many 
reasons for this. In many cases, the indicator cells are sub-optimal for high-titer replication 
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of the virus. Some viruses associated with lesions may be defective; for example, Measles 
virus (MeV) associated with subacute schlerosing panencephalitis may cause cytopathic 
effects without liberating virions [56 and references therein]. Other viruses cause persistent, 
sub-clinical infections in their natural hosts and may have evolved to replicate slowly. Thus, 
prolonged incubation, often up to two months, is required for the isolation of some 
polyomavirus JC virus variants that have an archetypal regulatory region [57; J. Lednicky, 
unpublished] . We have been able to isolate viruses considered “nearly impossible” to 
isolate in vitro by maintaining cell cultures for prolonged periods post-inoculation with 
clinical (or environmental) samples. A companion process to the long-term maintenance of 
cultures is the periodic performance of “blind passages” of the infected cell (discussed in 
more detail below). 
The key to maintaining cells over many months is to slow down their metabolism and/or 
their population doubling time. This is performed on a case-by-case basis, since not all cells 
will respond the same way to any given protocol, and there may be variability within a 
given cell line, depending on age, passage history, etc. An important goal is to maintain the 
cells in a state relevant for the target virus. For example, would the target virus normally 
infect (and replicate in) cells that are mitotically active/dividing, as for parvoviruses?  If so, 
the cells should not be allowed to become confluent. On the other hand, does the virus 
normally infect contact-inhibited “confluent” cells?  Should the cells be terminally 
differentiated? Must the cells be rotated to create air and liquid interfaces as performed for 
the isolation of rhinoviruses using cells in roller bottles?  
The three usual ways of maintaining cells for long-term observation are: 
a. Use growth medium with a reduced glucose concentration. For example, commercial 
Dulbecco’s Modified Eagle Medium (DMEM) is sold as “high” or “low” glucose 
formulations. Cells can be propagated in high glucose DMEM, then transitioned to low 
glucose DMEM after they are inoculated with virus. 
b. Switch from nutrient rich to traditional growth media formulations after the cells are 
inoculated with virus. For example, cells might be grown in DMEM, but once infected, 
maintained in Eagle's Minimum Essential Medium (EMEM). As a rough measure, 
DMEM has about 4x the concentration of amino acids found in EMEM. 
c. Reduce the amount of serum in the cell growth medium after the cells have been 
inoculated with virus. For example, instead of 10% FBS, in many cases cell growth 
media with 1 – 3% serum can be used to re-feed cells. Furthermore, instead of FBS, calf 
serum can sometimes be used for the maintenance/re-feed media. This helps to slow 
down cell replication and metabolism because overall, calf serum has a lower 
concentration of growth promoting factors than FBS. 
We have used the procedures above, solely or combinations thereof, for the isolation of 
various viruses. It is a good idea to validate growth media for each application; we have 
found that cell growth media are not necessarily equitable between manufacturers (i.e., 
all things kept equal, DMEM from supplier A may not work as well as DMEM from 
supplier B). 
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One technique that that has worked well for the isolation of viruses that infect and replicate 
slowly in cells derived from African green monkeys is this: substitute Vero E6 for other cell 
lines derived from African green monkey cells. Vero E6 cells are more contact-inhibited than 
similar closely related cell lines, and can be maintained for long periods of times with 
minimal to no media changes. For example, we have been able to isolate human 
metapneumoviruses (CPE detected in 10 – 14 days) and other paramyxoviruses such as 
parainfluenza 4A and 4B viruses in Vero E6 cells maintained in serum-free media, with 
changes of the growth media every two weeks. This concept was popularized by Akibo et al 
[58] for the isolation of metapneumoviruses, whereas Vero E6 cells were previously thought 
less useful than tertiary monkey kidney (tMK) and the cell line LLC-MK2 for the isolation of 
those viruses. 
8. Adventitious viruses in cell-lines 
It is not uncommon to receive virus-contaminated cell lines from suppliers, and this is 
especially true for cells obtained through inter-laboratory transfer. One problem is that 
the cells may have become infected with bovine viruses (from serum) that replicate 
relatively slowly (i.e., the time it takes for them to complete a replication cycle and form 
progeny virions is higher than that of the cell population doubling time). These 
contaminating viruses are referred to as “adventitious” viruses (i.e., they are viruses that 
should not be present). 
Many times, the adventitious viruses go unnoticed, and the deterioration of the cells is 
attributed to some type of “folklore” prevalent among cell culture practitioners. For 
example, we have encountered batches of cells that deteriorated when seeded at low 
densities, but not at high densities. Researchers who had been working with those 
particular cells did not question the cell propagation instructions provided with the cells. 
We discovered the reason the cells survived when seeded at high densities was because 
they were infected with parvovirus, and many parvoviruses require actively replicating 
cells to form progeny virions in vitro. Upon further investigation, we found that some cells 
lines that are available from commercial sources are packaged along with instructions that 
suggest that for propagation, no more than five cell passages (with seedings at high 
densities) should be attempted for “optimal” results. We surmise that a similar issue 
exists for those cells (that they are infected with parvo- or other viruses that require 
actively replicating cells)!  
Apart from sera, contaminating viruses can also be traced to laboratory workers, to animal-
sourced enzymes used for cell culture (such as porcine trypsin), and to other biological used 
for cell culture. A recent compilation of bovine and porcine viruses that may contaminate 
bovine serum and porcine trypsin is available in ref. 59. As new viruses are discovered, 
awareness of their possible presence in biologicals like sera and trypsin draws more interest 
and attention. For example, porcine trypsin has been traced as the source of Torque teno sus 
virus (TTSuV), a member of the family Anelloviridae that is a contaminant of many cell lines. 
Indeed, TTSuV was found in fifteen cell lineages, originating from thirteen different species, 
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infect (and replicate in) cells that are mitotically active/dividing, as for parvoviruses?  If so, 
the cells should not be allowed to become confluent. On the other hand, does the virus 
normally infect contact-inhibited “confluent” cells?  Should the cells be terminally 
differentiated? Must the cells be rotated to create air and liquid interfaces as performed for 
the isolation of rhinoviruses using cells in roller bottles?  
The three usual ways of maintaining cells for long-term observation are: 
a. Use growth medium with a reduced glucose concentration. For example, commercial 
Dulbecco’s Modified Eagle Medium (DMEM) is sold as “high” or “low” glucose 
formulations. Cells can be propagated in high glucose DMEM, then transitioned to low 
glucose DMEM after they are inoculated with virus. 
b. Switch from nutrient rich to traditional growth media formulations after the cells are 
inoculated with virus. For example, cells might be grown in DMEM, but once infected, 
maintained in Eagle's Minimum Essential Medium (EMEM). As a rough measure, 
DMEM has about 4x the concentration of amino acids found in EMEM. 
c. Reduce the amount of serum in the cell growth medium after the cells have been 
inoculated with virus. For example, instead of 10% FBS, in many cases cell growth 
media with 1 – 3% serum can be used to re-feed cells. Furthermore, instead of FBS, calf 
serum can sometimes be used for the maintenance/re-feed media. This helps to slow 
down cell replication and metabolism because overall, calf serum has a lower 
concentration of growth promoting factors than FBS. 
We have used the procedures above, solely or combinations thereof, for the isolation of 
various viruses. It is a good idea to validate growth media for each application; we have 
found that cell growth media are not necessarily equitable between manufacturers (i.e., 
all things kept equal, DMEM from supplier A may not work as well as DMEM from 
supplier B). 
 
The Art of Animal Cell Culture for Virus Isolation 
 
167 
One technique that that has worked well for the isolation of viruses that infect and replicate 
slowly in cells derived from African green monkeys is this: substitute Vero E6 for other cell 
lines derived from African green monkey cells. Vero E6 cells are more contact-inhibited than 
similar closely related cell lines, and can be maintained for long periods of times with 
minimal to no media changes. For example, we have been able to isolate human 
metapneumoviruses (CPE detected in 10 – 14 days) and other paramyxoviruses such as 
parainfluenza 4A and 4B viruses in Vero E6 cells maintained in serum-free media, with 
changes of the growth media every two weeks. This concept was popularized by Akibo et al 
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those viruses. 
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attributed to some type of “folklore” prevalent among cell culture practitioners. For 
example, we have encountered batches of cells that deteriorated when seeded at low 
densities, but not at high densities. Researchers who had been working with those 
particular cells did not question the cell propagation instructions provided with the cells. 
We discovered the reason the cells survived when seeded at high densities was because 
they were infected with parvovirus, and many parvoviruses require actively replicating 
cells to form progeny virions in vitro. Upon further investigation, we found that some cells 
lines that are available from commercial sources are packaged along with instructions that 
suggest that for propagation, no more than five cell passages (with seedings at high 
densities) should be attempted for “optimal” results. We surmise that a similar issue 
exists for those cells (that they are infected with parvo- or other viruses that require 
actively replicating cells)!  
Apart from sera, contaminating viruses can also be traced to laboratory workers, to animal-
sourced enzymes used for cell culture (such as porcine trypsin), and to other biological used 
for cell culture. A recent compilation of bovine and porcine viruses that may contaminate 
bovine serum and porcine trypsin is available in ref. 59. As new viruses are discovered, 
awareness of their possible presence in biologicals like sera and trypsin draws more interest 
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Indeed, TTSuV was found in fifteen cell lineages, originating from thirteen different species, 
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and its presence in the cell lines probably traced to the use of porcine trypsin during the 
propagation of those cells [60]. Anelloviruses are small DNA viruses that replicate within 
the nuclei of infected cells, and CPE due to their presence have not been well described at 
present. Porcine circoviruses 1 and 2 (PCV1 and PCV2) have also been detected in cell lines 
including those used for vaccines, and have been traced to the use of porcine trypsin [61-63].  
We recently traced a filtered amino acid supplement as the source of a contaminating 
reovirus, and learned from some industry colleagues they had made the same finding. 
However, as typical of these cases, the findings are not published and thus the information 
not widely disseminated. Reoviruses however can have wide host range and infect many 
different cell lines [60, 64].  
In some cases, unusual bacteria, and even some single-celled eukaryotic microorganisms 
cause cell contamination problems that are attributed to viruses. This is because many 
people engaged in cell culture have little experience with the detection and identification of 
these types of organisms. We were once tasked with identifying a “virus” affecting some 
important in-house developed cancer cell lines, which turned out to be infected with 
chlamydia.  
Adventitious viruses can confound research results in many unexpected ways. In one 
memorable event, cells were thought to have been transformed through a “hit and run” 
mechanism, as the transformed cells did not retain an oncogene that had been transfected 
into the precursor (non-transformed) cells. However, it was shown that the cells were 
infected with bovine polyomavirus, and were expressing its tumor protein genes (Lednicky, 
unpublished observations). This dashed the investigators’ hopes for a patent application. It 
is also distressing when one performs electron microscopy and discovers that more than one 
virus is present in the specimen being viewed (or worse, only the wrong virus is visualized). 
Contaminated cell lines are a main reason gene expression studies can vary significantly 
between laboratories. Biopharma and the vaccine industry are by now very cognizant of the 
dangers posed by using contaminated cell lines, due to historic and recent problems caused 
by adventitious viruses.  
In recent years, we have helped various researchers as well as biotechnology companies 
identify adventitious viruses affecting their work. Among the adventitious viruses we have 
recently found are: 
• Bovine herpesvirus 4 (BoHV-4) in human HeLa and Hek293, and in canine MDCK cells. 
BoHV-4 has been reported by others to be capable of infecting cells of various different 
species, including human cells [65]. In MDCK cells, cells infected with some strains of 
BoHV-4 produce vacuoles at the cell to cell junctions, and this is often mistaken for “cell 
stress” due to nutrient depletion.  
• BVDV in MDBK (Madin Darby Bovine Kidney) cells. This finding is consistent with the 
known biology of BVDV, and MDBK cells are often used for in vitro studies of BVDV. 
For example, see [66]. 
• Mouse minute virus (MMV) in Chinese hamster ovary (CHO) cells. MMV is a notorious 
contaminant of rodent cell lines important for the biopharmaceutical industry [67].  
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• Reovirus in various mammalian and insect cell lines. Electron microscopy was used to 
identify these viruses; follow-up tests were not performed to determine the viral 
species. Nevertheless, the presence of reoviruses in insect cell lines was a surprise to our 
industry clients, who experienced catastrophic losses of insect cell lines used for 
baculovirus-based technologies. 
• Vesivirus in Crandell–Rees Feline Kidney (CRFK) cells. We have detected one instance 
of vesivirus contamination of CRFK cells, using electron microscopy. 
NOTE: We have also experienced a few cases where researchers working with cells that 
were contaminated with adventitious viruses had attributed cell deterioration to poor 
technique (graduate students were often blamed).  
9. Engineered cell lines for virus isolation 
As elegantly pointed out by Dr. Paul Olivo [68], rapid diagnostic assays based on direct 
detection of viral antigen or nucleic acid are used with increased frequency in clinical 
virology laboratories. Regardless, virus culture remains the only way to detect infectious 
virus and to analyze clinically relevant viral phenotypes, such as drug resistance. Growth of 
viruses in cell culture is costly, labor intensive and time-consuming and requires the use of 
many different cell lines. Transgenic technology offers the possibility of using genetically 
modified (“engineered”) cell lines to improve virus growth in cell culture and to facilitate 
detection of virus-infected cells. Whereas various approaches are available, the two common 
applications of cell engineering for diagnostic virology are: (a) engineering of susceptible 
cell lines to over-express virus receptors, and (b) genetically modifying cells so that they 
express a reporter gene only after infection with a specific virus, allowing for the detection 
of infectious virus by rapid and simple enzyme assays such as β-galactosidase assays 
without the need for antibodies. 
Conceptually, just because a cell line is susceptible and permissive for a virus does not also 
mean that the optimal virus receptor is present on the cell surface. The number of viral 
receptors on the cell surface might also be suboptimal. If an authentic gene for the viral 
receptor is over-expressed (through genetic engineering), virus attachment and entrance 
into the cell should be improved. For that reason, we have engineered Vero E6 and other 
cells (such as Mv1 Lu, which are mink lung cells), that over-express canine signaling 
lymphocyte activation molecule (cSLAM), thought to be the major virus receptor of Canine 
distemper virus (CDV). Essentially the same rationale was used by others in their decisions to 
engineer cSLAM-over-expressing Vero-derived cell lines [69, 70]. Analogous to the 
experience of the other groups, we find that many CDV strains are detected within one day 
of infection of the SLAM-expressing cells vs. up to one month in conventional Vero cells. A 
photograph of Mv1-cSLAM cells showing syncytia within 16 hrs of infection by an 
American type 2 CDV strain is shown in the figure below. A related cell line that expresses 
human SLAM, Vero-hSLAM, is used for the isolation of MeV [71], a virus closely related to 
CDV and is also often difficult to isolate using conventional Vero cells. 
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• Reovirus in various mammalian and insect cell lines. Electron microscopy was used to 
identify these viruses; follow-up tests were not performed to determine the viral 
species. Nevertheless, the presence of reoviruses in insect cell lines was a surprise to our 
industry clients, who experienced catastrophic losses of insect cell lines used for 
baculovirus-based technologies. 
• Vesivirus in Crandell–Rees Feline Kidney (CRFK) cells. We have detected one instance 
of vesivirus contamination of CRFK cells, using electron microscopy. 
NOTE: We have also experienced a few cases where researchers working with cells that 
were contaminated with adventitious viruses had attributed cell deterioration to poor 
technique (graduate students were often blamed).  
9. Engineered cell lines for virus isolation 
As elegantly pointed out by Dr. Paul Olivo [68], rapid diagnostic assays based on direct 
detection of viral antigen or nucleic acid are used with increased frequency in clinical 
virology laboratories. Regardless, virus culture remains the only way to detect infectious 
virus and to analyze clinically relevant viral phenotypes, such as drug resistance. Growth of 
viruses in cell culture is costly, labor intensive and time-consuming and requires the use of 
many different cell lines. Transgenic technology offers the possibility of using genetically 
modified (“engineered”) cell lines to improve virus growth in cell culture and to facilitate 
detection of virus-infected cells. Whereas various approaches are available, the two common 
applications of cell engineering for diagnostic virology are: (a) engineering of susceptible 
cell lines to over-express virus receptors, and (b) genetically modifying cells so that they 
express a reporter gene only after infection with a specific virus, allowing for the detection 
of infectious virus by rapid and simple enzyme assays such as β-galactosidase assays 
without the need for antibodies. 
Conceptually, just because a cell line is susceptible and permissive for a virus does not also 
mean that the optimal virus receptor is present on the cell surface. The number of viral 
receptors on the cell surface might also be suboptimal. If an authentic gene for the viral 
receptor is over-expressed (through genetic engineering), virus attachment and entrance 
into the cell should be improved. For that reason, we have engineered Vero E6 and other 
cells (such as Mv1 Lu, which are mink lung cells), that over-express canine signaling 
lymphocyte activation molecule (cSLAM), thought to be the major virus receptor of Canine 
distemper virus (CDV). Essentially the same rationale was used by others in their decisions to 
engineer cSLAM-over-expressing Vero-derived cell lines [69, 70]. Analogous to the 
experience of the other groups, we find that many CDV strains are detected within one day 
of infection of the SLAM-expressing cells vs. up to one month in conventional Vero cells. A 
photograph of Mv1-cSLAM cells showing syncytia within 16 hrs of infection by an 
American type 2 CDV strain is shown in the figure below. A related cell line that expresses 
human SLAM, Vero-hSLAM, is used for the isolation of MeV [71], a virus closely related to 
CDV and is also often difficult to isolate using conventional Vero cells. 
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Similarly we and others have engineered MDCK cells that over-express a sialyl transferase 1 
(SIAT1) that catalyze the formation of α-2,6 - linked sialic acid receptors recognized by 
human influenza A viruses. In our hands, most contemporary human influenza H1N1 and 
H3N2 viruses are detected earlier, and form higher virus titers in the engineered MDCK 
cells, than occurs in conventional MDCK cells (J. Lednicky and D. Wyatt, data to be 
presented elsewhere), in agreement with a recent report [72]. Apart from standard MDCK 
cells, we have also engineered additional cell lines that over-express SIAT1, and also, cell 
lines that over-express SIAT4 to catalyze the formation of α-2,3 - linked sialic acid receptors 
(data and information to be presented elsewhere). With these SIAT1 and SIAT4 over-
expressing cells, we have isolated influenza viruses that others were unable to, and also, as 
for [72], we have recovered viruses from frozen stocks that others had great difficulty with.  
Another example of a cell line that has been engineered for effective isolation of a virus is 
L20B, used for the isolation of poliovirus, which is an enterovirus. L20B cells are derived 
from mouse L cells, and were engineered to express the poliovirus receptor. One advantage 
of using these cells over human cell lines such as Hep2 and RD for the isolation of 
polioviruses is that few human enteroviruses can complete their replication cycle in mouse 
cells [73]. Thus, it is possible to engineer cells normally not permissive for a particular virus 
into a permissive version. 
 
Figure 1. Mv1Lu-cSLAM cells 16 hrs post-inoculation with lung homogenate from a dog with 
distemper including neurologic signs. Multinucleated cells, a sign of CDV infection, are evident. An 
American type 2 CDV variant was isolated. Original magnification at 400X. 
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For the genetic modification of cultured cells (to express a virus receptor), it is no longer 
necessary to first clone a cDNA of a particular virus receptor in many instances. Many 
companies now sell full-length cDNAs of human (and non-human) genes already cloned 
into plasmid expression vectors. Some of the new generation expression vectors are also 
highly active across species, thus eliminating the need to optimize enhancer/promoter 
sequences in the expression vector.  
The second general approach for the engineering of cells for virus detection/isolation, that of 
modifying cells to express reporter genes in response to virus infection, is still relatively new 
but has already proven useful for diagnostic virology. For example, the ELVIS HSV system 
marketed by the company Diagnostic Hybrids for the detection and typing of human herpes 
simplex viruses (HSV) 1 and 2. The ELVIS HSV system uses BHK cells engineered to express 
β-galactosidase in response to HSV infection. After the engineered cells are inoculated with 
clinical specimen, a blue precipitate forms over the infected cells due to interaction of β-
galactosidase with a colorimetric substrate. Formation of a blue color facilitates detection of 
infected cells, with the net effect of reducing the time from sample inoculation to virus 
detection from (typically) seven or more days to one to two days. A subsequent 
immunofluorescence assay using monocolonal antibodies specific to HSV 1 or 2 is used to 
type the virus. 
10. Paradigms for virus isolation 
We are often asked “What is the best combination of indicator cells to use for the (primary) 
isolation of viruses from clinical specimens?”  Of course, this is not a question that has one 
correct answer. Indeed, there is no magic combination that is universally applicable. And 
variability exists according to the availability of reagents in various countries. The best 
answer to the question of which cells to use is to rely on the experience of the virologists 
working on site, and to use as wide a variety of indicator cells as possible for the isolation of 
unknown viruses. There are however some guidelines that are applicable across many 
applications: 
a. Many respiratory viruses replicate in the upper respiratory tract, and require 
temperatures lower than 37°C for optimal replication. For each type of indicator cell 
line (or primary cells), it is advisable to inoculate replicate cell cultures, and incubate 
one at 35° to 37°C, the other at 32° to 34°C. 
b. Cultures should not be considered negative for virus isolation if CPE are not detected. 
A second measure should be considered and well-thought criteria should be developed 
before rejecting a “negative” culture. For example, would CPE form if the cultures were 
held for a longer period of time? Examples of secondary evaluations include 
performance of hemagglutination (using spent culture media) or hemadsorption tests 
(performed directly on the infected cells), and electron microscopy. Hemagglutination 
and hemadsorption tests are best performed using red blood cells from two unrelated 
species (e.g., one mammalian and one avian species). Electron microscopy should be 
performed using material from spent media to detect liberated virions, and also, on a 
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Similarly we and others have engineered MDCK cells that over-express a sialyl transferase 1 
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into a permissive version. 
 
Figure 1. Mv1Lu-cSLAM cells 16 hrs post-inoculation with lung homogenate from a dog with 
distemper including neurologic signs. Multinucleated cells, a sign of CDV infection, are evident. An 
American type 2 CDV variant was isolated. Original magnification at 400X. 
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For the genetic modification of cultured cells (to express a virus receptor), it is no longer 
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sample of the infected cells (often, the number of liberated virions is too low to be easily 
visualized through electron microscopy, and virus infection is determined only by 
examining the infected cells themselves). 
c. For all work, non-infected cultures (negative controls) should be maintained and 
examined in parallel with any virus-infected cultures. 
d. Where economically feasible, new generation molecular tests should be used to assist in 
the identification of new viruses.  
e. Some viruses require “adaptation” prior to adequate replication in cultured cells and 
the formation of CPE. In the past, the process referred to as “blind culture” was 
performed when virus was suspected but CPE inapparent. A popular version of this 
method is to periodically remove samples from a culture of presumably infected cells, 
and to inoculate that into a new batch of cells. This process is repeated four times. An 
adjunct to former process is to split the infected cells (if confluent) into a larger flask or 
into several flasks and allow the cells to replicate. This may make CPE apparent if 
actively replicating cells are optimal for the detection of the CPE caused by a particular 
virus. 
f. The isolation of viruses from mosquitoes, ticks, etc., can be challenging. Many 
mosquito-borne viruses are best amplified to high titer in mosquito cell lines, where 
they often proliferate without causing CPE, prior to subculture in animal cells. 
Occasionally, it has also been necessary to inoculate newborn or suckling rodents 
(subcutaneously or intracerebrally) to obtain a high virus titer for the inoculation of cell 
cultures. 
g. During the primary isolation of virus from clinical or environmental specimens, many 
laboratories routinely filter specimens though a 0.45µm filter prior to inoculation of cell 
cultures. This filtration step is performed to remove bacteria, fungi, and other potential 
microbial contaminants, and non-living particulates. A problem with this filtration step 
is that many viruses are pleomorphic and some have long, filamentous forms that may 
exceed 0.45 µm. This includes some influenza viruses, and morbilliviruses. Also, in 
clinical specimens, many viruses are attached to cellular and other debris, and are 
trapped by the filter. We recommend the inoculation of two batches of cells; one with a 
filtered aliquot, the other unfiltered, of the virus specimen. Unfortunately, it is not 
uncommon these days for bacteria in clinical specimens (such as normal flora that are 
contaminants of naopharyngeal swabs) to be resistant to penicillin and streptomycin; 
we prefer to use an antibiotic mixture that includes neomycin in addition to penicillin 
and streptomycin.  
h. When economically possible, we suggest inoculation of cells growing on a relatively 
large growing surface with specimen. The idea behind this is to effect a dilution of the 
inoculum over a wide area, reducing the concentration of toxic agents. For example, 
add a small inoculum (e.g. 100 µl) to cells in a flask with a growing surface of 75 cubic 
centimeters (T75 flask). This is especially helpful when specimens must be pre-treated 
with a high concentration of antibiotics (such as when attempting the isolation of virus 
from a stool sample). 
 
The Art of Animal Cell Culture for Virus Isolation 
 
173 
i. A largely forgotten finding is that antibiotics can suppress the growth of some 
viruses. This concept is anti-dogmatic, but should always be considered when 
attempts at the isolation of a particular virus are not very successful. A recent 
example is described in [74].  
j. Some viruses remain cell-associated, as mentioned above, and for effective virus 
isolation, the virions must be liberated from the material they are attached to. This is 
one reason some clinical specimens designated for virus isolation are “vortexed” in the 
presence of glass beads prior to inoculation of the specimen onto cells. Instead of bead 
disruption, in some cases, freeze-thaw of the specimen can be used to dissociate the 
virions from the cells or debris they are attached to. Freeze-thaw cannot be used for 
herpesviruses and other viruses that are rapidly inactivated by such as process. Some 
viruses such as JC virus can be dissociated from cell debris by pretreatment of the 
specimen with neuraminidase. In any case, it is advisable to explore whether 
mechanical or biochemical options are available to improve virus isolation. However, 
for biosafety reasons, it is always best not to use procedures that create aerosols. 
11. Closing remarks 
In this article, we have discussed some of the art behind virus isolation through cell culture. 
Due to the complexities of cell culture, and the nature of the biomaterials used, it is not 
possible to consistently attain the same end results at all times. Moreover, viruses constantly 
mutate, and so the “rules of the game” can change. Therefore, the practice of cell culture for 
virus isolation is part art, part science, and part luck. Nevertheless, following principles 
mentioned in this manuscript, we have succeeded at maintaining cultured cells for long 
periods, and have isolated and propagated many “difficult” viruses.  
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1. Introduction 
It is estimated that hepatitis C virus (HCV) has infected at least 170 million people 
worldwide [1]. More than 80% of infected patients develop the chronic infection, which 
leads to serious liver diseases, such as liver cirrhosis and hepatocellular carcinoma [2,3]. 
Chronic HCV infections may proceed with asymptomatic or with non-specific symptoms 
(fatigue, depression) for many years. Despite increasing knowledge about the virus 
pathogenesis, there is still no vaccine and successful antiviral therapy. The current standard 
of chronic hepatitis C therapy based on pegylated IFN-α 2a (PegIFN-α) and ribavirin (RBV) 
has limited efficacy and undesirable side effects. There is an urgent need for more effective 
therapies. 
HCV is classified as a member of the Flaviviridae family and serves as a sole member of 
genus Hepacivirus. The genome of this enveloped virus consists of a single-stranded 
positive-sense RNA of approximately 9.6kb, which contains an open reading frame (ORF) 
encoding a polyprotein precursor of around 3000 amino acids (Figure 1). This single, large 
ORF is flanked by well conserved 5’ and 3’ untranslated regions (UTRs) [4]. The HCV 5’ 
UTR is a highly structured element, which includes internal ribosome entry site (IRES), a 
fragment required for genome translation [5,6]. The 3’ UTR contains short variable region, 
poly(U/UC) tract and X-tail region. The X-tail region forms highly conserved three stable 
stem-loop structures, which together with the poly(U/UC) are crucial for RNA replication 
[7,8]. Besides viral UTRs which are significant for translation and RNA replication, rest of 
the genome is diverse among several HCV isolates. According to genome differences, HCV 
isolates are divided into six particular genotypes, that differ in their nucleotide sequences by 
31-34% [9]. Infections with genotype 1 are the most prevalent and dangerous, leading to 
liver injury and hepatocellular carcinoma [10-12]. Patients infected with genotypes 1, 4, 5 
and 6 respond to treatment less effectively than patients infected with genotypes 2 and 3 
[12,13]. 
 The Author(s). Licensee In ech. This chapter is distribut d under he terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
 
Biomedical Tissue Culture 
 
178 
[74] Asada M, Yoshida M, Suzuki T, et al. Macrolide Antibiotics Inhibit Respiratory 







© 2012 Godzik, licensee InTech. This is an open access chapter distributed under the terms of the Creative 
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
Tissue-Based Model of HCV Replication as a 
Replacement for Animal Models in Drug Testing 
Paulina Godzik 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/51217 
1. Introduction 
It is estimated that hepatitis C virus (HCV) has infected at least 170 million people 
worldwide [1]. More than 80% of infected patients develop the chronic infection, which 
leads to serious liver diseases, such as liver cirrhosis and hepatocellular carcinoma [2,3]. 
Chronic HCV infections may proceed with asymptomatic or with non-specific symptoms 
(fatigue, depression) for many years. Despite increasing knowledge about the virus 
pathogenesis, there is still no vaccine and successful antiviral therapy. The current standard 
of chronic hepatitis C therapy based on pegylated IFN-α 2a (PegIFN-α) and ribavirin (RBV) 
has limited efficacy and undesirable side effects. There is an urgent need for more effective 
therapies. 
HCV is classified as a member of the Flaviviridae family and serves as a sole member of 
genus Hepacivirus. The genome of this enveloped virus consists of a single-stranded 
positive-sense RNA of approximately 9.6kb, which contains an open reading frame (ORF) 
encoding a polyprotein precursor of around 3000 amino acids (Figure 1). This single, large 
ORF is flanked by well conserved 5’ and 3’ untranslated regions (UTRs) [4]. The HCV 5’ 
UTR is a highly structured element, which includes internal ribosome entry site (IRES), a 
fragment required for genome translation [5,6]. The 3’ UTR contains short variable region, 
poly(U/UC) tract and X-tail region. The X-tail region forms highly conserved three stable 
stem-loop structures, which together with the poly(U/UC) are crucial for RNA replication 
[7,8]. Besides viral UTRs which are significant for translation and RNA replication, rest of 
the genome is diverse among several HCV isolates. According to genome differences, HCV 
isolates are divided into six particular genotypes, that differ in their nucleotide sequences by 
31-34% [9]. Infections with genotype 1 are the most prevalent and dangerous, leading to 
liver injury and hepatocellular carcinoma [10-12]. Patients infected with genotypes 1, 4, 5 
and 6 respond to treatment less effectively than patients infected with genotypes 2 and 3 
[12,13]. 
 The Author(s). Licensee In ech. This chapter is distribut d under he terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
 




Figure 1. Genome organization of HCV 
The HCV polyprotein precursor is co- and post-translationally processed into 10 proteins, 
that are divided into two groups, structural proteins: core protein, two glycoproteins (E1, 
E2), p7; and non-structural proteins: NS2, NS3, NS4A, NS4B, NS5A and NS5B. The HCV 
core protein forms viral nucleocapsid and also regulates cellular and viral gene expression, 
cell transformation and apoptosis by the interaction with cellular proteins and signaling 
pathways [14,15]. The two glycoproteins, E1 and E2, are essential components of the virion 
envelope and necessary for viral entry [16]. E2 plays a crucial role in attachment of the virus 
to a cell, by the interaction with host receptor – CD81 [17,18]. The p7 protein is a small 
polypeptide that forms an ion channel, suggesting that it belongs to the viroporin family 
[19,20]. The NS2 protein is a transmembrane protein, which together with amino-terminal 
domain of the NS3 protein create NS2-3 protease that cleaves the site between NS2 and NS3 
during processing of the polyprotein [21]. The NS3 and NS4A (NS3-NS4A) built a multi-
functional complex essential for viral polyprotein processing and RNA replication. The 
NS4A protein is a cofactor of NS3 protease activity and catalyzes polyprotein cleavage. The 
442 C-terminal amino acids of the NS3 is a helicase that plays a crucial role in RNA 
replication [22]. The NS4B is an integral membrane protein that serves as a membrane 
anchor for the replication complex [23]. The NS5A protein is a membrane-anchored 
phosphoprotein, important in viral replication, but exact function of this protein is not 
known [22]. The last protein, NS5B is a viral RNA-dependent RNA polymerase which is 
crucial for RNA replication.  
The first step of the HCV life cycle is attachment of the virus to a cell via E2 and cell receptor 
interaction [Figure 2]. CD81 has been the most extensively studied as a putative HCV 
receptor [17]. Several cell surface molecules, like: scavenger receptor B type I (SR-BI), low-
density lipoprotein receptor (LDL-R) or asialoglycoprotein receptor (ASGP-R) have been 
also proposed to mediate HCV binding [24-27]. HCV entry into cells by pH-dependent 
endocytosis, but the mechanism of HCV fusion remains controversial [27,28]. Released viral 
RNA into the cytoplasm of infected cell serves directly as messenger RNA in an internal 
ribosome entry site-directed translation of the HCV polyprotein. The precursor polyprotein, 
which is targeted to the ER membrane is processed by cellular and viral proteases into 10 
proteins. HCV replication starts with synthesis of complemantary negative-strand RNA 
which then serves as a template for production of numerous positive-strand genomic RNAs, 
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both steps are catalyzed by the NS5B RNA-dependent RNA polymerase (RdRp).These 
RNAs serve as mRNA in translation, as a template for synthesis more negative strands and 
as substrates for viral assembly. Little is known about HCV assembly and release. It is 
suggested that core protein is sufficient for viral assembly and its interaction with RNA may 
play a role in switching from RNA replication to packaging [29,30]. After viral RNA 
association with core, viral nucleocapsids are formed and bud into the ER. Newly produced 
virions may leave the cell through the constitutive secretory pathway [28].  
 
Figure 2. HCV life cycle 
2. Models of HCV study 
The current standard of HCV therapy that relay on combination with pegylated IFN-α 2a 
and ribavirin yield limited success rates and reach about 40-80%, depending on HCV 
genotype, viremia, age and gender of the patients [31-33]. These facts and the large number 
of infected individuals stress the pressing need for the development of improved antiviral 
strategies. Understanding of the viral life cycle is crucial to identify effective antiviral agents. 
The lack of small animal models for HCV hamper studies on viral replication. 
2.1. Animal models 
The chimpanzee is the only animal that can be infected with HCV. Unfortunately, this 
model is limited by restricted availability of animals, ethical dilemmas and high cost. 
Recently, other models have been used to study different aspects of HCV biology and novel 
antiviral drugs. Researchers had created severe combined immunodeficient (SCID) mice 
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both steps are catalyzed by the NS5B RNA-dependent RNA polymerase (RdRp).These 
RNAs serve as mRNA in translation, as a template for synthesis more negative strands and 
as substrates for viral assembly. Little is known about HCV assembly and release. It is 
suggested that core protein is sufficient for viral assembly and its interaction with RNA may 
play a role in switching from RNA replication to packaging [29,30]. After viral RNA 
association with core, viral nucleocapsids are formed and bud into the ER. Newly produced 
virions may leave the cell through the constitutive secretory pathway [28].  
 
Figure 2. HCV life cycle 
2. Models of HCV study 
The current standard of HCV therapy that relay on combination with pegylated IFN-α 2a 
and ribavirin yield limited success rates and reach about 40-80%, depending on HCV 
genotype, viremia, age and gender of the patients [31-33]. These facts and the large number 
of infected individuals stress the pressing need for the development of improved antiviral 
strategies. Understanding of the viral life cycle is crucial to identify effective antiviral agents. 
The lack of small animal models for HCV hamper studies on viral replication. 
2.1. Animal models 
The chimpanzee is the only animal that can be infected with HCV. Unfortunately, this 
model is limited by restricted availability of animals, ethical dilemmas and high cost. 
Recently, other models have been used to study different aspects of HCV biology and novel 
antiviral drugs. Researchers had created severe combined immunodeficient (SCID) mice 
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with chimeric livers composed of human and murine hepatocytes that support robust HCV 
replication [34]. This model was used to demonstrate the antiviral activity of the HCV 
NS3/4A protease inhibitor BILN-2061. Reduction of the viral load in genotype 1b infected 
mice after protease inhibitor treatment was similar to results obtained in human clinical 
trials [35]. Unfortunately, these chimeric mice are not suitable for evaluation of 
immunotherapeutic agents and vaccines, because of the lack of functional immune system 
[34]. 
2.2. Tissue culture 
The primary host cell supporting HCV replication is the hepatocyte. HCV replication has 
been detected in hepatoma, B- and T-cell lines, primary cultures of human or chimpanzee 
hepatocytes and peripheral blood mononuclear cells. However, the replication levels are 
very low and do not allow to study HCV replication in detail [36].  
Since HCV discovery in 1989, intensive research to create tissue-based model of HCV 
replication begun. In the late 1990s few independent groups of researchers had developed 
the first in vitro hepatitis C virus replication system based on viral cDNA [37,38]. The HCV 
genome (called “H77”) isolated from patients infected with genotype 1a was used to create 
plasmid containing full HCV genome transcripted to cDNA. Plasmids containing the full-
length HCV cDNA were linearized with XbaI and then used as a template in in vitro 
transcription. Transcripted RNAs were infectious, when injected directly into chimpanzees 
liver [38]. These plasmids were adapted at H77 5’ terminus with the T7 promoter and at 3’ 
terminus with the hepatitis delta cis-acting ribozyme in continuity with T7 terminator 
sequences. The vectors were used in transfection of HepG2 and CV-1 cell line. The HCV 
genomic RNA was generated by T7 RNA polymerase that was provided by infection with 
recombinant vaccinia virus (vTF7-3) (Figure 3.) [39]. This system has experimental 
limitations, because of cytopathic and pleiotropic effects of vaccinia virus infection [40].  
 
Figure 3. Construction of vectors used for the binary HCV replication system (according to [39], 
modified) 
2.2.1. Development of HCV replicons 
According to the low level of HCV replication obtained in full-length cDNA systems, 
researchers tried to create subgenomic replicon systems. In 1999 the first subgenomic 
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replicon system, which allowed HCV replication in the human hepatoma cell line Huh-7 
was established. Viral RNA was isolated from the liver of the patient chronically infected 
with genotype 1b (Con1). These bicistronic replicons consist of 5’ HCV IRES, neomycin 
phosphatransferase gene (as a selectable marker), encephalomyocarditis virus (EMCV) IRES 
and the HCV nonstructural genes from NS2 or NS3 up to NS5B. Translation of the marker 
was under control of HCV IRES and translation of the HCV polyprotein was under control 
of EMCV IRES. As a negative control, a defective genome carrying an in-frame 10-amino 
acid deletion in the NS5B active site was generated (Figure 4).  
 
Figure 4. Structure of the HCV subgenomic replicons. The structure of the replicons composed of 5’ 
HCV UTR (Untranslated Region), neo (neomycin phosphatransferase gene), encephalomyocarditis virus 
(EMCV) IRES, the HCV nonstructural genes from NS2 or NS3 up to NS5B and 3’ HCV UTR. Δ indicates 
the position of 10-amino acid deletion in NS5B. 
Although transfection of Huh-7 cells with transcripts synthetized in vitro and selection with 
neomycin resulted in a low number of surviving cell colonies, neomycin-resistant cell 
colonies harbored 1000-5000 copies of positive-sense HCV RNA per cell, which gave 
evidence of high level replication in transfected cells. To exclude the possibility that 
resistance was due to plasmid DNA integrated into the host cell genome, DNA of each clone 
was analyzed by neo-specific PCR [41]. Low frequency of transfected cells may indicate that 
replicon RNAs acquire adaptive mutations to effectively replicate in the Huh-7 cell line or 
only a low number of cells in the culture support efficient HCV replication. Analysis of the 
replicon RNAs confirmed the occurrence of cell culture-adaptive mutations that enhance 
RNA replication [42,43]. Mutations increasing replication were found in the non-structural 
coding region, especially in NS4B, NS5A and NS5B. The NS3 mutations had minimal or no 
impact on replication, but can enhance replication synergistically when combined with 
adaptive mutations in NS4B, NS5A and NS5B. In the same Huh-7 cell line up to 100-fold 
differences in their ability to support replicon amplification were found, which may indicate 
that some cellular factors also might be responsible for the different levels of permissiveness 
of Huh-7 cells [43].  
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Although transfection of Huh-7 cells with transcripts synthetized in vitro and selection with 
neomycin resulted in a low number of surviving cell colonies, neomycin-resistant cell 
colonies harbored 1000-5000 copies of positive-sense HCV RNA per cell, which gave 
evidence of high level replication in transfected cells. To exclude the possibility that 
resistance was due to plasmid DNA integrated into the host cell genome, DNA of each clone 
was analyzed by neo-specific PCR [41]. Low frequency of transfected cells may indicate that 
replicon RNAs acquire adaptive mutations to effectively replicate in the Huh-7 cell line or 
only a low number of cells in the culture support efficient HCV replication. Analysis of the 
replicon RNAs confirmed the occurrence of cell culture-adaptive mutations that enhance 
RNA replication [42,43]. Mutations increasing replication were found in the non-structural 
coding region, especially in NS4B, NS5A and NS5B. The NS3 mutations had minimal or no 
impact on replication, but can enhance replication synergistically when combined with 
adaptive mutations in NS4B, NS5A and NS5B. In the same Huh-7 cell line up to 100-fold 
differences in their ability to support replicon amplification were found, which may indicate 
that some cellular factors also might be responsible for the different levels of permissiveness 
of Huh-7 cells [43].  
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Although HCV is divided into 6 genotypes, replicons have only been reported for genotypes 
1 and 2. The establishment of efficiently replicating replicons based on genotype 1a was 
more challenging than generating functional genotype 1b subgenomic replicons. The first 
subgenomic replicons (pH77) containing sequences from genotype 1a were constructed in 
2003. The replicons were created analogically to previously characterized 1b replicons, and 
consisted of 5’ HCV IRES, neo, EMCV IRES and the HCV nonstructural genes from NS2 or 
NS3 up to NS5B. As a positive control, constructs described in [41] were used. 
Unfortunately, subgenomic replicons pH77 were unable to support stable replication after 
RNA electroporation into Huh-7 cells with neomycin selection. Replacing first 75 residues of 
NS3 coding sequence from type 1a with type 1b resulted in replication. The chimeric 
subgenomic replicons between HCV type 1a and type 1b were able to replicate in Huh-7 
cells, albeit with reduced colony formation efficiency and low viral RNA levels [44]. 
Transfection of highly permissive Huh-7 subline, Huh-7.5 with H77 replicons containing 
adaptive Ser-to-Ile substitution (S2204I) in NS5A allowed the development of the first 
colonies supporting H77 replication. The low frequency of cells supporting H77 
replication suggested that efficient H77 replication in Huh-7.5 cells may require at least 
two adaptive mutations. In all cell clones analyzed, replicating RNAs had acquired a 
second amino acid substitution in the helicase domain of NS3. Both these mutations, 
when combined with NS5A S2204I, enhanced the colony-forming ability of subgenomic 
H77 RNA and allowed the detection of HCV RNA after RNA transfection of either 
subgenomic replicons [45].  
The only non-genotype 1 subgenomic replicon capable of efficient replication in cell culture 
is the genotype 2a clone JFH1 isolated from a patient with fulminant hepatitis. Fulminant 
viral hepatitis is a serious form of acute hepatitis and is characterized by a broad viral 
replication in the host and an intensified host immune response against the virus-infected 
cells. The replicon was constructed according to the method used in [41], then in vitro 
transcripted and transfected into Huh-7 line. The colony-forming ability of the replicon was 
60-fold higher than a Con1 (genotype 1b) subgenomic RNA harboring highly adaptive 
mutations. Clones of this subgenomic replicon replicated without common amino acid 
mutations. Furthermore, JFH1 subgenomic replicon replicated efficiently without neomycin 
selection in a transient replication assay. This genotype 2a subgenomic replicon is important 
for studying the differences in viral characteristics between genotypes 1 and 2 and to 
understand the mechanisms of viral replication and persistence [46]. In addition, the JFH1 
subgenomic replicon produced colonies in a human hepatocyte-derived cell line, and in 
IMY-N9, a cell line developed by fusing human hepatocytes and HepG2 cells [47]. 
Replication of JFH1 subgenomic replicon was also shown in two human non-hepatocyte-
derived cell lines, HeLa and 293, which provided useful information about HCV replication 
and cell tropisms [48]. 
The subgenomic replicon system is a powerful tool that could be used to study HCV RNA 
replication in tissue-based assays. It also allows to investigate functions of particular HCV 
proteins, but has its limitations because of no possibility to product viral particles. 
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2.2.2. Development of an infectious HCV cell culture system 
The first robust cell culture model of HCV infection, in which infectious HCV can be 
produced, was reported in 2005. To create HCV constructs, HCV RNA was isolated from 
Japanese patient with fulminant hepatitis C (JFH1) [49]. A 32-year-old man was admitted 
with a 5-day history of general fatigue, fever and acute liver failure. No evidence of 
previous liver diseases was found. Anti-HCV antibodies were not detected at the time of 
admission. The titer of serum HCV RNA was 105 copies/ml and the genotype of the isolate 
was 2a. Its sequence slightly deviates from other genotype 2a strains isolated from patients 
with chronic hepatitis. This strain has 9,678 bp genome and contains a long open reading 
frame spanning nucleotide 341-9439 and coding 3033 amino acids [50]. Based on the 
consensus sequence of JFH1, plasmid pJHF1 containing the full-length JFH1 cDNA 
downstream of the T7 RNA promoter was constructed (Figure 5).  
 
Figure 5. Organization of the full-length HCV construct pJFH1 
The plasmids were linearized at the 3’ end of the HCV cDNA by XbaI digestion, then in vitro 
transcripted and electroporated to Huh-7. The genome-length RNA was detected in JFH1-
transfected cells after 24 h and remained detectable up to 72 h. About 70-80% of the cells 
were positive for core and nonstructural proteins at 72 h after electroporation, indicating 
high levels of HCV genome replication in Huh-7 cells. In JFH1-transfected cells the viral 
RNA concentration in the medium increased rapidly at 5 days after transfection and 
remained high for the next 7 days, followed by a slow decrease. HCV particles of spherical 
morphology with an average diameter of about 55 nm were detected  in cell medium, which 
confirms secretion of viral particles after JFH1 transfection into Huh-7. Secreted virus was 
infectious for naïve Huh-7 cells and for chimpanzee. Although JFH1 virus was infectious for 
the chimpanzee, infection resulted in transient viraemia and no pathological changes in the 
liver. Infectivity of viral particles was neutralized by CD81-specific antibodies, confirming 
specificity of the infection and the important role of CD81 in HCV entry [49].  
The JFH1 system described above was limited by low level of infection [49]. Effective viral 
infection was achieved using cured cell lines such as Huh-7.5 and Huh-7.5.1 [51,52]. These 
cell lines were obtained by intrerferon treatment of Huh-7 supporting subgenomic replicons. 
Replicon-containing Huh-7 cells were cured of HCV RNA by initially passing cells twice in 
the absence of neomycin. Then cells were passaged four times in the presence of IFN-α 
creating Huh-7.5 line [51]. The Huh-7.5.1 cell line was delivered from Huh-7.5 replicon cell 
line by culturing 3 weeks in the presence of human IFN-γ to eradicate replicon [52]. 
Transfection of the JFH1 genome into Huh-7.5 and Huh-7.5.1 cells support high levels of 
HCV replication in more than 75% of transfected cells. Huh-7.5 line is more permissive for 
HCV replication than parental Huh-7 [51]. 
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This in vitro HCV replication system based on genotype 2a (JFH1) is used worldwide to test 
the viral life cycle and new antiviral drugs. Its main advantage is markedly enhanced 
replication efficiency compared with other HCV clones and secretion of virus particles into 
the cell medium. JFH1 is the only clone without adaptive mutations that is infectious to 
cultured cells and chimpanzees. The limitation of this method is its restricted adaptation to 
genotype 2a. The most prevalent and dangerous is infection with genotype 1, which leads to 
liver damage and hepatocellular carcinoma. It has been difficult to disseminate non-JFH1 
HCV strains in cell lines, despite establishment of chimeric viruses. Full-length chimeric 
genomes were constructed with the use of the core-NS2 gene regions from H77 (genotype 
1a) and NS3-NS5B gene regions from JFH1 (genotype 2a). Genotype 1a/2a was able to 
replicate in Huh-7, but viral particles were not infectious for naïve cells [53]. The JFH1 strain 
is still the only HCV isolate that can be propagated in Huh-7 cells.  
In vitro HCV replication system based on genotype 1a was established in 2006. In vitro 
transcribed full-length HCV RNA from clone H77 was used for transfection of immortalized 
human hepatocytes (IHH) by electroporation [54]. Human hepatocytes used in this 
experiment were immortalized by transfection of the HCV core genomic region from 
genotype 1a [55]. Reverse transcription-PCR of cellular RNA isolated from full-length HCV 
transfected cells suggested that viral RNA replication appeared. Absence of integrated H77 
DNA in IHH genome confirmed HCV genomic RNA replication in the cytoplasm of IHH. 
The presence of HCV in IHH cell culture medium was detected. Furthermore, virus-like 
particles were observed in the cytoplasm. HCV infection was also observed after 
transferring culture media of HCV-replicating cells into naïve IHH [54]. Probably, in IHH 
cellular defense mechanisms against HCV infection are reduced. Further studies are 
necessary to test usage of this replication system in novel drug testing. 
2.2.3. Cell lines permissive for HCV replication 
Hepatoma cell line Huh-7 and its subline Huh-7.5 are the most permissive cell lines for in 
vitro HCV replication identified so far, indicating that a favorable cellular environment 
exists within these cells. Although adaptive mutations in the HCV NS proteins are required 
to develop HCV replication at higher frequency. The replication efficiencies of subgenomic 
RNAs in replication assays can vary by as much as 100-fold between different passages of 
Huh-7 cells. These differences suggest that effective replication depends on host cell 
conditions or cellular factors. Replication efficiency decreases with increasing amounts of 
transfected replicon RNA, indicating that viral RNA or proteins are cytopathic or that host 
cell factors in Huh7 cells limit RNA replication [43]. Several Huh-7 lines harboring 
subgenomic HCV replicons were cured of HCV RNA by prolonged treatment with IFN-α. 
Huh-7.5 is the most permissive cured subline identified so far. The frequency of Huh-7.5 
cells able to support HCV replication is approximately three-fold higher than that of the 
parental Huh-7 cells. Furthermore, more than 75% of the cells that survive the transfection 
procedure harbor replicating HCV RNAs. The highly permissive subline (Huh-7.5) was 
obtained from neomycin-selected clones that harbored replicons without adaptive changes 
in the NS3-5B region [51]. 
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Ihe first in vitro non-Huh-7 system of HCV replication was described in 2003. Subgenomic 
HCV RNAs (Con1) replicated in nonhepatic human epithelial cells. Subgenomic RNA 
isolated from Huh-7 cell lines that replicate HCV RNA were used in transfection of HeLa 
cells (cervix carcinoma). Neomycin-resistant cell clones were obtained. Replicons isolated 
from these cells carried new mutations that could be involved in the control of tropism of 
the virus [56]. 
3. Antiviral therapies for chronic hepatitis C 
The current standard of treatment of chronic hepatitis C is a combination of pegylated 
interferon and ribavirin. This therapy leads to 40-50% sustained virological response (SVR) 
in patients infected with genotype 1, 93% in patients infected with genotype 2, 79% in 
patients infected with genotype 3 and 69% in patients infected with genotype 4 [29-31]. 
Among patients infected with genotype 1, only 19-24% treated with PegIFN-α and RBV can 
achieve rapid virological response (RVR) [57]. Pegylated interferon is associated with 
numerous side effects: 50% of patients experience flu-like symptoms, 25% psychiatric 
symptoms, 20% symptoms of fatigue and 10% symptoms of gastritis. The major side effect 
(36%) of ribavirin is anaemia [58]. 
Current standard of chronic hepatitis C therapy has limited efficacy and undesirable side 
effects. There is a pressing need to develop a new antiviral drugs against chronic hepatitis C.  
3.1. Inhibitors of hepatitis C virus 
An infectious HCV cell culture system is a powerful tool that could be used to study HCV 
life cycle and function of particular viral proteins. These studies allow to find viral targets 
for direct-acting antiviral (DDA) drugs and develop Specifically Targeted Antiviral 
Therapies for HCV (STAT-C). These therapies let to achieve better effectiveness of treatment, 
its shortening, and the diminishment and limitation of side effects. Current studies are focused 
on searching the new therapeutic agents for hepatitis C, which are directed against viral 
proteins. Several HCV inhibitors have reached clinical development, but the most advanced 
include inhibitors of NS3/4A protease, two of them: boceprevir and telaprevir were approved 
in 2011 by the Food and Drug Administration (FDA) for the treatment of chronic hepatitis C 
genotype 1 infection, in combination with PegIFN-α and RBV. 
3.1.1. NS3/4A protease inhibitors 
The NS3 protease is one of the most attractive targets for developing new therapies against 
HCV, because of its essential role in viral replication [59,60]. The NS3 inhibitors are divided 
into two groups, according to different mechanisms of action: covalent and non-covalent 
inhibitors. Both covalent and non-covalent NS3 protease inhibitors have been developed to 
bind NS3 active site.  
A covalent trap called also ‘warhead’ form covalent reversible or irreversible bonds with 
serine hydroxyl of NS3 protease catalytic site [61]. Several classes of HCV protease inhibitors 
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the cell medium. JFH1 is the only clone without adaptive mutations that is infectious to 
cultured cells and chimpanzees. The limitation of this method is its restricted adaptation to 
genotype 2a. The most prevalent and dangerous is infection with genotype 1, which leads to 
liver damage and hepatocellular carcinoma. It has been difficult to disseminate non-JFH1 
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procedure harbor replicating HCV RNAs. The highly permissive subline (Huh-7.5) was 
obtained from neomycin-selected clones that harbored replicons without adaptive changes 
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Ihe first in vitro non-Huh-7 system of HCV replication was described in 2003. Subgenomic 
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inhibitors. Both covalent and non-covalent NS3 protease inhibitors have been developed to 
bind NS3 active site.  
A covalent trap called also ‘warhead’ form covalent reversible or irreversible bonds with 
serine hydroxyl of NS3 protease catalytic site [61]. Several classes of HCV protease inhibitors 
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with electrophilic functionality have been reported: aldehyde, ketone, α-ketoamide, α-
ketoacid and boric acid/ester. The ketoamides have been the most successful class of 
covalent inhibitors. Among them, the most clinically advanced are boceprevir and telaprevir 
[62]. The new AASLD guidelines suggest addition of the NS3/NS4A inhibitors boceprevir or 
telaprevir to optimize treatment for patients infected with genotype 1.  
Boceprevir (SCH 503034) (Figure 6) has been reported as safe and well tolerated in phase I 
and phase II clinical trials. In a phase II trial (SPRINT-1), patients treated with boceprevir for 
48 weeks in combination with pegylated interferon and ribavirin demonstrated SVR rates 
67-75% compared with SVR rates of 38% in the control arm [62]. Boceprevir (Victrelis) was 
approved by the FDA in May 2011, on the basis of the efficacy and safety results from two 
large phase III clinical studies that evaluated approximately 1,500 adult patients with 
chronic HCV genotype 1 infection. Both studies included two treatment arms with 
boceprevir: a response-guided therapy (RGT) arm, in which patients with undetectable 
virus (HCV-RNA) at week 8 of treatment were eligible for a shorter duration of therapy, as 
well as a 48-week treatment arm. All patients receiving boceprevir in these studies were first 
treated with peginterferon alfa-2b and ribavirin in a 4-week lead-in phase, followed by the 
addition of boceprevir after week 4. The studies also included a control arm in which 
patients received 48 weeks of treatment with peginterferon alfa-2b and ribavirin alone. In 
these studies boceprevir yielded sustained virological response rates as high as 67%. 
 
Figure 6. Chemical structure of boceprevir 
Boceprevir was approved by FDA for the treatment of chronic hepatitis C genotype 1 
infection, in combination with peginterferon alfa and ribavirin, in adult patients with 
compensated liver disease, including cirrhosis, who were previously untreated or who have 
failed previous interferon and ribavirin therapy.  
Telaprevir (VX-950) (Figure 7) has been reported as generally safe and well tolerated. Its 
potent inhibition of NS3 protease activity was demonstrated in a mouse model and then 
 
Tissue-Based Model of HCV Replication as a Replacement for Animal Models in Drug Testing 
 
189 
proved in a phase II clinical trial [63-65]. In a phase II clinical trial (PROVE-1) observed SVR 
rate was 35-67% with telaprevir compared with 41% in the control arm. In combination 
therapy with pegylated interferon and ribavirin (PROVE-2) resulted in 69% SVR [62].  
 
Figure 7. Chemical structure of telaprevir 
FDA approved telaprevir (Incivek) in May 2011 to treat certain adults with chronic hepatitis 
C infection. Telaprevir is used for patients who had either not received interferon-based 
drug therapy for their infection or who had not responded adequately to prior therapies. 
Telaprevir is approved for use with combination therapy made up of peginterferon alfa and 
ribavirin. The safety and effectiveness of telaprevir was evaluated in III phase three clinical 
trials with about 2,250 adult patients who were previously untreated, or who had received 
prior therapy. In all studies patients also received the drug with standard of care. In 
previously untreated patients, 79% of those receiving telaprevir experienced a sustained 
virologic response (i.e. the infection was no longer detected in the blood 24 weeks after 
stopping treatment) compared to standard treatment alone. The sustained virologic 
response for patients treated with telaprevir across all studies, and across all patient groups, 
was between 20% and 45% higher than current standard of care. The studies indicate that 
treatment with telaprevir can be shortened from 48 weeks to 24 weeks in most patients. 
Sixty percent of previously untreated patients achieved an early response and received only 
24 weeks of treatment (compared to the standard of care of 48 weeks). The SVR for these 
patients was 90%. 
Several non-covalent inhibitors of NS3 protease have demonstrated potent reduction of 
HCV RNA and promising safety profiles in HCV infected patients. Non-covalent NS3 
protease inhibitors rely on network of hydrogen bonding interactions and polar interactions 
to obtain binding energy. Ciluprevir was the first direct acting antiviral compound that 
demonstrated significant viral reduction in patients. The most advanced non-covalent NS3 
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protease inhibitors: danoprevir, vaniprevir, TMC435350, BI 201335 and BMS-650032 are 
currently in clinical development [66]. 
Ciluprevir (BILN-2061) was the first NS3 protease inhibitor tested for antiviral effect in 
humans. Unfortunately clinical study was terminated due to significant mitochondrial 
toxicity in cardiac myocytes of several preclinical species [67]. The antiviral efficacy, 
pharmacokinetics, and tolerability of 25, 200, and 500 mg BILN 2061 twice daily given as 
monotherapy for 2 days in 31 patients infected with chronic genotype 1 HCV infection and 
with minimal liver fibrosis were assessed in a placebo-controlled, double-blind pilot study. 
In 2 subsequent placebo-controlled studies of similar design, 200 mg BILN 2061 twice daily 
was administered for 2 days to 10 patients with advanced liver fibrosis and to 10 patients 
with compensated cirrhosis. Viral RNA reductions of 2–3 log10 copies/mL were achieved in 
most of the patients. There was a trend toward a higher number of patients receiving 500 mg 
BILN 2061 achieving a viral RNA reduction ≥3 log10 copies/mL as compared with patients 
receiving 25 mg BILN 2061 [68]. The antiviral activity of ciluprevir was also examined in 
patients infected with genotype 2 and 3. The antiviral efficacy of BILN-2061 was less 
pronounced and more variable in patients with HCV genotype 2 or 3 infection compared 
with previous results in patients with HCV genotype 1 [69]. 
Antiviral activity of danoprevir (ITMN-191/RG7227) was demonstrated in a randomized, 
placebo-controlled, 14-day multiple ascending dose study in patients with chronic HCV 
genotype 1 infection. Danoprevir displayed a slightly more than proportional increase in 
exposure with increasing daily dose and was rapidly eliminated from the plasma 
compartment. Maximal decreases in HCV RNA were: −3.9log10IU/ml and −3.2log10IU/ml 
[70]. Danoprevir is currently in phase IIb clinical study in combination with PegIFN/RBV. 
Eighty six percent of patients were HCV RNA negative by week 4 of treatment and 92% 
were negative by week 12 of treatment [66]. 
Vaniprevir (MK-7009) is another NS3 protease inhibitor, which entered phase IIb 
development in combination with PegIFN-α and RBV. In the early phase of clinical trial 
vaniprevir showed 69%-82% clearance of HCV RNA in patients after 4 weeks of treatment.  
Opera-1 trial (double blind, placebo-controlled phase IIa trial) examined TMC435350 in 
combination with PegIFN-α and RBV in patients infected with genotype 1. TMC435350 in 
combination with PegIFN/RBV showed antiviral activity superior to PegIFN/RBV alone. In 
the 25, 75, 200 mg 4-week triple therapy arms, 6/9, 9/9 and 10/10 patients had HCV-RNA 
concentrations below the lower limit of detection (<25 IU/mL) and 3/9, 8/9 and 7/10 had 
undetectable HCV RNA (<10 IU/mL) at day 28, respectively [71]. TMC435350 is currently in 
phase IIb clinical trial. 
Activity of BI 201335 was demonstrated in phase IIb clinical trial (SILEN-C2) that included 
HCV infected patients with confirmed non-response to at least 12 weeks of PegIFN/RBV 
treatment. After 4 weeks of treatment with BI 201335 in combination with PegIFN-α and 
RBV up to 69% patients had HCV RNA below the limit of detection and after 12 weeks of 
treatment up to 59% patients had HCV RNA below the limit of detection. SILEN-C2 
confirmed robust antiviral activity with overall good tolerability and safety [72]. 
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Asunaprevir (BMS-650032), a novel HCV NS3 protease inhibitor in clinical development, 
was evaluated for safety, antiviral activity, and resistance in four double-blind, placebo-
controlled, sequential-panel, single- and multiple-ascending-dose (SAD and MAD) studies 
in healthy subjects or patients with chronic HCV genotype 1 infection. Asunaprevir at doses 
of 200 to 600 mg resulted in rapid HCV RNA decrease from the baseline; maximal mean 
changes in HCV RNA over time were 2.7 and 3.5 log(10) IU/ml in the SAD and MAD 
studies, respectively [73]. Currently, asunaprevir is being examined in an innovative 
programme in combination with NS5A inhibitor BMS-790052 in prior non-responders to 
PegIFN/RBV therapy [66]. 
3.1.2. NS3 helicase inhibitors 
NS3 helicase is needed for HCV replication and is a potent STAT-C target. Small peptide 
and tropolones have been reported to inhibit NS3. Peptide inhibitors are quite attractive 
candidates for antiviral agents. It is relatively easy to design a peptide that fits a studied 
protein, regardless of the size and chemical properties of the target site. The first 
experiments performed with a radioactive helicase assay revealed the inhibitory activity of 
these peptides (of various lengths and composition) and pointed at a peptide composed of 
14 amino acids (p14, RRGRTGRGRRGIYR) as the best helicase inhibitor. The first helicase 
inhibitor corresponded to a highly conserved arginine-rich sequence of domain 2 of the 
helicase. The 50% inhibitory activity (IC50) value was 725 ± 109 nM, indicating that the 
peptide is a very efficient NS3 helicase inhibitor. The antiviral activity of p14 was tested in a 
subgenomic HCV replicon assay that showed that the peptide at micromolar concentrations 
can reduce HCV RNA replication [74]. 
Tropolones possess multiple biological activities: antiviral, antimicrobial, and cytotoxic 
effects on various human tumour cell lines [75-77] . They may also exert an insecticidal as 
well as a metalloprotease inhibitory effects [78]. The antiviral activity of hydroxylated 
tropolone derivatives was demonstrated for human influenza virus and human 
immunodeficiency virus-type 1. Dibromo-morpholinometyltropolone (DBMTr, Figure 8A) is 
one of the potent NS3 helisace inhibitor among tropolones, which exert anti-helicase activity 
with an IC50 of 17.56 μM [79].  
Other tropolones, like 3,5,7-tri[(4′-methylpiperazin-1′-yl)methyl]tropolone, 3,5,7-tri[(4′-
methylpiperidin-1′-yl)methyl]tropolone and 3,5,7-tri[(3′-methylpiperidin-1′-yl)methyl] 
tropolone demonstrate NS3 inhibition (Figure 8B). Among them, the most active anti-
helicase compound 3,5,7-tri[(4′-methylpiperazin-1′-yl)methyl]tropolone (IC50 = 3.4 μM),  
inhibited RNA replication by 50% at 46.9 μM (EC50) and exhibited the lowest cytotoxicity 
(CC50) >1 mM resulting in a selectivity index (SI = CC50/EC50) >21. The most efficient 
replication inhibitor, 3,5,7-tri[(4′-methylpiperidin-1′-yl)methyl]tropolone, inhibited RNA 
replication with an EC50 of 32.0 μM and a SI value of 17.4, whereas 3,5,7-tri[(3′-
methylpiperidin-1′-yl)methyl]tropolone exhibited a slightly lower activity with an EC50 of 
35.6 μM and a SI of 9.8. Moreover, these three tropolone derivatives inhibit replication of the 
HCV subgenomic replicon in cell cultures [80]. Despite the intensive studies, no inhibitors of 
HS3 helicase are in clinical use. 
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Figure 8. Chemical structure of tropolones: (A): dibromo-morpholinometyltropolone, (B):  3,5,7-tri[(4′-
methylpiperazin-1′-yl)methyl]tropolone (2), 3,5,7-tri[(4′-methylpiperidin-1′-yl)methyl]tropolone (6) and 
3,5,7-tri[(3′-methylpiperidin-1′-yl)methyl]tropolone (7) 
3.1.3. NS5A inhibitors 
The HCV NS5A as a part of replication complex is essential for RNA replication. It also has 
been associated with subverting host intracellular signaling pathways. The potent antiviral 
activity of different NS5A inhibitors has already been demonstrated in early clinical trial 
phase. Among them,  BMS-790052 entered phase III of clinical trial. Extended Rapid 
Virologic Response (eRVR) was achieved up to 83% of HCV genotype 1 patients under 
BMS-790052 treatment in combination with peg-IFN and ribavirin. BMS-790052 was well 
tolerated with a safety profile comparable in the placebo group [81]. BMS-790052 has been 
shown in vitro to have a low genetic barrier of resistance [82]. Another potent NS5A 
inhibitor, PPI-461, with a preclinical profile similar to BMS-790052 entered clinical trial [83]. 
Given the successful nature of clinical trial NS5A inhibitors can now be viewed as a 
potential cornerstone of HCV combination therapy. 
3.1.4. NS5B inhibitors 
The HCV NS5B RNA-dependent RNA polymerase as a catalytic component of HCV 
replication complex plays a crucial role in viral replication cycle. Because NS5B is 
structurally distinct from mammalian DNA and RNA polymerase enzymes, it is a potent 
target for the development of new anti-HCV agents. The inhibitors of NS5B are divided into 
two classes: nucleoside inhibitors (NIs) and non-nucleoside inhibitors (NNIs). The 
nucleoside inhibitors bind to the active site of polymerase, resulting in chain termination 
and premature termination of HCV RNA synthesis. Optimization of nucleoside analogues is 
complicated by NIs interaction with cellular polymerases and signaling pathways. The most 
advanced candidate for drug is RG7128, which is currently in phase II clinical trial and has 
shown highly promising safety, tolerability and efficacy profile. In a 14-day monotherapy 
RG7128 showed high antiviral efficacy, achieving viral load decreases up to 2.7 log IU/ml at 
the end of dosing period. In phase IIa study 88% of infected patients with genotype 1 and 
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90% of patients infected with genotype 2 or 3 achieved undetectable viral load after 4 weeks 
of combination treatment with RG7128, PEG and RBV. Moreover, there were no evidence of 
resistance selection during two weeks of monotherapy. These results suggest a high 
antiviral activity in HCV infected patients and a high barrier to resistance of nucleoside 
analogues as inhibitors of HCV replication [84].  
The HCV non-nucleoside inhibitors bind to one of the four allosteric binding sites within the 
HCV polymerase: site I (Thumb I) for JTK-109, site II (Thumb II) for PF-868554, VCH-759, 
VCH-916 and VCH-222, site III (Palm I) for ANA-598, A-848837 and ABT-333, and site IV 
(Palm II) for HCV-796, resulting in conformational changes of the protein and inhibition of 
catalytic activity of polymerase. Currently, a number of NNIs have entered the clinical trial 
(Table 1).  
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Table 1. HCV NS5B non-nucleoside inhibitors under clinical investigation 
HCV-796 was the first inhibitor that showed an antiviral effect in HCV-infected patients, but 
due to hepatic toxicity HCV-796 was withdrawn from clinical trial. PF-868554, VCH-759, 
VCH-916, VCH-222, ANA-598 and ABT-333 proved antiviral activity in early clinical trials 
and some have been advanced to phase II.  
PF-868554 was tested in monotherapy over 8 days in genotype 1 patients with chronic 
infection. All patients demonstrated antiviral response after 48 hours of treatment. In phase 
IIa clinical trials patients with genotype 1 were treated with PF-868554 in combination with 
Peg-IFN/RBV. By week 4 HCV RNA plasma levels dropped up to 4.43 log10 compared with 
placebo and Peg-IFN/RBV group. After 12 weeks of treatment up to 88% had undetectable 
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VCH-222 antiviral activity in HCV replicons resulted in EC50 values of 22.3nM for genotype 
1a, 11.2nM for genotype 1b and 4.6μM for genotype 2a. Patients with genotype 1 were 
treated with VCH-222 for 3 days in phase Ib clinical study. All patients demonstrated rapid 
and significant antiviral response with 3 log10 in plasma HCV RNA [85]. 
ANA598 activity against genotype 1 was shown in in vitro HCV replicon system [86]. In 
phase II clinical  study genotype 1 patients received ANA598 in combination with  Peg-
IFN/RBV for 12 weeks. Early virological response was achieved in 73% of HCV infected 
patients [85].  
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ABT-333 entered clinical trial after showing in replicon assays its potent inhibition of 
genotype 1a and 1b polymerases. Antiviral activity of ABT-333 was evaluated in 
combination with Peg-IFN/RBV. At the last day of therapy (Day 28) 41.7% of patients had 
undetectable HCV RNA [85]. 
Non-nucleoside polymerase inhibitors selected different NS5B mutations which exhibited 
resistance profiles. Given the distinct binding sites and resistance profiles among different 
NNIs, it is likely that two to three NNIs could be used in combination [85]. Antiviral activity 
and tolerability of the HCV NNIs is promising, but the use of NS5B inhibitors in treatment 
of HCV infection need more studies in future clinical trials. 
4. Conclusions 
The current standard of care (SOC) of chronic hepatitis C infection based on pegylated-IFN 
and ribavirin has limited efficacy and undesirable side effects. Efficient therapies must be 
developed to eliminate HCV infections, which pose a serious worldwide health problem. 
More than 80% of HCV infected patients develop the persistent infection, which leads to 
serious liver diseases, like liver cirrhosis or hepatocellular carcinoma. The lack of small 
animal models for HCV hamper studies on viral replication and search for potent antiviral 
targets. Development of HCV replicons able to replicate in cell line Huh-7 and in vitro 
HCV infection system using the JFH-1 clone provide a good method for screening the new 
antiviral drugs. An infectious HCV cell culture system is a powerful tool that could be 
used to study HCV life cycle and function of particular viral proteins. These studies allow 
to find viral targets for direct-acting antiviral (DAA) drugs and develop Specifically 
Targeted Antiviral Therapies for HCV (STAT-C). STAT-C let to achieve better 
effectiveness of treatment, its shortening, and the diminishment and limitation of side 
effects. Current studies are focused on searching for the new therapeutic agents for 
hepatitis C, which are directed against viral enzymes. Several HCV pro-drugs selected in 
in vitro HCV replicon system as  potent HCV inhibitors, have reached clinical 
development, but the most advanced include inhibitors of NS3/4A protease. Two of them: 
boceprevir and telaprevir were approved in 2011 by the Food and Drug Administration 
(FDA) for the treatment of chronic hepatitis C genotype 1 infection, in combination with 
PegIFN-α and RBV. 
The most intensive studies are focused on searching for novel DAAs against HCV genotype 
1. Infections with genotype 1 are the most prevalent and dangerous, leading to liver injury 
and hepatocellular carcinoma. Moreover, patients infected with genotypes 1 respond to SOC 
less effectively than patients infected with genotypes 2 and 3. Because an infectious HCV 
cell culture system is restrictive adapt to genotype 2a, subgenomic HCV replicon systems 
are used worldwide for screening new antivirals against genotype 1.  
In conclusion, in vitro tissue-based model of HCV replication allowed to determine the viral 
life cycle and function of particular viral proteins, which is crucial for the development of 
novel more efficient antivirals. 
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1. Introduction 
It is quite clear nowadays that the pathogenesis of infectious disease, although determined 
by pathogenic features of their causative agents, cannot be fully comprehended without 
structural (morphologic) analysis of immediate interaction between these agents and cells, 
tissues, and defense systems of the host. In diseases caused by agents adapted to certain 
cellular targets, the pathogenesis is, in addition, influenced by histophysiologic features of 
these targets wich are utilized or distorted or both by the pathogen.  
Acute diarrheal diseases caused by Gram-negative bacteria: Vibrio cholerae, diarrheagenic 
Escherichia coli, Shigella, Salmonella, Aeromonas and enteropathogenic Yersinia, are examples of 
this type of infection. All of these agents target the same cell type, the enterocyte, and 
produce potent exotoxinas. [1] 
The morphologic method either produced an impetus to bacteriologic studies or served as a 
tool in the evaluation of bacterial pathogenicity, including that of genetically altered 
microorganisms. In particular, morphologic studies have revealed that enteric bacteria 
either colonize enterocytes while remaining epicellular ( i.e., bound to the cell surface) with 
or whithout affecting cellular architecture, or they invade the cell with or whithout its 
destruction. On the other hand, biochemical studies have shown that prevalence of the 
secretory or destructive inflammatory disturbances in the gut is, for the most part, 
determined by bacterial exototoxins. Although exotoxins affect enterocytes by a variety of 
mechanisms, they can be combined into two groups that are referred to as cytotonic and 
cytotoxic or respectively, as enterotoxins and cytotoxins. It has also been established that 
each step in host-pathogen interaction is governed by multiple determinants encoded in 
bacterial plasmid and chromosome genes. [1,2,3] 
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The genus Aeromonas comprises gram-negative bacteria that can be isolated from water and 
a diversity of foods. Some strains are important diarrhea producers, particularly in children 
under five years and in older adults [4,5]. 
The clinical manifestations of diarrhea vary from autolimited symptoms to severe cases with 
presence of mucus and blood in faeces, suggesting that, as in Escherichia coli pathogenic 
types, Aeromonas virulence is multifactorial [6,7]. In recent years Aeromonas spp. have 
emerged as an important human pathogen, with increasing incidence among travelers 
(causative agent of traveler´s diarrhea), due to their presence in food as well as in treated 
water for human consumption [8].  
The aim of this chapter, is to show that with the development of an in vitro animal model, to 
explore the mechanisms related to the colonization of the digestive tract, as well as the 
determination of the mechanisms of interaction with the host epithelium, provide a valuable 
tool in the study of bacterial entropathogenicity that the genus Aeromonas  
2. Interaction host/bacterial pathogen 
The Aeromonas enteropathogenic capability is usually underrated [7,9,10]. Information about 
decisive diarrhea virulence factors is limited, due to lack of appropriate animal models for 
the study of Aeromonas genus. [7,10,11]). With the models developed up to now, it has 
obtained scarce information about the interaction between the host and Aeromonas spp. 
[10,11,12,13,14]. 
In this regard, the development of an in vitro model to explore the mechanisms related to the 
colonization of the digestive tract by Aeromonas spp. as well as the determination of the 
mechanisms of interaction with the host epithelium, provides a valuable tool in the study of 
Aeromonas pathogenicity. On the other hand, the critical steps in the pathogenesis of virulent 
strains involve the adhesion and colonization of the intestinal mucosa by Aeromonas. 
The present focuses in the analysis of the mechanisms causing the pathogenicity of 
Aeromonas strains in co-cultures of isolated bacteria with intestinal cells. Ultrastructural 
aspects of mouse small intestinal tissue cultures infected with Aeromonas strains are 
described using a novel experimental procedure which allows to culture Aeromonas inside a 
previously sterilized short cylinder of mouse´s small intestine. 
3. Materials and methods 
3.1. Bacterial strains and growth conditions 
Two strains of Aeromonas caviae were used, one (A) isolated from an asymptomatic patient 
and the other one (D) from a patient with diarrhea in which the isolated Aeromonas was the 
only enteropathogen. The strains were inoculated in trypticase soya agar (HIMEDIA 
laboratories Ltd., Bombay, India 400 086) at a concentration of 1.5 X 108 CFU/ml and 
incubated for 24h. After incubation the media were gently filtered and the corresponding 
Aeromonas strain resuspended in 1ml Basal Medium Eagle (BME). 
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3.2. Tissue culture procedure 
Segments of the small intestine were removed from the abdominal cavity of young adult 
NMRI mice to prepare small intestine cylinders of ~3cm in length that were sterilized with a 
10% chlorine solution. One end of each intestinal cylinder was tied with sterile surgical 
thread and the cavity was filled with 1.5 X 108 CFU/ml of a given one of the two Aeromonas 
strains suspended in BME. After filling, the cylinders were tied close with surgical thread. 
The whole preparations were co-cultured in 50ml of tissue culture media containing 90% 
BME with Earle´s salts and L-glutamine, 10% horse serum, 5000IU/ml penicillin and 5mg/ml 
streptomycin, 360mOsm, pH 7.2, at 37°C, under constant rotation at 70rpm, for 24h and 48h. 
During the incubation period, the media were oxygenated every 4h during daytime. Control 
small intestine cylinders were cultured for 48h under the same conditions but without 
Aeromonas inside. Once the programmed culture time was accomplished, the intestinal 
cylinders were removed from the flask and immediately immersed in a fixing solution 
containing 3% glutaraldehyde and 3% formaldehyde in 0.1M cacodylate buffer, pH 6.3 [15] 
during 6h at 4°C. 
The intestinal cylinders were cut in small sections of approximately 3mm3, washed in 0.1M 
cacodylate buffer, pH 7.2, and postfixed for 24h in 1% osmium tetroxide prepared in the same 
buffer. The tissue was then dehydrated in ascending concentration ethanol solutions, 
followed by propylene oxide and finally embedded in Epon 812. Sections of 1μm were 
stained with 1% toluidin blue and observed under a high resolution light microscope. 
Sections of 90 nm were contrasted with uranyl acetate [16] and lead citrate [17] using a 
modification of this classic method [18] and were analyzed using a Hitachi-7000 transmission 
electron microscope. [19,20]. 
4. Effects of Aeromonas caviae co-cultured in mouse small intestine 
The experimental desing herein presented offers appropriate conditions for the 
physiopathologic study of the interrelationship between the intestinal wall and bacteria 
under in vitro conditions very similar to in situ conditions.  
On the other hand, this experimental model employed using co-cultures of mouse intestinal 
mucosa with Aeromonas caviae revealed important information on the pathogenicity of this 
species in gastrointestinal infections. The strain A, isolated from asymptomatic patient, 
produce minor to mild alterations of the intestinal wall, while more pronounced alterations 
were found at both periods of incubations when strain D, from the patient with diarrhea, 
was used to prepare the co-cultures. 
The damage produced was demonstrated by the alterations of the integrity of intestinal 
microvilli, disruption of the epithelium and presence of mucosal microulcerations, which 
were brought about by the fact that this strain is an high cytotoxin producer and may 
possess other virulence factors [4,21] 
These strains belong to the A. caviae species and were considered of lesser virulence than 
other strains of this species [22]. 
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Light microscopical observations revealed a varying degree of histological alterations of the 
intestinal wall, according to the severity of the damage. The major tissue damage is shown 
in Figure 1, where a large bacterial cluster can be seen occupying the crypts between 
intestinal folds. In most cases, the intestinal wall showed a high degree of generalized 
cellular atrophy with tissue lysis when the diarrhea producing strain (D) was used. These 
images were seen at 24h as well as at the 48h samples of incubation. 
 
Figure 1. Large cluslers of Aeromonas occupied the intestinal crypts when the co-cultures were 
prepared using the strain D. which comes from symptomatic patient. Note: the high degree of tissular 
lysis. Bar: 9.4μm. 
In cases of moderate damage, the basic cytoarchitecture of the intestinal mucosa was 
preserved and it was possible to recognize enterocytes, mucous cells and germinative or 
mother cells. The villi as well as the majority of the crypts were seen, althought some of 
them were shorter and thicker (Figures 2 and 3). 
These mild damages were caused when the strain A from the asymptomatic species was 
employed for the co-culture. Microvilli were seen forming part of the apical surface of the 
enterocyte as well as cytoplasmatic protrusion that come from the apical portion of the 
enterocytes (Figure 4). 
Some segments of the intestinal cylinder co-cultured with Aeromonas strains showing a 
higher degree of alterations contains clusters of spheroidal cells associated to bacterial 
elements (Figures 3 and 6). 
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Figure 2. A case of mild damage of the small intestinal epithelium produced when the asymptomatic 
strain (A) was co-cultured during 48h. Well-aligned enterocytes can be seen, with a few of them 
exhibiting a dark content indicating cellular atrophy. The arrow points at an exocytic fragment. Bar 
24.0μm 
 
Figure 3. In addition to the exocytic detachment fragments (straight arrows), clusters of extraintestinal 
cells close to the epithelium are also seen (curved arrow). Some Aeromonas (circle) are present. Note that 
bacterial cells are not in contact with the entenocytes. Strain A was used co-cultured. Bar: 24.0um. 
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Transmission electron microscopy revealed minor alterations of the intestinal mucosa when 
the strain from asymptomatic patients (A) was co-cultured. Most enterocytes were seen with 
seen with typical ultrastructural characteristics, however, they showed numerous apical 
protrusion detachments (Figures 2 and 4). In more damaged regions, there was a 
progressive atrophy of the epithelial cells showing loss of microvilli and large cellular 
vacuoles loaded with cellular detritus (Figure 5). 
 
 
Figure 4. Enterocytes show almost normal ultrastmctural characteristics at 24h of co-culture when the 
asymptomatic strain (A) was employed. The main pathological feature observed in these cultures is the 
presence of exocytic detachments (arrow). The enterocytic epithelial cell, cytoplasm and microvilli also 
have normal ultrastructural features. Bar: l.0μm. 
In the intestinal regions having intermediate epithelial alterations, globular cells identified 
as blood and lymphatic cells were observed in the gut lumen associated to Aeromonas and 
cellular debris (Figures 3 and 6). Eosinophils were seen with multilobular nuclei and their 
characteristic lysosomes with crystal-like structures (Figures 7 and 8). In Figure 8 
phagocytated Aeromonas within the eosinophilic cytoplasm are clearly visible. 
Cells identified as lymphocytes (Figure 7) and others as plasma cells (Figure 9) were also 
observed as part of the clusters of globular cells found in the small intestine cylinder lumen 
after two days of culture. 
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Figure 5. After 48h, the co-cultures prepared with strain A, the enterocytes showed large vacuoles (V) 
loaded with cytoplasmic debris (’EC,: EC") as seen in this photograph. Note the signicant reduction of 
the microvilli. Bar: l.0pm. 
 
Figure 6. In all analyzed cases. the Aeromonas (straight arrow) are not seen attached to the surface of 
enterocytes that. while showing show a signicant reduction of microvilli, have preserved their 
glycocalix cover (curved arrow). Bar: 0.4μm. 
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have normal ultrastructural features. Bar: l.0μm. 
In the intestinal regions having intermediate epithelial alterations, globular cells identified 
as blood and lymphatic cells were observed in the gut lumen associated to Aeromonas and 
cellular debris (Figures 3 and 6). Eosinophils were seen with multilobular nuclei and their 
characteristic lysosomes with crystal-like structures (Figures 7 and 8). In Figure 8 
phagocytated Aeromonas within the eosinophilic cytoplasm are clearly visible. 
Cells identified as lymphocytes (Figure 7) and others as plasma cells (Figure 9) were also 
observed as part of the clusters of globular cells found in the small intestine cylinder lumen 
after two days of culture. 
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Figure 5. After 48h, the co-cultures prepared with strain A, the enterocytes showed large vacuoles (V) 
loaded with cytoplasmic debris (’EC,: EC") as seen in this photograph. Note the signicant reduction of 
the microvilli. Bar: l.0pm. 
 
Figure 6. In all analyzed cases. the Aeromonas (straight arrow) are not seen attached to the surface of 
enterocytes that. while showing show a signicant reduction of microvilli, have preserved their 
glycocalix cover (curved arrow). Bar: 0.4μm. 
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Figure 7. Among the globular cells located in the intestinal lumen of the co-cultures prepared using 
strain A from the asymptomatic patient. abundant eosinophilic granulocytes (B) were found. Numerous 
cytoplasmic lysosomes containing crystal-like inclusions characterize these cells and nuclear lobules are 
also visible. Proles of Aeromonas (arrow) are detected outside the eosinophilic cells. Lym: lymphocyte. 
Bar: 0.5 μm. 
 
Figure 8. Within the cytoplasm of eosinophils. Aeromonas (‘A’) could be observed in association with 
the lysosomes. indicating the phagocytic capability of these cells. N. nucleus. Bar: 0.7 in. 
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In Figure 10 an image is shown of a cylinder of small intestinal segment incubated for 48h 
using the same culture conditions but without Aeromonas in its lumen, with the purpose to 
compare the control cylinders to the ones co-cultured with the bacteriae. No atrophic cells 
are seen and there are no visible epithelial protrusions, extraepithelial cells nor 
microulcerations of the intestinal wall. The villi and crypts show minor changes due to the 
culture conditions. 
 
Figure 9. Plasma cells were other lymphatic elements frequently observed in the lumen of clustered 
cells. In this particular case. note the proliferation of the rough endoplasmic reticulum. Bar: 0.4 μm. 
 
Figure 10. A control small intestine cylinder incubated without Aeromonas during 48h. Note the well 
preserved villi and cryptae as well as the absence of atrophic enterocytes and epithelial protrusions. 
Extraepithelial cells are not seen. Bar: 24.0 μm. 
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The cylinders of small intestinal cultures incubated for 24h and 48h revealed good 
preservation. The glycocalyx was clearly observed covering the microvilli (Figure 11). No 
vesicular chains were observed in or between the microvilli, nor was any type of bacteria 
observed in the intestinal lumen. 
 
Figure 11. a: Segments of enterocytes from a control sample with normal ultrstructural characteristics 
alter 48h of culture. Bar: 1.5μm. b: detail of the normal ultrastructural features of an intestinal epithelial 
cell. Note the absence of vesicles between microvilli. Arrows, glycocalyx. Bar: 0.5 μm 
After 24h de incubation, the Aeromonas spp. strain cultured with the intestinal tissue showed 
vesicular elements attached to the bacterial outer membrane (Figure 12). These vesicles were 
seen alone, in pairs, or in groups of five or more vesicular units organized in chains 
emerging from the external membrane. Adjacent to these vesicles some complex 
membranous structures were observed (Figure 12). 
The small intestine tissue cultivated with Aeromonas spp. and incubated for 24h did not 
present any alteration or modification in its cellular structure. The only outstanding 
observation was the presence of vesicular chains composed of four to ten vesicular units, 
which were aligned between microvilli spaces (Figure 13). 
 





Figure 12. Cross sections of Aeromonas spp. cultured for 24h. Short chains of vesicles (in a) and large 
chains of vesicles (in b) can be seen emerging from the external bacterial membrane. Notice adjacent 
complex membranous structures (curved arrow) to these chains. Thick arrows: bacterial external 
membrane; short arrows: chains of vesicles. Bars: 0.17 μm in a, 0.15 μm in b. 
When the segments of the small intestine were cultivated with Aeromonas spp., and then 
incubated for 48h, severe damage of the enterocytic epithelial surface was seen, with regions 
of tissular lysis on the surface of the intestinal microvilli (Figures 14 and 15). Numerous 
defensive cells such as lymphocytes were also observed (Figure 15), as well as abundant 
eosinophils showing their typical crystal-like structures inside lysosomes (Figure 16), and 
phagocytic mononuclear cells (Figure 17). Inside the cytoplasm of both of these cell types, 
Aeromonas spp. could be observed (Figures 16 and 17) 
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Figure 13. At a higher magnification, it is possible to identify the glycocalyx(asterisk) of the microvilli, 
and the particular vesicular chains (curved arrows) appearing between microvilli after 24h of culture 
with an Aeromonas spp. strain. Some microvilli fibrillary roots (straight arrow) are clearly seen. Bar: 
0.35&#956;m 
 
Figure 14. Light microscopic image of a segment of a small intestinal cylinder cultivated with Aeromonas 
spp. for 48h. The enterocytic epithelial surface shows regions with tissular lysis (arrow). Bar: 7.0 μm. 
 



















Figure 15. Notice the lysis (straight arrow) of the surface of the small intestine and the presence of 
defensive cells or lymphocytes (curved arrows) after 48h culture with Aeromonas from the symptomatic 
patient. Bar: 4.4 μm. 
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Figure 15. Notice the lysis (straight arrow) of the surface of the small intestine and the presence of 
defensive cells or lymphocytes (curved arrows) after 48h culture with Aeromonas from the symptomatic 
patient. Bar: 4.4 μm. 
 

















Figure 16. Eosinophils containing numerous phagocyted Aeromonas spp. (straight arrows) from 
symptomatic strain, are a common feature of the 48h intestinal Aeromonas cultures. These eosinophils 
show lysosome crystal-like structures (curved arrows). N: nucleus, *: cellular debris. Bar: 0.95 μm. 
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Figure 17. After 48h culture of Aeromonas spp. with small intestine tissue it is possible to see, within 
cellular clusters adjacent to the enterocytes, numerous phagocyte mononuclear cells. Inside the 
cytoplasm of these cells, phagocyted Aeromonas (arrows) can be identified. Bar:0.65 μm. 
The pathogenicity of Aeromonas has been confirmed with this procedure and its virulence 
has been corroborated as strain-specific and not species-specific. 
When the intestinal epithelium lesions were observed no bacteriae adhered to the cells were 
seen, indicating that direct bacteria-epithelial cell contact was nor required for tissue 
alterations: on the contrary, it seems that Aeromonas triggers a chemotactic response which 
activates migratory actions to the lymphatic cells from the adjacent lymphatic plaques. 
The lymphatic submucous plaques and the autonomous defensive structures are able to act 
in culture conditions even in the absence of the circulatory blood elements, bone marrow 
cells or other lymphatic organs. Among the defense elements that migrate in answer to the 
chemotactic stimulus are the eosinophilic granulocytes, which have been reported to 
participate only in parasitic diseases. In this investigation their capability to defend 
intestinal cells against bacterial aggressions [23,24] is ultrastructurally documented. 
Under the conditions of the experiment, no alteration of the intestinal epithelium was 
observed in the cultures from the small intestine with Aeromonas spp. incubated during 24h, 
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except for vesicular chains aligned between microvilli spaces (Figure 13), which were not 
distinguished from those vesicular elements seen attached to the bacterial outer membrane 
(Figure 12) in the same cultures. 
On the other hand, in cultures with 48h incubation, Aeromonas initially induced important 
tissue damage, including necrosis and lysis of the intestinal microvilli (Figures 14 y 15). 
The vesicles produced on the surface of the bacterial outer membrane are also constituted by 
a double membrane unit. The production of these vesicles was observed in all the cultures 
analyzed. However, the more important vesicular formation was detected in the cultures 
incubated for 24h, whereas in the samples incubated for 48h, the vesicles were found where 
the intestinal damage was more severe. 
The ultrastructural analysis suggest that Aeromonas spp. produce vesicles that form chains 
and can be seen between the microvilli of the intestinal epithelium. The contact between 
them could be one the mechanisms that trigger virulence factors produced by Aeromonas 
spp., contained in the vesicles, and that could subsequently initiate mechanisms that attract 
eosinophils and mononuclear cells into the intestinal lumen. 
The vesicles do not appear to be intestinal exocytic vesicles because they are formed on the 
surface of the bacterial outer membrane. Moreover, no clathrin-like outer skeleton is seen, 
which suggest that this vesicular system is a part of the pathogenic mechanism of action that 
induces the migration of eosinophils and macrophages. 
In the cultures with a 24h incubation period, the vesicular chains were found adhered to the 
bacterial outer membrane as well as occupying the free spaces between microvilli. In 
cultures incubated for 48h, the vesicles were absent, whereas some regions of the enterocytic 
epithelial surface lost their organization, leading to tissue lysis. The vesicles could constitute 
a carrier tool that facilitates the approximation and the interchange of enterotoxins, 
inmunologicals material or any other natural element responsible for the virulence and 
pathogenicity of Aeromonas spp., similar to what has been described by [25]. 
The strain isolated from the patient with diarrhea produced important alterations in the 
intestinal mucosa, indicating its enteropathogenic potential. This strain is a cytotoxin 
producer and, as has been pointed out for Shigella, a correlation exists between the severity 
of the lesions of the mucosal membrane and the toxigenicity of a particular strain [1]. 
5. Conclusion 
In conclusion the genus Aeromonas has great enteropathogenic potential, although 
additional studies are necessary to understand more about the pathogenicity of other 
Aeromonas strains, this procedure also may useful to determinate currently unknown 
interactions between a variety of other enteropathogenic bacteria and, the results obtained 
in these studies give a valuable contribution for the future application of this procedure in 
the bacterial patogenicity research. 
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1. Introduction 
1.1. Respiratory Tract Infections (RTIs) 
Respiratory tract infections (RTIs) are caused directly or indirectly by any infectious agent 
that implants and replicates in the respiratory tract, in the pulmonary parenchyma or onto 
pleural sierose and causes clinical syndromes with prevalent respiratory symptoms [1]. 
When the respiratory tract is only the first site of infection, patients show respiratory 
syndromes, but then symptoms involve the specific anatomic district target of the infectious 
agent, as we can see in some infectious disease: Measles, Scarlet fever, Mononucleosis, 
Meningococcal disease and Varicella. Even with these limitations RTIs are the most common 
infections in men and are a significant cause of morbidity and mortality in both developing 
and developed countries among infants, youngsters and elderly people, and are the first 
cause of temporary invalidation (absence from work or school), visiting emergency service 
and family doctor consultancies during the winter season, independently from the age [2]. 
so they are a great socioeconomic and medical burden. In 2010, the World Health 
Organization (WHO) estimated that RTIs caused about 3 million deaths worldwide, 
including developed countries, being the first cause of child mortality [3]. Respiratory 
infections are common in both hospital and community settings. The third national 
prevalence survey conducted in 2006 found that infections of the lower respiratory tract 
(LRTI, not pneumonia) and pneumonia together accounted for 19.9 percent of the 
Healthcare Associated Infections (HCAIs) in acute hospitals. It I important also to consider 
the hospital-acquired infections affecting the respiratory tract that cause considerable 
morbidity and mortality. This type of respiratory infections generally affects those who are 
affected from serious diseases [4]. RTIs can be classified in, infections of the upper 
respiratory tract (URIs), which affect the nose, sinuses and throat (common cold, tonsillitis, 
sinusitis, laryngitis, influenza) and infections of the lower respiratory tract (LRTIs), which 
 The Author(s). Li ensee InT ch. This chapter is distr buted under the terms of the Creativ  Commons 
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1. Introduction 
1.1. Respiratory Tract Infections (RTIs) 
Respiratory tract infections (RTIs) are caused directly or indirectly by any infectious agent 
that implants and replicates in the respiratory tract, in the pulmonary parenchyma or onto 
pleural sierose and causes clinical syndromes with prevalent respiratory symptoms [1]. 
When the respiratory tract is only the first site of infection, patients show respiratory 
syndromes, but then symptoms involve the specific anatomic district target of the infectious 
agent, as we can see in some infectious disease: Measles, Scarlet fever, Mononucleosis, 
Meningococcal disease and Varicella. Even with these limitations RTIs are the most common 
infections in men and are a significant cause of morbidity and mortality in both developing 
and developed countries among infants, youngsters and elderly people, and are the first 
cause of temporary invalidation (absence from work or school), visiting emergency service 
and family doctor consultancies during the winter season, independently from the age [2]. 
so they are a great socioeconomic and medical burden. In 2010, the World Health 
Organization (WHO) estimated that RTIs caused about 3 million deaths worldwide, 
including developed countries, being the first cause of child mortality [3]. Respiratory 
infections are common in both hospital and community settings. The third national 
prevalence survey conducted in 2006 found that infections of the lower respiratory tract 
(LRTI, not pneumonia) and pneumonia together accounted for 19.9 percent of the 
Healthcare Associated Infections (HCAIs) in acute hospitals. It I important also to consider 
the hospital-acquired infections affecting the respiratory tract that cause considerable 
morbidity and mortality. This type of respiratory infections generally affects those who are 
affected from serious diseases [4]. RTIs can be classified in, infections of the upper 
respiratory tract (URIs), which affect the nose, sinuses and throat (common cold, tonsillitis, 
sinusitis, laryngitis, influenza) and infections of the lower respiratory tract (LRTIs), which 
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affect the airways and lungs (influenza, bronchitis, pneumonia, bronchiolitis, tuberculosis, 
that is a persistent bacterial infection of the lungs). LRTIs include two serious conditions – 
acute bronchitis and pneumonia: 
Acute bronchitis (inflammation of the bronchi) is an acute respiratory infection in which the 
dominant symptom is coughing without localized infection. It must not not be confused 
with chronic bronchitis, which is a chronic obstructive pulmonary disease (COPD). Acute 
bronchitis is usually an infection that is community-acquired and typically it arises as a 
complication of URI caused by a virus, when bacterial infection supervenes. Children that 
seem prone to bronchitis generally have poor living conditions (overcrowding,poor hygiene 
and poor nutrition) and the respiratory disease may be exacerbated by maternal smoking, 
especially during pregnancy. It I reported that individuals who have experienced childhood 
bronchitis are at risk of developing further symptoms during their teenage years if they then 
smoke [5]. Pneumonia (inflammation of the lung) is a serious condition, that caused may 
death after RTI, especially in older adults and infants. It may be acquired in hospital or the 
community. The alveoli become filled with pus, air is excluded, and the lung is said to be 
‘consolidated’.In bronchopneumonia, consolidation is widely distributed; in lobar 
pneumonia,it is localized [6]. In the community, bacterial pneumonia is most frequently 
caused by Streptococcus pneumonia that infects most commonly people with pre-
existinghealth problems, frequently developing as a complication of some other RTI (for 
example influenza or measles). The establishment of a pharmacological treatment is 
complicated because some strains of Streptococcus pneumoniae are now resistant to penicillin, 
so vaccination has been recommended in the UK since 2003. The pneumococcal vaccine is 
part of the childhood immunization program and it is also recommended to people over 65 
years of age. It is also recommended for people following splenectomy and those with 
dysfunction of the spleen, sickle cell disease, coeliac disease, chronic renal disease, chronic 
respiratory disease, chronic heart conditions, liver disease, diabetes mellitus, 
immunosuppression and HIV. After vaccination, about 80 per cent of healthy adults 
develop a good antibody response within three weeks. Other bacteria responsible for 
community-acquired pneumonia include Mycoplasma pneumoniae, Haemophilus influenzae, 
Legionella pneumophila and Staphylococcus aureus, including the strain that produces the 
Panton–Valentine leukocidin toxin [7]. It I mandatory also to consider hospital acquired 
pneumonia. It mainly affects critically ill and postoperative patients. Risk factors include 
obesity, impaired consciousness, a history of smoking and underlying respiratory disease. In 
hospital, bacteria, viruses or fungi can cause pneumonia, but most hospital-acquired 
pneumonia is caused by S. aureus and Gram-negative opportunists [8]. URIs that involve the 
nasal passages, pharynx, tonsils and epiglottis are minor infections acquired in the 
community and are caused by viruses. URIs can, however, have serious consequences for 
the very young and older adults. They also account for a high proportion of days lost from 
work and school, so their impact on the health of individuals and their social and economic 
consequences should not be dismissed. The nasal discharge associated with colds contains 
viral particles, dead cells from the nasal mucosa and bacteria, but these are of the same type  
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as are present in health. Bacterial invasion of the damaged epithelium is rare, and antibiotics 
are seldom required. Acute ear infection occurs as a complication with up to 30 percent of 
URIs. Because most URIs are self-limiting, their complications are more important than the 
infections, mastoiditis and other complications of URIs account for nearly 5 percent of all 
URI worldwide leading to hearing impairment or deafness most of the times in developing 
countries where there is limited access to adequate medical treatments. RTIs are 
extraordinary frequent because of a great number of antigenically distinct aetiological 
agents, their great diffusion and the short period of immunization. Moreover the anatomic 
structure of the respiratory tract shows high variable physicochemical parameters such as 
temperature, pH, and humidity that assurance a great number of habitat for various 
microorganisms. Moreover the respiratory tract is directly connected to the external 
environment and it is continuously crossed by the airflow that frequently contains irritant 
agents (atmospheric contaminants, cigarette smoke, cold air, fines) that may injure the local 
mucosa end predispose to the implantation of microorganisms. Fortunately there is a huge 
amount of mechanisms of defense that preserve the integrity of this anatomic site, the 
nasopharyngeal lymphatic system, ciliary cells, salivary lisozima, antibodies, interferons 
and pulmonary macrophafges. The infectious agents of RTIs can be viruses, bacteria, fungi 
and protozoa, but they are usually caused by a virus [1, 2]. Bacterial agents causing RTIs can 
implant directly onto the mucosa of the respiratory tract, but more frequently they 
superinfect a tract of mucosa previously injured by a virus. Streptococcus pneumoniae, 
Haemophilus influenzae, and Moraxella catarrhalis are the most common organisms that cause 
the bacterial superinfection of viral acute sinusitis [8]. The sequence viral-bacterial infection 
is very frequent and must be considered to establish an appropriate pharmacological 
treatment. Parasitic infections of the respiratory tract occur worldwide among both 
immunocompetent and immunocompromised patients and may affect the respiratory 
system in a variety of ways. The most common parasites involved are, Ascariasis, Schistosoma 
and Toxoplasma gondii. Since the clinical presentations and radiographic findings of several 
of these diseases may mimic tuberculosis and malignancy it is important to consider 
parasitic infections in the differential diagnosis of such respiratory syndromes. If identified 
early, most parasitic respiratory diseases are curable with medical or surgical treatments [9]. 
RTIs are transmitted by airflow, pathogens enter the organism trough the upper respiratory 
tract and sometimes trough the conjunctivae, that have been infected by direct contact 
especially for viruses, or trough vectors, whereas the elimination of the infecting particles 
takes place trough cough. Rarely the respiratory tract can be reached by circulating 
microorganisms in blood. The reservoir for the majority of RTIss are infected humans that 
guarantee an optimal environment for the survival of the infecting agent, but some 
microorganisms that occasionally infect humans have animal reservoir; for example in 2002, 
a new Coronavirus (CoV) emerged in the People's Republic of China, associated with a 
severe acute respiratory syndrome (SARS) and mortality in humans. The epidemic rapidly 
spread throughout the world before being contained in 2003, although sporadic cases 
occurred thereafter in Asia. The virus was thought to be of zoonotic origin from a wild 
animal reservoir (Himalayan palm civets, Paguma larvata), but the definitive host is still 
unknown [10]. RTIs are generally epidemic because they are very contagious, generally they 
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are seldom required. Acute ear infection occurs as a complication with up to 30 percent of 
URIs. Because most URIs are self-limiting, their complications are more important than the 
infections, mastoiditis and other complications of URIs account for nearly 5 percent of all 
URI worldwide leading to hearing impairment or deafness most of the times in developing 
countries where there is limited access to adequate medical treatments. RTIs are 
extraordinary frequent because of a great number of antigenically distinct aetiological 
agents, their great diffusion and the short period of immunization. Moreover the anatomic 
structure of the respiratory tract shows high variable physicochemical parameters such as 
temperature, pH, and humidity that assurance a great number of habitat for various 
microorganisms. Moreover the respiratory tract is directly connected to the external 
environment and it is continuously crossed by the airflow that frequently contains irritant 
agents (atmospheric contaminants, cigarette smoke, cold air, fines) that may injure the local 
mucosa end predispose to the implantation of microorganisms. Fortunately there is a huge 
amount of mechanisms of defense that preserve the integrity of this anatomic site, the 
nasopharyngeal lymphatic system, ciliary cells, salivary lisozima, antibodies, interferons 
and pulmonary macrophafges. The infectious agents of RTIs can be viruses, bacteria, fungi 
and protozoa, but they are usually caused by a virus [1, 2]. Bacterial agents causing RTIs can 
implant directly onto the mucosa of the respiratory tract, but more frequently they 
superinfect a tract of mucosa previously injured by a virus. Streptococcus pneumoniae, 
Haemophilus influenzae, and Moraxella catarrhalis are the most common organisms that cause 
the bacterial superinfection of viral acute sinusitis [8]. The sequence viral-bacterial infection 
is very frequent and must be considered to establish an appropriate pharmacological 
treatment. Parasitic infections of the respiratory tract occur worldwide among both 
immunocompetent and immunocompromised patients and may affect the respiratory 
system in a variety of ways. The most common parasites involved are, Ascariasis, Schistosoma 
and Toxoplasma gondii. Since the clinical presentations and radiographic findings of several 
of these diseases may mimic tuberculosis and malignancy it is important to consider 
parasitic infections in the differential diagnosis of such respiratory syndromes. If identified 
early, most parasitic respiratory diseases are curable with medical or surgical treatments [9]. 
RTIs are transmitted by airflow, pathogens enter the organism trough the upper respiratory 
tract and sometimes trough the conjunctivae, that have been infected by direct contact 
especially for viruses, or trough vectors, whereas the elimination of the infecting particles 
takes place trough cough. Rarely the respiratory tract can be reached by circulating 
microorganisms in blood. The reservoir for the majority of RTIss are infected humans that 
guarantee an optimal environment for the survival of the infecting agent, but some 
microorganisms that occasionally infect humans have animal reservoir; for example in 2002, 
a new Coronavirus (CoV) emerged in the People's Republic of China, associated with a 
severe acute respiratory syndrome (SARS) and mortality in humans. The epidemic rapidly 
spread throughout the world before being contained in 2003, although sporadic cases 
occurred thereafter in Asia. The virus was thought to be of zoonotic origin from a wild 
animal reservoir (Himalayan palm civets, Paguma larvata), but the definitive host is still 
unknown [10]. RTIs are generally epidemic because they are very contagious, generally they 
 
Biomedical Tissue Culture 
 
224 
are more frequent during autumn and winter when atmospheric pollution is higher and 
permanence indoor increases. Acquired immunity after RTIs is generally short because the 
majority of the most common aetiological agents are ineffective immunogens; the 
immunological response to RTIs generally produces initially IgM and after IgG, so that the 
presence of IgG has a diagnostic value only if it increases for times or is very high. During 
RTIs many viral and bacterial immunogens induce the production of secretory IgA that are 
released in to the muco where they compete for tissue receptors and link to microorganisms. 
The periodic genetic mutations of RTIs aetiological agents vanish both natural and acquired 
immunity; each time that genetic mutations that involve major antigens take place, 
especially for viruses, the diffusion of the infecting agent of RTIs becomes pandemic [11]. An 
example of immune evasion due to genetic variability is given by INFVs that are dynamic 
and are continuously evolving. INFVs can change in two different ways: antigenic drift and 
antigenic shift. Antigenic drift takes place continuously while antigenic shift happens only 
occasionally. INF A viruses undergo both kinds of changes; INF B viruses change only by 
the more gradual process of antigenic drift. Antigenic drift refers to small, gradual changes 
that occur through point mutations in the two genes that contain the genetic material to 
produce the main surface proteins, hemagglutinin (HA), and neuraminidase (NA). These 
point mutations occur unpredictably and result in minor changes to these surface proteins. 
Antigenic drift produces new virus strains that may not be recognized by antibodies to 
earlier INFVs strains. This is one of the main reasons why people can become infected with 
INFVs more than one time and why global surveillance is critical in order to monitor the 
evolution of human INFVs for selection of which strains should be included in the annual 
production of INF vaccine. In most years, one or two of the three virus strains in the INF 
vaccine are updated to keep up with the changes in the circulating INFVs. For this reason, 
the immunization against INF needs to be vaccinated every year. Antigenic shift refers to an 
abrupt, major change to produce a novel INFV A subtype in humans that was not currently 
circulating among people. Antigenic shift can occur either through direct animal (poultry)-
to-human transmission or through mixing of human influenza A and animal influenza A 
virus genes to create a new human influenza A subtype virus through genetic reassortment. 
Antigenic shift results in a new human INFV A subtype [12, 13].  
2. Viral RTIs 
At least two hundred different viruses can establish RTIs and they belong to the 
Adenoviridae, Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Coronaviridae, Herpesviridae 
and Parvoviridae familes. Viruses the most frequently associated with RTIs are, Adenovirus 
(ADV), BoV, CoV, Enterovirus (ENTV), INFV A, B, C, Metapneumovirus (hMetV), 
Parainfluenza (IPV) viruses 1, 2, 3, 4, Rhinoviruses (RV), Respiratory Syncitial Viruses 
(RSV). While it is true that respiratory viruses place a greater burden on people in 
developing countries, these viruses are still a big health threat in the developed world, 
where over 100 million people have been killed INFV in the last century alone (Piralla et al. 
2011). In children, viruses are responsible for the majority of RTIs, with bacteria thought to 
be responsible for fewer than 15% of cases; acute pharyngitis is caused by viruses in more  
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than 70% percent of cases in young children, mild pharyngeal redness and swelling and 
tonsil enlargement are typical [2, 15]. The most pathogenetic viruses for humans are, INFV 
and RSV with high mortality rate in elderly people and infants respectively. INFVs have the 
highest evolution rate, being the INF A viruses those causing the most severe and expansive 
outbreaks. Genetic variations in INF A viruses usually lead to global epidemics or 
pandemics; the latest FluA (H1N1) outbreak in 2009 was originated by a variant INF A 
H1N1 of swine origin, classified by the World Health Organization (WHO) as level 6 alert, 
pandemic [16]. Viruses cause most URIs, with RVs accounting for the 25-30% of cases, IPV, 
ADV, RSV, INFV 25-35%, CoV 10% and ENTV (Coxsackievirus, CoxV) less than 5% [17]. 
Acute viral infections predispose to bacterial infections of the sinuses and middle ear, and 
aspiration of infected secretions and cells can result in LRIs. To date the most common 
causes of viral LRIs are RSVs. They tend to be highly seasonal, unlike PINFV, the next most 
common cause of viral LRIs. The epidemiology of influenza viruses in children in 
developing countries deserves urgent investigation because safe and effective vaccines are 
available. Before the effective use of measles vaccine, the Measles virus was the most 
important viral cause of respiratory tract–related morbidity and mortality in children in 
developing countries. ADVs are medium-sized (90-100 nm), non-enveloped icosohedral 
viruses with double-stranded DNA. There are over 50 types that are immunologically 
distinct that can cause infections in humans. ADVS are relatively resistant to chemical and 
physical agents and to adverse pH conditions and can live for a long time outside the body 
and most commonly cause respiratory illness. The symptoms of ADV infection can range 
from the common cold to pneumonia, croup, and bronchitis. Some ADVs types can cause 
other illnesses such as gastroenteritis, conjunctivitis, cystitis, and less commonly, 
neurological disease. Infants and people with weakened immune systems are at high risk for 
severe complications of ADV infection and some people infected with ADV can have 
ongoing infections in their tonsils, adenoids, and intestines that do not cause symptoms. 
They can shed the virus for months or years [18].Human bocavirus (hBoV), the second 
parvovirus potentially pathogenic to humans after Parvovirus B19 (Pb19), was discovered 
by PCR in respiratory samples collected from young children with respiratory diseases in 
Sweden in 2005. Since the first description of hBoV as a possible human pathogen of lower 
respiratory tract infections in children, it has been detected in at least 19 countries in the five 
continents. HBoV infections shows a variety of clinical symptoms; the most common 
symptoms in hBoV-infected children without coinfections are cough (85%), followed by 
rinorrhea (67%), fever (59%), difficulty in breathing (48%), diarrhea (16%), conjunctivitis 
(9%) and rash (9%), body temperature ranging from 37.5 to 40.2oC, wheezing; nausea, sore 
throat, headache and myalgia were also recorded in hBoV-infected children of older age and 
adults. The age distribution of hBoV-infected humans ranges from 10 days to 60 years, but 
hBoV was primarily detected in young children aged 6 months to 3 years. That a peak 
detection of hBoV is among children of 6 to 24 months of age [19]. CoVs (order Nidovirales, 
family Coronaviridae, genus Coronavirus) are a diverse group of large, enveloped, positive-
stranded RNA viruses that cause respiratory and enteric diseases in humans and other 
 
Biomedical Tissue Culture 
 
224 
are more frequent during autumn and winter when atmospheric pollution is higher and 
permanence indoor increases. Acquired immunity after RTIs is generally short because the 
majority of the most common aetiological agents are ineffective immunogens; the 
immunological response to RTIs generally produces initially IgM and after IgG, so that the 
presence of IgG has a diagnostic value only if it increases for times or is very high. During 
RTIs many viral and bacterial immunogens induce the production of secretory IgA that are 
released in to the muco where they compete for tissue receptors and link to microorganisms. 
The periodic genetic mutations of RTIs aetiological agents vanish both natural and acquired 
immunity; each time that genetic mutations that involve major antigens take place, 
especially for viruses, the diffusion of the infecting agent of RTIs becomes pandemic [11]. An 
example of immune evasion due to genetic variability is given by INFVs that are dynamic 
and are continuously evolving. INFVs can change in two different ways: antigenic drift and 
antigenic shift. Antigenic drift takes place continuously while antigenic shift happens only 
occasionally. INF A viruses undergo both kinds of changes; INF B viruses change only by 
the more gradual process of antigenic drift. Antigenic drift refers to small, gradual changes 
that occur through point mutations in the two genes that contain the genetic material to 
produce the main surface proteins, hemagglutinin (HA), and neuraminidase (NA). These 
point mutations occur unpredictably and result in minor changes to these surface proteins. 
Antigenic drift produces new virus strains that may not be recognized by antibodies to 
earlier INFVs strains. This is one of the main reasons why people can become infected with 
INFVs more than one time and why global surveillance is critical in order to monitor the 
evolution of human INFVs for selection of which strains should be included in the annual 
production of INF vaccine. In most years, one or two of the three virus strains in the INF 
vaccine are updated to keep up with the changes in the circulating INFVs. For this reason, 
the immunization against INF needs to be vaccinated every year. Antigenic shift refers to an 
abrupt, major change to produce a novel INFV A subtype in humans that was not currently 
circulating among people. Antigenic shift can occur either through direct animal (poultry)-
to-human transmission or through mixing of human influenza A and animal influenza A 
virus genes to create a new human influenza A subtype virus through genetic reassortment. 
Antigenic shift results in a new human INFV A subtype [12, 13].  
2. Viral RTIs 
At least two hundred different viruses can establish RTIs and they belong to the 
Adenoviridae, Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Coronaviridae, Herpesviridae 
and Parvoviridae familes. Viruses the most frequently associated with RTIs are, Adenovirus 
(ADV), BoV, CoV, Enterovirus (ENTV), INFV A, B, C, Metapneumovirus (hMetV), 
Parainfluenza (IPV) viruses 1, 2, 3, 4, Rhinoviruses (RV), Respiratory Syncitial Viruses 
(RSV). While it is true that respiratory viruses place a greater burden on people in 
developing countries, these viruses are still a big health threat in the developed world, 
where over 100 million people have been killed INFV in the last century alone (Piralla et al. 
2011). In children, viruses are responsible for the majority of RTIs, with bacteria thought to 
be responsible for fewer than 15% of cases; acute pharyngitis is caused by viruses in more  
 
Viral DNA and cDNA Array in the Diagnosis of Respiratory Tract Infections 
 
225 
than 70% percent of cases in young children, mild pharyngeal redness and swelling and 
tonsil enlargement are typical [2, 15]. The most pathogenetic viruses for humans are, INFV 
and RSV with high mortality rate in elderly people and infants respectively. INFVs have the 
highest evolution rate, being the INF A viruses those causing the most severe and expansive 
outbreaks. Genetic variations in INF A viruses usually lead to global epidemics or 
pandemics; the latest FluA (H1N1) outbreak in 2009 was originated by a variant INF A 
H1N1 of swine origin, classified by the World Health Organization (WHO) as level 6 alert, 
pandemic [16]. Viruses cause most URIs, with RVs accounting for the 25-30% of cases, IPV, 
ADV, RSV, INFV 25-35%, CoV 10% and ENTV (Coxsackievirus, CoxV) less than 5% [17]. 
Acute viral infections predispose to bacterial infections of the sinuses and middle ear, and 
aspiration of infected secretions and cells can result in LRIs. To date the most common 
causes of viral LRIs are RSVs. They tend to be highly seasonal, unlike PINFV, the next most 
common cause of viral LRIs. The epidemiology of influenza viruses in children in 
developing countries deserves urgent investigation because safe and effective vaccines are 
available. Before the effective use of measles vaccine, the Measles virus was the most 
important viral cause of respiratory tract–related morbidity and mortality in children in 
developing countries. ADVs are medium-sized (90-100 nm), non-enveloped icosohedral 
viruses with double-stranded DNA. There are over 50 types that are immunologically 
distinct that can cause infections in humans. ADVS are relatively resistant to chemical and 
physical agents and to adverse pH conditions and can live for a long time outside the body 
and most commonly cause respiratory illness. The symptoms of ADV infection can range 
from the common cold to pneumonia, croup, and bronchitis. Some ADVs types can cause 
other illnesses such as gastroenteritis, conjunctivitis, cystitis, and less commonly, 
neurological disease. Infants and people with weakened immune systems are at high risk for 
severe complications of ADV infection and some people infected with ADV can have 
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respiratory tract infections in children, it has been detected in at least 19 countries in the five 
continents. HBoV infections shows a variety of clinical symptoms; the most common 
symptoms in hBoV-infected children without coinfections are cough (85%), followed by 
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(9%) and rash (9%), body temperature ranging from 37.5 to 40.2oC, wheezing; nausea, sore 
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animals. There are three groups of CoV; groups 1 and 2 contain mammalian viruses, while 
group 3 contains only avian viruses. Within each group, CoVs are classified into distinct 
species by host range, antigenic relationships, and genomic organization. The viruses can 
cause severe disease in many animals, and several viruses, including infectious bronchitis 
virus, feline infectious peritonitis virus, and transmissible gastroenteritis virus, are 
significant veterinary pathogens. Human coronaviruses (hCoVs) are found in both group 1 
(HCoV-229E) and group 2 (HCoV-OC43) and are responsiblefor ~30% of mild upper 
respiratory tract illnesses [19]. In March 2003, a novel CoV, SARS-CoV was discovered in 
association with cases of severe acute respiratory syndrome (SARS). The sequence of the 
complete genome of SARS-CoV has been now determined; it is 29,727 nucleotides in length, 
has 11 open reading frames, and the genome organization is similar to that of other CoVs. 
Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closely 
related to any of the previously characterized CoV. By late April 2003, over 4300 SARS cases 
and 250 SARS-related deaths were reported to WHO from over 25 countries around the 
world. Most of these cases occurred after exposure to SARS patients in household or 
healthcare settings. The incubation period for the disease is usually from 2 to 7 days. 
Infection is usually characterized by fever, which is followed a few days later by a dry, non-
productive cough, and shortness of breath. Death from progressive respiratory failure 
occurs in about 3% to nearly 10% of cases. Evidence of SARS-CoV infection has been 
documented in SARS patients throughout the world. SARSCoV RNA has frequently been 
detected in respiratory specimens, and convalescent-phase serum specimens from SARS 
patients contain antibodies that react with SARS-CoV [19]. Enteroviruses (ENTV) genus 
belongs to the Picornaviridae family positive single stand ssRNA viruses. Current taxonomy 
divides non-polio human ENTVs into four species (human ENTVs A to D), including a total 
of 108 serotypes. Individual serotypes have different temporal patterns of circulation and 
can be associated with different clinical manifestations. Although the majority of human 
ENTV infections remain asymptomatic, these viruses are associated with various clinical 
syndromes, ranging from minor febrile illness to severe and potentially fatal pathologies, 
including aseptic meningitis, encephalitis, myopericarditis, acute flaccid paralysis, and 
severe neonatal sepsis-like disease. ENTVs are responsible for a wide range URIs and LRTIs 
occurring in adults and infants. These viruses are considered as the third etiological cause of 
bronchiolitis in young infants aged 1-12 months. Moreover, several clinical case studies 
reported the etiological role of the Cox A16, the ENTV 71 and of a newly discovered 
genotype ENTV-104 in the development of acute or fatal pneumonia indicating that ENTVs 
belonging to species A to C can be responsible for severe LRTIs in immunocompetent 
infants or adults. Taking into account the recent epidemiological and clinical data and 
because of frequent mutations and intra-species enteroviral RNA genomic recombination 
events, the respiratory strains of ENTV are considered also as potential agents of emerging 
infectious diseases in human populations [21]. There are three types of INFV: A, B, and C. 
Only INF A viruses are further classified by subtype on the basis of the two main surface 
glycoproteins HA and NA. INF type A viruses can infect people, birds, pigs, horses, and 
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other animals, but wild birds are the natural hosts for these viruses. INF viruses type A are 
divided into subtypes and named on the basis of two proteins on the surface of the virus: 
HA and NA. There are 16 known HA subtypes and 9 known NA subtypes and many 
different combinations of HA and NA proteins are possible. Only some INF A subtypes (i.e., 
H1N1, H1N2, and H3N2) are currently in general circulation among people, other subtypes 
are found most commonly in other animal species. For example, H7N7 and H3N8 viruses 
cause illness in horses, and H3N8 also has recently been shown to cause illness in dogs. 
Only INF A viruses infect birds, and all known subtypes of INF A viruses can infect birds. 
Typically, wild birds do not become sick when they are infected with avian INF A viruses, 
however, domestic poultry, such as turkeys and chickens, can become very sick and die 
from avian flu, and some avian INF A viruses also can cause serious disease and death in 
wild birds. Highly pathogenic avian INF A virus strains (HPAI) can cause severe illness and 
high mortality in poultry. More recently, some HPAI viruses (e.g., H5N1) have been found 
to cause no illness in some poultry, such as ducks. Avian INF A viruses of the subtypes H5 
and H7,including H5N1, H7N7, and H7N3 viruses, have been associated with HPAI, and 
human infection with these viruses have ranged from mild (H7N3, H7N7) to severe and 
fatal disease (H7N7, H5N1). In general, direct human infection with avian INFVs occurs 
very infrequently, and has been associated with direct contact (e.g., touching) infected sick 
or dead infected birds (domestic poultry). INF B viruses are usually found only in humans. 
Unlike INF A viruses, these viruses are not classified according to subtype. INF B viruses 
can cause morbidity and mortality among humans, but in general are associated with less 
severe epidemics than INF A viruses. Although INF type B viruses can cause human 
epidemics, they have not caused pandemics. INF C viruses cause mild illness in humans 
and do not cause epidemics or pandemics. These viruses are not classified according to 
subtype [22]. 
HMPV is a respiratory viral pathogen that causes a spectrum of illnesses that range from 
asymptomatic infection to severe bronchiolitis. In 2001, van den Hoogen et al described the 
identification of this new human viral pathogen from respiratory samples submitted for 
viral culture during the winter season. Half of the initial 28 hMPV isolates were cultured 
from patients younger than 1 year, and 96% were isolated from children younger than 6 
years. Seroprevalence studies revealed that 25% of all children aged 6-12 months who were 
tested in the Netherlands had detectable antibodies to hMPV; by age 5 years, 100% of 
patients showed evidence of past infection. Separate reports from all areas of the world 
support the early contention that this newly discovered virus is ubiquitous, and, like human 
respiratory RSV infection, is seasonal in nature. Although the description of this viral 
pathogen was first described in children, subsequent reports have highlighted the 
importance of hMPV as a cause of respiratory illness in adults of all ages in patients with 
cancer, in the elderly population (as a cause of serious LRTI), and in adults with underlying 
chronic medical conditions [23]. Human parainfluenza viruses (hPIV) belong to the 
Paramyxoviridae family and are negative-sense, single-stranded RNA viruses that show 
fusion and hemagglutinin-neuraminidase glycoprotein "spikes" on their surface. There are  
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are found most commonly in other animal species. For example, H7N7 and H3N8 viruses 
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Only INF A viruses infect birds, and all known subtypes of INF A viruses can infect birds. 
Typically, wild birds do not become sick when they are infected with avian INF A viruses, 
however, domestic poultry, such as turkeys and chickens, can become very sick and die 
from avian flu, and some avian INF A viruses also can cause serious disease and death in 
wild birds. Highly pathogenic avian INF A virus strains (HPAI) can cause severe illness and 
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to cause no illness in some poultry, such as ducks. Avian INF A viruses of the subtypes H5 
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four serotypes (1 through 4) and two subtypes (4a and 4b) that show different clinical and 
epidemiologic features. The virion varies in size (average diameter between 150 and 200 
nm) and shape, is unstable in the environment (surviving a few hours on environmental 
surfaces), and is readily inactivated with soap and water. HPIV are common causes of RTIs 
in infants and young children; the most distinctive clinical feature of HPIV-1 and HPIV-2 is 
croup (i.e., laryngotracheobronchitis or swelling around the vocal chords and other parts of 
the upper and middle airway); HPIV-1 is the leading cause of croup in children, whereas 
HPIV-2 is less frequently detected. HPIV-3 is more often associated with bronchiolitis 
(swelling of the small airways leading to the lungs) and pneumonia. HPIV-4 is detected 
infrequently, and is less likely to cause severe disease; but it may be more common than 
once thought. HPIVs can cause repeated infections with all serotypes throughout life. 
Reinfections usually manifested by an upper respiratory tract illness (e.g., a cold, sore 
throat). HPIVs can also cause serious LRTIs with repeat infection (e.g., pneumonia, 
bronchitis, and bronchiolitis), especially among older adults and patients with 
compromised immune systems. The incubation period (time from exposure to the virus to 
onset of symptoms) for HPIVs generally ranges from 2 to 7 days [24]. RVs are small (30 
nm), nonenveloped viruses that contain a single-strand RNA genome within an 
icosahedral (20-sided) capsid, that RV can be transmitted by aerosol or direct contact. The 
nasal mucosa is the primary site of onculation, although the conjunctiva may also be 
involved, though to a lesser extent. RVs attache their selves to the respiratory epithelium 
and spreads locally. The optimum temperature for RVs repolication is 33-35°C and so does 
not replicate efficiently at body temperature. This could be the major reason why RVs 
replicate well in the nasal passages and upper trachebronchial tree but not so well in the 
lower respiratory tract. RVs are well known for causing the common cold, although they 
have also been implicated in causing bronchitis and asthma attacks. There is little or no 
cross-protection between serotypes, making it very difficult to make vaccines. These 
viruses seems to affect children first, and then there are many modes of transmission that 
range from aerosol to direct hand-to-hand contact [25]. RSV, is a respiratory virus negative-
sense, single-stranded RNA of the family Paramyxoviridae that infects the lungs and 
breathing passages. Most otherwise healthy people recover from RSV infection in 1 to 2 
peeks. However, infection can be severe in some people, such as certain infants, young 
children, and older adults. In fact, RSV is the most common cause of bronchiolitis 
(inflammation of the small airways in the lung) and pneumonia in children under 1 year of 
age in the United States. In addition, RSV is more often being recognized as an important 
cause of respiratory illness in older adults. Initially isolated RSV from chimpanzees with 
URI as the causative agent of most epidemic bronchiolitis cases. Subsequently, RSV has 
been associated LRTIs infection in infants and multiple epidemiologic studies have 
confirmed the role of this virus as the leading cause of LRT infection in infants and young 
children. Peak of incidence of occurrence of severe RSV disease is observed at age 2-8 
months. Overall, 4-5 million children younger than 4 years acquire an RSV infection, and 
more than 125,000 children are hospitalized annually in the United States because of this 
infection. This translates to 3-9 per 1000 children younger than 1 year who are hospitalized 
annually for this condition. Virtually all children have had at least one RSV infection by 
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their third birthday. The WHO has targeted RSV for vaccine development, which is not 
surprising, given the prevalence and potential severity of this condition [26]. Other less 
common cause of viral URI is Herpes simplex virus (HSV).  
Table 1 resumes viral cusative agents of Respiratory Tract Infection (RTIs). 
Virus group Antigenic types RTIs
Rhinoviruses 100 types and  
1 subtypes 
Common Cold, Pharyngitis, Acute Laryngitis, 
Sinusitis, Acute Bronchitis, Bronchiolitis, Acute 
Pneumonia 




4 types Common Cold, Pharyngitis, Acute Laryngitis, Acute 
Laryngotracheobronchitis (Croup), Sinusitis, Acute 
Bronchitis, Bronchiolitis, Acute Pneumonia 
Respiratory 
Syncytial virus 
2 types Common Cold, Acute Laryngotracheobronchitis 
(Croup), Acute Bronchitis, Bronchiolitis, Acute 
Pneumonia 
Influenza viruses 3 types Common Cold, Pharyngitis, Acute Laryngitis, Acute 
Laryngotracheobronchitis (Croup), Sinusitis, Acute 
Bronchitis, Bronchiolitis, Acute Pneumonia 
Adenoviruses 47 types Common Cold, Pharyngitis, Acute Laryngitis, 




 Common Cold, , Acute Laryngitis, Bronchiolitis, 
Acute Pneumonia 
Rubeola virus  Common Cold, Acute Bronchitis, Acute Pneumonia 
Enteroviruses 5 types Common cold, Pharyngitis, Acute Bronchitis, 
Bronchiolitis, Acute Pneumonia 
Rubella virus  Common cold, , Acute Bronchitis 
Varicella Zooster 
virus 




2 types Pharyngitis, Epiglottitis, Oral cavity Infections, 
Acute Pneumonia 





1 type Pharyngitis 
Epstein Barr virus  Epiglottitis 
Human herpes  
virus 6 
 Acute Pneumonia 
Table 1. Viral cusative agents of Respiratory Tract Infection (RTIs) 
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four serotypes (1 through 4) and two subtypes (4a and 4b) that show different clinical and 
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their third birthday. The WHO has targeted RSV for vaccine development, which is not 
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common cause of viral URI is Herpes simplex virus (HSV).  
Table 1 resumes viral cusative agents of Respiratory Tract Infection (RTIs). 
Virus group Antigenic types RTIs
Rhinoviruses 100 types and  
1 subtypes 
Common Cold, Pharyngitis, Acute Laryngitis, 
Sinusitis, Acute Bronchitis, Bronchiolitis, Acute 
Pneumonia 




4 types Common Cold, Pharyngitis, Acute Laryngitis, Acute 
Laryngotracheobronchitis (Croup), Sinusitis, Acute 
Bronchitis, Bronchiolitis, Acute Pneumonia 
Respiratory 
Syncytial virus 
2 types Common Cold, Acute Laryngotracheobronchitis 
(Croup), Acute Bronchitis, Bronchiolitis, Acute 
Pneumonia 
Influenza viruses 3 types Common Cold, Pharyngitis, Acute Laryngitis, Acute 
Laryngotracheobronchitis (Croup), Sinusitis, Acute 
Bronchitis, Bronchiolitis, Acute Pneumonia 
Adenoviruses 47 types Common Cold, Pharyngitis, Acute Laryngitis, 




 Common Cold, , Acute Laryngitis, Bronchiolitis, 
Acute Pneumonia 
Rubeola virus  Common Cold, Acute Bronchitis, Acute Pneumonia 
Enteroviruses 5 types Common cold, Pharyngitis, Acute Bronchitis, 
Bronchiolitis, Acute Pneumonia 
Rubella virus  Common cold, , Acute Bronchitis 
Varicella Zooster 
virus 




2 types Pharyngitis, Epiglottitis, Oral cavity Infections, 
Acute Pneumonia 





1 type Pharyngitis 
Epstein Barr virus  Epiglottitis 
Human herpes  
virus 6 
 Acute Pneumonia 
Table 1. Viral cusative agents of Respiratory Tract Infection (RTIs) 
 
Biomedical Tissue Culture 
 
230 
The relative importance of individual viral agents in early life is open to debate. Certainly, 
RSV, RV, PIV, and INFV are predominant in the published data. However there are several 
factors limiting the ability to draw a definitive conclusion about which virus is the most 
common or important: differences in the way that data are collected (PCR versus 
immunoassay) between and within studies and the impact of assay sensitivity; differences in 
study design affecting age, recruitment criteria, and which viruses are studied. About viral 
aetiology and infant hospitalization due to respiratory infection, INFVs, ADV, hMPV, PIV, 
RVs, and RSV can all cause bronchiolitis, necessitating hospitalization; RSV has most 
commonly been reported to be the main cause of hospitalization due to bronchiolitis and 
increased disease severity, followed by RV and then by influenza virus and viral coinfection 
is relatively common, occurring in about 20% of cases. Even there is no consensus on the 
effect of coinfection on disease severity, coinfection with both hMPV and RSV increased the 
intensive care unit admission rate. While knowledge of which virus is predominant is 
relevant for the design of vaccines and specific prophylactic treatments, what can be 
observed is the similarity of symptoms caused by a wide range of viral agents. It may 
therefore be more appropriate to focus on ways to target the symptoms and not the agent. 
This may be especially relevant when an excess immune response causes the disease or 
when there are multiple serologically distinct subtypes circulating.  
3. Diagnosis of viral RTIs 
Respiratory viruses, that belong to several taxonomic families, show overlapping clinical 
signs and symptoms. In clinical practice, a specific virus is often not identified due to the 
lack of sensitive tests and/or the presence of as-yet-unknown pathogens [27]. Because of the 
great variety of possible pathogenic agents involved, and because of the high frequency of 
coinfections, especially among young children, whose immune system is still developing, it 
is mandatory to use diagnostic methods that allow multiple, sensitive, efficacious and rapid 
identification of all possible viruses simultaneously possibly present in the clinical sample 
[27]. Respiratory viruses have become increasingly recognized as serious causes of 
morbidity and mortality in immunocompromised patients. Rapid and sensitive detection of 
respiratory viruses is essential for early diagnosis and administration of appropriate 
antiviral therapy as well as for effective implementation of infection control measures. 
Rapid diagnosis of respiratory viruses can enable: 
- To establish a direct antiviral therapy, when available, that is crucial considering that 
antivirals are only effective if administered in the early stages of infection ;  
- To abolish unnecessary use of antibiotics, that are often prescribed to patients infected 
with respiratory viruses, with the result in no relief from symptoms and likelihood that 
antibiotic resistance will occur in concomitant bacteria ; 
- To understand the viral natural history and pathophysiology, which may allow 
physicians to better understand potential complications[28]; 
- To implement appropriate personal protective equipment and measures, such as 
quarantine of infected patients, to minimize spread and prevention of unnecessary 
isolation (often at great expense) of uninfected individuals; particularly important with 
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newly emerging or re-emerging pathogens, including severe acute respiratory 
syndrome caused by CoV, highly pathogenic avian INF and swine-origin INFV H1N1 
(S-OIV H1N1) [29]; 
- To perform accurate epidemiological studies, that allow clinicians to identify 
populations at risk and determine which populations should consider vaccination (if a 
suitable vaccine is available);  
- finally, to implement rapid viral diagnosis that significantly decreases length of hospital 
stay and unnecessary laboratory testing [30].  
However, even with the best viral detection assays currently available, a specific pathogen 
cannot be identified in 20% to 50% of RTIss. Existing viral diagnostic methods are limited in 
sensitivity and scope [31]. Several works suggest that respiratory viruses are 
underdiagnosed and they might be responsible for a considerable part of the total number 
of non characterized acquired pneumonia cases [32, 33, 34, 35, 36]. Traditional diagnostics 
methods besides being too slow, laborious and with a low sensitivity threshold, do not 
identify common viruses and high incidence viruses, like RV, or new viruses, like CoV. 
Emerging viruses like MetV or BoV recently discovered and with a very high clinical 
incidence, especially among children, are not detected neither with the use of traditional 
techniques nor with more modern methods of molecular diagnostics[37]. The discovery of 
respiratory viruses occurred initially between 1933 and 1965 when INFV, ENTV, ADV, RSV, 
RV, PINV and CoV were found by virus culture. In the 1990s, the development of high 
throughput viral detection and diagnostics instruments increased diagnostic sensitivity and 
enabled the search and the discover also of new viruses [38]. Since many respiratory viruses 
can present with similar signs and symptoms, it is impossible to differentiate one virus 
infection from another clinically. The clinician therefore relies on the laboratory to identify 
the virus. Many clinicians commonly diagnose patients syndromically with influenza or 
influenza-like illness without laboratory identification of a virus. The positive predictive 
value (PPV) of a clinical diagnosis of influenza virus infection in an adult case ranged from 
18% to 87% compared with cases of laboratory-confirmed influenza virus infection. During 
periods of high INF virus activity, a clinical diagnosis based on acute onset of high fever and 
cough can be highly predictive of influenza (PPV, 79% to 87%; negative predictive value 
[NPV], 39% to 75%). The consequences of not identifying INF virus in a nursing home or on 
a hospital ward could be catastrophic. INFVs outbreaks in a hospital can be devastating 
given the wide range of immunocompromised patients (cancer patients and transplant 
recipients) that are highly susceptible to life-threatening influenza virus infection. In either 
setting, specific antiviral agents such as M2 channel inhibitors (amantidine and rimantidine) 
or NA inhibitors (oseltamivir and zanamavir) can be prescribed; however, these drugs are 
effective only when given within the first 24 h following infection. The traditional methods 
by which respiratory viruses are routinely diagnosed: virus culture, serology, 
immunofluorescence/antigen detection, and nucleic acid/PCR-based tests. The gold 
standard for the diagnosis of respiratory virus infections, virus isolation by culture, takes 
days to weeks (shell vial assays are not available for the diagnostics of all respiratory 
viruses), and many new viruses remain unculturable [39]. Virus culture consists in infecting 
cell lines with clinical samples; virus isolation is performed using three or four cell lines and, 
together with embryonated hen eggs for INFV, provides the means for isolating respiratory  
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The relative importance of individual viral agents in early life is open to debate. Certainly, 
RSV, RV, PIV, and INFV are predominant in the published data. However there are several 
factors limiting the ability to draw a definitive conclusion about which virus is the most 
common or important: differences in the way that data are collected (PCR versus 
immunoassay) between and within studies and the impact of assay sensitivity; differences in 
study design affecting age, recruitment criteria, and which viruses are studied. About viral 
aetiology and infant hospitalization due to respiratory infection, INFVs, ADV, hMPV, PIV, 
RVs, and RSV can all cause bronchiolitis, necessitating hospitalization; RSV has most 
commonly been reported to be the main cause of hospitalization due to bronchiolitis and 
increased disease severity, followed by RV and then by influenza virus and viral coinfection 
is relatively common, occurring in about 20% of cases. Even there is no consensus on the 
effect of coinfection on disease severity, coinfection with both hMPV and RSV increased the 
intensive care unit admission rate. While knowledge of which virus is predominant is 
relevant for the design of vaccines and specific prophylactic treatments, what can be 
observed is the similarity of symptoms caused by a wide range of viral agents. It may 
therefore be more appropriate to focus on ways to target the symptoms and not the agent. 
This may be especially relevant when an excess immune response causes the disease or 
when there are multiple serologically distinct subtypes circulating.  
3. Diagnosis of viral RTIs 
Respiratory viruses, that belong to several taxonomic families, show overlapping clinical 
signs and symptoms. In clinical practice, a specific virus is often not identified due to the 
lack of sensitive tests and/or the presence of as-yet-unknown pathogens [27]. Because of the 
great variety of possible pathogenic agents involved, and because of the high frequency of 
coinfections, especially among young children, whose immune system is still developing, it 
is mandatory to use diagnostic methods that allow multiple, sensitive, efficacious and rapid 
identification of all possible viruses simultaneously possibly present in the clinical sample 
[27]. Respiratory viruses have become increasingly recognized as serious causes of 
morbidity and mortality in immunocompromised patients. Rapid and sensitive detection of 
respiratory viruses is essential for early diagnosis and administration of appropriate 
antiviral therapy as well as for effective implementation of infection control measures. 
Rapid diagnosis of respiratory viruses can enable: 
- To establish a direct antiviral therapy, when available, that is crucial considering that 
antivirals are only effective if administered in the early stages of infection ;  
- To abolish unnecessary use of antibiotics, that are often prescribed to patients infected 
with respiratory viruses, with the result in no relief from symptoms and likelihood that 
antibiotic resistance will occur in concomitant bacteria ; 
- To understand the viral natural history and pathophysiology, which may allow 
physicians to better understand potential complications[28]; 
- To implement appropriate personal protective equipment and measures, such as 
quarantine of infected patients, to minimize spread and prevention of unnecessary 
isolation (often at great expense) of uninfected individuals; particularly important with 
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newly emerging or re-emerging pathogens, including severe acute respiratory 
syndrome caused by CoV, highly pathogenic avian INF and swine-origin INFV H1N1 
(S-OIV H1N1) [29]; 
- To perform accurate epidemiological studies, that allow clinicians to identify 
populations at risk and determine which populations should consider vaccination (if a 
suitable vaccine is available);  
- finally, to implement rapid viral diagnosis that significantly decreases length of hospital 
stay and unnecessary laboratory testing [30].  
However, even with the best viral detection assays currently available, a specific pathogen 
cannot be identified in 20% to 50% of RTIss. Existing viral diagnostic methods are limited in 
sensitivity and scope [31]. Several works suggest that respiratory viruses are 
underdiagnosed and they might be responsible for a considerable part of the total number 
of non characterized acquired pneumonia cases [32, 33, 34, 35, 36]. Traditional diagnostics 
methods besides being too slow, laborious and with a low sensitivity threshold, do not 
identify common viruses and high incidence viruses, like RV, or new viruses, like CoV. 
Emerging viruses like MetV or BoV recently discovered and with a very high clinical 
incidence, especially among children, are not detected neither with the use of traditional 
techniques nor with more modern methods of molecular diagnostics[37]. The discovery of 
respiratory viruses occurred initially between 1933 and 1965 when INFV, ENTV, ADV, RSV, 
RV, PINV and CoV were found by virus culture. In the 1990s, the development of high 
throughput viral detection and diagnostics instruments increased diagnostic sensitivity and 
enabled the search and the discover also of new viruses [38]. Since many respiratory viruses 
can present with similar signs and symptoms, it is impossible to differentiate one virus 
infection from another clinically. The clinician therefore relies on the laboratory to identify 
the virus. Many clinicians commonly diagnose patients syndromically with influenza or 
influenza-like illness without laboratory identification of a virus. The positive predictive 
value (PPV) of a clinical diagnosis of influenza virus infection in an adult case ranged from 
18% to 87% compared with cases of laboratory-confirmed influenza virus infection. During 
periods of high INF virus activity, a clinical diagnosis based on acute onset of high fever and 
cough can be highly predictive of influenza (PPV, 79% to 87%; negative predictive value 
[NPV], 39% to 75%). The consequences of not identifying INF virus in a nursing home or on 
a hospital ward could be catastrophic. INFVs outbreaks in a hospital can be devastating 
given the wide range of immunocompromised patients (cancer patients and transplant 
recipients) that are highly susceptible to life-threatening influenza virus infection. In either 
setting, specific antiviral agents such as M2 channel inhibitors (amantidine and rimantidine) 
or NA inhibitors (oseltamivir and zanamavir) can be prescribed; however, these drugs are 
effective only when given within the first 24 h following infection. The traditional methods 
by which respiratory viruses are routinely diagnosed: virus culture, serology, 
immunofluorescence/antigen detection, and nucleic acid/PCR-based tests. The gold 
standard for the diagnosis of respiratory virus infections, virus isolation by culture, takes 
days to weeks (shell vial assays are not available for the diagnostics of all respiratory 
viruses), and many new viruses remain unculturable [39]. Virus culture consists in infecting 
cell lines with clinical samples; virus isolation is performed using three or four cell lines and, 
together with embryonated hen eggs for INFV, provides the means for isolating respiratory  
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viruses. Tissue cultures can take up to 15 days, therefore, the infection can often be resolved 
before the infectious agent is defined. Shell vial culture (SVC), first described in the early 
1990s for murine Cytomegalovirus (CMV) is a modification of the conventional cell culture 
technique for rapid detection of viruses in vitro that involves inoculation of the clinical 
specimen on to cell monolayer grown on a cover slip in a shell vial culture tube, followed by 
low speed centrifugation and incubation. In this system the low speed centrifugation 
enhances viral infectivity to the susceptible cells because it produces a minor trauma to the 
cell surface by the low speed centrifugation mechanical force and enhances the viral entry in 
to the cells, reducing the total time taken for the virus to produce infection of cells. Shell vials 
of R-Mix, a combination of mink lung cells and human adenocarcinoma cells (strains Mv1Lu 
and A549) enable the detection of respiratory viruses from prospective clinical respiratory 
specimens [40]. The rapidity of the technique without any compromise on sensitivity has 
made SVC very popular in the field of clinical virology [41]. SVC as traditional cell culture 
assay requires specific technical and manual skills and is performed only in specialized 
laboratories. Isolation in cell culture, with the traditional method or the SVC assay is time 
consuming and have low sensitivity, but it is still considered the gold standard for the 
diagnosis of viral infections because molecular methods may not necessarily indicate that the 
virus is causing disease, viral RNA has been detected in asymptomatic children and during 
viral persistence. For these reasons traditional cell culture and SVC assay are still routinely 
used diagnostically and have a predominant role in epidemiological studies, are used to 
follow the course of an infection. A variety of serological tests including the 
hemagglutination inhibition (HAI) test, complement fixation, and enzyme immunoassay 
(EIA) are used for testing paired acute- and convalescent-phase sera for diagnosing 
infections, and in the case of INFV, HAI is able to subtype the virus as being H1 or H3 virus. 
EIAs was introduced in the 1980s and 1990s, lacks in sensitivity and is usually relegated to 
point-of-care testing in defined settings. CFT and haeagglutination-inhibition HAI techniques 
are usually used for serology. Any serological diagnosis is going to be retrospective because 
the antibody response to a viral infection can take 2 weeks to develop, but serological tests as 
cell culture assays are used in epidemiological studies. Serology assays that test blood 
samples for either virus-specific antibodies or viral antigen by a functional assay are labor-
intensive and slow to produce results. Direct fluorescent antibody (DFA) staining of cells 
derived from nasopharyngeal swabs or nasopharyngeal aspirates (NPA) became the 
mainstay for many laboratories and provide a rapid test result in about 3 h. Direct fluorescent 
antibody (DFA) but suffers from low sensitivity and is available for only a limited number of 
respiratory viruses [42]. Molecular tests are more sensitive than other diagnostic approaches, 
including virus isolation in cell culture, SVC), DFA staining, and EIA, and now form the 
backbone of clinical virology laboratory testing around the world. The polymerase chain 
reaction (PCR) is a scientific technique in molecular biology to amplify a single or a few 
copies of a piece of DNA or cDNA across several orders of magnitude, generating thousands 
to millions of copies of a particular sequences. Reverse transcription-PCR (RT-PCR), that 
produces a cDNA template from an RNA template and amplify the cDNA target is a highly 
sensitive method for diagnosis of viral infection and has been used successfully in children 
with RSV. This method was found to be 100-fold more sensitive than single-round PCR and 
was capable of detecting 0.05 PFU of tissue culture-passaged virus. Multiplex polymerase 
chain reaction (PCR) assays introduced in the last ten years to avoid separate amplifications 
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of the viruses under investigation that are resource intensive, time consuming and labor 
intensive and can detect up to 19 different viruses in a single test using numerous primer 
couples that have the same annealig temperature. Several multiplex PCR tests are now 
commercially available and tests are working their way into clinical laboratories, but the 
majority of the multiplex PCR assays have not included recently discovered respiratory 
pathogens and require validation of results by post PCR hybridization or semi/nested PCR 
which make the assay cost ineffective and increases chances of cross contamination. The 
appearance of eight new respiratory viruses, including the SARS CoV in 2003 and swine-
origin INF A/H1N1 in 2009, in the human population in the past nine years has tested the 
ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic 
acid amplification procedures including PCR, nucleic acid sequence-based amplification 
(NASBA), and loop-mediated isothermal amplification (LAMP) were developed for most 
respiratory viruses by the end of the decade, and today, these highly sensitive NAATs are 
used in the routine clinical laboratory for detecting respiratory viruses. The profile of viruses 
detected in RTIs is changing due to the increasing use of nucleic acid-based diagnostic 
screens and the discovery of newly isolated viruses. Knowledge of the infecting agent does 
not routinely alter treatment except insofar as a positive viral identification will reduce the 
inappropriate use of antibiotics and may allow the cohorting of patients to reduce nosocomial 
infection. Several “new” viruses have been characterized, in part triggered by especially RT-
PCR. Recently isolated respiratory viral agents include human hMPV, found in samples from 
children with RSV-like bronchiolitis who were RSV negative; hBoV, discovered by a random 
PCR screen of respiratory tract samples; and two new polyomaviruses, WU and KI. The 
discovery of new agents of infection is important because they may play a role as coinfecting 
agents, altering disease severity. Newly discovered viruses may also be important in future 
outbreaks; for example, the severe acute respiratory syndrome (SARS) caused by a CoV [43]. 
Polymerase chain reaction (PCR) testing is rapid and highly sensitive. At times it seems that it 
has supplanted culture isolation as a new gold standard for the detection of respiratory 
viruses in a research setting. However, most PCR tests target only 1 virus at a time, making 
these assays cumbersome when screening a clinical specimen for all viruses that have a PCR 
test available. Moreover, reliable PCR assay need to be developed to detect or identify novel 
viruses. Molecular technology has better sensitivity and the development of multiplex 
amplifications makes it possible to detect a broader panel of viruses. ADV, PIV, hCoV, BoV 
can now be detected by multiplex assays. These assays are based on different types of 
technology, such as ligation-dependent probe amplification (MLPA1), dual priming 
oligonucleotide (DPO) technology, target specific primer extension (TSPE), or target-specific 
extension (TSE). For the simultaneous detection of up to 20 viruses, a number of multiplex 
PCR assays have been proposed [44, 45, 46, 47, 48]. It is believed that PCR has replaced tissue 
culture and serology as the gold standard for the detection of respiratory viruses owing to its 
speed, availability and versatility. Even if molecular detection has many proven advantages 
over standard virological methods, tissue culture remains an important method for detecting 
novel viral mutations within a virus population, for the detection of novel viruses and for 
phenotypic characterization of viral isolates [48]. Recently, DNA microarray testing has 
emerged as a promising new technology for broad-spectrum virus detection [49, 50, 51]. 
Panviral DNA microarrays represent the most robust approach for massively parallel viral 
surveillance and detection. The Virochip (Virochip; University of California San Francisco 
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viruses. Tissue cultures can take up to 15 days, therefore, the infection can often be resolved 
before the infectious agent is defined. Shell vial culture (SVC), first described in the early 
1990s for murine Cytomegalovirus (CMV) is a modification of the conventional cell culture 
technique for rapid detection of viruses in vitro that involves inoculation of the clinical 
specimen on to cell monolayer grown on a cover slip in a shell vial culture tube, followed by 
low speed centrifugation and incubation. In this system the low speed centrifugation 
enhances viral infectivity to the susceptible cells because it produces a minor trauma to the 
cell surface by the low speed centrifugation mechanical force and enhances the viral entry in 
to the cells, reducing the total time taken for the virus to produce infection of cells. Shell vials 
of R-Mix, a combination of mink lung cells and human adenocarcinoma cells (strains Mv1Lu 
and A549) enable the detection of respiratory viruses from prospective clinical respiratory 
specimens [40]. The rapidity of the technique without any compromise on sensitivity has 
made SVC very popular in the field of clinical virology [41]. SVC as traditional cell culture 
assay requires specific technical and manual skills and is performed only in specialized 
laboratories. Isolation in cell culture, with the traditional method or the SVC assay is time 
consuming and have low sensitivity, but it is still considered the gold standard for the 
diagnosis of viral infections because molecular methods may not necessarily indicate that the 
virus is causing disease, viral RNA has been detected in asymptomatic children and during 
viral persistence. For these reasons traditional cell culture and SVC assay are still routinely 
used diagnostically and have a predominant role in epidemiological studies, are used to 
follow the course of an infection. A variety of serological tests including the 
hemagglutination inhibition (HAI) test, complement fixation, and enzyme immunoassay 
(EIA) are used for testing paired acute- and convalescent-phase sera for diagnosing 
infections, and in the case of INFV, HAI is able to subtype the virus as being H1 or H3 virus. 
EIAs was introduced in the 1980s and 1990s, lacks in sensitivity and is usually relegated to 
point-of-care testing in defined settings. CFT and haeagglutination-inhibition HAI techniques 
are usually used for serology. Any serological diagnosis is going to be retrospective because 
the antibody response to a viral infection can take 2 weeks to develop, but serological tests as 
cell culture assays are used in epidemiological studies. Serology assays that test blood 
samples for either virus-specific antibodies or viral antigen by a functional assay are labor-
intensive and slow to produce results. Direct fluorescent antibody (DFA) staining of cells 
derived from nasopharyngeal swabs or nasopharyngeal aspirates (NPA) became the 
mainstay for many laboratories and provide a rapid test result in about 3 h. Direct fluorescent 
antibody (DFA) but suffers from low sensitivity and is available for only a limited number of 
respiratory viruses [42]. Molecular tests are more sensitive than other diagnostic approaches, 
including virus isolation in cell culture, SVC), DFA staining, and EIA, and now form the 
backbone of clinical virology laboratory testing around the world. The polymerase chain 
reaction (PCR) is a scientific technique in molecular biology to amplify a single or a few 
copies of a piece of DNA or cDNA across several orders of magnitude, generating thousands 
to millions of copies of a particular sequences. Reverse transcription-PCR (RT-PCR), that 
produces a cDNA template from an RNA template and amplify the cDNA target is a highly 
sensitive method for diagnosis of viral infection and has been used successfully in children 
with RSV. This method was found to be 100-fold more sensitive than single-round PCR and 
was capable of detecting 0.05 PFU of tissue culture-passaged virus. Multiplex polymerase 
chain reaction (PCR) assays introduced in the last ten years to avoid separate amplifications 
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of the viruses under investigation that are resource intensive, time consuming and labor 
intensive and can detect up to 19 different viruses in a single test using numerous primer 
couples that have the same annealig temperature. Several multiplex PCR tests are now 
commercially available and tests are working their way into clinical laboratories, but the 
majority of the multiplex PCR assays have not included recently discovered respiratory 
pathogens and require validation of results by post PCR hybridization or semi/nested PCR 
which make the assay cost ineffective and increases chances of cross contamination. The 
appearance of eight new respiratory viruses, including the SARS CoV in 2003 and swine-
origin INF A/H1N1 in 2009, in the human population in the past nine years has tested the 
ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic 
acid amplification procedures including PCR, nucleic acid sequence-based amplification 
(NASBA), and loop-mediated isothermal amplification (LAMP) were developed for most 
respiratory viruses by the end of the decade, and today, these highly sensitive NAATs are 
used in the routine clinical laboratory for detecting respiratory viruses. The profile of viruses 
detected in RTIs is changing due to the increasing use of nucleic acid-based diagnostic 
screens and the discovery of newly isolated viruses. Knowledge of the infecting agent does 
not routinely alter treatment except insofar as a positive viral identification will reduce the 
inappropriate use of antibiotics and may allow the cohorting of patients to reduce nosocomial 
infection. Several “new” viruses have been characterized, in part triggered by especially RT-
PCR. Recently isolated respiratory viral agents include human hMPV, found in samples from 
children with RSV-like bronchiolitis who were RSV negative; hBoV, discovered by a random 
PCR screen of respiratory tract samples; and two new polyomaviruses, WU and KI. The 
discovery of new agents of infection is important because they may play a role as coinfecting 
agents, altering disease severity. Newly discovered viruses may also be important in future 
outbreaks; for example, the severe acute respiratory syndrome (SARS) caused by a CoV [43]. 
Polymerase chain reaction (PCR) testing is rapid and highly sensitive. At times it seems that it 
has supplanted culture isolation as a new gold standard for the detection of respiratory 
viruses in a research setting. However, most PCR tests target only 1 virus at a time, making 
these assays cumbersome when screening a clinical specimen for all viruses that have a PCR 
test available. Moreover, reliable PCR assay need to be developed to detect or identify novel 
viruses. Molecular technology has better sensitivity and the development of multiplex 
amplifications makes it possible to detect a broader panel of viruses. ADV, PIV, hCoV, BoV 
can now be detected by multiplex assays. These assays are based on different types of 
technology, such as ligation-dependent probe amplification (MLPA1), dual priming 
oligonucleotide (DPO) technology, target specific primer extension (TSPE), or target-specific 
extension (TSE). For the simultaneous detection of up to 20 viruses, a number of multiplex 
PCR assays have been proposed [44, 45, 46, 47, 48]. It is believed that PCR has replaced tissue 
culture and serology as the gold standard for the detection of respiratory viruses owing to its 
speed, availability and versatility. Even if molecular detection has many proven advantages 
over standard virological methods, tissue culture remains an important method for detecting 
novel viral mutations within a virus population, for the detection of novel viruses and for 
phenotypic characterization of viral isolates [48]. Recently, DNA microarray testing has 
emerged as a promising new technology for broad-spectrum virus detection [49, 50, 51]. 
Panviral DNA microarrays represent the most robust approach for massively parallel viral 
surveillance and detection. The Virochip (Virochip; University of California San Francisco 
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[UCSF]) is a panviral DNA microarray capable of detecting all known viruses, as well as 
novel viruses related to known viral families in a single assay. The Virochip has been used to 
indentify SARS, Xenotropic murine leukemia virus-related (a novel Retrovirus) from patients 
with familial prostate cancer, and a novel clade of human RV [52]. The Virochip has also 
proven to be successful in a clinical veterinary setting by successfully identifying a novel CoV 
from a beluga whale held in an aquatic containment facility and by identifying foot-and-
mouth disease virus (FMDV) in ticks collected from a livestock market in Nairobi, Kenya. 
However, the usefulness and sensitivity of the Virochip platform have not been tested on 
clinical veterinary specimens [53]. In-house microarray platforms have been designed to 
detect all known viruses, as well as novel viruses related to known viral families (Virochip; 
University of California San Francisco [UCSF]). These Virochip consists of 22 000 
oligonucleotide probes representing all 1800 fully or partially sequenced viruses in GenBank 
as of Fall 2004 [54]. The performance of the Virochip in respiratory virus detection has been 
tested using virally infected tissue culture cells and in selected patient cohorts, and it 
demonstrated high sensitivity and specificity [55]. To date, the Virochip has not been 
compared directly with standard diagnostic tests for viruses in a clinical setting; thus, the 
Virochip has been compared with conventional clinical DFA- and PCR-based testing in the 
detection of respiratory viruses associated with RTIs in children [56]. We report In this study 
the analysis of 10 clinical samples from patients, with respiratory tract infection symptoms 
that resulted negative for Influenza A(H1N1)v infection, and 8 samples from Quality Control 
for Molecular Diagnostics (QCMD) with known viral load of types and subtypes of 17 
respiratory viruses, by the Clinical Array Technology (CLARTR) PneumoVir kit® (Geomica), 
a 120 spots array that make possible the specific identification of: INFV A, B and C; IPV 1, 2, 3 
and 4 (subtypes A and B); RSV type A (RSV-A) and type B (RSV-B); RV; MPV (subtypes A 
and B); ENT (Echovirus); ADV; CoV and BoV. An internal control is included, to assure that 
the amplification step is performed successfully and to avoid false negative results. We used 
a proprietary image processing software, installed in a reader (SAICLART®), that is able to 
detect and resolve the genotypes automatically, avoiding the subjectivity that may introduce 
the user interaction, and provide fast, accurate and reproducible results. All samples have 
been analyzed three times and all results have been confirmed by single virus RT PCR 
(Roche) and Light Cycler, Roche, detector. All viruses detected by PneumoVir kit in the 
analyzed samples have been confirmed by RT PCR (Roche), in some cases at a sensitivity 
level higher than what was declared from the manufacturer. We detected single infection 
with: RSVA, MPV A, Coronavirus 229. One coinfection of MPV A, RSV A, RSV B, one 
coinfection of Corona 229, IPV3, RSV A, and one coinfection of BoV, MPV A. Only in the 
sample with the coinfection Corona 229, IPV3, RSV A, the Real Time PCR did not confirm the 
presence of IPV3 genome. Therefore we believe that the CLART can readily detect respiratory 
viruses in various clinical respiratory samples (pharyngeal and nasal swabs, nasopharyngeal 
lavage, pharyngeal exudates). The signal intensity increased according to the viral titer. These 
data directly correlate sample viral titers with the successful detection by the CLART and 
highlight the importance of sensitivity when utilizing the Virochip platform in a clinical 
settings. The CLART positively identified respiratory viruses in the all QCMD samples 
randomly mixed demonstrating high specificity inside the range of the sensitivity of the 
method. Together, the data in this report demonstrate that the CLART can successfully detect 
respiratory viruses frequently found in human respiratory swabs. The ability of the CLART 
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to positively detect viruses with a high degree of genetic variance, as is found in the 
specimens tested here, is a benefit that may outweigh concerns regarding costs and 
turnaround time. Furthermore, the advantages in the technical effort, cost, and turnaround 
time involved in using the CLART as a viral discovery platform far exceed those of next-
generation sequencing platforms. In conclusion CLART provides, at very competitive cost, a 
system capable of detecting and identifying simultaneously several respiratory viruses, in 
clinical specimens with high sensitivity and specificity.  
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[UCSF]) is a panviral DNA microarray capable of detecting all known viruses, as well as 
novel viruses related to known viral families in a single assay. The Virochip has been used to 
indentify SARS, Xenotropic murine leukemia virus-related (a novel Retrovirus) from patients 
with familial prostate cancer, and a novel clade of human RV [52]. The Virochip has also 
proven to be successful in a clinical veterinary setting by successfully identifying a novel CoV 
from a beluga whale held in an aquatic containment facility and by identifying foot-and-
mouth disease virus (FMDV) in ticks collected from a livestock market in Nairobi, Kenya. 
However, the usefulness and sensitivity of the Virochip platform have not been tested on 
clinical veterinary specimens [53]. In-house microarray platforms have been designed to 
detect all known viruses, as well as novel viruses related to known viral families (Virochip; 
University of California San Francisco [UCSF]). These Virochip consists of 22 000 
oligonucleotide probes representing all 1800 fully or partially sequenced viruses in GenBank 
as of Fall 2004 [54]. The performance of the Virochip in respiratory virus detection has been 
tested using virally infected tissue culture cells and in selected patient cohorts, and it 
demonstrated high sensitivity and specificity [55]. To date, the Virochip has not been 
compared directly with standard diagnostic tests for viruses in a clinical setting; thus, the 
Virochip has been compared with conventional clinical DFA- and PCR-based testing in the 
detection of respiratory viruses associated with RTIs in children [56]. We report In this study 
the analysis of 10 clinical samples from patients, with respiratory tract infection symptoms 
that resulted negative for Influenza A(H1N1)v infection, and 8 samples from Quality Control 
for Molecular Diagnostics (QCMD) with known viral load of types and subtypes of 17 
respiratory viruses, by the Clinical Array Technology (CLARTR) PneumoVir kit® (Geomica), 
a 120 spots array that make possible the specific identification of: INFV A, B and C; IPV 1, 2, 3 
and 4 (subtypes A and B); RSV type A (RSV-A) and type B (RSV-B); RV; MPV (subtypes A 
and B); ENT (Echovirus); ADV; CoV and BoV. An internal control is included, to assure that 
the amplification step is performed successfully and to avoid false negative results. We used 
a proprietary image processing software, installed in a reader (SAICLART®), that is able to 
detect and resolve the genotypes automatically, avoiding the subjectivity that may introduce 
the user interaction, and provide fast, accurate and reproducible results. All samples have 
been analyzed three times and all results have been confirmed by single virus RT PCR 
(Roche) and Light Cycler, Roche, detector. All viruses detected by PneumoVir kit in the 
analyzed samples have been confirmed by RT PCR (Roche), in some cases at a sensitivity 
level higher than what was declared from the manufacturer. We detected single infection 
with: RSVA, MPV A, Coronavirus 229. One coinfection of MPV A, RSV A, RSV B, one 
coinfection of Corona 229, IPV3, RSV A, and one coinfection of BoV, MPV A. Only in the 
sample with the coinfection Corona 229, IPV3, RSV A, the Real Time PCR did not confirm the 
presence of IPV3 genome. Therefore we believe that the CLART can readily detect respiratory 
viruses in various clinical respiratory samples (pharyngeal and nasal swabs, nasopharyngeal 
lavage, pharyngeal exudates). The signal intensity increased according to the viral titer. These 
data directly correlate sample viral titers with the successful detection by the CLART and 
highlight the importance of sensitivity when utilizing the Virochip platform in a clinical 
settings. The CLART positively identified respiratory viruses in the all QCMD samples 
randomly mixed demonstrating high specificity inside the range of the sensitivity of the 
method. Together, the data in this report demonstrate that the CLART can successfully detect 
respiratory viruses frequently found in human respiratory swabs. The ability of the CLART 
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to positively detect viruses with a high degree of genetic variance, as is found in the 
specimens tested here, is a benefit that may outweigh concerns regarding costs and 
turnaround time. Furthermore, the advantages in the technical effort, cost, and turnaround 
time involved in using the CLART as a viral discovery platform far exceed those of next-
generation sequencing platforms. In conclusion CLART provides, at very competitive cost, a 
system capable of detecting and identifying simultaneously several respiratory viruses, in 
clinical specimens with high sensitivity and specificity.  
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